<http://www.inferico.com/kegg-cmpo.owl#inst32_KEGGMap_hsa05220_Abst_Gene_hsa_9846>&&hsa05220&GAB2; GRB2-associated binding protein 2; K08091 growth factor receptor bound protein 2-associated protein 2 
<http://www.inferico.com/kegg-cmpo.owl#inst22_KEGGMap_hsa04110_Abst_Gene_hsa_701>&RL&hsa04110&BUB1B, BUB1beta, BUBR1, Bub1A, MAD3L, MVA1, SSK1, hBUBR1; BUB1 mitotic checkpoint serine/threonine kinase B (EC:2.7.11.1); K06637 mitotic checkpoint serine/threonine-protein kinase BUB1 beta [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst110_KEGGMap_hsa04110_Abst_Gene_Group_Abst_Gene_hsa_6500_Abst_Gene_hsa_6502_Abst_Gene_hsa_8454_Abst_Gene_hsa_9978>&&hsa04110&
<http://www.inferico.com/kegg-cmpo.owl#inst34_KEGGMap_hsa04012_Abst_Gene_hsa_5609family>&&hsa04012&MAP2K4, JNKK, JNKK1, MAPKK4, MEK4, MKK4, PRKMK4, SAPKK-1, SAPKK1, SEK1, SERK1, SKK1; mitogen-activated protein kinase kinase 4 (EC:2.7.12.2); K04430 mitogen-activated protein kinase kinase 4 [EC:2.7.12.2] MAP2K7, JNKK2, MAPKK7, MEK, MEK_7, MKK7, PRKMK7, SAPKK-4, SAPKK4; mitogen-activated protein kinase kinase 7 (EC:2.7.12.2); K04431 mitogen-activated protein kinase kinase 7 [EC:2.7.12.2] 
<http://www.inferico.com/kegg-cmpo.owl#inst21_KEGGMap_hsa05200_Abst_Gene_hsa_23624family>&RL&hsa05200&CBLC, CBL-3, CBL-SL, RNF57; Cbl proto-oncogene C, E3 ubiquitin protein ligase; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19] CBL, C-CBL, CBL2, FRA11B, NSLL, RNF55; Cbl proto-oncogene, E3 ubiquitin protein ligase; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19] CBLB, Cbl-b, Nbla00127, RNF56; Cbl proto-oncogene B, E3 ubiquitin protein ligase; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2932>&&&GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_823>&&&CAPN1, CANP, CANP1, CANPL1, muCANP, muCL; calpain 1, (mu/I) large subunit (EC:3.4.22.52); K01367 calpain-1 [EC:3.4.22.52] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_118788>&&&PIK3AP1, BCAP; phosphoinositide-3-kinase adaptor protein 1; K12230 phosphoinositide 3-kinase adapter protein 1 
<http://www.inferico.com/kegg-cmpo.owl#inst202_KEGGMap_hsa05200_Abst_Gene_hsa_5155>&L&hsa05200&PDGFB, IBGC5, PDGF-2, PDGF2, SIS, SSV, c-sis; platelet-derived growth factor beta polypeptide; K17386 platelet-derived growth factor subunit B 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3912>&&&LAMB1, CLM, LIS5; laminin, beta 1; K05636 laminin, beta 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_23624>&LR&&CBLC, CBL-3, CBL-SL, RNF57; Cbl proto-oncogene C, E3 ubiquitin protein ligase; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19] 
<http://www.inferico.com/kegg-cmpo.owl#inst74_KEGGMap_hsa05200_Abst_Gene_hsa_5337>&&hsa05200&PLD1; phospholipase D1, phosphatidylcholine-specific (EC:3.1.4.4); K01115 phospholipase D1/2 [EC:3.1.4.4] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3164>&&&NR4A1, GFRP1, HMR, N10, NAK-1, NGFIB, NP10, NUR77, TR3; nuclear receptor subfamily 4, group A, member 1; K04465 nuclear receptor subfamily 4 group A member 1 
<http://www.inferico.com/kegg-cmpo.owl#inst12_KEGGMap_hsa05220_Abst_Gene_hsa_3065family>&&hsa05220&HDAC1, GON-10, HD1, RPD3, RPD3L1; histone deacetylase 1 (EC:3.5.1.98); K06067 histone deacetylase 1/2 [EC:3.5.1.98] HDAC2, HD2, RPD3, YAF1; histone deacetylase 2 (EC:3.5.1.98); K06067 histone deacetylase 1/2 [EC:3.5.1.98] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_824>&&&CAPN2, CANP2, CANPL2, CANPml, mCANP; calpain 2, (m/II) large subunit (EC:3.4.22.53); K03853 calpain-2 [EC:3.4.22.53] 
<http://www.inferico.com/kegg-cmpo.owl#inst55_KEGGMap_hsa04110_Abst_Gene_hsa_8317>&&hsa04110&CDC7, CDC7L1, HsCDC7, Hsk1, huCDC7; cell division cycle 7 (EC:2.7.11.1); K02214 cell division control protein 7 [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst27_KEGGMap_hsa04014_Abst_Gene_hsa_25family>&L&hsa04014&ABL2, ABLL, ARG; ABL proto-oncogene 2, non-receptor tyrosine kinase (EC:2.7.10.2); K08887 abelson tyrosine-protein kinase 2 [EC:2.7.10.2] ABL1, ABL, JTK7, bcr/abl, c-ABL, c-ABL1, p150, v-abl; ABL proto-oncogene 1, non-receptor tyrosine kinase (EC:2.7.10.2); K06619 abelson tyrosine-protein kinase 1 [EC:2.7.10.2] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1647>&&&GADD45A, DDIT1, GADD45; growth arrest and DNA-damage-inducible, alpha; K04402 growth arrest and DNA-damage-inducible protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_9700>&&&ESPL1, ESP1, SEPA; extra spindle pole bodies homolog 1 (S. cerevisiae) (EC:3.4.22.49); K02365 separase [EC:3.4.22.49] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3913>&&&LAMB2, LAMS, NPHS5; laminin, beta 2 (laminin S); K06243 laminin, beta 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6237>&L&&RRAS; related RAS viral (r-ras) oncogene homolog; K07829 Ras-related protein R-Ras 
<http://www.inferico.com/kegg-cmpo.owl#cpd_C00044>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8503>&LR&&PIK3R3, p55, p55-GAMMA, p55PIK; phosphoinositide-3-kinase, regulatory subunit 3 (gamma); K02649 phosphoinositide-3-kinase, regulatory subunit 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_27148>&&&STK36, FU; serine/threonine kinase 36 (EC:2.7.11.1); K06228 fused [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1950>&R&&EGF, HOMG4, URG; epidermal growth factor; K04357 epidermal growth factor 
<http://www.inferico.com/kegg-cmpo.owl#inst46_KEGGMap_hsa04151_Abst_Gene_hsa_3265family>&&hsa04151&HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, RASH1, p21ras; Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas NRAS, ALPS4, CMNS, N-ras, NCMS, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas KRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_3320_Abst_Gene_hsa_3326_Abst_Gene_hsa_367_Abst_Gene_hsa_7184>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_9170>&&&LPAR2, EDG-4, EDG4, LPA-2, LPA2; lysophosphatidic acid receptor 2; K04291 lysophosphatidic acid receptor 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_10926>&&&DBF4, ASK, CHIF, DBF4A, ZDBF1; DBF4 zinc finger; K06629 activator of S phase kinase 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_ko_K10785>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst41_KEGGMap_hsa04110_Abst_Gene_hsa_10744family>&&hsa04110&PTTG2; pituitary tumor-transforming 2; K06635 securin PTTG1, EAP1, HPTTG, PTTG, TUTR1; pituitary tumor-transforming 1; K06635 securin 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1290>&&&COL5A2, EDSC; collagen, type V, alpha 2; K06236 collagen, type I/II/III/V/XI/XXIV/XXVII, alpha 
<http://www.inferico.com/kegg-cmpo.owl#inst53_KEGGMap_hsa05220_Abst_Gene_hsa_3265family>&&hsa05220&HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, RASH1, p21ras; Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas NRAS, ALPS4, CMNS, N-ras, NCMS, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas KRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_9618>&&&TRAF4, CART1, MLN62, RNF83; TNF receptor-associated factor 4; K09848 TNF receptor-associated factor 4 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_1019_Abst_Gene_hsa_1021_Abst_Gene_hsa_595_Abst_Gene_hsa_894_Abst_Gene_hsa_896>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3910>&&&LAMA4, CMD1JJ, LAMA3, LAMA4*-1; laminin, alpha 4; K06241 laminin, alpha 4 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_9088>&&&PKMYT1, MYT1, PPP1R126; protein kinase, membrane associated tyrosine/threonine 1 (EC:2.7.11.1); K06633 membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst194_KEGGMap_hsa05200_Abst_Gene_hsa_4843>&&hsa05200&NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_ko_K10784>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst113_KEGGMap_hsa04151_Abst_Gene_Group_Abst_Gene_hsa_2475_Abst_Gene_hsa_57521_Abst_Gene_hsa_64223>&&hsa04151&
<http://www.inferico.com/kegg-cmpo.owl#inst33_KEGGMap_hsa05220_Abst_Gene_hsa_1398family>&RL&hsa05220&CRKL; v-crk avian sarcoma virus CT10 oncogene homolog-like; K04438 proto-oncogene C-crk CRK, CRKII, p38; v-crk avian sarcoma virus CT10 oncogene homolog; K04438 proto-oncogene C-crk 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2846>&&&LPAR4, GPR23, LPA4, P2RY9, P2Y5-LIKE, P2Y9; lysophosphatidic acid receptor 4; K04275 lysophosphatidic acid receptor 4 
<http://www.inferico.com/kegg-cmpo.owl#inst118_KEGGMap_hsa04151_Abst_Gene_Group_Abst_Gene_hsa_11140_Abst_Gene_hsa_3320_Abst_Gene_hsa_3326_Abst_Gene_hsa_7184>&&hsa04151&
<http://www.inferico.com/kegg-cmpo.owl#inst98_KEGGMap_hsa04014_Abst_Gene_hsa_55770>&&hsa04014&EXOC2, SEC5, SEC5L1, Sec5p; exocyst complex component 2; K17637 exocyst complex component 2 
<http://www.inferico.com/kegg-cmpo.owl#inst91_KEGGMap_hsa05200_Compound_cpd_C00951family>&&hsa05200&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3381>&&&IBSP, BNSP, BSP, BSP-II, SP-II; integrin-binding sialoprotein; K06253 integrin binding sialoprotein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_100533105>&&&C8orf44-SGK3; C8orf44-SGK3 readthrough (EC:2.7.11.1); K13304 serum/glucocorticoid-regulated kinase 3 [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst66_KEGGMap_hsa05200_Abst_Gene_hsa_595>&L&hsa05200&CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3911>&&&LAMA5; laminin, alpha 5; K06240 laminin, alpha 3/5 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_10928>&&&RALBP1, RIP1, RLIP1, RLIP76; ralA binding protein 1; K08773 RalA-binding protein 1 
<http://www.inferico.com/kegg-cmpo.owl#cpd_C16038>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst20_KEGGMap_hsa04014_Abst_Gene_hsa_5900>&&hsa04014&RALGDS, RGDS, RGF, RalGEF; ral guanine nucleotide dissociation stimulator; K08732 ral guanine nucleotide dissociation stimulator 
<http://www.inferico.com/kegg-cmpo.owl#inst28_KEGGMap_hsa05220_Abst_Gene_hsa_1026>&&hsa05220&CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1; cyclin-dependent kinase inhibitor 1A (p21, Cip1); K06625 cyclin-dependent kinase inhibitor 1A 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4803>&R&&NGF, Beta-NGF, HSAN5, NGFB; nerve growth factor (beta polypeptide); K02582 nerve growth factor, beta 
<http://www.inferico.com/kegg-cmpo.owl#cpd_C01245>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst45_KEGGMap_hsa05220_Abst_Gene_hsa_10000family>&&hsa05220&AKT3, MPPH, MPPH2, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1] AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1] AKT2, HIHGHH, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_64926>&R&&RASAL3; RAS protein activator like 3; K17634 RAS protein activator-like 3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_25847>&&&ANAPC13, APC13, SWM1; anaphase promoting complex subunit 13; K12456 anaphase-promoting complex subunit 13 
<http://www.inferico.com/kegg-cmpo.owl#inst12_KEGGMap_hsa04012_Abst_Gene_hsa_2064>&&hsa04012&ERBB2, CD340, HER-2, HER-2/neu, HER2, MLN_19, NEU, NGL, TKR1; erb-b2 receptor tyrosine kinase 2 (EC:2.7.10.1); K05083 receptor tyrosine-protein kinase erbB-2 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_89780>&LR&&WNT3A; wingless-type MMTV integration site family, member 3A; K00312 wingless-type MMTV integration site family, member 3 
<http://www.inferico.com/kegg-cmpo.owl#inst14_KEGGMap_hsa05220_Abst_Gene_hsa_2122>&CR&hsa05220&MECOM, AML1-EVI-1, EVI1, MDS1, MDS1-EVI1, PRDM3; MDS1 and EVI1 complex locus; K04462 ecotropic virus integration site 1 protein 
<http://www.inferico.com/kegg-cmpo.owl#inst40_KEGGMap_hsa04110_Abst_Gene_hsa_494551family>&&hsa04110&WEE2, WEE1B; WEE1 homolog 2 (S. pombe) (EC:2.7.10.2); K06632 wee1-like protein kinase [EC:2.7.11.1] WEE1, WEE1A, WEE1hu; WEE1 G2 checkpoint kinase (EC:2.7.10.2); K06632 wee1-like protein kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_382>&&&ARF6; ADP-ribosylation factor 6; K07941 ADP-ribosylation factor 6 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4804>&&&NGFR, CD271, Gp80-LNGFR, TNFRSF16, p75(NTR), p75NTR; nerve growth factor receptor; K02583 nerve growth factor receptor (TNFR superfamily member 16) 
<http://www.inferico.com/kegg-cmpo.owl#inst77_KEGGMap_hsa04012_Abst_Gene_Group_Abst_Gene_hsa_2065_Abst_Gene_hsa_2065>&&hsa04012&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2538>&&&G6PC, G6PC1, G6PT, GSD1, GSD1a; glucose-6-phosphatase, catalytic subunit (EC:3.1.3.9); K01084 glucose-6-phosphatase [EC:3.1.3.9] 
<http://www.inferico.com/kegg-cmpo.owl#inst42_KEGGMap_hsa04014_Abst_Gene_hsa_100137049family>&&hsa04014&PLA2G4B, HsT16992, cPLA2-beta; phospholipase A2, group IVB (cytosolic) (EC:3.1.1.4); K16342 cytosolic phospholipase A2 [EC:3.1.1.4] PLA2G4E; phospholipase A2, group IVE (EC:3.1.1.4); K16342 cytosolic phospholipase A2 [EC:3.1.1.4] PLA2G4D, cPLA2delta; phospholipase A2, group IVD (cytosolic) (EC:3.1.1.4); K16342 cytosolic phospholipase A2 [EC:3.1.1.4] PLA2G4C, CPLA2-gamma; phospholipase A2, group IVC (cytosolic, calcium-independent) (EC:3.1.1.4); K16342 cytosolic phospholipase A2 [EC:3.1.1.4] JMJD7-PLA2G4B, HsT16992, cPLA2-beta; JMJD7-PLA2G4B readthrough; K16342 cytosolic phospholipase A2 [EC:3.1.1.4] PLA2G12A, GXII, PLA2G12, ROSSY; phospholipase A2, group XIIA (EC:3.1.1.4); K01047 secretory phospholipase A2 [EC:3.1.1.4] PLA2G4F, PLA2G4FZ; phospholipase A2, group IVF (EC:3.1.1.4); K16342 cytosolic phospholipase A2 [EC:3.1.1.4] PLA2G12B, FKSG71, GXIIB, GXIIIsPLA2, PLA2G13; phospholipase A2, group XIIB (EC:3.1.1.4); K01047 secretory phospholipase A2 [EC:3.1.1.4] PLA1A, PS-PLA1, PSPLA1; phospholipase A1 member A (EC:3.1.1.-); K13618 phospholipase A1 member A [EC:3.1.1.-] PLA2G2D, PLA2IID, SPLASH, sPLA2-IID, sPLA2S; phospholipase A2, group IID (EC:3.1.1.4); K01047 secretory phospholipase A2 [EC:3.1.1.4] PLA2G5, FRFB, GV-PLA2, PLA2-10, hVPLA(2); phospholipase A2, group V (EC:3.1.1.4); K01047 secretory phospholipase A2 [EC:3.1.1.4] PLA2G4A, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K16342 cytosolic phospholipase A2 [EC:3.1.1.4] PLA2G2A, MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2; phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4); K01047 secretory phospholipase A2 [EC:3.1.1.4] PLA2G2E, GIIE_sPLA2, sPLA2-IIE; phospholipase A2, group IIE (EC:3.1.1.4); K01047 secretory phospholipase A2 [EC:3.1.1.4] PLA2G1B, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 secretory phospholipase A2 [EC:3.1.1.4] PLA2G2C; phospholipase A2, group IIC (EC:3.1.1.4); K01047 secretory phospholipase A2 [EC:3.1.1.4] PLA2G2F; phospholipase A2, group IIF (EC:3.1.1.4); K01047 secretory phospholipase A2 [EC:3.1.1.4] PLA2G16, AdPLA, H-REV107-1, HRASLS3, HREV107, HREV107-1, HREV107-3, HRSL3; phospholipase A2, group XVI (EC:3.1.1.4 3.1.1.32); K16817 HRAS-like suppressor 3 [EC:3.1.1.32 3.1.1.4] PLA2G3, GIII-SPLA2, SPLA2III, sPLA2-III; phospholipase A2, group III (EC:3.1.1.4); K01047 secretory phospholipase A2 [EC:3.1.1.4] PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2, iPLA2beta; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K16343 calcium-independent phospholipase A2 [EC:3.1.1.4] PLA2G10, GXPLA2, GXSPLA2, SPLA2; phospholipase A2, group X (EC:3.1.1.4); K01047 secretory phospholipase A2 [EC:3.1.1.4] 
<http://www.inferico.com/kegg-cmpo.owl#inst51_KEGGMap_hsa04151_Abst_Gene_hsa_4846>&&hsa04151&NOS3, ECNOS, eNOS; nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39); K13242 nitric-oxide synthase, endothelial [EC:1.14.13.39] 
<http://www.inferico.com/kegg-cmpo.owl#inst56_KEGGMap_hsa05220_Abst_Gene_Group_Abst_Gene_hsa_7046_Abst_Gene_hsa_7048>&&hsa05220&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5915>&RL&&RARB, HAP, MCOPS12, NR1B2, RRB2; retinoic acid receptor, beta; K08528 retinoic acid receptor beta 
<http://www.inferico.com/kegg-cmpo.owl#inst200_KEGGMap_hsa05200_Abst_Gene_hsa_598>&&hsa05200&BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS; BCL2-like 1; K04570 BCL2-like 1 (apoptosis regulator Bcl-X) 
<http://www.inferico.com/kegg-cmpo.owl#inst95_KEGGMap_hsa04151_Abst_Gene_hsa_10488family>&&hsa04151&CREB3L1, OASIS; cAMP responsive element binding protein 3-like 1; K09048 cyclic AMP-responsive element-binding protein 3 CREB3L3, CREB-H, CREBH, HYST1481; cAMP responsive element binding protein 3-like 3; K09048 cyclic AMP-responsive element-binding protein 3 CREB3L4, AIBZIP, ATCE1, CREB3, CREB4, JAL, hJAL; cAMP responsive element binding protein 3-like 4; K09048 cyclic AMP-responsive element-binding protein 3 ATF6B, CREB-RP, CREBL1, G13; activating transcription factor 6 beta; K09049 cyclic AMP-dependent transcription factor ATF-6 beta CREB1, CREB; cAMP responsive element binding protein 1; K05870 cyclic AMP-responsive element-binding protein 1 ATF2, CRE-BP1, CREB-2, CREB2, HB16, TREB7; activating transcription factor 2 (EC:2.3.1.48); K04450 cyclic AMP-dependent transcription factor ATF-2 CREB3, LUMAN, LZIP, sLZIP; cAMP responsive element binding protein 3; K09048 cyclic AMP-responsive element-binding protein 3 CREB5, CRE-BPA, CREB-5; cAMP responsive element binding protein 5; K09047 cyclic AMP-responsive element-binding protein 5 ATF4, CREB-2, CREB2, TAXREB67, TXREB; activating transcription factor 4; K04374 cyclic AMP-dependent transcription factor ATF-4 CREB3L2, BBF2H7; cAMP responsive element binding protein 3-like 2; K09048 cyclic AMP-responsive element-binding protein 3 
<http://www.inferico.com/kegg-cmpo.owl#inst164_KEGGMap_hsa05200_Abst_Gene_hsa_9063>&&hsa05200&PIAS2, ARIP3, DIP, MIZ, MIZ1, PIASX, PIASX-ALPHA, PIASX-BETA, SIZ2, ZMIZ4; protein inhibitor of activated STAT, 2; K16063 E3 SUMO-protein ligase PIAS2 [EC:6.3.2.-] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_10393>&&&ANAPC10, APC10, DOC1; anaphase promoting complex subunit 10; K03357 anaphase-promoting complex subunit 10 
<http://www.inferico.com/kegg-cmpo.owl#inst60_KEGGMap_hsa05200_Abst_Gene_hsa_5604family>&&hsa05200&MAP2K2, CFC4, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2] MAP2K1, CFC3, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2] 
<http://www.inferico.com/kegg-cmpo.owl#inst117_KEGGMap_hsa04110_Abst_Gene_Group_Abst_Gene_hsa_1874_Abst_Gene_hsa_1875_Abst_Gene_hsa_5933_Abst_Gene_hsa_7027_Abst_Gene_hsa_7029>&R&hsa04110&
<http://www.inferico.com/kegg-cmpo.owl#inst29_KEGGMap_hsa04012_Abst_Gene_hsa_6776family>&&hsa04012&STAT5B, STAT5; signal transducer and activator of transcription 5B; K11224 signal transducer and activator of transcription 5B STAT5A, MGF, STAT5; signal transducer and activator of transcription 5A; K11223 signal transducer and activator of transcription 5A 
<http://www.inferico.com/kegg-cmpo.owl#inst28_KEGGMap_hsa04014_Abst_Gene_hsa_9610>&&hsa04014&RIN1; Ras and Rab interactor 1; K17638 Ras and Rab interactor 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7529>&&&YWHAB, GW128, HEL-S-1, HS1, KCIP-1, YWHAA; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta; K16197 14-3-3 protein beta/theta/zeta 
<http://www.inferico.com/kegg-cmpo.owl#inst21_KEGGMap_hsa05220_Abst_Gene_hsa_4792>&&hsa05220&NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5914>&R&&RARA, NR1B1, RAR; retinoic acid receptor, alpha; K08527 retinoic acid receptor alpha 
<http://www.inferico.com/kegg-cmpo.owl#cpd_C15493>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst49_KEGGMap_hsa04014_Compound_cpd_C00035>&&hsa04014&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_51343>&&&FZR1, CDC20C, CDH1, FZR, FZR2, HCDH, HCDH1; fizzy/cell division cycle 20 related 1 (Drosophila); K03364 cell division cycle 20-like protein 1, cofactor of APC complex 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1163>&&&CKS1B, CKS1, PNAS-16, PNAS-18, ckshs1; CDC28 protein kinase regulatory subunit 1B; K02219 cyclin-dependent kinase regulatory subunit CKS1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1030>&&&CDKN2B, CDK4I, INK4B, MTS2, P15, TP15, p15INK4b; cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4); K04685 cyclin-dependent kinase inhibitor 2B 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3693>&&&ITGB5; integrin, beta 5; K06588 integrin beta 5 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3560>&&&IL2RB, CD122, IL15RB, P70-75; interleukin 2 receptor, beta; K05069 interleukin 2 receptor beta 
<http://www.inferico.com/kegg-cmpo.owl#inst18_KEGGMap_hsa04014_Abst_Gene_hsa_7074>&&hsa04014&TIAM1; T-cell lymphoma invasion and metastasis 1; K05731 T-lymphoma invasion and metastasis-inducing protein 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8324>&&&FZD7, FzE3; frizzled class receptor 7; K02432 frizzled 1/7 
<http://www.inferico.com/kegg-cmpo.owl#inst30_KEGGMap_hsa04110_Abst_Gene_hsa_8555family>&&hsa04110&CDC14B, CDC14B3, Cdc14B1, Cdc14B2, hCDC14B; cell division cycle 14B (EC:3.1.3.16 3.1.3.48); K06639 cell division cycle 14 [EC:3.1.3.16 3.1.3.48] CDC14A, cdc14, hCDC14; cell division cycle 14A (EC:3.1.3.16 3.1.3.48); K06639 cell division cycle 14 [EC:3.1.3.16 3.1.3.48] 
<http://www.inferico.com/kegg-cmpo.owl#inst25_KEGGMap_hsa04151_Abst_Gene_hsa_1027>&L&hsa04151&CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1; cyclin-dependent kinase inhibitor 1B (p27, Kip1); K06624 cyclin-dependent kinase inhibitor 1B 
<http://www.inferico.com/kegg-cmpo.owl#inst105_KEGGMap_hsa04014_Compound_cpd_C00575>&&hsa04014&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_2066_Abst_Gene_hsa_2066>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2277>&R&&FIGF, VEGF-D, VEGFD; c-fos induced growth factor (vascular endothelial growth factor D); K05449 vascular endothelial growth factor C/D 
<http://www.inferico.com/kegg-cmpo.owl#inst135_KEGGMap_hsa05200_Compound_cpd_C00149>&&hsa05200&
<http://www.inferico.com/kegg-cmpo.owl#inst24_KEGGMap_hsa04012_Abst_Gene_hsa_1026>&&hsa04012&CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1; cyclin-dependent kinase inhibitor 1A (p21, Cip1); K06625 cyclin-dependent kinase inhibitor 1A 
<http://www.inferico.com/kegg-cmpo.owl#inst16_KEGGMap_hsa05220_Abst_Gene_hsa_7048>&&hsa05220&TGFBR2, AAT3, FAA3, LDS1B, LDS2, LDS2B, MFS2, RIIC, TAAD2, TGFR-2, TGFbeta-RII; transforming growth factor, beta receptor II (70/80kDa) (EC:2.7.11.30); K04388 TGF-beta receptor type-2 [EC:2.7.11.30] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6416>&&&MAP2K4, JNKK, JNKK1, MAPKK4, MEK4, MKK4, PRKMK4, SAPKK-1, SAPKK1, SEK1, SERK1, SKK1; mitogen-activated protein kinase kinase 4 (EC:2.7.12.2); K04430 mitogen-activated protein kinase kinase 4 [EC:2.7.12.2] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7477>&LR&&WNT7B; wingless-type MMTV integration site family, member 7B; K00572 wingless-type MMTV integration site family, member 7 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5521>&&&PPP2R2B, B55BETA, PP2AB55BETA, PP2ABBETA, PP2APR55B, PP2APR55BETA, PR2AB55BETA, PR2ABBETA, PR2APR55BETA, PR52B, PR55-BETA, PR55BETA, SCA12; protein phosphatase 2, regulatory subunit B, beta (EC:3.1.3.16); K04354 serine/threonine-protein phosphatase 2A regulatory subunit B 
<http://www.inferico.com/kegg-cmpo.owl#inst24_KEGGMap_hsa04151_Abst_Gene_hsa_4609>&L&hsa04151&MYC, MRTL, MYCC, bHLHe39, c-Myc; v-myc avian myelocytomatosis viral oncogene homolog; K04377 Myc proto-oncogene protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3694>&&&ITGB6, AI1H; integrin, beta 6; K06589 integrin beta 6 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5568>&&&PRKACG, BDPLT19, KAPG, PKACg; protein kinase, cAMP-dependent, catalytic, gamma (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3561>&&&IL2RG, CD132, CIDX, IL-2RG, IMD4, P64, SCIDX, SCIDX1; interleukin 2 receptor, gamma; K05070 interleukin 2 receptor gamma 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8325>&&&FZD8, FZ-8, hFZ8; frizzled class receptor 8; K02375 frizzled 5/8 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_472>&R&&ATM, AT1, ATA, ATC, ATD, ATDC, ATE, TEL1, TELO1; ATM serine/threonine kinase (EC:2.7.11.1); K04728 ataxia telangiectasia mutated family protein [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6500>&&&SKP1, EMC19, OCP-II, OCP2, SKP1A, TCEB1L, p19A; S-phase kinase-associated protein 1 (EC:3.1.1.3); K03094 S-phase kinase-associated protein 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_387>&L&&RHOA, ARH12, ARHA, RHO12, RHOH12; ras homolog family member A; K04513 Ras homolog gene family, member A 
<http://www.inferico.com/kegg-cmpo.owl#inst18_KEGGMap_hsa05200_Abst_Gene_hsa_26060>&&hsa05200&APPL1, APPL, DIP13alpha; adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1; K08733 DCC-interacting protein 13 alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7478>&LR&&WNT8A, WNT8D; wingless-type MMTV integration site family, member 8A; K00714 wingless-type MMTV integration site family, member 8 
<http://www.inferico.com/kegg-cmpo.owl#inst70_KEGGMap_hsa05200_Abst_Gene_hsa_5900>&&hsa05200&RALGDS, RGDS, RGF, RalGEF; ral guanine nucleotide dissociation stimulator; K08732 ral guanine nucleotide dissociation stimulator 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_51434>&&&ANAPC7, APC7; anaphase promoting complex subunit 7; K03354 anaphase-promoting complex subunit 7 
<http://www.inferico.com/kegg-cmpo.owl#inst80_KEGGMap_hsa05200_Abst_Gene_hsa_7157>&CL&hsa05200&TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53 
<http://www.inferico.com/kegg-cmpo.owl#inst39_KEGGMap_hsa04151_Abst_Gene_hsa_4790family>&&hsa04151&RELA, NFKB3, p65; v-rel avian reticuloendotheliosis viral oncogene homolog A; K04735 transcription factor p65 NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor NF-kappa-B p105 subunit 
<http://www.inferico.com/kegg-cmpo.owl#inst26_KEGGMap_hsa04210_Abst_Gene_hsa_5566family>&&hsa04210&PRKACG, BDPLT19, KAPG, PKACg; protein kinase, cAMP-dependent, catalytic, gamma (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11] PRKACB, PKA_C-beta, PKACB; protein kinase, cAMP-dependent, catalytic, beta (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11] PRKACA, PKACA, PPNAD4; protein kinase, cAMP-dependent, catalytic, alpha (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11] PRKAR1A, ACRDYS1, ADOHR, CAR, CNC, CNC1, PKR1, PPNAD1, PRKAR1, TSE1; protein kinase, cAMP-dependent, regulatory, type I, alpha (EC:2.7.11.1); K04739 cAMP-dependent protein kinase regulator PRKAR2B, PRKAR2, RII-BETA; protein kinase, cAMP-dependent, regulatory, type II, beta (EC:2.7.11.1); K04739 cAMP-dependent protein kinase regulator PRKAR2A, PKR2, PRKAR2; protein kinase, cAMP-dependent, regulatory, type II, alpha (EC:2.7.11.1); K04739 cAMP-dependent protein kinase regulator PRKAR1B, PRKAR1; protein kinase, cAMP-dependent, regulatory, type I, beta (EC:2.7.11.1); K04739 cAMP-dependent protein kinase regulator PRKX, PKX1; protein kinase, X-linked (EC:2.7.11.1); K04345 protein kinase A [EC:2.7.11.11] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5520>&&&PPP2R2A, B55A, B55ALPHA, PR52A, PR55A; protein phosphatase 2, regulatory subunit B, alpha (EC:3.1.3.16); K04354 serine/threonine-protein phosphatase 2A regulatory subunit B 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_25759>&&&SHC2, SCK, SHCB, SLI; SHC (Src homology 2 domain containing) transforming protein 2; K17447 SHC- transforming protein 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1032>&R&&CDKN2D, INK4D, p19, p19-INK4D; cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4); K06623 cyclin-dependent kinase inhibitor 2D 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5567>&&&PRKACB, PKA_C-beta, PKACB; protein kinase, cAMP-dependent, catalytic, beta (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11] 
<http://www.inferico.com/kegg-cmpo.owl#inst23_KEGGMap_hsa04110_Abst_Gene_hsa_5111>&&hsa04110&PCNA, ATLD2; proliferating cell nuclear antigen; K04802 proliferating cell nuclear antigen 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3691>&&&ITGB4, CD104; integrin, beta 4; K06525 integrin beta 4 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8326>&&&FZD9, CD349, FZD3; frizzled class receptor 9; K02842 frizzled 9/10 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6850>&&&SYK, p72-Syk; spleen tyrosine kinase (EC:2.7.10.2); K05855 spleen tyrosine kinase [EC:2.7.10.2] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2057>&&&EPOR, EPO-R; erythropoietin receptor; K05079 erythropoietin receptor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3918>&&&LAMC2, B2T, BM600, CSF, EBR2, EBR2A, LAMB2T, LAMNB2; laminin, gamma 2; K06246 laminin, gamma 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_83593>&LR&&RASSF5, Maxp1, NORE1, NORE1A, NORE1B, RAPL, RASSF3; Ras association (RalGDS/AF-6) domain family member 5; K08015 Ras association domain-containing protein 5 
<http://www.inferico.com/kegg-cmpo.owl#inst46_KEGGMap_hsa05200_Abst_Gene_hsa_10297family>&RL&hsa05200&APC, BTPS2, DP2, DP2.5, DP3, GS, PPP1R46; adenomatous polyposis coli; K02085 adenomatosis polyposis coli protein APC2, APCL; adenomatosis polyposis coli 2; K02085 adenomatosis polyposis coli protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_9610>&&&RIN1; Ras and Rab interactor 1; K17638 Ras and Rab interactor 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7479>&LR&&WNT8B; wingless-type MMTV integration site family, member 8B; K00714 wingless-type MMTV integration site family, member 8 
<http://www.inferico.com/kegg-cmpo.owl#inst36_KEGGMap_hsa05200_Abst_Gene_hsa_1950>&&hsa05200&EGF, HOMG4, URG; epidermal growth factor; K04357 epidermal growth factor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_51433>&&&ANAPC5, APC5; anaphase promoting complex subunit 5; K03352 anaphase-promoting complex subunit 5 
<http://www.inferico.com/kegg-cmpo.owl#inst37_KEGGMap_hsa05200_Abst_Gene_hsa_3082>&&hsa05200&HGF, DFNB39, F-TCF, HGFB, HPTA, SF; hepatocyte growth factor (hepapoietin A; scatter factor); K05460 hepatocyte growth factor 
<http://www.inferico.com/kegg-cmpo.owl#inst72_KEGGMap_hsa05200_Abst_Gene_hsa_387family>&&hsa05200&RHOA, ARH12, ARHA, RHO12, RHOH12; ras homolog family member A; K04513 Ras homolog gene family, member A RAC3; ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3); K07861 Ras-related C3 botulinum toxin substrate 3 RAC2, EN-7, Gx, HSPC022, p21-Rac2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2); K07860 Ras-related C3 botulinum toxin substrate 2 RAC1, MIG5, Rac-1, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1164>&&&CKS2, CKSHS2; CDC28 protein kinase regulatory subunit 2; K02219 cyclin-dependent kinase regulatory subunit CKS1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5566>&&&PRKACA, PKACA, PPNAD4; protein kinase, cAMP-dependent, catalytic, alpha (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1031>&&&CDKN2C, INK4C, p18, p18-INK4C; cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4); K06622 cyclin-dependent kinase inhibitor 2C 
<http://www.inferico.com/kegg-cmpo.owl#inst70_KEGGMap_hsa04012_Abst_Gene_hsa_5594family>&&hsa04012&MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 mitogen-activated protein kinase 1/3 [EC:2.7.11.24] MAPK1, ERK, ERK-2, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk, p42-MAPK; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 mitogen-activated protein kinase 1/3 [EC:2.7.11.24] 
<http://www.inferico.com/kegg-cmpo.owl#inst38_KEGGMap_hsa04151_Abst_Gene_hsa_1147family>&&hsa04151&IKBKB, IKK-beta, IKK2, IKKB, IMD15, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10] IKBKG, AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IMD33, IP, IP1, IP2, IPD2, NEMO, ZC2HC9; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; K07210 inhibitor of nuclear factor kappa-B kinase subunit gamma CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10] 
<http://www.inferico.com/kegg-cmpo.owl#inst20_KEGGMap_hsa04151_Abst_Gene_hsa_3667>&&hsa04151&IRS1, HIRS-1; insulin receptor substrate 1; K16172 insulin receptor substrate 1 
<http://www.inferico.com/kegg-cmpo.owl#inst92_KEGGMap_hsa04110_Abst_Gene_hsa_1869family>&&hsa04110&E2F1, E2F-1, RBAP1, RBBP3, RBP3; E2F transcription factor 1; K17454 transcription factor E2F1 E2F2, E2F-2; E2F transcription factor 2; K09389 transcription factor E2F2 E2F3, E2F-3; E2F transcription factor 3; K06620 transcription factor E2F3 
<http://www.inferico.com/kegg-cmpo.owl#inst178_KEGGMap_hsa05200_Abst_Gene_hsa_1029>&CR&hsa05200&CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A; K06621 cyclin-dependent kinase inhibitor 2A 
<http://www.inferico.com/kegg-cmpo.owl#inst26_KEGGMap_hsa04012_Abst_Gene_hsa_2475>&&hsa04012&MTOR, FRAP, FRAP1, FRAP2, RAFT1, RAPT1; mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1); K07203 FKBP12-rapamycin complex-associated protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_64399>&&&HHIP, HIP; hedgehog interacting protein; K06231 hedgehog interacting protein 
<http://www.inferico.com/kegg-cmpo.owl#inst69_KEGGMap_hsa04014_Abst_Gene_hsa_51196>&&hsa04014&PLCE1, NPHS3, PLCE, PPLC; phospholipase C, epsilon 1 (EC:3.1.4.11); K05860 phosphatidylinositol phospholipase C, epsilon [EC:3.1.4.11] 
<http://www.inferico.com/kegg-cmpo.owl#inst66_KEGGMap_hsa04012_Abst_Gene_hsa_374>&&hsa04012&AREG, AR, AREGB, CRDGF, SDGF; amphiregulin; K09782 amphiregulin 
<http://www.inferico.com/kegg-cmpo.owl#inst62_KEGGMap_hsa04110_Abst_Gene_hsa_2932>&&hsa04110&GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26] 
<http://www.inferico.com/kegg-cmpo.owl#inst47_KEGGMap_hsa05200_Abst_Gene_hsa_1147family>&&hsa05200&IKBKB, IKK-beta, IKK2, IKKB, IMD15, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10] IKBKG, AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IMD33, IP, IP1, IP2, IPD2, NEMO, ZC2HC9; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; K07210 inhibitor of nuclear factor kappa-B kinase subunit gamma CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5347>&&&PLK1, PLK, STPK13; polo-like kinase 1 (EC:2.7.11.21); K06631 polo-like kinase 1 [EC:2.7.11.21] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1292>&&&COL6A2, PP3610; collagen, type VI, alpha 2; K06238 collagen, type VI, alpha 
<http://www.inferico.com/kegg-cmpo.owl#inst65_KEGGMap_hsa04014_Abst_Gene_hsa_4301>&L&hsa04014&MLLT4, AF6; myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4; K05702 afadin 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4233>&&&MET, AUTS9, HGFR, RCCP2, c-Met; MET proto-oncogene, receptor tyrosine kinase (EC:2.7.10.1); K05099 proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst5_KEGGMap_hsa04210_Abst_Gene_hsa_598>&&hsa04210&BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS; BCL2-like 1; K04570 BCL2-like 1 (apoptosis regulator Bcl-X) 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_246184>&&&CDC26, ANAPC12, APC12, C9orf17; cell division cycle 26; K03359 anaphase-promoting complex subunit 12 
<http://www.inferico.com/kegg-cmpo.owl#inst46_KEGGMap_hsa04012_Abst_Gene_hsa_25759family>&&hsa04012&SHC2, SCK, SHCB, SLI; SHC (Src homology 2 domain containing) transforming protein 2; K17447 SHC- transforming protein 2 SHC1, SHC, SHCA; SHC (Src homology 2 domain containing) transforming protein 1; K06279 SHC- transforming protein 1 SHC4, RaLP, SHCD; SHC (Src homology 2 domain containing) family, member 4; K17449 SHC- transforming protein 4 SHC3, N-Shc, NSHC, RAI, SHCC; SHC (Src homology 2 domain containing) transforming protein 3; K17448 SHC- transforming protein 3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_64223>&&&MLST8, GBL, GbetaL, LST8, POP3, WAT1; MTOR associated protein, LST8 homolog (S. cerevisiae); K08266 G protein beta subunit-like 
<http://www.inferico.com/kegg-cmpo.owl#inst44_KEGGMap_hsa04210_Abst_Gene_hsa_7186>&&hsa04210&TRAF2, MGC:45012, TRAP, TRAP3; TNF receptor-associated factor 2; K03173 TNF receptor-associated factor 2 
<http://www.inferico.com/kegg-cmpo.owl#inst89_KEGGMap_hsa04110_Abst_Gene_hsa_7709>&&hsa04110&ZBTB17, MIZ-1, ZNF151, ZNF60, pHZ-67; zinc finger and BTB domain containing 17; K10500 zinc finger and BTB domain-containing protein 17 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1291>&&&COL6A1, OPLL; collagen, type VI, alpha 1; K06238 collagen, type VI, alpha 
<http://www.inferico.com/kegg-cmpo.owl#inst30_KEGGMap_hsa04151_Abst_Gene_hsa_572>&&hsa04151&BAD, BBC2, BCL2L8; BCL2-associated agonist of cell death; K02158 BCL2-antagonist of cell death 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3690>&&&ITGB3, BDPLT16, BDPLT2, CD61, GP3A, GPIIIa, GT; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); K06493 integrin beta 3 
<http://www.inferico.com/kegg-cmpo.owl#inst70_KEGGMap_hsa04110_Abst_Gene_hsa_902>&&hsa04110&CCNH, CAK, CycH, p34, p37; cyclin H; K06634 cyclin H 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1869>&&&E2F1, E2F-1, RBAP1, RBBP3, RBP3; E2F transcription factor 1; K17454 transcription factor E2F1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2056>&R&&EPO, EP, MVCD2; erythropoietin; K05437 erythropoietin 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4149>&&&MAX, bHLHd4; MYC associated factor X; K04453 Max protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_10744>&&&PTTG2; pituitary tumor-transforming 2; K06635 securin 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_100137049>&&&PLA2G4B, HsT16992, cPLA2-beta; phospholipase A2, group IVB (cytosolic) (EC:3.1.1.4); K16342 cytosolic phospholipase A2 [EC:3.1.1.4] 
<http://www.inferico.com/kegg-cmpo.owl#inst113_KEGGMap_hsa05200_Abst_Gene_hsa_1387family>&&hsa05200&CREBBP, CBP, KAT3A, RSTS; CREB binding protein (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48] EP300, KAT3B, RSTS2, p300; E1A binding protein p300 (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48] 
<http://www.inferico.com/kegg-cmpo.owl#inst228_KEGGMap_hsa05200_Abst_Gene_hsa_2308>&L&hsa05200&FOXO1, FKH1, FKHR, FOXO1A; forkhead box O1; K07201 forkhead box protein O1 
<http://www.inferico.com/kegg-cmpo.owl#inst172_KEGGMap_hsa05200_Abst_Gene_hsa_6502>&&hsa05200&SKP2, FBL1, FBXL1, FLB1, p45; S-phase kinase-associated protein 2, E3 ubiquitin protein ligase; K03875 F-box and leucine-rich repeat protein 1 (S-phase kinase-associated protein 2) 
<http://www.inferico.com/kegg-cmpo.owl#inst47_KEGGMap_hsa04210_Abst_Gene_hsa_8772>&&hsa04210&FADD, GIG3, MORT1; Fas (TNFRSF6)-associated via death domain; K02373 FAS-associated death domain protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_23533>&LR&&PIK3R5, F730038I15Rik, FOAP-2, P101-PI3K, p101; phosphoinositide-3-kinase, regulatory subunit 5; K02649 phosphoinositide-3-kinase, regulatory subunit 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3914>&&&LAMB3, AI1A, BM600-125KDA, LAM5, LAMNB1; laminin, beta 3; K06244 laminin, beta 3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2271>&RL&&FH, FMRD, HLRCC, LRCC, MCL, MCUL1; fumarate hydratase (EC:4.2.1.2); K01679 fumarate hydratase, class II [EC:4.2.1.2] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_9965>&R&&FGF19; fibroblast growth factor 19; K04358 fibroblast growth factor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5781>&&&PTPN11, BPTP3, CFC, NS1, PTP-1D, PTP2C, SH-PTP2, SH-PTP3, SHP2; protein tyrosine phosphatase, non-receptor type 11 (EC:3.1.3.48); K07293 tyrosine-protein phosphatase non-receptor type 11 [EC:3.1.3.48] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5563>&&&PRKAA2, AMPK, AMPK2, AMPKa2, PRKAA; protein kinase, AMP-activated, alpha 2 catalytic subunit (EC:2.7.11.1 2.7.11.27 2.7.11.31); K07198 5'-AMP-activated protein kinase, catalytic alpha subunit [EC:2.7.11.11] 
<http://www.inferico.com/kegg-cmpo.owl#inst4_KEGGMap_hsa05200_Abst_Gene_hsa_842>&&hsa05200&CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62] 
<http://www.inferico.com/kegg-cmpo.owl#inst60_KEGGMap_hsa04151_Abst_Gene_hsa_1026>&&hsa04151&CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1; cyclin-dependent kinase inhibitor 1A (p21, Cip1); K06625 cyclin-dependent kinase inhibitor 1A 
<http://www.inferico.com/kegg-cmpo.owl#cpd_C00575>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1293>&&&COL6A3; collagen, type VI, alpha 3; K06238 collagen, type VI, alpha 
<http://www.inferico.com/kegg-cmpo.owl#inst80_KEGGMap_hsa04151_Abst_Gene_hsa_6850>&&hsa04151&SYK, p72-Syk; spleen tyrosine kinase (EC:2.7.10.2); K05855 spleen tyrosine kinase [EC:2.7.10.2] 
<http://www.inferico.com/kegg-cmpo.owl#inst102_KEGGMap_hsa04110_Abst_Gene_Group_Abst_Gene_hsa_1017_Abst_Gene_hsa_890_Abst_Gene_hsa_8900>&&hsa04110&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1956>&RL&&EGFR, ERBB, ERBB1, HER1, NISBD2, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_26291>&R&&FGF21; fibroblast growth factor 21; K04358 fibroblast growth factor 
<http://www.inferico.com/kegg-cmpo.owl#inst16_KEGGMap_hsa04014_Abst_Gene_hsa_2549family>&&hsa04014&GAB2; GRB2-associated binding protein 2; K08091 growth factor receptor bound protein 2-associated protein 2 GAB1; GRB2-associated binding protein 1; K09593 GRB2-associated-binding protein 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3915>&&&LAMC1, LAMB2; laminin, gamma 1 (formerly LAMB2); K05635 laminin, gamma 1 
<http://www.inferico.com/kegg-cmpo.owl#inst30_KEGGMap_hsa04210_Abst_Gene_hsa_596family>&R&hsa04210&BCL2, Bcl-2, PPP1R50; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2 BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS; BCL2-like 1; K04570 BCL2-like 1 (apoptosis regulator Bcl-X) 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5562>&&&PRKAA1, AMPK, AMPKa1; protein kinase, AMP-activated, alpha 1 catalytic subunit (EC:2.7.11.1 2.7.11.26 2.7.11.27 2.7.11.31); K07198 5'-AMP-activated protein kinase, catalytic alpha subunit [EC:2.7.11.11] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5602>&&&MAPK10, JNK3, JNK3A, PRKM10, SAPK1b, p493F12, p54bSAPK; mitogen-activated protein kinase 10 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24] 
<http://www.inferico.com/kegg-cmpo.owl#inst220_KEGGMap_hsa05200_Abst_Gene_hsa_4609>&L&hsa05200&MYC, MRTL, MYCC, bHLHe39, c-Myc; v-myc avian myelocytomatosis viral oncogene homolog; K04377 Myc proto-oncogene protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5868>&&&RAB5A, RAB5; RAB5A, member RAS oncogene family; K07887 Ras-related protein Rab-5A 
<http://www.inferico.com/kegg-cmpo.owl#inst169_KEGGMap_hsa05200_Abst_Gene_hsa_1869family>&&hsa05200&E2F1, E2F-1, RBAP1, RBBP3, RBP3; E2F transcription factor 1; K17454 transcription factor E2F1 E2F2, E2F-2; E2F transcription factor 2; K09389 transcription factor E2F2 E2F3, E2F-3; E2F transcription factor 3; K06620 transcription factor E2F3 
<http://www.inferico.com/kegg-cmpo.owl#inst105_KEGGMap_hsa04151_Abst_Gene_hsa_595family>&RL&hsa04151&CCNE2, CYCE2; cyclin E2; K06626 cyclin E CCND2, KIAK0002, MPPH3; cyclin D2; K10151 cyclin D2 CCND3; cyclin D3; K10152 cyclin D3 CCNE1, CCNE; cyclin E1; K06626 cyclin E CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5290>&LR&&PIK3CA, CLOVE, CWS5, MCAP, MCM, MCMTC, PI3K, p110-alpha; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (EC:2.7.11.1 2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_79444>&&&BIRC7, KIAP, LIVIN, ML-IAP, MLIAP, RNF50; baculoviral IAP repeat containing 7; K16061 baculoviral IAP repeat-containing protein 7/8 
<http://www.inferico.com/kegg-cmpo.owl#inst104_KEGGMap_hsa04110_Abst_Gene_Group_Abst_Gene_hsa_23594_Abst_Gene_hsa_23595_Abst_Gene_hsa_4998_Abst_Gene_hsa_4999_Abst_Gene_hsa_5000_Abst_Gene_hsa_5001>&&hsa04110&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4318>&&&MMP9, CLG4B, GELB, MANDP2, MMP-9; matrix metallopeptidase 9 (EC:3.4.24.35); K01403 matrix metalloproteinase-9 (gelatinase B) [EC:3.4.24.35] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_10161_Abst_Gene_hsa_10681_Abst_Gene_hsa_1128_Abst_Gene_hsa_1129_Abst_Gene_hsa_1902_Abst_Gene_hsa_2149_Abst_Gene_hsa_23566_Abst_Gene_hsa_2782_Abst_Gene_hsa_2783_Abst_Gene_hsa_2784_Abst_Gene_hsa_2785_Abst_Gene_hsa_2786_Abst_Gene_hsa_2787_Abst_Gene_hsa_2788_Abst_Gene_hsa_2790_Abst_Gene_hsa_2791_Abst_Gene_hsa_2792_Abst_Gene_hsa_2793_Abst_Gene_hsa_2846_Abst_Gene_hsa_51764_Abst_Gene_hsa_54331_Abst_Gene_hsa_55970_Abst_Gene_hsa_57121_Abst_Gene_hsa_59345_Abst_Gene_hsa_648044_Abst_Gene_hsa_9170_Abst_Gene_hsa_94235>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst7_KEGGMap_hsa04210_Abst_Gene_hsa_596>&R&hsa04210&BCL2, Bcl-2, PPP1R50; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2 
<http://www.inferico.com/kegg-cmpo.owl#inst188_KEGGMap_hsa05200_Abst_Gene_hsa_51384family>&L&hsa05200&WNT3A; wingless-type MMTV integration site family, member 3A; K00312 wingless-type MMTV integration site family, member 3 WNT7B; wingless-type MMTV integration site family, member 7B; K00572 wingless-type MMTV integration site family, member 7 WNT8A, WNT8D; wingless-type MMTV integration site family, member 8A; K00714 wingless-type MMTV integration site family, member 8 WNT8B; wingless-type MMTV integration site family, member 8B; K00714 wingless-type MMTV integration site family, member 8 WNT1, BMND16, INT1, OI15; wingless-type MMTV integration site family, member 1; K03209 wingless-type MMTV integration site family, member 1 WNT2, INT1L1, IRP; wingless-type MMTV integration site family member 2; K00182 wingless-type MMTV integration site family, member 2 WNT3, INT4, TETAMS; wingless-type MMTV integration site family, member 3; K00312 wingless-type MMTV integration site family, member 3 WNT5A, hWNT5A; wingless-type MMTV integration site family, member 5A; K00444 wingless-type MMTV integration site family, member 5 WNT4, SERKAL, WNT-4; wingless-type MMTV integration site family, member 4; K00408 wingless-type MMTV integration site family, member 4 WNT6; wingless-type MMTV integration site family, member 6; K00445 wingless-type MMTV integration site family, member 6 WNT7A; wingless-type MMTV integration site family, member 7A; K00572 wingless-type MMTV integration site family, member 7 WNT16; wingless-type MMTV integration site family, member 16; K01558 wingless-type MMTV integration site family, member 16 WNT11, HWNT11; wingless-type MMTV integration site family, member 11; K01384 wingless-type MMTV integration site family, member 11 WNT2B, WNT13; wingless-type MMTV integration site family, member 2B; K00182 wingless-type MMTV integration site family, member 2 WNT9A, WNT14; wingless-type MMTV integration site family, member 9A; K01064 wingless-type MMTV integration site family, member 9 WNT9B, WNT14B, WNT15; wingless-type MMTV integration site family, member 9B; K01064 wingless-type MMTV integration site family, member 9 WNT10B, SHFM6, WNT-12; wingless-type MMTV integration site family, member 10B; K01357 wingless-type MMTV integration site family, member 10 WNT10A, OODD, SSPS, STHAG4; wingless-type MMTV integration site family, member 10A; K01357 wingless-type MMTV integration site family, member 10 WNT5B; wingless-type MMTV integration site family, member 5B; K00444 wingless-type MMTV integration site family, member 5 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3556>&&&IL1RAP, C3orf13, IL-1RAcP, IL1R3; interleukin 1 receptor accessory protein; K04723 interleukin 1 receptor accessory protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1026>&&&CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1; cyclin-dependent kinase inhibitor 1A (p21, Cip1); K06625 cyclin-dependent kinase inhibitor 1A 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1111>&&&CHEK1, CHK1; checkpoint kinase 1 (EC:2.7.11.1); K02216 serine/threonine-protein kinase Chk1 [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5601>&&&MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK; mitogen-activated protein kinase 9 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_650>&&&BMP2, BDA2, BMP2A; bone morphogenetic protein 2; K04662 bone morphogenetic protein 2/4 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5649>&&&RELN, LIS2, PRO1598, RL; reelin; K06249 reelin [EC:3.4.21.-] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5516>&&&PPP2CB, PP2Abeta, PP2CB; protein phosphatase 2, catalytic subunit, beta isozyme (EC:3.1.3.16); K04382 serine/threonine-protein phosphatase 2A catalytic subunit [EC:3.1.3.16] 
<http://www.inferico.com/kegg-cmpo.owl#inst73_KEGGMap_hsa04151_Abst_Gene_hsa_5594family>&&hsa04151&MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 mitogen-activated protein kinase 1/3 [EC:2.7.11.24] MAPK1, ERK, ERK-2, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk, p42-MAPK; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 mitogen-activated protein kinase 1/3 [EC:2.7.11.24] 
<http://www.inferico.com/kegg-cmpo.owl#inst203_KEGGMap_hsa05200_Abst_Gene_hsa_2277family>&&hsa05200&FIGF, VEGF-D, VEGFD; c-fos induced growth factor (vascular endothelial growth factor D); K05449 vascular endothelial growth factor C/D PGF, D12S1900, PGFL, PLGF, PlGF-2, SHGC-10760; placental growth factor; K16859 placenta growth factor VEGFA, MVCD1, VEGF, VPF; vascular endothelial growth factor A; K05448 vascular endothelial growth factor A VEGFB, VEGFL, VRF; vascular endothelial growth factor B; K16858 vascular endothelial growth factor B VEGFC, Flt4-L, LMPH1D, VRP; vascular endothelial growth factor C; K05449 vascular endothelial growth factor C/D 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_9126>&&&SMC3, BAM, BMH, CDLS3, CSPG6, HCAP, SMC3L1; structural maintenance of chromosomes 3; K06669 structural maintenance of chromosome 3 (chondroitin sulfate proteoglycan 6) 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6714>&&&SRC, ASV, SRC1, c-SRC, p60-Src; SRC proto-oncogene, non-receptor tyrosine kinase (EC:2.7.10.2); K05704 tyrosine-protein kinase Src [EC:2.7.10.2] 
<http://www.inferico.com/kegg-cmpo.owl#inst5_KEGGMap_hsa04012_Abst_Gene_hsa_2066>&&hsa04012&ERBB4, ALS19, HER4, p180erbB4; erb-b2 receptor tyrosine kinase 4 (EC:2.7.10.1); K05085 receptor tyrosine-protein kinase erbB-4 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6932>&&&TCF7, TCF-1; transcription factor 7 (T-cell specific, HMG-box); K02620 transcription factor 7 
<http://www.inferico.com/kegg-cmpo.owl#inst39_KEGGMap_hsa04012_Abst_Gene_hsa_9542>&&hsa04012&NRG2, DON1, HRG2, NTAK; neuregulin 2; K05456 neuregulin 2 
<http://www.inferico.com/kegg-cmpo.owl#inst40_KEGGMap_hsa04012_Abst_Gene_hsa_2002>&&hsa04012&ELK1; ELK1, member of ETS oncogene family; K04375 ETS domain-containing protein Elk-1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_54583>&&&EGLN1, C1orf12, ECYT3, HALAH, HIF-PH2, HIFPH2, HPH-2, HPH2, PHD2, SM20, ZMYND6; egl-9 family hypoxia-inducible factor 1 (EC:1.14.11.29); K09592 hypoxia-inducible factor prolyl hydroxylase [EC:1.14.11.29] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5515>&&&PPP2CA, PP2Ac, PP2CA, PP2Calpha, RP-C; protein phosphatase 2, catalytic subunit, alpha isozyme (EC:3.1.3.16); K04382 serine/threonine-protein phosphatase 2A catalytic subunit [EC:3.1.3.16] 
<http://www.inferico.com/kegg-cmpo.owl#inst35_KEGGMap_hsa04210_Abst_Gene_hsa_10000family>&&hsa04210&AKT3, MPPH, MPPH2, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1] AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1] AKT2, HIHGHH, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst50_KEGGMap_hsa04014_Abst_Gene_hsa_10125family>&&hsa04014&RASGRP1, CALDAG-GEFI, CALDAG-GEFII, RASGRP, V, hRasGRP1; RAS guanyl releasing protein 1 (calcium and DAG-regulated); K04350 RAS guanyl-releasing protein 1 RASGRP2, CALDAG-GEFI, CDC25L; RAS guanyl releasing protein 2 (calcium and DAG-regulated); K12361 RAS guanyl-releasing protein 2 RASGRP3, GRP3; RAS guanyl releasing protein 3 (calcium and DAG-regulated); K12362 RAS guanyl-releasing protein 3 RASGRP4; RAS guanyl releasing protein 4; K12363 RAS guanyl-releasing protein 4 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_699>&&&BUB1, BUB1A, BUB1L, hBUB1; BUB1 mitotic checkpoint serine/threonine kinase (EC:2.7.11.1); K02178 checkpoint serine/threonine-protein kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7471>&LR&&WNT1, BMND16, INT1, OI15; wingless-type MMTV integration site family, member 1; K03209 wingless-type MMTV integration site family, member 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2792>&&&GNGT1, GNG1; guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1; K04548 guanine nucleotide-binding protein G(T) subunit gamma-T1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_23594_Abst_Gene_hsa_23595_Abst_Gene_hsa_4998_Abst_Gene_hsa_4999_Abst_Gene_hsa_5000_Abst_Gene_hsa_5001>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst265_KEGGMap_hsa05200_Abst_Gene_Group_Abst_Gene_hsa_6921_Abst_Gene_hsa_6923_Abst_Gene_hsa_7428_Abst_Gene_hsa_8453_Abst_Gene_hsa_9978>&R&hsa05200&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1028>&&&CDKN1C, BWCR, BWS, KIP2, WBS, p57, p57Kip2; cyclin-dependent kinase inhibitor 1C (p57, Kip2); K09993 cyclin-dependent kinase inhibitor 1C 
<http://www.inferico.com/kegg-cmpo.owl#inst52_KEGGMap_hsa05200_Abst_Gene_hsa_1027>&L&hsa05200&CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1; cyclin-dependent kinase inhibitor 1B (p27, Kip1); K06624 cyclin-dependent kinase inhibitor 1B 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3554>&&&IL1R1, CD121A, D2S1473, IL-1R-alpha, IL1R, IL1RA, P80; interleukin 1 receptor, type I; K04386 interleukin 1 receptor type I 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_57521>&&&RPTOR, KOG1, Mip1; regulatory associated protein of MTOR, complex 1; K07204 regulatory associated protein of mTOR 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_652>&&&BMP4, BMP2B, BMP2B1, MCOPS6, OFC11, ZYME; bone morphogenetic protein 4; K04662 bone morphogenetic protein 2/4 
<http://www.inferico.com/kegg-cmpo.owl#inst146_KEGGMap_hsa05200_Abst_Gene_hsa_5468>&&hsa05200&PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma; peroxisome proliferator-activated receptor gamma; K08530 peroxisome proliferator-activated receptor gamma 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_123745>&&&PLA2G4E; phospholipase A2, group IVE (EC:3.1.1.4); K16342 cytosolic phospholipase A2 [EC:3.1.1.4] 
<http://www.inferico.com/kegg-cmpo.owl#inst12_KEGGMap_hsa04151_Abst_Gene_hsa_7248>&RL&hsa04151&TSC1, LAM, TSC; tuberous sclerosis 1; K07206 tuberous sclerosis 1 
<http://www.inferico.com/kegg-cmpo.owl#inst49_KEGGMap_hsa04110_Abst_Gene_hsa_7157>&C&hsa04110&TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2793>&&&GNGT2, G-GAMMA-8, G-GAMMA-C, GNG8, GNG9, GNGT8; guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2; K04549 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 
<http://www.inferico.com/kegg-cmpo.owl#inst16_KEGGMap_hsa04110_Abst_Gene_hsa_4175>&&hsa04110&MCM6, MCG40308, Mis5, P105MCM; minichromosome maintenance complex component 6 (EC:3.6.4.12); K02542 DNA replication licensing factor MCM6 [EC:3.6.4.12] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1027>&L&&CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1; cyclin-dependent kinase inhibitor 1B (p27, Kip1); K06624 cyclin-dependent kinase inhibitor 1B 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3688>&&&ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12); K05719 integrin beta 1 
<http://www.inferico.com/kegg-cmpo.owl#inst13_KEGGMap_hsa05220_Abst_Gene_hsa_1487family>&&hsa05220&CTBP2; C-terminal binding protein 2; K04496 C-terminal binding protein CTBP1, BARS; C-terminal binding protein 1; K04496 C-terminal binding protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7472>&LR&&WNT2, INT1L1, IRP; wingless-type MMTV integration site family member 2; K00182 wingless-type MMTV integration site family, member 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3552>&&&IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1; interleukin 1, alpha; K04383 interleukin 1 alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1022>&&&CDK7, CAK1, CDKN7, HCAK, MO15, STK1, p39MO15; cyclin-dependent kinase 7 (EC:2.7.11.23 2.7.11.22); K02202 cyclin-dependent kinase 7 [EC:2.7.11.22 2.7.11.23] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8453>&&&CUL2; cullin 2; K03870 cullin 2 
<http://www.inferico.com/kegg-cmpo.owl#inst76_KEGGMap_hsa04110_Abst_Gene_hsa_8379>&&hsa04110&MAD1L1, MAD1, PIG9, TP53I9, TXBP181; MAD1 mitotic arrest deficient-like 1 (yeast); K06638 mitotic spindle assembly checkpoint protein MAD1 
<http://www.inferico.com/kegg-cmpo.owl#inst28_KEGGMap_hsa04110_Abst_Gene_hsa_699>&&hsa04110&BUB1, BUB1A, BUB1L, hBUB1; BUB1 mitotic checkpoint serine/threonine kinase (EC:2.7.11.1); K02178 checkpoint serine/threonine-protein kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst4_KEGGMap_hsa04012_Abst_Gene_hsa_2066>&&hsa04012&ERBB4, ALS19, HER4, p180erbB4; erb-b2 receptor tyrosine kinase 4 (EC:2.7.10.1); K05085 receptor tyrosine-protein kinase erbB-4 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst106_KEGGMap_hsa04110_Abst_Gene_Group_Abst_Gene_hsa_10926_Abst_Gene_hsa_8317>&&hsa04110&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2790>&&&GNG10; guanine nucleotide binding protein (G protein), gamma 10; K04545 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1288>&&&COL4A6, CXDELq22.3, DELXq22.3, DFNX6; collagen, type IV, alpha 6; K06237 collagen, type IV, alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7473>&LR&&WNT3, INT4, TETAMS; wingless-type MMTV integration site family, member 3; K00312 wingless-type MMTV integration site family, member 3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3685>&&&ITGAV, CD51, MSK8, VNRA, VTNR; integrin, alpha V; K06487 integrin alpha V 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1021>&&&CDK6, MCPH12, PLSTIRE; cyclin-dependent kinase 6 (EC:2.7.11.22); K02091 cyclin-dependent kinase 6 [EC:2.7.11.22] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8321>&&&FZD1; frizzled class receptor 1; K02432 frizzled 1/7 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5863>&&&RGL2, HKE1.5, KE1.5, RAB2L; ral guanine nucleotide dissociation stimulator-like 2; K17636 ral guanine nucleotide dissociation stimulator-like 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8454>&&&CUL1; cullin 1; K03347 cullin 1 
<http://www.inferico.com/kegg-cmpo.owl#inst8_KEGGMap_hsa05200_Abst_Gene_hsa_51384family>&R&hsa05200&WNT3A; wingless-type MMTV integration site family, member 3A; K00312 wingless-type MMTV integration site family, member 3 WNT7B; wingless-type MMTV integration site family, member 7B; K00572 wingless-type MMTV integration site family, member 7 WNT8A, WNT8D; wingless-type MMTV integration site family, member 8A; K00714 wingless-type MMTV integration site family, member 8 WNT8B; wingless-type MMTV integration site family, member 8B; K00714 wingless-type MMTV integration site family, member 8 WNT1, BMND16, INT1, OI15; wingless-type MMTV integration site family, member 1; K03209 wingless-type MMTV integration site family, member 1 WNT2, INT1L1, IRP; wingless-type MMTV integration site family member 2; K00182 wingless-type MMTV integration site family, member 2 WNT3, INT4, TETAMS; wingless-type MMTV integration site family, member 3; K00312 wingless-type MMTV integration site family, member 3 WNT5A, hWNT5A; wingless-type MMTV integration site family, member 5A; K00444 wingless-type MMTV integration site family, member 5 WNT4, SERKAL, WNT-4; wingless-type MMTV integration site family, member 4; K00408 wingless-type MMTV integration site family, member 4 WNT6; wingless-type MMTV integration site family, member 6; K00445 wingless-type MMTV integration site family, member 6 WNT7A; wingless-type MMTV integration site family, member 7A; K00572 wingless-type MMTV integration site family, member 7 WNT16; wingless-type MMTV integration site family, member 16; K01558 wingless-type MMTV integration site family, member 16 WNT11, HWNT11; wingless-type MMTV integration site family, member 11; K01384 wingless-type MMTV integration site family, member 11 WNT2B, WNT13; wingless-type MMTV integration site family, member 2B; K00182 wingless-type MMTV integration site family, member 2 WNT9A, WNT14; wingless-type MMTV integration site family, member 9A; K01064 wingless-type MMTV integration site family, member 9 WNT9B, WNT14B, WNT15; wingless-type MMTV integration site family, member 9B; K01064 wingless-type MMTV integration site family, member 9 WNT10B, SHFM6, WNT-12; wingless-type MMTV integration site family, member 10B; K01357 wingless-type MMTV integration site family, member 10 WNT10A, OODD, SSPS, STHAG4; wingless-type MMTV integration site family, member 10A; K01357 wingless-type MMTV integration site family, member 10 WNT5B; wingless-type MMTV integration site family, member 5B; K00444 wingless-type MMTV integration site family, member 5 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2791>&&&GNG11, GNGT11; guanine nucleotide binding protein (G protein), gamma 11; K04546 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1902>&&&LPAR1, EDG2, GPR26, Gpcr26, LPA1, Mrec1.3, VZG1, edg-2, rec.1.3, vzg-1; lysophosphatidic acid receptor 1; K04289 lysophosphatidic acid receptor 1 
<http://www.inferico.com/kegg-cmpo.owl#inst262_KEGGMap_hsa05200_Abst_Gene_Group_Abst_Gene_hsa_1017_Abst_Gene_hsa_898_Abst_Gene_hsa_9134>&&hsa05200&
<http://www.inferico.com/kegg-cmpo.owl#inst64_KEGGMap_hsa04014_Abst_Gene_hsa_23533family>&L&hsa04014&PIK3R3, p55, p55-GAMMA, p55PIK; phosphoinositide-3-kinase, regulatory subunit 3 (gamma); K02649 phosphoinositide-3-kinase, regulatory subunit PIK3R5, F730038I15Rik, FOAP-2, P101-PI3K, p101; phosphoinositide-3-kinase, regulatory subunit 5; K02649 phosphoinositide-3-kinase, regulatory subunit PIK3CA, CLOVE, CWS5, MCAP, MCM, MCMTC, PI3K, p110-alpha; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (EC:2.7.11.1 2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] PIK3R2, MPPH, MPPH1, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit PIK3R1, AGM7, GRB1, IMD36, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3, p110gamma, p120-PI3K; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma (EC:2.7.11.1 2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] PIK3CD, APDS, IMD14, P110DELTA, PI3K, p110D; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] PIK3CB, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] 
<http://www.inferico.com/kegg-cmpo.owl#inst11_KEGGMap_hsa04151_Abst_Gene_hsa_7249>&RL&hsa04151&TSC2, LAM, PPP1R160, TSC4; tuberous sclerosis 2; K07207 tuberous sclerosis 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7474>&LR&&WNT5A, hWNT5A; wingless-type MMTV integration site family, member 5A; K00444 wingless-type MMTV integration site family, member 5 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1287>&&&COL4A5, ASLN, ATS, CA54; collagen, type IV, alpha 5; K06237 collagen, type IV, alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3553>&&&IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1 beta 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8322>&&&FZD4, CD344, EVR1, FEVR, FZD4S, Fz-4, Fz4, FzE4, GPCR, hFz4; frizzled class receptor 4; K02354 frizzled 4 
<http://www.inferico.com/kegg-cmpo.owl#inst26_KEGGMap_hsa04014_Abst_Gene_hsa_5578family>&L&hsa04014&PRKCB, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13] PRKCA, AAG6, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13] PRKCG, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_54361>&LR&&WNT4, SERKAL, WNT-4; wingless-type MMTV integration site family, member 4; K00408 wingless-type MMTV integration site family, member 4 
<http://www.inferico.com/kegg-cmpo.owl#inst24_KEGGMap_hsa04110_Abst_Gene_hsa_5347>&&hsa04110&PLK1, PLK, STPK13; polo-like kinase 1 (EC:2.7.11.21); K06631 polo-like kinase 1 [EC:2.7.11.21] 
<http://www.inferico.com/kegg-cmpo.owl#inst19_KEGGMap_hsa05200_Abst_Gene_hsa_25family>&R&hsa05200&BCR, ALL, BCR1, CML, D22S11, D22S662, PHL; breakpoint cluster region (EC:2.7.11.1); K08878 breakpoint cluster region protein [EC:2.7.11.1] ABL1, ABL, JTK7, bcr/abl, c-ABL, c-ABL1, p150, v-abl; ABL proto-oncogene 1, non-receptor tyrosine kinase (EC:2.7.10.2); K06619 abelson tyrosine-protein kinase 1 [EC:2.7.10.2] 
<http://www.inferico.com/kegg-cmpo.owl#inst56_KEGGMap_hsa04012_Abst_Gene_hsa_3725>&L&hsa04012&JUN, AP-1, AP1, c-Jun; jun proto-oncogene; K04448 transcription factor AP-1 
<http://www.inferico.com/kegg-cmpo.owl#inst100_KEGGMap_hsa04014_Abst_Gene_hsa_5966>&L&hsa04014&REL, C-Rel; v-rel avian reticuloendotheliosis viral oncogene homolog; K09254 c-Rel proto-oncogene protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4312>&&&MMP1, CLG, CLGN; matrix metallopeptidase 1 (EC:3.4.24.7); K01388 matrix metalloproteinase-1 (interstitial collagenase) [EC:3.4.24.7] 
<http://www.inferico.com/kegg-cmpo.owl#inst11_KEGGMap_hsa05220_Abst_Gene_hsa_7040family>&&hsa05220&TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1 TGFB2, LDS4, TGF-beta2; transforming growth factor, beta 2; K13376 transforming growth factor beta-2 TGFB3, ARVD, ARVD1, RNHF, TGF-beta3; transforming growth factor, beta 3; K13377 transforming growth factor beta-3 
<http://www.inferico.com/kegg-cmpo.owl#inst35_KEGGMap_hsa04012_Abst_Gene_hsa_23624family>&L&hsa04012&CBLC, CBL-3, CBL-SL, RNF57; Cbl proto-oncogene C, E3 ubiquitin protein ligase; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19] CBL, C-CBL, CBL2, FRA11B, NSLL, RNF55; Cbl proto-oncogene, E3 ubiquitin protein ligase; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19] CBLB, Cbl-b, Nbla00127, RNF56; Cbl proto-oncogene B, E3 ubiquitin protein ligase; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7124>&&&TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_2064_Abst_Gene_hsa_2066>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7039>&&&TGFA, TFGA; transforming growth factor, alpha; K08774 transforming growth factor, alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7475>&LR&&WNT6; wingless-type MMTV integration site family, member 6; K00445 wingless-type MMTV integration site family, member 6 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3551>&&&IKBKB, IKK-beta, IKK2, IKKB, IMD15, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10] 
<http://www.inferico.com/kegg-cmpo.owl#inst8_KEGGMap_hsa04012_Abst_Gene_hsa_6776family>&&hsa04012&STAT5B, STAT5; signal transducer and activator of transcription 5B; K11224 signal transducer and activator of transcription 5B STAT5A, MGF, STAT5; signal transducer and activator of transcription 5A; K11223 signal transducer and activator of transcription 5A 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8323>&&&FZD6, FZ-6, FZ6, HFZ6, NDNC10; frizzled class receptor 6; K02376 frizzled 6 
<http://www.inferico.com/kegg-cmpo.owl#inst63_KEGGMap_hsa04151_Abst_Gene_hsa_842>&&hsa04151&CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62] 
<http://www.inferico.com/kegg-cmpo.owl#inst62_KEGGMap_hsa04014_Abst_Gene_hsa_83593>&L&hsa04014&RASSF5, Maxp1, NORE1, NORE1A, NORE1B, RAPL, RASSF3; Ras association (RalGDS/AF-6) domain family member 5; K08015 Ras association domain-containing protein 5 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2002>&&&ELK1; ELK1, member of ETS oncogene family; K04375 ETS domain-containing protein Elk-1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2353>&&&FOS, AP-1, C-FOS, p55; FBJ murine osteosarcoma viral oncogene homolog; K04379 proto-oncogene protein c-fos 
<http://www.inferico.com/kegg-cmpo.owl#inst10_KEGGMap_hsa04110_Abst_Gene_hsa_23595>&&hsa04110&ORC3, LAT, LATHEO, ORC3L; origin recognition complex, subunit 3; K02605 origin recognition complex subunit 3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_2064_Abst_Gene_hsa_2065>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4313>&&&MMP2, CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1; matrix metallopeptidase 2 (EC:3.4.24.24); K01398 matrix metalloproteinase-2 (gelatinase A) [EC:3.4.24.24] 
<http://www.inferico.com/kegg-cmpo.owl#inst84_KEGGMap_hsa04151_Abst_Gene_hsa_10319family>&&hsa04151&LAMB1, CLM, LIS5; laminin, beta 1; K05636 laminin, beta 1 LAMB2, LAMS, NPHS5; laminin, beta 2 (laminin S); K06243 laminin, beta 2 COL5A2, EDSC; collagen, type V, alpha 2; K06236 collagen, type I/II/III/V/XI/XXIV/XXVII, alpha LAMA4, CMD1JJ, LAMA3, LAMA4*-1; laminin, alpha 4; K06241 laminin, alpha 4 IBSP, BNSP, BSP, BSP-II, SP-II; integrin-binding sialoprotein; K06253 integrin binding sialoprotein LAMA5; laminin, alpha 5; K06240 laminin, alpha 3/5 LAMC2, B2T, BM600, CSF, EBR2, EBR2A, LAMB2T, LAMNB2; laminin, gamma 2; K06246 laminin, gamma 2 COL6A2, PP3610; collagen, type VI, alpha 2; K06238 collagen, type VI, alpha COL6A1, OPLL; collagen, type VI, alpha 1; K06238 collagen, type VI, alpha LAMB3, AI1A, BM600-125KDA, LAM5, LAMNB1; laminin, beta 3; K06244 laminin, beta 3 COL6A3; collagen, type VI, alpha 3; K06238 collagen, type VI, alpha LAMC1, LAMB2; laminin, gamma 1 (formerly LAMB2); K05635 laminin, gamma 1 RELN, LIS2, PRO1598, RL; reelin; K06249 reelin [EC:3.4.21.-] COL4A6, CXDELq22.3, DELXq22.3, DFNX6; collagen, type IV, alpha 6; K06237 collagen, type IV, alpha COL4A5, ASLN, ATS, CA54; collagen, type IV, alpha 5; K06237 collagen, type IV, alpha COL5A1, EDSC; collagen, type V, alpha 1; K06236 collagen, type I/II/III/V/XI/XXIV/XXVII, alpha COL24A1; collagen, type XXIV, alpha 1; K06236 collagen, type I/II/III/V/XI/XXIV/XXVII, alpha LAMC3, OCCM; laminin, gamma 3; K06247 laminin, gamma 3 VTN, V75, VN, VNT; vitronectin; K06251 vitronectin COL11A1, CO11A1, COLL6, STL2; collagen, type XI, alpha 1; K06236 collagen, type I/II/III/V/XI/XXIV/XXVII, alpha COL11A2, DFNA13, DFNB53, FBCG2, HKE5, PARP, STL3; collagen, type XI, alpha 2; K06236 collagen, type I/II/III/V/XI/XXIV/XXVII, alpha COL6A5, COL29A1, VWA4; collagen, type VI, alpha 5; K06238 collagen, type VI, alpha COL5A3; collagen, type V, alpha 3; K06236 collagen, type I/II/III/V/XI/XXIV/XXVII, alpha SPP1, BNSP, BSPI, ETA-1, OPN; secreted phosphoprotein 1; K06250 secreted phosphoprotein 1 LAMB4; laminin, beta 4; K06245 laminin, beta 4 TNN, TN-W; tenascin N; K06252 tenascin THBS4, TSP-4, TSP4; thrombospondin 4; K04659 thrombospondin 2/3/4/5 LAMA1, LAMA, PTBHS, S-LAM-alpha; laminin, alpha 1; K05637 laminin, alpha 1/2 THBS1, THBS, THBS-1, TSP, TSP-1, TSP1; thrombospondin 1; K16857 thrombospondin 1 FN1, CIG, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF; fibronectin 1; K05717 fibronectin 1 TNR, TN-R; tenascin R; K06252 tenascin THBS2, TSP2; thrombospondin 2; K04659 thrombospondin 2/3/4/5 THBS3, TSP3; thrombospondin 3; K04659 thrombospondin 2/3/4/5 VWF, F8VWF, VWD; von Willebrand factor; K03900 von Willebrand factor TNXB, EDS3, HXBL, TENX, TN-X, TNX, TNXB1, TNXB2, TNXBS, VUR8, XB, XBS; tenascin XB; K06252 tenascin COMP, EDM1, EPD1, MED, PSACH, THBS5; cartilage oligomeric matrix protein; K04659 thrombospondin 2/3/4/5 TNC, 150-225, DFNA56, GMEM, GP, HXB, JI, TN, TN-C; tenascin C; K06252 tenascin COL27A1, STLS; collagen, type XXVII, alpha 1; K06236 collagen, type I/II/III/V/XI/XXIV/XXVII, alpha COL4A2, ICH, POREN2; collagen, type IV, alpha 2; K06237 collagen, type IV, alpha LAMA2, LAMM; laminin, alpha 2; K05637 laminin, alpha 1/2 LAMA3, BM600, E170, LAMNA, LOCS; laminin, alpha 3; K06240 laminin, alpha 3/5 COL4A4, CA44; collagen, type IV, alpha 4; K06237 collagen, type IV, alpha COL4A3; collagen, type IV, alpha 3 (Goodpasture antigen); K06237 collagen, type IV, alpha COL2A1, ANFH, AOM, COL11A3, SEDC, STL1; collagen, type II, alpha 1; K06236 collagen, type I/II/III/V/XI/XXIV/XXVII, alpha COL4A1, BSVD, RATOR; collagen, type IV, alpha 1; K06237 collagen, type IV, alpha COL3A1, EDS4A; collagen, type III, alpha 1; K06236 collagen, type I/II/III/V/XI/XXIV/XXVII, alpha CHAD, SLRR4A; chondroadherin; K06248 chondroadherin COL1A2, OI4; collagen, type I, alpha 2; K06236 collagen, type I/II/III/V/XI/XXIV/XXVII, alpha COL1A1, EDSC, OI1, OI2, OI3, OI4; collagen, type I, alpha 1; K06236 collagen, type I/II/III/V/XI/XXIV/XXVII, alpha COL6A6; collagen, type VI, alpha 6; K06238 collagen, type VI, alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_29945>&&&ANAPC4, APC4; anaphase promoting complex subunit 4; K03351 anaphase-promoting complex subunit 4 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7476>&LR&&WNT7A; wingless-type MMTV integration site family, member 7A; K00572 wingless-type MMTV integration site family, member 7 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_1869_Abst_Gene_hsa_1870_Abst_Gene_hsa_1871_Abst_Gene_hsa_7027_Abst_Gene_hsa_7029>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst104_KEGGMap_hsa05200_Abst_Gene_hsa_2271>&RL&hsa05200&FH, FMRD, HLRCC, LRCC, MCL, MCUL1; fumarate hydratase (EC:4.2.1.2); K01679 fumarate hydratase, class II [EC:4.2.1.2] 
<http://www.inferico.com/kegg-cmpo.owl#inst64_KEGGMap_hsa04110_Abst_Gene_hsa_85417family>&&hsa04110&CCNB3; cyclin B3; K05868 cyclin B CCNB2, HsT17299; cyclin B2; K05868 cyclin B CCNB1, CCNB; cyclin B1; K05868 cyclin B 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1289>&&&COL5A1, EDSC; collagen, type V, alpha 1; K06236 collagen, type I/II/III/V/XI/XXIV/XXVII, alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_54541>&&&DDIT4, Dig2, REDD-1, REDD1; DNA-damage-inducible transcript 4; K08270 DNA-damage-inducible transcript 4 
<http://www.inferico.com/kegg-cmpo.owl#inst125_KEGGMap_hsa05200_Abst_Gene_hsa_4437>&&hsa05200&MSH3, DUP, MRP1; mutS homolog 3; K08736 DNA mismatch repair protein MSH3 
<http://www.inferico.com/kegg-cmpo.owl#inst12_KEGGMap_hsa04110_Abst_Gene_hsa_5000>&&hsa04110&ORC4, ORC4L, ORC4P; origin recognition complex, subunit 4; K02606 origin recognition complex subunit 4 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_9915>&&&ARNT2, WEDAS, bHLHe1; aryl-hydrocarbon receptor nuclear translocator 2; K15589 aryl hydrocarbon receptor nuclear translocator 2 
<http://www.inferico.com/kegg-cmpo.owl#inst51_KEGGMap_hsa04210_Abst_Gene_hsa_1439family>&&hsa04210&CSF2RB, CD131, CDw131, IL3RB, IL5RB, SMDP5; colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage); K04738 cytokine receptor common subunit beta IL3RA, CD123, IL3R, IL3RAY, IL3RX, IL3RY, hIL-3Ra; interleukin 3 receptor, alpha (low affinity); K04737 interleukin 3 receptor alpha 
<http://www.inferico.com/kegg-cmpo.owl#inst208_KEGGMap_hsa05200_Abst_Gene_hsa_1019>&&hsa05200&CDK4, CMM3, PSK-J3; cyclin-dependent kinase 4 (EC:2.7.11.22); K02089 cyclin-dependent kinase 4 [EC:2.7.11.22] 
<http://www.inferico.com/kegg-cmpo.owl#inst93_KEGGMap_hsa04014_Abst_Gene_ko_K10784family>&&hsa04014&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_2064_Abst_Gene_hsa_2064>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_10125>&&&RASGRP1, CALDAG-GEFI, CALDAG-GEFII, RASGRP, V, hRasGRP1; RAS guanyl releasing protein 1 (calcium and DAG-regulated); K04350 RAS guanyl-releasing protein 1 
<http://www.inferico.com/kegg-cmpo.owl#inst47_KEGGMap_hsa05220_Abst_Gene_hsa_1029>&CR&hsa05220&CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A; K06621 cyclin-dependent kinase inhibitor 2A 
<http://www.inferico.com/kegg-cmpo.owl#inst63_KEGGMap_hsa04210_Abst_Gene_hsa_8743>&&hsa04210&TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL; tumor necrosis factor (ligand) superfamily, member 10; K04721 tumor necrosis factor ligand superfamily member 10 
<http://www.inferico.com/kegg-cmpo.owl#inst46_KEGGMap_hsa05220_Abst_Gene_hsa_23533family>&&hsa05220&PIK3R3, p55, p55-GAMMA, p55PIK; phosphoinositide-3-kinase, regulatory subunit 3 (gamma); K02649 phosphoinositide-3-kinase, regulatory subunit PIK3R5, F730038I15Rik, FOAP-2, P101-PI3K, p101; phosphoinositide-3-kinase, regulatory subunit 5; K02649 phosphoinositide-3-kinase, regulatory subunit PIK3CA, CLOVE, CWS5, MCAP, MCM, MCMTC, PI3K, p110-alpha; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (EC:2.7.11.1 2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] PIK3R2, MPPH, MPPH1, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit PIK3R1, AGM7, GRB1, IMD36, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3, p110gamma, p120-PI3K; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma (EC:2.7.11.1 2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] PIK3CD, APDS, IMD14, P110DELTA, PI3K, p110D; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] PIK3CB, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_9470>&&&EIF4E2, 4E-LP, 4EHP, EIF4EL3, IF4e; eukaryotic translation initiation factor 4E family member 2; K03259 translation initiation factor 4E 
<http://www.inferico.com/kegg-cmpo.owl#inst64_KEGGMap_hsa04210_Abst_Gene_hsa_356>&&hsa04210&FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6; Fas ligand (TNF superfamily, member 6); K04389 tumor necrosis factor ligand superfamily member 6 
<http://www.inferico.com/kegg-cmpo.owl#inst54_KEGGMap_hsa04110_Abst_Gene_hsa_4087family>&&hsa04110&SMAD2, JV18, JV18-1, MADH2, MADR2, hMAD-2, hSMAD2; SMAD family member 2; K04500 mothers against decapentaplegic homolog 2/3 SMAD3, HSPC193, HsT17436, JV15-2, LDS1C, LDS3, MADH3; SMAD family member 3; K04500 mothers against decapentaplegic homolog 2/3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5609>&&&MAP2K7, JNKK2, MAPKK7, MEK, MEK_7, MKK7, PRKMK7, SAPKK-4, SAPKK4; mitogen-activated protein kinase kinase 7 (EC:2.7.12.2); K04431 mitogen-activated protein kinase kinase 7 [EC:2.7.12.2] 
<http://www.inferico.com/kegg-cmpo.owl#inst21_KEGGMap_hsa04012_Abst_Gene_hsa_2932>&&hsa04012&GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_22821>&R&&RASA3, GAP1IP4BP, GAPIII; RAS p21 protein activator 3; K12380 Ras GTPase-activating protein 3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8717>&&&TRADD, Hs.89862; TNFRSF1A-associated via death domain; K03171 tumor necrosis factor receptor type 1-associated DEATH domain protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7074>&&&TIAM1; T-cell lymphoma invasion and metastasis 1; K05731 T-lymphoma invasion and metastasis-inducing protein 1 
<http://www.inferico.com/kegg-cmpo.owl#inst65_KEGGMap_hsa04012_Abst_Gene_hsa_4609>&L&hsa04012&MYC, MRTL, MYCC, bHLHe39, c-Myc; v-myc avian myelocytomatosis viral oncogene homolog; K04377 Myc proto-oncogene protein 
<http://www.inferico.com/kegg-cmpo.owl#inst37_KEGGMap_hsa04014_Abst_Gene_hsa_356>&&hsa04014&FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6; Fas ligand (TNF superfamily, member 6); K04389 tumor necrosis factor ligand superfamily member 6 
<http://www.inferico.com/kegg-cmpo.owl#inst32_KEGGMap_hsa04210_Abst_Gene_hsa_841>&&hsa04210&CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61); K04398 caspase 8 [EC:3.4.22.61] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2885>&&&GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2 
<http://www.inferico.com/kegg-cmpo.owl#inst48_KEGGMap_hsa05200_Abst_Gene_hsa_2475>&&hsa05200&MTOR, FRAP, FRAP1, FRAP2, RAFT1, RAPT1; mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1); K07203 FKBP12-rapamycin complex-associated protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5296>&LR&&PIK3R2, MPPH, MPPH1, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit 
<http://www.inferico.com/kegg-cmpo.owl#inst70_KEGGMap_hsa04210_Abst_Gene_Group_Abst_Gene_hsa_11213_Abst_Gene_hsa_3654_Abst_Gene_hsa_3656_Abst_Gene_hsa_4615_Abst_Gene_hsa_51135>&&hsa04210&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2535>&&&FZD2, Fz2, fz-2, fzE2, hFz2; frizzled class receptor 2; K02235 frizzled 2 
<http://www.inferico.com/kegg-cmpo.owl#inst21_KEGGMap_hsa04151_Abst_Gene_hsa_1436family>&&hsa04151&NGFR, CD271, Gp80-LNGFR, TNFRSF16, p75(NTR), p75NTR; nerve growth factor receptor; K02583 nerve growth factor receptor (TNFR superfamily member 16) MET, AUTS9, HGFR, RCCP2, c-Met; MET proto-oncogene, receptor tyrosine kinase (EC:2.7.10.1); K05099 proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1] EGFR, ERBB, ERBB1, HER1, NISBD2, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1] INSR, CD220, HHF5; insulin receptor (EC:2.7.10.1); K04527 insulin receptor [EC:2.7.10.1] IGF1R, CD221, IGFIR, IGFR, JTK13; insulin-like growth factor 1 receptor (EC:2.7.10.1); K05087 insulin-like growth factor 1 receptor [EC:2.7.10.1] KDR, CD309, FLK1, VEGFR, VEGFR2; kinase insert domain receptor (EC:2.7.10.1); K05098 kinase insert domain protein receptor [EC:2.7.10.1] EPHA2, ARCC2, CTPA, CTPP1, CTRCT6, ECK; EPH receptor A2 (EC:2.7.10.1); K05103 Eph receptor A2 [EC:2.7.10.1] FLT1, FLT, FLT-1, VEGFR-1, VEGFR1; fms-related tyrosine kinase 1 (EC:2.7.10.1); K05096 FMS-like tyrosine kinase 1 [EC:2.7.10.1] CSF1R, C-FMS, CD115, CSF-1R, CSFR, FIM2, FMS, HDLS, M-CSF-R; colony stimulating factor 1 receptor (EC:2.7.10.1); K05090 macrophage colony-stimulating factor 1 receptor [EC:2.7.10.1] FLT4, FLT41, LMPH1A, PCL, VEGFR3; fms-related tyrosine kinase 4 (EC:2.7.10.1); K05097 FMS-like tyrosine kinase 4 [EC:2.7.10.1] TEK, CD202B, TIE-2, TIE2, VMCM, VMCM1; TEK tyrosine kinase, endothelial (EC:2.7.10.1); K05121 endothelial-specific receptor tyrosine kinase [EC:2.7.10.1] KIT, C-Kit, CD117, PBT, SCFR; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (EC:2.7.10.1); K05091 proto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1] PDGFRB, CD140B, IBGC4, IMF1, JTK12, PDGFR, PDGFR-1, PDGFR1; platelet-derived growth factor receptor, beta polypeptide (EC:2.7.10.1); K05089 platelet-derived growth factor receptor beta [EC:2.7.10.1] PDGFRA, CD140A, PDGFR-2, PDGFR2, RHEPDGFRA; platelet-derived growth factor receptor, alpha polypeptide (EC:2.7.10.1); K04363 platelet-derived growth factor receptor alpha [EC:2.7.10.1] FGFR2, BBDS, BEK, BFR-1, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25; fibroblast growth factor receptor 2 (EC:2.7.10.1); K05093 fibroblast growth factor receptor 2 [EC:2.7.10.1] FGFR4, CD334, JTK2, TKF; fibroblast growth factor receptor 4 (EC:2.7.10.1); K05095 fibroblast growth factor receptor 4 [EC:2.7.10.1] FGFR3, ACH, CD333, CEK2, HSFGFR3EX, JTK4; fibroblast growth factor receptor 3 (EC:2.7.10.1); K05094 fibroblast growth factor receptor 3 [EC:2.7.10.1] FGFR1, BFGFR, CD331, CEK, FGFBR, FGFR-1, FLG, FLT-2, FLT2, HBGFR, HH2, HRTFDS, KAL2, N-SAM, OGD, bFGF-R-1; fibroblast growth factor receptor 1 (EC:2.7.10.1); K04362 fibroblast growth factor receptor 1 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4846>&&&NOS3, ECNOS, eNOS; nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39); K13242 nitric-oxide synthase, endothelial [EC:1.14.13.39] 
<http://www.inferico.com/kegg-cmpo.owl#inst25_KEGGMap_hsa04014_Abst_Gene_hsa_51196>&&hsa04014&PLCE1, NPHS3, PLCE, PPLC; phospholipase C, epsilon 1 (EC:3.1.4.11); K05860 phosphatidylinositol phospholipase C, epsilon [EC:3.1.4.11] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5295>&LR&&PIK3R1, AGM7, GRB1, IMD36, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_29941>&&&PKN3, UTDP4-1; protein kinase N3 (EC:2.7.11.13); K06071 protein kinase N [EC:2.7.11.13] 
<http://www.inferico.com/kegg-cmpo.owl#inst44_KEGGMap_hsa04012_Abst_Gene_hsa_6654family>&&hsa04012&SOS2; son of sevenless homolog 2 (Drosophila); K03099 son of sevenless SOS1, GF1, GGF1, GINGF, HGF, NS4; son of sevenless homolog 1 (Drosophila); K03099 son of sevenless 
<http://www.inferico.com/kegg-cmpo.owl#inst38_KEGGMap_hsa04014_Abst_Gene_hsa_5599family>&&hsa04014&MAPK10, JNK3, JNK3A, PRKM10, SAPK1b, p493F12, p54bSAPK; mitogen-activated protein kinase 10 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24] MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK; mitogen-activated protein kinase 9 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24] MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c; mitogen-activated protein kinase 8 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_1017_Abst_Gene_hsa_1019_Abst_Gene_hsa_1021_Abst_Gene_hsa_595_Abst_Gene_hsa_894_Abst_Gene_hsa_896_Abst_Gene_hsa_898_Abst_Gene_hsa_9134>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst100_KEGGMap_hsa04151_Abst_Gene_hsa_5578family>&L&hsa04151&PRKCA, AAG6, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13] PRKCZ, PKC-ZETA, PKC2; protein kinase C, zeta (EC:2.7.11.13); K18952 atypical protein kinase C zeta type [EC:2.7.11.13] 
<http://www.inferico.com/kegg-cmpo.owl#inst223_KEGGMap_hsa05200_Abst_Gene_hsa_842>&&hsa05200&CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_613>&R&&BCR, ALL, BCR1, CML, D22S11, D22S662, PHL; breakpoint cluster region (EC:2.7.11.1); K08878 breakpoint cluster region protein [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst121_KEGGMap_hsa05200_Abst_Gene_hsa_7048>&&hsa05200&TGFBR2, AAT3, FAA3, LDS1B, LDS2, LDS2B, MFS2, RIIC, TAAD2, TGFR-2, TGFbeta-RII; transforming growth factor, beta receptor II (70/80kDa) (EC:2.7.11.30); K04388 TGF-beta receptor type-2 [EC:2.7.11.30] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4843>&&&NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39] 
<http://www.inferico.com/kegg-cmpo.owl#inst98_KEGGMap_hsa04110_Abst_Gene_hsa_7027family>&&hsa04110&TFDP2, DP2; transcription factor Dp-2 (E2F dimerization partner 2); K09392 transcription factor Dp-2 TFDP1, DP1, DRTF1, Dp-1; transcription factor Dp-1; K04683 transcription factor Dp-1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5294>&LR&&PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3, p110gamma, p120-PI3K; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma (EC:2.7.11.1 2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] 
<http://www.inferico.com/kegg-cmpo.owl#inst67_KEGGMap_hsa04151_Compound_cpd_C04637>&&hsa04151&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5605>&&&MAP2K2, CFC4, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_90993>&&&CREB3L1, OASIS; cAMP responsive element binding protein 3-like 1; K09048 cyclic AMP-responsive element-binding protein 3 
<http://www.inferico.com/kegg-cmpo.owl#inst25_KEGGMap_hsa04210_Abst_Gene_hsa_112401family>&&hsa04210&BIRC7, KIAP, LIVIN, ML-IAP, MLIAP, RNF50; baculoviral IAP repeat containing 7; K16061 baculoviral IAP repeat-containing protein 7/8 BIRC8, ILP-2, ILP2, hILP2; baculoviral IAP repeat containing 8; K16061 baculoviral IAP repeat-containing protein 7/8 BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1; baculoviral IAP repeat containing 2; K16060 baculoviral IAP repeat-containing protein 2/3 BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2; baculoviral IAP repeat containing 3; K16060 baculoviral IAP repeat-containing protein 2/3 XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3; X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase; K04725 E3 ubiquitin-protein ligase XIAP 
<http://www.inferico.com/kegg-cmpo.owl#inst79_KEGGMap_hsa04151_Abst_Gene_hsa_930>&&hsa04151&CD19, B4, CVID3; CD19 molecule; K06465 CD19 antigen 
<http://www.inferico.com/kegg-cmpo.owl#inst48_KEGGMap_hsa04151_Abst_Gene_hsa_28227family>&&hsa04151&PPP2R2B, B55BETA, PP2AB55BETA, PP2ABBETA, PP2APR55B, PP2APR55BETA, PR2AB55BETA, PR2ABBETA, PR2APR55BETA, PR52B, PR55-BETA, PR55BETA, SCA12; protein phosphatase 2, regulatory subunit B, beta (EC:3.1.3.16); K04354 serine/threonine-protein phosphatase 2A regulatory subunit B PPP2R2A, B55A, B55ALPHA, PR52A, PR55A; protein phosphatase 2, regulatory subunit B, alpha (EC:3.1.3.16); K04354 serine/threonine-protein phosphatase 2A regulatory subunit B PPP2CB, PP2Abeta, PP2CB; protein phosphatase 2, catalytic subunit, beta isozyme (EC:3.1.3.16); K04382 serine/threonine-protein phosphatase 2A catalytic subunit [EC:3.1.3.16] PPP2CA, PP2Ac, PP2CA, PP2Calpha, RP-C; protein phosphatase 2, catalytic subunit, alpha isozyme (EC:3.1.3.16); K04382 serine/threonine-protein phosphatase 2A catalytic subunit [EC:3.1.3.16] PPP2R1B, PP2A-Abeta, PR65B; protein phosphatase 2, regulatory subunit A, beta (EC:3.1.3.16); K03456 serine/threonine-protein phosphatase 2A regulatory subunit A PPP2R1A, PP2A-Aalpha, PP2AAALPHA, PR65A; protein phosphatase 2, regulatory subunit A, alpha (EC:3.1.3.16); K03456 serine/threonine-protein phosphatase 2A regulatory subunit A PPP2R2D, MDS026; protein phosphatase 2, regulatory subunit B, delta; K04354 serine/threonine-protein phosphatase 2A regulatory subunit B PPP2R5E; protein phosphatase 2, regulatory subunit B', epsilon isoform; K11584 serine/threonine-protein phosphatase 2A regulatory subunit B' PPP2R5D, B56D; protein phosphatase 2, regulatory subunit B', delta; K11584 serine/threonine-protein phosphatase 2A regulatory subunit B' PPP2R5C, B56G, PR61G; protein phosphatase 2, regulatory subunit B', gamma; K11584 serine/threonine-protein phosphatase 2A regulatory subunit B' PPP2R5B, B56B, PR61B; protein phosphatase 2, regulatory subunit B', beta; K11584 serine/threonine-protein phosphatase 2A regulatory subunit B' PPP2R5A, B56A, PR61A; protein phosphatase 2, regulatory subunit B', alpha; K11584 serine/threonine-protein phosphatase 2A regulatory subunit B' PPP2R3A, PPP2R3, PR130, PR72; protein phosphatase 2, regulatory subunit B'', alpha (EC:3.1.3.16); K11583 serine/threonine-protein phosphatase 2A regulatory subunit B'' PPP2R2C, B55-GAMMA, IMYPNO, IMYPNO1, PR52, PR55G; protein phosphatase 2, regulatory subunit B, gamma (EC:3.1.3.16); K04354 serine/threonine-protein phosphatase 2A regulatory subunit B PPP2R3C, C14orf10, G4-1, G5pr; protein phosphatase 2, regulatory subunit B'', gamma; K11583 serine/threonine-protein phosphatase 2A regulatory subunit B'' PPP2R3B, NYREN8, PPP2R3L, PPP2R3LY, PR48; protein phosphatase 2, regulatory subunit B'', beta; K11583 serine/threonine-protein phosphatase 2A regulatory subunit B'' 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5293>&LR&&PIK3CD, APDS, IMD14, P110DELTA, PI3K, p110D; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1029>&CR&&CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A; K06621 cyclin-dependent kinase inhibitor 2A 
<http://www.inferico.com/kegg-cmpo.owl#inst96_KEGGMap_hsa04110_Abst_Gene_hsa_7027family>&&hsa04110&TFDP2, DP2; transcription factor Dp-2 (E2F dimerization partner 2); K09392 transcription factor Dp-2 TFDP1, DP1, DRTF1, Dp-1; transcription factor Dp-1; K04683 transcription factor Dp-1 
<http://www.inferico.com/kegg-cmpo.owl#inst9_KEGGMap_hsa04210_Abst_Gene_hsa_7157>&CL&hsa04210&TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53 
<http://www.inferico.com/kegg-cmpo.owl#inst2_KEGGMap_hsa05200_Abst_Gene_hsa_1630>&&hsa05200&DCC, CRC18, CRCR1, IGDCC1, MRMV1, NTN1R1; DCC netrin 1 receptor; K06765 deleted in colorectal carcinoma 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5604>&&&MAP2K1, CFC3, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2] 
<http://www.inferico.com/kegg-cmpo.owl#inst91_KEGGMap_hsa04014_Compound_cpd_C00076>&&hsa04014&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5519>&&&PPP2R1B, PP2A-Abeta, PR65B; protein phosphatase 2, regulatory subunit A, beta (EC:3.1.3.16); K03456 serine/threonine-protein phosphatase 2A regulatory subunit A 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_51384>&LR&&WNT16; wingless-type MMTV integration site family, member 16; K01558 wingless-type MMTV integration site family, member 16 
<http://www.inferico.com/kegg-cmpo.owl#inst99_KEGGMap_hsa05200_Abst_Gene_hsa_5727>&&hsa05200&PTCH1, BCNS, HPE7, NBCCS, PTC, PTC1, PTCH, PTCH11; patched 1; K06225 patched 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_85417>&&&CCNB3; cyclin B3; K05868 cyclin B 
<http://www.inferico.com/kegg-cmpo.owl#inst263_KEGGMap_hsa05200_Abst_Gene_Group_Abst_Gene_hsa_27148_Abst_Gene_hsa_51684>&&hsa05200&
<http://www.inferico.com/kegg-cmpo.owl#inst10_KEGGMap_hsa04014_Compound_cpd_C05981>&&hsa04014&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3558>&R&&IL2, IL-2, TCGF, lymphokine; interleukin 2; K05429 interleukin 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3643>&&&INSR, CD220, HHF5; insulin receptor (EC:2.7.10.1); K04527 insulin receptor [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst56_KEGGMap_hsa04014_Abst_Gene_hsa_83593>&&hsa04014&RASSF5, Maxp1, NORE1, NORE1A, NORE1B, RAPL, RASSF3; Ras association (RalGDS/AF-6) domain family member 5; K08015 Ras association domain-containing protein 5 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5518>&&&PPP2R1A, PP2A-Aalpha, PP2AAALPHA, PR65A; protein phosphatase 2, regulatory subunit A, alpha (EC:3.1.3.16); K03456 serine/threonine-protein phosphatase 2A regulatory subunit A 
<http://www.inferico.com/kegg-cmpo.owl#inst80_KEGGMap_hsa04014_Abst_Gene_hsa_6654>&&hsa04014&SOS1, GF1, GGF1, GINGF, HGF, NS4; son of sevenless homolog 1 (Drosophila); K03099 son of sevenless 
<http://www.inferico.com/kegg-cmpo.owl#inst33_KEGGMap_hsa04210_Abst_Gene_hsa_843>&&hsa04210&CASP10, ALPS2, FLICE2, MCH4; caspase 10, apoptosis-related cysteine peptidase (EC:3.4.22.63); K04400 caspase 10 [EC:3.4.22.63] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5869>&&&RAB5B; RAB5B, member RAS oncogene family; K07888 Ras-related protein Rab-5B 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_7046_Abst_Gene_hsa_7048>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_701>&RL&&BUB1B, BUB1beta, BUBR1, Bub1A, MAD3L, MVA1, SSK1, hBUBR1; BUB1 mitotic checkpoint serine/threonine kinase B (EC:2.7.11.1); K06637 mitotic checkpoint serine/threonine-protein kinase BUB1 beta [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst90_KEGGMap_hsa04151_Abst_Gene_hsa_3716family>&R&hsa04151&JAK3, JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK; Janus kinase 3 (EC:2.7.10.2); K11218 Janus kinase 3 [EC:2.7.10.2] JAK1, JAK1A, JAK1B, JTK3; Janus kinase 1 (EC:2.7.10.2); K11217 Janus kinase 1 [EC:2.7.10.2] JAK2, JTK10, THCYT3; Janus kinase 2 (EC:2.7.10.2); K04447 Janus kinase 2 [EC:2.7.10.2] 
<http://www.inferico.com/kegg-cmpo.owl#inst113_KEGGMap_hsa04110_Abst_Gene_Group_Abst_Gene_hsa_10459_Abst_Gene_hsa_4085_Abst_Gene_hsa_701_Abst_Gene_hsa_9184>&R&hsa04110&
<http://www.inferico.com/kegg-cmpo.owl#inst75_KEGGMap_hsa04151_Abst_Gene_hsa_23533family>&&hsa04151&PIK3R5, F730038I15Rik, FOAP-2, P101-PI3K, p101; phosphoinositide-3-kinase, regulatory subunit 5; K02649 phosphoinositide-3-kinase, regulatory subunit PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3, p110gamma, p120-PI3K; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma (EC:2.7.11.1 2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_283748>&&&PLA2G4D, cPLA2delta; phospholipase A2, group IVD (cytosolic) (EC:3.1.1.4); K16342 cytosolic phospholipase A2 [EC:3.1.1.4] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5291>&LR&&PIK3CB, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] 
<http://www.inferico.com/kegg-cmpo.owl#inst31_KEGGMap_hsa04014_Compound_cpd_C00076>&&hsa04014&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_4087_Abst_Gene_hsa_4088_Abst_Gene_hsa_4089>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_10342>&R&&TFG, HMSNP, SPG57, TF6, TRKT3; TRK-fused gene; K09292 protein TFG 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6934>&&&TCF7L2, TCF-4, TCF4; transcription factor 7-like 2 (T-cell specific, HMG-box); K04491 transcription factor 7-like 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3559>&&&IL2RA, CD25, IDDM10, IL2R, TCGFR, p55; interleukin 2 receptor, alpha; K05068 interleukin 2 receptor alpha 
<http://www.inferico.com/kegg-cmpo.owl#inst64_KEGGMap_hsa04012_Abst_Gene_hsa_145957>&&hsa04012&NRG4, HRG4; neuregulin 4; K05458 neuregulin 4 
<http://www.inferico.com/kegg-cmpo.owl#inst211_KEGGMap_hsa05200_Abst_Gene_hsa_4312family>&&hsa05200&MMP9, CLG4B, GELB, MANDP2, MMP-9; matrix metallopeptidase 9 (EC:3.4.24.35); K01403 matrix metalloproteinase-9 (gelatinase B) [EC:3.4.24.35] MMP1, CLG, CLGN; matrix metallopeptidase 1 (EC:3.4.24.7); K01388 matrix metalloproteinase-1 (interstitial collagenase) [EC:3.4.24.7] MMP2, CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1; matrix metallopeptidase 2 (EC:3.4.24.24); K01398 matrix metalloproteinase-2 (gelatinase A) [EC:3.4.24.24] 
<http://www.inferico.com/kegg-cmpo.owl#inst29_KEGGMap_hsa05220_Abst_Gene_hsa_6654family>&&hsa05220&SOS2; son of sevenless homolog 2 (Drosophila); K03099 son of sevenless SOS1, GF1, GGF1, GINGF, HGF, NS4; son of sevenless homolog 1 (Drosophila); K03099 son of sevenless 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_9846>&&&GAB2; GRB2-associated binding protein 2; K08091 growth factor receptor bound protein 2-associated protein 2 
<http://www.inferico.com/kegg-cmpo.owl#inst9_KEGGMap_hsa04110_Abst_Gene_hsa_23594>&&hsa04110&ORC6, ORC6L; origin recognition complex, subunit 6; K02608 origin recognition complex subunit 6 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_10274>&&&STAG1, SA1, SCC3A; stromal antigen 1; K06671 cohesin complex subunit SA-1/2 
<http://www.inferico.com/kegg-cmpo.owl#inst6_KEGGMap_hsa04210_Abst_Gene_hsa_1676>&&hsa04210&DFFA, DFF-45, DFF1, ICAD; DNA fragmentation factor, 45kDa, alpha polypeptide; K02310 DNA fragmentation factor, 45 kD, alpha subunit 
<http://www.inferico.com/kegg-cmpo.owl#inst33_KEGGMap_hsa05200_Abst_Gene_hsa_2260family>&&hsa05200&FGFR2, BBDS, BEK, BFR-1, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25; fibroblast growth factor receptor 2 (EC:2.7.10.1); K05093 fibroblast growth factor receptor 2 [EC:2.7.10.1] FGFR3, ACH, CD333, CEK2, HSFGFR3EX, JTK4; fibroblast growth factor receptor 3 (EC:2.7.10.1); K05094 fibroblast growth factor receptor 3 [EC:2.7.10.1] FGFR1, BFGFR, CD331, CEK, FGFBR, FGFR-1, FLG, FLT-2, FLT2, HBGFR, HH2, HRTFDS, KAL2, N-SAM, OGD, bFGF-R-1; fibroblast growth factor receptor 1 (EC:2.7.10.1); K04362 fibroblast growth factor receptor 1 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst5_KEGGMap_hsa04014_Abst_Gene_hsa_5894>&&hsa04014&RAF1, CMD1NN, CRAF, NS5, Raf-1, c-Raf; Raf-1 proto-oncogene, serine/threonine kinase (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst52_KEGGMap_hsa04110_Abst_Gene_hsa_7040family>&&hsa04110&TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1 TGFB2, LDS4, TGF-beta2; transforming growth factor, beta 2; K13376 transforming growth factor beta-2 TGFB3, ARVD, ARVD1, RNHF, TGF-beta3; transforming growth factor, beta 3; K13377 transforming growth factor beta-3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7534>&&&YWHAZ, 14-3-3-zeta, HEL-S-3, HEL4, KCIP-1, YWHAD; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta; K16197 14-3-3 protein beta/theta/zeta 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1612>&R&&DAPK1, DAPK; death-associated protein kinase 1 (EC:2.7.11.1); K08803 death-associated protein kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst39_KEGGMap_hsa05220_Abst_Gene_hsa_1869family>&&hsa05220&E2F1, E2F-1, RBAP1, RBBP3, RBP3; E2F transcription factor 1; K17454 transcription factor E2F1 E2F2, E2F-2; E2F transcription factor 2; K09389 transcription factor E2F2 E2F3, E2F-3; E2F transcription factor 3; K06620 transcription factor E2F3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5573>&&&PRKAR1A, ACRDYS1, ADOHR, CAR, CNC, CNC1, PKR1, PPNAD1, PRKAR1, TSE1; protein kinase, cAMP-dependent, regulatory, type I, alpha (EC:2.7.11.1); K04739 cAMP-dependent protein kinase regulator 
<http://www.inferico.com/kegg-cmpo.owl#inst8_KEGGMap_hsa04014_Abst_Gene_hsa_2885>&&hsa04014&GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3480>&&&IGF1R, CD221, IGFIR, IGFR, JTK13; insulin-like growth factor 1 receptor (EC:2.7.10.1); K05087 insulin-like growth factor 1 receptor [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7535>&&&ZAP70, SRK, STCD, STD, TZK, ZAP-70; zeta-chain (TCR) associated protein kinase 70kDa (EC:2.7.10.2); K07360 tyrosine-protein kinase ZAP-70 [EC:2.7.10.2] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_9978>&&&RBX1, BA554C12.1, RNF75, ROC1; ring-box 1, E3 ubiquitin protein ligase; K03868 RING-box protein 1 
<http://www.inferico.com/kegg-cmpo.owl#inst68_KEGGMap_hsa04014_Abst_Gene_hsa_5900>&&hsa04014&RALGDS, RGDS, RGF, RalGEF; ral guanine nucleotide dissociation stimulator; K08732 ral guanine nucleotide dissociation stimulator 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_84699>&&&CREB3L3, CREB-H, CREBH, HYST1481; cAMP responsive element binding protein 3-like 3; K09048 cyclic AMP-responsive element-binding protein 3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_836>&&&CASP3, CPP32, CPP32B, SCA-1; caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56); K02187 caspase 3 [EC:3.4.22.56] 
<http://www.inferico.com/kegg-cmpo.owl#inst48_KEGGMap_hsa04210_Abst_Gene_hsa_8717>&&hsa04210&TRADD, Hs.89862; TNFRSF1A-associated via death domain; K03171 tumor necrosis factor receptor type 1-associated DEATH domain protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2064>&&&ERBB2, CD340, HER-2, HER-2/neu, HER2, MLN_19, NEU, NGL, TKR1; erb-b2 receptor tyrosine kinase 2 (EC:2.7.10.1); K05083 receptor tyrosine-protein kinase erbB-2 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst40_KEGGMap_hsa04210_Abst_Gene_hsa_11213family>&&hsa04210&IRAK4, IPD1, IRAK-4, NY-REN-64, REN64; interleukin-1 receptor-associated kinase 4 (EC:2.7.11.1); K04733 interleukin-1 receptor-associated kinase 4 [EC:2.7.11.1] IRAK1, IRAK, pelle; interleukin-1 receptor-associated kinase 1 (EC:2.7.11.1); K04730 interleukin-1 receptor-associated kinase 1 [EC:2.7.11.1] IRAK2, IRAK-2; interleukin-1 receptor-associated kinase 2; K04731 interleukin-1 receptor-associated kinase 2 [EC:2.7.11.1] IRAK3, ASRT5, IRAKM; interleukin-1 receptor-associated kinase 3 (EC:2.7.11.1); K04732 interleukin-1 receptor-associated kinase 3 [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst58_KEGGMap_hsa04151_Abst_Gene_hsa_200186>&&hsa04151&CRTC2, TORC-2, TORC2; CREB regulated transcription coactivator 2; K16333 CREB-regulated transcription coactivator 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8515>&&&ITGA10, PRO827; integrin, alpha 10; K06586 integrin alpha 10 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_51135>&&&IRAK4, IPD1, IRAK-4, NY-REN-64, REN64; interleukin-1 receptor-associated kinase 4 (EC:2.7.11.1); K04733 interleukin-1 receptor-associated kinase 4 [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_57144>&&&PAK7, PAK5; p21 protein (Cdc42/Rac)-activated kinase 7 (EC:2.7.11.1); K05736 p21-activated kinase 7 [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_55844>&&&PPP2R2D, MDS026; protein phosphatase 2, regulatory subunit B, delta; K04354 serine/threonine-protein phosphatase 2A regulatory subunit B 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_29882>&&&ANAPC2, APC2; anaphase promoting complex subunit 2; K03349 anaphase-promoting complex subunit 2 
<http://www.inferico.com/kegg-cmpo.owl#inst70_KEGGMap_hsa04151_Abst_Gene_hsa_5728>&RL&hsa04151&PTEN, 10q23del, BZS, CWS1, DEC, GLM2, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [EC:3.1.3.16 3.1.3.48 3.1.3.67] 
<http://www.inferico.com/kegg-cmpo.owl#inst184_KEGGMap_hsa05200_Abst_Gene_hsa_650family>&&hsa05200&BMP2, BDA2, BMP2A; bone morphogenetic protein 2; K04662 bone morphogenetic protein 2/4 BMP4, BMP2B, BMP2B1, MCOPS6, OFC11, ZYME; bone morphogenetic protein 4; K04662 bone morphogenetic protein 2/4 
<http://www.inferico.com/kegg-cmpo.owl#inst79_KEGGMap_hsa04110_Abst_Gene_hsa_7272>&&hsa04110&TTK, CT96, ESK, MPH1, MPS1, MPS1L1, PYT; TTK protein kinase (EC:2.7.12.1); K08866 serine/threonine-protein kinase TTK/MPS1 [EC:2.7.12.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst67_KEGGMap_hsa04012_Abst_Gene_hsa_1950>&&hsa04012&EGF, HOMG4, URG; epidermal growth factor; K04357 epidermal growth factor 
<http://www.inferico.com/kegg-cmpo.owl#inst253_KEGGMap_hsa05200_Compound_cpd_C03917>&&hsa05200&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_1956_Abst_Gene_hsa_1956>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst32_KEGGMap_hsa04012_Abst_Gene_hsa_2549>&&hsa04012&GAB1; GRB2-associated binding protein 1; K09593 GRB2-associated-binding protein 1 
<http://www.inferico.com/kegg-cmpo.owl#inst92_KEGGMap_hsa05200_Compound_cpd_C00187>&&hsa05200&
<http://www.inferico.com/kegg-cmpo.owl#inst58_KEGGMap_hsa04110_Abst_Gene_hsa_994family>&&hsa04110&CDC25B; cell division cycle 25B (EC:3.1.3.48); K05866 M-phase inducer phosphatase 2 [EC:3.1.3.48] CDC25C, CDC25, PPP1R60; cell division cycle 25C (EC:3.1.3.48); K05867 M-phase inducer phosphatase 3 [EC:3.1.3.48] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8516>&&&ITGA8; integrin, alpha 8; K06584 integrin alpha 8 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_27006>&R&&FGF22; fibroblast growth factor 22; K04358 fibroblast growth factor 
<http://www.inferico.com/kegg-cmpo.owl#inst28_KEGGMap_hsa05200_Abst_Gene_hsa_5156family>&&hsa05200&PDGFRB, CD140B, IBGC4, IMF1, JTK12, PDGFR, PDGFR-1, PDGFR1; platelet-derived growth factor receptor, beta polypeptide (EC:2.7.10.1); K05089 platelet-derived growth factor receptor beta [EC:2.7.10.1] PDGFRA, CD140A, PDGFR-2, PDGFR2, RHEPDGFRA; platelet-derived growth factor receptor, alpha polypeptide (EC:2.7.10.1); K04363 platelet-derived growth factor receptor alpha [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2810>&&&SFN, YWHAS; stratifin; K06644 stratifin 
<http://www.inferico.com/kegg-cmpo.owl#inst8_KEGGMap_hsa04110_Abst_Gene_hsa_6500family>&&hsa04110&SKP1, EMC19, OCP-II, OCP2, SKP1A, TCEB1L, p19A; S-phase kinase-associated protein 1 (EC:3.1.1.3); K03094 S-phase kinase-associated protein 1 CUL1; cullin 1; K03347 cullin 1 RBX1, BA554C12.1, RNF75, ROC1; ring-box 1, E3 ubiquitin protein ligase; K03868 RING-box protein 1 
<http://www.inferico.com/kegg-cmpo.owl#inst27_KEGGMap_hsa04210_Abst_Gene_hsa_4792>&&hsa04210&NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha 
<http://www.inferico.com/kegg-cmpo.owl#inst261_KEGGMap_hsa05200_Abst_Gene_Group_Abst_Gene_hsa_1019_Abst_Gene_hsa_1021_Abst_Gene_hsa_595>&&hsa05200&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_9184>&&&BUB3, BUB3L, hBUB3; BUB3 mitotic checkpoint protein; K02180 cell cycle arrest protein BUB3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5001>&&&ORC5, ORC5L, ORC5P, ORC5T, PPP1R117; origin recognition complex, subunit 5; K02607 origin recognition complex subunit 5 
<http://www.inferico.com/kegg-cmpo.owl#cpd_C00187>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8517>&&&IKBKG, AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IMD33, IP, IP1, IP2, IPD2, NEMO, ZC2HC9; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; K07210 inhibitor of nuclear factor kappa-B kinase subunit gamma 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1613>&R&&DAPK3, DLK, ZIP, ZIPK; death-associated protein kinase 3 (EC:2.7.11.1); K08803 death-associated protein kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst79_KEGGMap_hsa04014_Abst_Gene_hsa_5879>&&hsa04014&RAC1, MIG5, Rac-1, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1 
<http://www.inferico.com/kegg-cmpo.owl#inst17_KEGGMap_hsa04210_Abst_Gene_hsa_842>&&hsa04210&CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6464>&&&SHC1, SHC, SHCA; SHC (Src homology 2 domain containing) transforming protein 1; K06279 SHC- transforming protein 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1438>&&&CSF2RA, CD116, CDw116, CSF2R, CSF2RAX, CSF2RAY, CSF2RX, CSF2RY, GM-CSF-R-alpha, GMCSFR, GMR, SMDP4; colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage); K05066 granulocyte-macrophage colony-stimulating factor receptor alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_839>&&&CASP6, MCH2; caspase 6, apoptosis-related cysteine peptidase (EC:3.4.22.59); K04396 caspase 6 [EC:3.4.22.59] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5000>&&&ORC4, ORC4L, ORC4P; origin recognition complex, subunit 4; K02606 origin recognition complex subunit 4 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1874>&&&E2F4, E2F-4; E2F transcription factor 4, p107/p130-binding; K04682 transcription factor E2F4/5 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8074>&R&&FGF23, ADHR, FGFN, HPDR2, HYPF, PHPTC; fibroblast growth factor 23; K04358 fibroblast growth factor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4286>&&&MITF, CMM8, MI, WS2, WS2A, bHLHe32; microphthalmia-associated transcription factor; K09455 microphthalmia-associated transcription factor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8822>&R&&FGF17, FGF-13, FGF-17, HH20; fibroblast growth factor 17; K04358 fibroblast growth factor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8737>&&&RIPK1, RIP, RIP1; receptor (TNFRSF)-interacting serine-threonine kinase 1 (EC:2.7.11.1); K02861 receptor-interacting serine/threonine-protein kinase 1 [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst160_KEGGMap_hsa05200_Abst_Gene_hsa_4193>&&hsa05200&MDM2, ACTFS, HDMX, hdm2; MDM2 proto-oncogene, E3 ubiquitin protein ligase; K06643 E3 ubiquitin-protein ligase Mdm2 [EC:6.3.2.19] 
<http://www.inferico.com/kegg-cmpo.owl#inst14_KEGGMap_hsa04151_Abst_Gene_hsa_5170>&&hsa04151&PDPK1, PDK1, PDPK2, PDPK2P, PRO0461; 3-phosphoinositide dependent protein kinase 1 (EC:2.7.11.1); K06276 3-phosphoinositide dependent protein kinase-1 [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst48_KEGGMap_hsa04012_Abst_Gene_hsa_815family>&&hsa04012&CAMK2A, CAMKA; calcium/calmodulin-dependent protein kinase II alpha (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17] CAMK2B, CAM2, CAMK2, CAMKB; calcium/calmodulin-dependent protein kinase II beta (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17] CAMK2D, CAMKD; calcium/calmodulin-dependent protein kinase II delta (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17] CAMK2G, CAMK, CAMK-II, CAMKG; calcium/calmodulin-dependent protein kinase II gamma (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_255631>&&&COL24A1; collagen, type XXIV, alpha 1; K06236 collagen, type I/II/III/V/XI/XXIV/XXVII, alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7976>&&&FZD3, Fz-3; frizzled class receptor 3; K02329 frizzled 3 
<http://www.inferico.com/kegg-cmpo.owl#inst37_KEGGMap_hsa04210_Abst_Gene_hsa_1147family>&&hsa04210&IKBKB, IKK-beta, IKK2, IKKB, IMD15, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10] IKBKG, AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IMD33, IP, IP1, IP2, IPD2, NEMO, ZC2HC9; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; K07210 inhibitor of nuclear factor kappa-B kinase subunit gamma CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10] 
<http://www.inferico.com/kegg-cmpo.owl#inst56_KEGGMap_hsa05200_Abst_Gene_hsa_2885>&&hsa05200&GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_148327>&&&CREB3L4, AIBZIP, ATCE1, CREB3, CREB4, JAL, hJAL; cAMP responsive element binding protein 3-like 4; K09048 cyclic AMP-responsive element-binding protein 3 
<http://www.inferico.com/kegg-cmpo.owl#inst215_KEGGMap_hsa05200_Abst_Gene_hsa_1441>&&hsa05200&CSF3R, CD114, GCSFR; colony stimulating factor 3 receptor (granulocyte); K05061 granulocyte colony-stimulating factor receptor 
<http://www.inferico.com/kegg-cmpo.owl#inst23_KEGGMap_hsa04151_Abst_Gene_hsa_2932>&&hsa04151&GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8823>&R&&FGF16, FGF-16, MF4; fibroblast growth factor 16; K04358 fibroblast growth factor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8605>&&&PLA2G4C, CPLA2-gamma; phospholipase A2, group IVC (cytosolic, calcium-independent) (EC:3.1.1.4); K16342 cytosolic phospholipase A2 [EC:3.1.1.4] 
<http://www.inferico.com/kegg-cmpo.owl#inst52_KEGGMap_hsa04014_Abst_Gene_hsa_100271927family>&R&hsa04014&RASAL3; RAS protein activator like 3; K17634 RAS protein activator-like 3 RASA3, GAP1IP4BP, GAPIII; RAS p21 protein activator 3; K12380 Ras GTPase-activating protein 3 RASA2, GAP1M; RAS p21 protein activator 2; K08053 Ras GTPase-activating protein 2 RASA1, CM-AVM, CMAVM, GAP, PKWS, RASA, RASGAP, p120GAP, p120RASGAP; RAS p21 protein activator (GTPase activating protein) 1; K04352 Ras GTPase-activating protein 1 SYNGAP1, MRD5, RASA1, RASA5, SYNGAP; synaptic Ras GTPase activating protein 1; K17631 Ras/Rap GTPase-activating protein SynGAP RASA4, CAPRI, GAPL; RAS p21 protein activator 4; K17630 Ras GTPase-activating protein 4 RASAL1, RASAL; RAS protein activator like 1 (GAP1 like); K17632 RAS protein activator-like 1 RASA4B; RAS p21 protein activator 4B; K17630 Ras GTPase-activating protein 4 RASAL2, NGAP; RAS protein activator like 2; K17633 RAS protein activator-like 2 
<http://www.inferico.com/kegg-cmpo.owl#inst70_KEGGMap_hsa04014_Abst_Gene_hsa_9610>&&hsa04014&RIN1; Ras and Rab interactor 1; K17638 Ras and Rab interactor 1 
<http://www.inferico.com/kegg-cmpo.owl#inst27_KEGGMap_hsa04110_Abst_Gene_hsa_10459family>&&hsa04110&MAD2L2, MAD2B, POLZ2, REV7; MAD2 mitotic arrest deficient-like 2 (yeast); K13728 mitotic spindle assembly checkpoint protein MAD2B MAD2L1, HSMAD2, MAD2; MAD2 mitotic arrest deficient-like 1 (yeast); K02537 mitotic spindle assembly checkpoint protein MAD2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_10718>&&&NRG3, HRG3, pro-NRG3; neuregulin 3; K05457 neuregulin 3 
<http://www.inferico.com/kegg-cmpo.owl#inst50_KEGGMap_hsa04012_Abst_Gene_hsa_1839>&&hsa04012&HBEGF, DTR, DTS, DTSF, HEGFL; heparin-binding EGF-like growth factor; K08523 heparin-binding EGF-like growth factor 
<http://www.inferico.com/kegg-cmpo.owl#inst147_KEGGMap_hsa05200_Abst_Gene_hsa_5915>&RL&hsa05200&RARB, HAP, MCOPS12, NR1B2, RRB2; retinoic acid receptor, beta; K08528 retinoic acid receptor beta 
<http://www.inferico.com/kegg-cmpo.owl#inst39_KEGGMap_hsa04210_Abst_Gene_hsa_23533family>&&hsa04210&PIK3R3, p55, p55-GAMMA, p55PIK; phosphoinositide-3-kinase, regulatory subunit 3 (gamma); K02649 phosphoinositide-3-kinase, regulatory subunit PIK3R5, F730038I15Rik, FOAP-2, P101-PI3K, p101; phosphoinositide-3-kinase, regulatory subunit 5; K02649 phosphoinositide-3-kinase, regulatory subunit PIK3CA, CLOVE, CWS5, MCAP, MCM, MCMTC, PI3K, p110-alpha; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (EC:2.7.11.1 2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] PIK3R2, MPPH, MPPH1, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit PIK3R1, AGM7, GRB1, IMD36, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3, p110gamma, p120-PI3K; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma (EC:2.7.11.1 2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] PIK3CD, APDS, IMD14, P110DELTA, PI3K, p110D; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] PIK3CB, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] 
<http://www.inferico.com/kegg-cmpo.owl#inst35_KEGGMap_hsa05200_Abst_Gene_hsa_7039>&&hsa05200&TGFA, TFGA; transforming growth factor, alpha; K08774 transforming growth factor, alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1439>&&&CSF2RB, CD131, CDw131, IL3RB, IL5RB, SMDP5; colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage); K04738 cytokine receptor common subunit beta 
<http://www.inferico.com/kegg-cmpo.owl#inst233_KEGGMap_hsa05200_Abst_Gene_hsa_2735family>&&hsa05200&GLI2, CJS, HPE9, PHS2, THP1, THP2; GLI family zinc finger 2; K16798 zinc finger protein GLI2 GLI3, ACLS, GCPS, GLI3-190, GLI3FL, PAP-A, PAPA, PAPA1, PAPB, PHS, PPDIV; GLI family zinc finger 3; K06230 zinc finger protein GLI3 GLI1, GLI; GLI family zinc finger 1; K16797 zinc finger protein GLI1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1875>&&&E2F5, E2F-5; E2F transcription factor 5, p130-binding; K04682 transcription factor E2F4/5 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2904>&&&GRIN2B, EIEE27, GluN2B, MRD6, NMDAR2B, NR2B, hNR3; glutamate receptor, ionotropic, N-methyl D-aspartate 2B; K05210 glutamate receptor ionotropic, NMDA 2B 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8772>&&&FADD, GIG3, MORT1; Fas (TNFRSF6)-associated via death domain; K02373 FAS-associated death domain protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5533>&&&PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16] 
<http://www.inferico.com/kegg-cmpo.owl#inst23_KEGGMap_hsa04012_Abst_Gene_hsa_6198family>&&hsa04012&RPS6KB2, KLS, P70-beta, P70-beta-1, P70-beta-2, S6K-beta2, S6K2, SRK, STK14B, p70(S6K)-beta, p70S6Kb; ribosomal protein S6 kinase, 70kDa, polypeptide 2 (EC:2.7.11.1); K04688 p70 ribosomal S6 kinase [EC:2.7.11.1] RPS6KB1, PS6K, S6K, S6K-beta-1, S6K1, STK14A, p70_S6KA, p70(S6K)-alpha, p70-S6K, p70-alpha; ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1); K04688 p70 ribosomal S6 kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6513>&&&SLC2A1, DYT17, DYT18, DYT9, EIG12, GLUT, GLUT-1, GLUT1, GLUT1DS, HTLVR, PED, CSE; solute carrier family 2 (facilitated glucose transporter), member 1; K07299 MFS transporter, SP family, solute carrier family 2 (facilitated glucose transporter), member 1 
<http://www.inferico.com/kegg-cmpo.owl#inst132_KEGGMap_hsa05200_Abst_Gene_hsa_2950>&&hsa05200&GSTP1, DFN7, FAEES3, GST3, GSTP, HEL-S-22, PI; glutathione S-transferase pi 1 (EC:2.5.1.18); K00799 glutathione S-transferase [EC:2.5.1.18] 
<http://www.inferico.com/kegg-cmpo.owl#inst102_KEGGMap_hsa05200_Abst_Gene_hsa_27148>&&hsa05200&STK36, FU; serine/threonine kinase 36 (EC:2.7.11.1); K06228 fused [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst120_KEGGMap_hsa05200_Abst_Gene_hsa_7046>&&hsa05200&TGFBR1, AAT5, ACVRLK4, ALK-5, ALK5, ESS1, LDS1, LDS1A, LDS2A, MSSE, SKR4, TGFR-1, tbetaR-I; transforming growth factor, beta receptor 1 (EC:2.7.11.30); K04674 TGF-beta receptor type-1 [EC:2.7.11.30] 
<http://www.inferico.com/kegg-cmpo.owl#inst81_KEGGMap_hsa04110_Abst_Gene_hsa_1032>&R&hsa04110&CDKN2D, INK4D, p19, p19-INK4D; cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4); K06623 cyclin-dependent kinase inhibitor 2D 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3791>&&&KDR, CD309, FLK1, VEGFR, VEGFR2; kinase insert domain receptor (EC:2.7.10.1); K05098 kinase insert domain protein receptor [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst176_KEGGMap_hsa05200_Abst_Gene_hsa_1030>&&hsa05200&CDKN2B, CDK4I, INK4B, MTS2, P15, TP15, p15INK4b; cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4); K04685 cyclin-dependent kinase inhibitor 2B 
<http://www.inferico.com/kegg-cmpo.owl#cpd_C00149>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8555>&&&CDC14B, CDC14B3, Cdc14B1, Cdc14B2, hCDC14B; cell division cycle 14B (EC:3.1.3.16 3.1.3.48); K06639 cell division cycle 14 [EC:3.1.3.16 3.1.3.48] 
<http://www.inferico.com/kegg-cmpo.owl#inst35_KEGGMap_hsa04110_Abst_Gene_hsa_5591>&&hsa04110&PRKDC, DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, IMD26, XRCC7, p350; protein kinase, DNA-activated, catalytic polypeptide (EC:2.7.11.1); K06642 DNA-dependent protein kinase catalytic subunit [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst68_KEGGMap_hsa04210_Abst_Gene_Group_Abst_Gene_hsa_7186_Abst_Gene_hsa_8717_Abst_Gene_hsa_8737>&&hsa04210&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_26281>&R&&FGF20, FGF-20, RHDA2; fibroblast growth factor 20; K04358 fibroblast growth factor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_23566>&&&LPAR3, EDG7, Edg-7, GPCR, HOFNH30, LP-A3, LPA3, RP4-678I3; lysophosphatidic acid receptor 3; K04294 lysophosphatidic acid receptor 3 
<http://www.inferico.com/kegg-cmpo.owl#inst116_KEGGMap_hsa04110_Abst_Gene_Group_Abst_Gene_hsa_1869_Abst_Gene_hsa_1870_Abst_Gene_hsa_1871_Abst_Gene_hsa_7027_Abst_Gene_hsa_7029>&&hsa04110&
<http://www.inferico.com/kegg-cmpo.owl#inst76_KEGGMap_hsa05200_Abst_Gene_hsa_5879family>&&hsa05200&RAC3; ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3); K07861 Ras-related C3 botulinum toxin substrate 3 RAC2, EN-7, Gx, HSPC022, p21-Rac2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2); K07860 Ras-related C3 botulinum toxin substrate 2 RAC1, MIG5, Rac-1, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1 CDC42, CDC42Hs, G25K; cell division cycle 42; K04393 cell division control protein 42 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5532>&&&PPP3CB, CALNA2, CALNB, CNA2, PP2Bbeta; protein phosphatase 3, catalytic subunit, beta isozyme (EC:3.1.3.16); K04348 serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16] 
<http://www.inferico.com/kegg-cmpo.owl#inst214_KEGGMap_hsa05200_Abst_Gene_hsa_1438>&&hsa05200&CSF2RA, CD116, CDw116, CSF2R, CSF2RAX, CSF2RAY, CSF2RX, CSF2RY, GM-CSF-R-alpha, GMCSFR, GMR, SMDP4; colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage); K05066 granulocyte-macrophage colony-stimulating factor receptor alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3440>&R&&IFNA2, IFN-alphaA, IFNA, IFNA2B, INFA2; interferon, alpha 2; K05414 interferon alpha 
<http://www.inferico.com/kegg-cmpo.owl#inst100_KEGGMap_hsa04110_Abst_Gene_Group_Abst_Gene_hsa_1017_Abst_Gene_hsa_898_Abst_Gene_hsa_9134>&&hsa04110&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5579>&L&&PRKCB, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13] 
<http://www.inferico.com/kegg-cmpo.owl#inst22_KEGGMap_hsa04012_Abst_Gene_hsa_1978>&&hsa04012&EIF4EBP1, 4E-BP1, 4EBP1, BP-1, PHAS-I; eukaryotic translation initiation factor 4E binding protein 1; K07205 eukaryotic translation initiation factor 4E binding protein 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2902>&&&GRIN1, GluN1, MRD8, NMD-R1, NMDA1, NMDAR1, NR1; glutamate receptor, ionotropic, N-methyl D-aspartate 1; K05208 glutamate receptor ionotropic, NMDA 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3570>&&&IL6R, CD126, IL-6R-1, IL-6RA, IL6Q, IL6RA, IL6RQ, gp80; interleukin 6 receptor; K05055 interleukin 6 receptor 
<http://www.inferico.com/kegg-cmpo.owl#inst9_KEGGMap_hsa04012_Abst_Gene_hsa_2064>&&hsa04012&ERBB2, CD340, HER-2, HER-2/neu, HER2, MLN_19, NEU, NGL, TKR1; erb-b2 receptor tyrosine kinase 2 (EC:2.7.10.1); K05083 receptor tyrosine-protein kinase erbB-2 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst71_KEGGMap_hsa04012_Abst_Gene_hsa_5604family>&&hsa04012&MAP2K2, CFC4, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2] MAP2K1, CFC3, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5228>&R&&PGF, D12S1900, PGFL, PLGF, PlGF-2, SHGC-10760; placental growth factor; K16859 placenta growth factor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8556>&&&CDC14A, cdc14, hCDC14; cell division cycle 14A (EC:3.1.3.16 3.1.3.48); K06639 cell division cycle 14 [EC:3.1.3.16 3.1.3.48] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2069>&&&EREG, ER; epiregulin; K09784 epiregulin 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2021>&&&ENDOG; endonuclease G; K01173 endonuclease G, mitochondrial 
<http://www.inferico.com/kegg-cmpo.owl#inst49_KEGGMap_hsa04210_Abst_Gene_hsa_8772>&&hsa04210&FADD, GIG3, MORT1; Fas (TNFRSF6)-associated via death domain; K02373 FAS-associated death domain protein 
<http://www.inferico.com/kegg-cmpo.owl#inst61_KEGGMap_hsa05200_Abst_Gene_hsa_83593>&R&hsa05200&RASSF5, Maxp1, NORE1, NORE1A, NORE1B, RAPL, RASSF3; Ras association (RalGDS/AF-6) domain family member 5; K08015 Ras association domain-containing protein 5 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6777>&&&STAT5B, STAT5; signal transducer and activator of transcription 5B; K11224 signal transducer and activator of transcription 5B 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_1017_Abst_Gene_hsa_898_Abst_Gene_hsa_9134>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2903>&&&GRIN2A, EPND, FESD, GluN2A, LKS, NMDAR2A, NR2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A; K05209 glutamate receptor ionotropic, NMDA 2A 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5578>&L&&PRKCA, AAG6, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13] 
<http://www.inferico.com/kegg-cmpo.owl#inst66_KEGGMap_hsa04110_Abst_Gene_hsa_1022>&&hsa04110&CDK7, CAK1, CDKN7, HCAK, MO15, STK1, p39MO15; cyclin-dependent kinase 7 (EC:2.7.11.23 2.7.11.22); K02202 cyclin-dependent kinase 7 [EC:2.7.11.22 2.7.11.23] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_1874_Abst_Gene_hsa_1875_Abst_Gene_hsa_5933_Abst_Gene_hsa_7027_Abst_Gene_hsa_7029>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst15_KEGGMap_hsa05200_Abst_Gene_hsa_5747>&&hsa05200&PTK2, FADK, FAK, FAK1, FRNK, PPP1R71, p125FAK, pp125FAK; protein tyrosine kinase 2 (EC:2.7.10.2); K05725 focal adhesion kinase 1 [EC:2.7.10.2] 
<http://www.inferico.com/kegg-cmpo.owl#inst87_KEGGMap_hsa04014_Abst_Gene_hsa_3363>&&hsa04014&HTR7, 5-HT7; 5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled; K04163 5-hydroxytryptamine receptor 7 
<http://www.inferico.com/kegg-cmpo.owl#inst186_KEGGMap_hsa05200_Abst_Gene_hsa_64399>&&hsa05200&HHIP, HIP; hedgehog interacting protein; K06231 hedgehog interacting protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6776>&&&STAT5A, MGF, STAT5; signal transducer and activator of transcription 5A; K11223 signal transducer and activator of transcription 5A 
<http://www.inferico.com/kegg-cmpo.owl#inst27_KEGGMap_hsa04012_Abst_Gene_hsa_10298family>&&hsa04012&PAK7, PAK5; p21 protein (Cdc42/Rac)-activated kinase 7 (EC:2.7.11.1); K05736 p21-activated kinase 7 [EC:2.7.11.1] PAK6, PAK5; p21 protein (Cdc42/Rac)-activated kinase 6 (EC:2.7.11.1); K05735 p21-activated kinase 6 [EC:2.7.11.1] PAK1, PAKalpha; p21 protein (Cdc42/Rac)-activated kinase 1 (EC:2.7.11.1); K04409 p21-activated kinase 1 [EC:2.7.11.1] PAK4; p21 protein (Cdc42/Rac)-activated kinase 4 (EC:2.7.11.1); K05734 p21-activated kinase 4 [EC:2.7.11.1] PAK3, MRX30, MRX47, OPHN3, PAK-3, PAK3beta, bPAK, beta-PAK; p21 protein (Cdc42/Rac)-activated kinase 3 (EC:2.7.11.1); K05733 p21-activated kinase 3 [EC:2.7.11.1] PAK2, PAK65, PAKgamma; p21 protein (Cdc42/Rac)-activated kinase 2 (EC:2.7.11.1); K04410 p21-activated kinase 2 [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1839>&&&HBEGF, DTR, DTS, DTSF, HEGFL; heparin-binding EGF-like growth factor; K08523 heparin-binding EGF-like growth factor 
<http://www.inferico.com/kegg-cmpo.owl#inst36_KEGGMap_hsa04210_Abst_Gene_hsa_9020>&&hsa04210&MAP3K14, FTDCR1B, HS, HSNIK, NIK; mitogen-activated protein kinase kinase kinase 14 (EC:2.7.11.25); K04466 mitogen-activated protein kinase kinase kinase 14 [EC:2.7.11.25] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5881>&&&RAC3; ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3); K07861 Ras-related C3 botulinum toxin substrate 3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5530>&&&PPP3CA, CALN, CALNA, CALNA1, CCN1, CNA1, PPP2B; protein phosphatase 3, catalytic subunit, alpha isozyme (EC:3.1.3.16); K04348 serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16] 
<http://www.inferico.com/kegg-cmpo.owl#inst87_KEGGMap_hsa04110_Abst_Gene_hsa_1874family>&&hsa04110&E2F4, E2F-4; E2F transcription factor 4, p107/p130-binding; K04682 transcription factor E2F4/5 E2F5, E2F-5; E2F transcription factor 5, p130-binding; K04682 transcription factor E2F4/5 
<http://www.inferico.com/kegg-cmpo.owl#inst100_KEGGMap_hsa05200_Abst_Gene_hsa_6608>&&hsa05200&SMO, FZD11, Gx, SMOH; smoothened, frizzled class receptor; K06226 smoothened 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5577>&&&PRKAR2B, PRKAR2, RII-BETA; protein kinase, cAMP-dependent, regulatory, type II, beta (EC:2.7.11.1); K04739 cAMP-dependent protein kinase regulator 
<http://www.inferico.com/kegg-cmpo.owl#inst46_KEGGMap_hsa04210_Abst_Gene_hsa_8717>&&hsa04210&TRADD, Hs.89862; TNFRSF1A-associated via death domain; K03171 tumor necrosis factor receptor type 1-associated DEATH domain protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_572>&&&BAD, BBC2, BCL2L8; BCL2-associated agonist of cell death; K02158 BCL2-antagonist of cell death 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8643>&L&&PTCH2, PTC2; patched 2; K11101 patched 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5008>&R&&OSM; oncostatin M; K05418 oncostatin M 
<http://www.inferico.com/kegg-cmpo.owl#inst27_KEGGMap_hsa04151_Abst_Gene_hsa_356>&&hsa04151&FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6; Fas ligand (TNF superfamily, member 6); K04389 tumor necrosis factor ligand superfamily member 6 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_354>&&&KLK3, APS, KLK2A1, PSA, hK3; kallikrein-related peptidase 3 (EC:3.4.21.77); K01351 semenogelase [EC:3.4.21.77] 
<http://www.inferico.com/kegg-cmpo.owl#inst49_KEGGMap_hsa04151_Abst_Gene_hsa_3320family>&&hsa04151&HSP90B1, ECGP, GP96, GRP94, HEL-S-125m, HEL35, TRA1; heat shock protein 90kDa beta (Grp94), member 1; K09487 heat shock protein 90kDa beta HSP90AB1, D6S182, HSP84, HSP90B, HSPC2, HSPCB; heat shock protein 90kDa alpha (cytosolic), class B member 1; K04079 molecular chaperone HtpG HSP90AA1, EL52, HSP86, HSP89A, HSP90A, HSP90N, HSPC1, HSPCA, HSPCAL1, HSPCAL4, HSPN, Hsp89, Hsp90, LAP-2, LAP2; heat shock protein 90kDa alpha (cytosolic), class A member 1; K04079 molecular chaperone HtpG 
<http://www.inferico.com/kegg-cmpo.owl#inst34_KEGGMap_hsa04110_Abst_Gene_hsa_1026>&&hsa04110&CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1; cyclin-dependent kinase inhibitor 1A (p21, Cip1); K06625 cyclin-dependent kinase inhibitor 1A 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_4171_Abst_Gene_hsa_4172_Abst_Gene_hsa_4173_Abst_Gene_hsa_4174_Abst_Gene_hsa_4175_Abst_Gene_hsa_4176>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5880>&&&RAC2, EN-7, Gx, HSPC022, p21-Rac2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2); K07860 Ras-related C3 botulinum toxin substrate 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_10319>&&&LAMC3, OCCM; laminin, gamma 3; K06247 laminin, gamma 3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3265>&L&&HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, RASH1, p21ras; Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas 
<http://www.inferico.com/kegg-cmpo.owl#inst24_KEGGMap_hsa04210_Abst_Gene_hsa_839>&&hsa04210&CASP6, MCH2; caspase 6, apoptosis-related cysteine peptidase (EC:3.4.22.59); K04396 caspase 6 [EC:3.4.22.59] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6774>&&&STAT3, ADMIO, APRF, HIES; signal transducer and activator of transcription 3 (acute-phase response factor); K04692 signal transducer and activator of transcription 3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_355>&&&FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas cell surface death receptor; K04390 tumor necrosis factor receptor superfamily member 6 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_399694>&&&SHC4, RaLP, SHCD; SHC (Src homology 2 domain containing) family, member 4; K17449 SHC- transforming protein 4 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_9623>&R&&TCL1B, SYN-1, TML1; T-cell leukemia/lymphoma 1B; K16836 T-cell leukemia/lymphoma 1B 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7531>&&&YWHAE, 14-3-3E, HEL2, KCIP-1, MDCR, MDS; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon; K06630 14-3-3 protein epsilon 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5576>&&&PRKAR2A, PKR2, PRKAR2; protein kinase, cAMP-dependent, regulatory, type II, alpha (EC:2.7.11.1); K04739 cAMP-dependent protein kinase regulator 
<http://www.inferico.com/kegg-cmpo.owl#cpd_C04637>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst122_KEGGMap_hsa05200_Abst_Gene_hsa_4087family>&&hsa05200&SMAD2, JV18, JV18-1, MADH2, MADR2, hMAD-2, hSMAD2; SMAD family member 2; K04500 mothers against decapentaplegic homolog 2/3 SMAD3, HSPC193, HsT17436, JV15-2, LDS1C, LDS3, MADH3; SMAD family member 3; K04500 mothers against decapentaplegic homolog 2/3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_356>&&&FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6; Fas ligand (TNF superfamily, member 6); K04389 tumor necrosis factor ligand superfamily member 6 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_26060>&&&APPL1, APPL, DIP13alpha; adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1; K08733 DCC-interacting protein 13 alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1969>&&&EPHA2, ARCC2, CTPA, CTPP1, CTRCT6, ECK; EPH receptor A2 (EC:2.7.10.1); K05103 Eph receptor A2 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2065>&&&ERBB3, ErbB-3, HER3, LCCS2, MDA-BF-1, c-erbB-3, c-erbB3, erbB3-S, p180-ErbB3, p45-sErbB3, p85-sErbB3; erb-b2 receptor tyrosine kinase 3 (EC:2.7.10.1); K05084 receptor tyrosine-protein kinase erbB-3 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6688>&RL&&SPI1, OF, PU.1, SFPI1, SPI-1, SPI-A; Spi-1 proto-oncogene; K09438 transcription factor PU.1 
<http://www.inferico.com/kegg-cmpo.owl#inst45_KEGGMap_hsa04014_Abst_Gene_hsa_5868family>&&hsa04014&RAB5A, RAB5; RAB5A, member RAS oncogene family; K07887 Ras-related protein Rab-5A RAB5B; RAB5B, member RAS oncogene family; K07888 Ras-related protein Rab-5B RAB5C, L1880, RAB5CL, RAB5L, RABL; RAB5C, member RAS oncogene family; K07889 Ras-related protein Rab-5C 
<http://www.inferico.com/kegg-cmpo.owl#inst26_KEGGMap_hsa04151_Abst_Gene_hsa_5934>&L&hsa04151&RBL2, P130, Rb2; retinoblastoma-like 2; K16332 retinoblastoma-like protein 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7532>&&&YWHAG, 14-3-3GAMMA, PPP1R170; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma; K16198 14-3-3 protein gamma/eta 
<http://www.inferico.com/kegg-cmpo.owl#inst14_KEGGMap_hsa04014_Abst_Gene_hsa_1435family>&R&hsa04014&EGF, HOMG4, URG; epidermal growth factor; K04357 epidermal growth factor NGF, Beta-NGF, HSAN5, NGFB; nerve growth factor (beta polypeptide); K02582 nerve growth factor, beta FIGF, VEGF-D, VEGFD; c-fos induced growth factor (vascular endothelial growth factor D); K05449 vascular endothelial growth factor C/D FGF19; fibroblast growth factor 19; K04358 fibroblast growth factor FGF21; fibroblast growth factor 21; K04358 fibroblast growth factor FGF22; fibroblast growth factor 22; K04358 fibroblast growth factor FGF23, ADHR, FGFN, HPDR2, HYPF, PHPTC; fibroblast growth factor 23; K04358 fibroblast growth factor FGF17, FGF-13, FGF-17, HH20; fibroblast growth factor 17; K04358 fibroblast growth factor FGF16, FGF-16, MF4; fibroblast growth factor 16; K04358 fibroblast growth factor FGF20, FGF-20, RHDA2; fibroblast growth factor 20; K04358 fibroblast growth factor PGF, D12S1900, PGFL, PLGF, PlGF-2, SHGC-10760; placental growth factor; K16859 placenta growth factor PDGFC, FALLOTEIN, SCDGF; platelet derived growth factor C; K05450 platelet derived growth factor C/D IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1 HGF, DFNB39, F-TCF, HGFB, HPTA, SF; hepatocyte growth factor (hepapoietin A; scatter factor); K05460 hepatocyte growth factor CSF1, CSF-1, MCSF; colony stimulating factor 1 (macrophage) (EC:2.7.10.1); K05453 macrophage colony-stimulating factor 1 FGF18, FGF-18, ZFGF5; fibroblast growth factor 18; K04358 fibroblast growth factor KITLG, FPH2, FPHH, KL-1, Kitl, MGF, SCF, SF, SHEP7; KIT ligand (EC:3.2.1.31); K05461 KIT ligand FGF8, AIGF, FGF-8, HBGF-8, HH6, KAL6; fibroblast growth factor 8 (androgen-induced); K04358 fibroblast growth factor FGF9, FGF-9, GAF, HBFG-9, HBGF-9, SYNS3; fibroblast growth factor 9; K04358 fibroblast growth factor FGF6, HBGF-6, HST2; fibroblast growth factor 6; K04358 fibroblast growth factor FGF7, HBGF-7, KGF; fibroblast growth factor 7; K04358 fibroblast growth factor FGF5, HBGF-5, Smag-82, TCMGLY; fibroblast growth factor 5; K04358 fibroblast growth factor FGF4, HBGF-4, HST, HST-1, HSTF1, K-FGF, KFGF; fibroblast growth factor 4; K04358 fibroblast growth factor FGF2, BFGF, FGF-2, FGFB, HBGF-2; fibroblast growth factor 2 (basic); K18497 fibroblast growth factor 2 FGF3, HBGF-3, INT2; fibroblast growth factor 3; K04358 fibroblast growth factor FGF1, AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-1, FGF-alpha, FGFA, GLIO703, HBGF-1, HBGF1; fibroblast growth factor 1 (acidic); K18496 fibroblast growth factor 1 ANGPT4, AGP4, ANG-3, ANG4; angiopoietin 4; K05467 angiopoietin 4 ANGPT1, AGP1, AGPT, ANG1; angiopoietin 1; K05465 angiopoietin 1 ANGPT2, AGPT2, ANG2; angiopoietin 2; K05466 angiopoietin 2 PDGFB, IBGC5, PDGF-2, PDGF2, SIS, SSV, c-sis; platelet-derived growth factor beta polypeptide; K17386 platelet-derived growth factor subunit B PDGFA, PDGF-A, PDGF1; platelet-derived growth factor alpha polypeptide; K04359 platelet-derived growth factor subunit A EFNA5, AF1, EFL5, EPLG7, GLC1M, LERK7, RAGS; ephrin-A5; K05462 ephrin-A EFNA2, ELF-1, EPLG6, HEK7-L, LERK-6, LERK6; ephrin-A2; K05462 ephrin-A VEGFA, MVCD1, VEGF, VPF; vascular endothelial growth factor A; K05448 vascular endothelial growth factor A EFNA1, B61, ECKLG, EFL1, EPLG1, LERK-1, LERK1, TNFAIP4; ephrin-A1; K05462 ephrin-A EFNA4, EFL4, EPLG4, LERK4; ephrin-A4; K05462 ephrin-A VEGFB, VEGFL, VRF; vascular endothelial growth factor B; K16858 vascular endothelial growth factor B EFNA3, EFL2, EPLG3, Ehk1-L, LERK3; ephrin-A3; K05462 ephrin-A VEGFC, Flt4-L, LMPH1D, VRP; vascular endothelial growth factor C; K05449 vascular endothelial growth factor C/D PDGFD, IEGF, MSTP036, SCDGF-B, SCDGFB; platelet derived growth factor D; K05450 platelet derived growth factor C/D INS, IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10; insulin; K04526 insulin FGF14, FGF-14, FHF-4, FHF4, SCA27; fibroblast growth factor 14; K04358 fibroblast growth factor FGF12, FGF12B, FHF1; fibroblast growth factor 12; K04358 fibroblast growth factor FGF13, FGF-13, FGF2, FHF-2, FHF2; fibroblast growth factor 13; K04358 fibroblast growth factor FGF10; fibroblast growth factor 10; K04358 fibroblast growth factor FGF11, FGF-11, FHF-3, FHF3; fibroblast growth factor 11; K04358 fibroblast growth factor 
<http://www.inferico.com/kegg-cmpo.owl#inst38_KEGGMap_hsa04110_Abst_Gene_hsa_6502>&&hsa04110&SKP2, FBL1, FBXL1, FLB1, p45; S-phase kinase-associated protein 2, E3 ubiquitin protein ligase; K03875 F-box and leucine-rich repeat protein 1 (S-phase kinase-associated protein 2) 
<http://www.inferico.com/kegg-cmpo.owl#inst26_KEGGMap_hsa05200_Abst_Gene_hsa_1956>&&hsa05200&EGFR, ERBB, ERBB1, HER1, NISBD2, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5575>&&&PRKAR1B, PRKAR1; protein kinase, cAMP-dependent, regulatory, type I, beta (EC:2.7.11.1); K04739 cAMP-dependent protein kinase regulator 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_27040>&&&LAT, LAT1, pp36; linker for activation of T cells; K07362 linker for activation of T cells 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7448>&&&VTN, V75, VN, VNT; vitronectin; K06251 vitronectin 
<http://www.inferico.com/kegg-cmpo.owl#inst53_KEGGMap_hsa04014_Abst_Gene_hsa_4763>&R&hsa04014&NF1, NFNS, VRNF, WSS; neurofibromin 1; K08052 neurofibromin 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6772>&&&STAT1, CANDF7, IMD31A, IMD31B, IMD31C, ISGF-3, STAT91; signal transducer and activator of transcription 1, 91kDa; K11220 signal transducer and activator of transcription 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_56034>&R&&PDGFC, FALLOTEIN, SCDGF; platelet derived growth factor C; K05450 platelet derived growth factor C/D 
<http://www.inferico.com/kegg-cmpo.owl#inst166_KEGGMap_hsa05200_Abst_Gene_hsa_1026>&&hsa05200&CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1; cyclin-dependent kinase inhibitor 1A (p21, Cip1); K06625 cyclin-dependent kinase inhibitor 1A 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_26060_Abst_Gene_hsa_842>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst6_KEGGMap_hsa05220_Abst_Gene_hsa_7157>&CL&hsa05220&TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2066>&&&ERBB4, ALS19, HER4, p180erbB4; erb-b2 receptor tyrosine kinase 4 (EC:2.7.10.1); K05085 receptor tyrosine-protein kinase erbB-4 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_145957>&&&NRG4, HRG4; neuregulin 4; K05458 neuregulin 4 
<http://www.inferico.com/kegg-cmpo.owl#inst5_KEGGMap_hsa05200_Abst_Gene_hsa_836>&&hsa05200&CASP3, CPP32, CPP32B, SCA-1; caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56); K02187 caspase 3 [EC:3.4.22.56] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6469>&&&SHH, HHG1, HLP3, HPE3, MCOPCB5, SMMCI, TPT, TPTPS; sonic hedgehog; K11988 sonic hedgehog 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7533>&&&YWHAH, YWHA1; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta; K16198 14-3-3 protein gamma/eta 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_9180>&&&OSMR, OSMRB, PLCA1; oncostatin M receptor; K05057 oncostatin M receptor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_27148_Abst_Gene_hsa_51684>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8243>&&&SMC1A, CDLS2, DXS423E, SB1.8, SMC1, SMC1L1, SMC1alpha, SMCB; structural maintenance of chromosomes 1A; K06636 structural maintenance of chromosome 1 
<http://www.inferico.com/kegg-cmpo.owl#inst102_KEGGMap_hsa04151_Abst_Gene_hsa_100533105family>&&hsa04151&C8orf44-SGK3; C8orf44-SGK3 readthrough (EC:2.7.11.1); K13304 serum/glucocorticoid-regulated kinase 3 [EC:2.7.11.1] SGK1, SGK; serum/glucocorticoid regulated kinase 1 (EC:2.7.11.1); K13302 serum/glucocorticoid-regulated kinase 1 [EC:2.7.11.1] SGK3, CISK, SGK2, SGKL; serum/glucocorticoid regulated kinase family, member 3 (EC:2.7.11.1); K13304 serum/glucocorticoid-regulated kinase 3 [EC:2.7.11.1] SGK2, H-SGK2, dJ138B7.2; serum/glucocorticoid regulated kinase 2 (EC:2.7.11.1); K13303 serum/glucocorticoid-regulated kinase 2 [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5529>&&&PPP2R5E; protein phosphatase 2, regulatory subunit B', epsilon isoform; K11584 serine/threonine-protein phosphatase 2A regulatory subunit B' 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5747>&&&PTK2, FADK, FAK, FAK1, FRNK, PPP1R71, p125FAK, pp125FAK; protein tyrosine kinase 2 (EC:2.7.10.2); K05725 focal adhesion kinase 1 [EC:2.7.10.2] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_27>&L&&ABL2, ABLL, ARG; ABL proto-oncogene 2, non-receptor tyrosine kinase (EC:2.7.10.2); K08887 abelson tyrosine-protein kinase 2 [EC:2.7.10.2] 
<http://www.inferico.com/kegg-cmpo.owl#inst18_KEGGMap_hsa05220_Abst_Gene_hsa_6776family>&&hsa05220&STAT5B, STAT5; signal transducer and activator of transcription 5B; K11224 signal transducer and activator of transcription 5B STAT5A, MGF, STAT5; signal transducer and activator of transcription 5A; K11223 signal transducer and activator of transcription 5A 
<http://www.inferico.com/kegg-cmpo.owl#inst231_KEGGMap_hsa05200_Abst_Gene_hsa_10000family>&&hsa05200&AKT3, MPPH, MPPH2, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1] AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1] AKT2, HIHGHH, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_2065_Abst_Gene_hsa_2065>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst6_KEGGMap_hsa05200_Abst_Gene_hsa_999>&&hsa05200&CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO; cadherin 1, type 1, E-cadherin (epithelial); K05689 cadherin 1, type 1, E-cadherin 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2322>&&&FLT3, CD135, FLK-2, FLK2, STK1; fms-related tyrosine kinase 3 (EC:2.7.10.1); K05092 fms-related tyrosine kinase 3 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7481>&LR&&WNT11, HWNT11; wingless-type MMTV integration site family, member 11; K01384 wingless-type MMTV integration site family, member 11 
<http://www.inferico.com/kegg-cmpo.owl#inst123_KEGGMap_hsa05200_Abst_Gene_hsa_4089>&&hsa05200&SMAD4, DPC4, JIP, MADH4, MYHRS; SMAD family member 4; K04501 mothers against decapentaplegic homolog 4 
<http://www.inferico.com/kegg-cmpo.owl#inst5_KEGGMap_hsa05220_Abst_Gene_hsa_25family>&R&hsa05220&BCR, ALL, BCR1, CML, D22S11, D22S662, PHL; breakpoint cluster region (EC:2.7.11.1); K08878 breakpoint cluster region protein [EC:2.7.11.1] ABL1, ABL, JTK7, bcr/abl, c-ABL, c-ABL1, p150, v-abl; ABL proto-oncogene 1, non-receptor tyrosine kinase (EC:2.7.10.2); K06619 abelson tyrosine-protein kinase 1 [EC:2.7.10.2] 
<http://www.inferico.com/kegg-cmpo.owl#cpd_C00533>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5613>&&&PRKX, PKX1; protein kinase, X-linked (EC:2.7.11.1); K04345 protein kinase A [EC:2.7.11.11] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5879>&&&RAC1, MIG5, Rac-1, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1 
<http://www.inferico.com/kegg-cmpo.owl#inst34_KEGGMap_hsa05220_Abst_Gene_hsa_23624family>&RL&hsa05220&CBLC, CBL-3, CBL-SL, RNF57; Cbl proto-oncogene C, E3 ubiquitin protein ligase; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19] CBL, C-CBL, CBL2, FRA11B, NSLL, RNF55; Cbl proto-oncogene, E3 ubiquitin protein ligase; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19] CBLB, Cbl-b, Nbla00127, RNF56; Cbl proto-oncogene B, E3 ubiquitin protein ligase; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5528>&&&PPP2R5D, B56D; protein phosphatase 2, regulatory subunit B', delta; K11584 serine/threonine-protein phosphatase 2A regulatory subunit B' 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2323>&&&FLT3LG, FL, FLT3L; fms-related tyrosine kinase 3 ligand; K05454 fms-related tyrosine kinase 3 ligand 
<http://www.inferico.com/kegg-cmpo.owl#inst28_KEGGMap_hsa04210_Abst_Gene_hsa_317>&&hsa04210&APAF1, APAF-1, CED4; apoptotic peptidase activating factor 1; K02084 apoptotic protease-activating factor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7709>&&&ZBTB17, MIZ-1, ZNF151, ZNF60, pHZ-67; zinc finger and BTB domain containing 17; K10500 zinc finger and BTB domain-containing protein 17 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7482>&LR&&WNT2B, WNT13; wingless-type MMTV integration site family, member 2B; K00182 wingless-type MMTV integration site family, member 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_1017_Abst_Gene_hsa_890_Abst_Gene_hsa_8900>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7046>&&&TGFBR1, AAT5, ACVRLK4, ALK-5, ALK5, ESS1, LDS1, LDS1A, LDS2A, MSSE, SKR4, TGFR-1, tbetaR-I; transforming growth factor, beta receptor 1 (EC:2.7.11.30); K04674 TGF-beta receptor type-1 [EC:2.7.11.30] 
<http://www.inferico.com/kegg-cmpo.owl#inst11_KEGGMap_hsa04110_Abst_Gene_hsa_5001>&&hsa04110&ORC5, ORC5L, ORC5P, ORC5T, PPP1R117; origin recognition complex, subunit 5; K02607 origin recognition complex subunit 5 
<http://www.inferico.com/kegg-cmpo.owl#inst50_KEGGMap_hsa05200_Abst_Gene_hsa_572>&&hsa05200&BAD, BBC2, BCL2L8; BCL2-associated agonist of cell death; K02158 BCL2-antagonist of cell death 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3569>&R&&IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6; K05405 interleukin 6 
<http://www.inferico.com/kegg-cmpo.owl#inst10_KEGGMap_hsa04012_Abst_Gene_hsa_2064>&&hsa04012&ERBB2, CD340, HER-2, HER-2/neu, HER2, MLN_19, NEU, NGL, TKR1; erb-b2 receptor tyrosine kinase 2 (EC:2.7.10.1); K05083 receptor tyrosine-protein kinase erbB-2 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst52_KEGGMap_hsa04012_Abst_Gene_hsa_2069>&&hsa04012&EREG, ER; epiregulin; K09784 epiregulin 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3654>&&&IRAK1, IRAK, pelle; interleukin-1 receptor-associated kinase 1 (EC:2.7.11.1); K04730 interleukin-1 receptor-associated kinase 1 [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1388>&&&ATF6B, CREB-RP, CREBL1, G13; activating transcription factor 6 beta; K09049 cyclic AMP-dependent transcription factor ATF-6 beta 
<http://www.inferico.com/kegg-cmpo.owl#inst30_KEGGMap_hsa04014_Compound_cpd_C01245>&&hsa04014&
<http://www.inferico.com/kegg-cmpo.owl#inst4_KEGGMap_hsa04151_Abst_Gene_hsa_6194>&&hsa04151&RPS6, S6; ribosomal protein S6; K02991 small subunit ribosomal protein S6e 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5878>&&&RAB5C, L1880, RAB5CL, RAB5L, RABL; RAB5C, member RAS oncogene family; K07889 Ras-related protein Rab-5C 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5527>&&&PPP2R5C, B56G, PR61G; protein phosphatase 2, regulatory subunit B', gamma; K11584 serine/threonine-protein phosphatase 2A regulatory subunit B' 
<http://www.inferico.com/kegg-cmpo.owl#inst11_KEGGMap_hsa04210_Abst_Gene_hsa_9131>&&hsa04210&AIFM1, AIF, CMT2D, CMTX4, COWCK, COXPD6, NADMR, NAMSD, PDCD8; apoptosis-inducing factor, mitochondrion-associated, 1; K04727 programmed cell death 8 (apoptosis-inducing factor) [EC:1.-.-.-] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_10971>&&&YWHAQ, 14-3-3, 1C5, HS1; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta; K16197 14-3-3 protein beta/theta/zeta 
<http://www.inferico.com/kegg-cmpo.owl#inst59_KEGGMap_hsa04210_Abst_Gene_hsa_3552family>&&hsa04210&IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1; interleukin 1, alpha; K04383 interleukin 1 alpha IL1B, IL-1, IL1-BETA, IL1F2; interleukin 1, beta; K04519 interleukin 1 beta 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8681>&&&JMJD7-PLA2G4B, HsT16992, cPLA2-beta; JMJD7-PLA2G4B readthrough; K16342 cytosolic phospholipase A2 [EC:3.1.1.4] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7132>&&&TNFRSF1A, CD120a, FPF, MS5, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR1-d2, TNFR55, TNFR60, p55, p55-R, p60; tumor necrosis factor receptor superfamily, member 1A; K03158 tumor necrosis factor receptor superfamily member 1A 
<http://www.inferico.com/kegg-cmpo.owl#inst6_KEGGMap_hsa04151_Abst_Gene_hsa_6198family>&&hsa04151&RPS6KB2, KLS, P70-beta, P70-beta-1, P70-beta-2, S6K-beta2, S6K2, SRK, STK14B, p70(S6K)-beta, p70S6Kb; ribosomal protein S6 kinase, 70kDa, polypeptide 2 (EC:2.7.11.1); K04688 p70 ribosomal S6 kinase [EC:2.7.11.1] RPS6KB1, PS6K, S6K, S6K-beta-1, S6K1, STK14A, p70_S6KA, p70(S6K)-alpha, p70-S6K, p70-alpha; ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1); K04688 p70 ribosomal S6 kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3566>&&&IL4R, CD124, IL-4RA, IL4RA; interleukin 4 receptor; K05071 interleukin 4 receptor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7483>&LR&&WNT9A, WNT14; wingless-type MMTV integration site family, member 9A; K01064 wingless-type MMTV integration site family, member 9 
<http://www.inferico.com/kegg-cmpo.owl#inst54_KEGGMap_hsa04014_Abst_Gene_hsa_387>&L&hsa04014&RHOA, ARH12, ARHA, RHO12, RHOH12; ras homolog family member A; K04513 Ras homolog gene family, member A 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6194>&&&RPS6, S6; ribosomal protein S6; K02991 small subunit ribosomal protein S6e 
<http://www.inferico.com/kegg-cmpo.owl#inst53_KEGGMap_hsa05200_Abst_Gene_hsa_598>&&hsa05200&BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS; BCL2-like 1; K04570 BCL2-like 1 (apoptosis regulator Bcl-X) 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8379>&&&MAD1L1, MAD1, PIG9, TP53I9, TXBP181; MAD1 mitotic arrest deficient-like 1 (yeast); K06638 mitotic spindle assembly checkpoint protein MAD1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5526>&&&PPP2R5B, B56B, PR61B; protein phosphatase 2, regulatory subunit B', beta; K11584 serine/threonine-protein phosphatase 2A regulatory subunit B' 
<http://www.inferico.com/kegg-cmpo.owl#inst234_KEGGMap_hsa05200_Abst_Gene_hsa_356>&&hsa05200&FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6; Fas ligand (TNF superfamily, member 6); K04389 tumor necrosis factor ligand superfamily member 6 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2321>&&&FLT1, FLT, FLT-1, VEGFR-1, VEGFR1; fms-related tyrosine kinase 1 (EC:2.7.10.1); K05096 FMS-like tyrosine kinase 1 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7048>&&&TGFBR2, AAT3, FAA3, LDS1B, LDS2, LDS2B, MFS2, RIIC, TAAD2, TGFR-2, TGFbeta-RII; transforming growth factor, beta receptor II (70/80kDa) (EC:2.7.11.30); K04388 TGF-beta receptor type-2 [EC:2.7.11.30] 
<http://www.inferico.com/kegg-cmpo.owl#inst55_KEGGMap_hsa04014_Abst_Gene_hsa_4301>&L&hsa04014&MLLT4, AF6; myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4; K05702 afadin 
<http://www.inferico.com/kegg-cmpo.owl#inst27_KEGGMap_hsa05200_Abst_Gene_hsa_2064>&&hsa05200&ERBB2, CD340, HER-2, HER-2/neu, HER2, MLN_19, NEU, NGL, TKR1; erb-b2 receptor tyrosine kinase 2 (EC:2.7.10.1); K05083 receptor tyrosine-protein kinase erbB-2 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#cpd_C07653>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7484>&LR&&WNT9B, WNT14B, WNT15; wingless-type MMTV integration site family, member 9B; K01064 wingless-type MMTV integration site family, member 9 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5525>&&&PPP2R5A, B56A, PR61A; protein phosphatase 2, regulatory subunit B', alpha; K11584 serine/threonine-protein phosphatase 2A regulatory subunit B' 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1385>&&&CREB1, CREB; cAMP responsive element binding protein 1; K05870 cyclic AMP-responsive element-binding protein 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5743>&&&PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1); K11987 prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst104_KEGGMap_hsa04151_Abst_Gene_hsa_118788>&&hsa04151&PIK3AP1, BCAP; phosphoinositide-3-kinase adaptor protein 1; K12230 phosphoinositide 3-kinase adapter protein 1 
<http://www.inferico.com/kegg-cmpo.owl#inst34_KEGGMap_hsa04210_Abst_Gene_hsa_823family>&&hsa04210&CAPN1, CANP, CANP1, CANPL1, muCANP, muCL; calpain 1, (mu/I) large subunit (EC:3.4.22.52); K01367 calpain-1 [EC:3.4.22.52] CAPN2, CANP2, CANPL2, CANPml, mCANP; calpain 2, (m/II) large subunit (EC:3.4.22.53); K03853 calpain-2 [EC:3.4.22.53] 
<http://www.inferico.com/kegg-cmpo.owl#inst148_KEGGMap_hsa05200_Abst_Gene_hsa_6256family>&&hsa05200&RXRG, NR2B3, RXRC; retinoid X receptor, gamma; K08526 retinoid X receptor gamma RXRB, DAUDI6, H-2RIIBP, NR2B2, RCoR-1; retinoid X receptor, beta; K08525 retinoid X receptor beta RXRA, NR2B1; retinoid X receptor, alpha; K08524 retinoid X receptor alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3479>&R&&IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_81579>&&&PLA2G12A, GXII, PLA2G12, ROSSY; phospholipase A2, group XIIA (EC:3.1.1.4); K01047 secretory phospholipase A2 [EC:3.1.1.4] 
<http://www.inferico.com/kegg-cmpo.owl#inst72_KEGGMap_hsa04014_Abst_Gene_hsa_22808>&&hsa04014&MRAS, M-RAs, R-RAS3, RRAS3; muscle RAS oncogene homolog; K07831 Ras-related protein M-Ras 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8115>&R&&TCL1A, TCL1; T-cell leukemia/lymphoma 1A; K10167 T-cell leukemia/lymphoma 1A 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_11140_Abst_Gene_hsa_3320_Abst_Gene_hsa_3326_Abst_Gene_hsa_7184>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2149>&&&F2R, CF2R, HTR, PAR-1, PAR1, TR; coagulation factor II (thrombin) receptor; K03914 coagulation factor II (thrombin) receptor 
<http://www.inferico.com/kegg-cmpo.owl#inst60_KEGGMap_hsa04012_Abst_Gene_hsa_1956>&R&hsa04012&EGFR, ERBB, ERBB1, HER1, NISBD2, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst8_KEGGMap_hsa04210_Abst_Gene_hsa_472>&R&hsa04210&ATM, AT1, ATA, ATC, ATD, ATDC, ATE, TEL1, TELO1; ATM serine/threonine kinase (EC:2.7.11.1); K04728 ataxia telangiectasia mutated family protein [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4763>&R&&NF1, NFNS, VRNF, WSS; neurofibromin 1; K08052 neurofibromin 1 
<http://www.inferico.com/kegg-cmpo.owl#inst134_KEGGMap_hsa05200_Compound_cpd_C00122>&&hsa05200&
<http://www.inferico.com/kegg-cmpo.owl#inst225_KEGGMap_hsa05200_Abst_Gene_hsa_4609>&L&hsa05200&MYC, MRTL, MYCC, bHLHe39, c-Myc; v-myc avian myelocytomatosis viral oncogene homolog; K04377 Myc proto-oncogene protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3565>&R&&IL4, BCGF-1, BCGF1, BSF-1, BSF1, IL-4; interleukin 4; K05430 interleukin 4 
<http://www.inferico.com/kegg-cmpo.owl#inst59_KEGGMap_hsa04151_Abst_Gene_hsa_23035family>&R&hsa04151&PHLPP2, PHLPPL; PH domain and leucine rich repeat protein phosphatase 2 (EC:3.1.3.16); K16340 PH domain and leucine-rich repeat-containing protein phosphatase [EC:3.1.3.16] PHLPP1, PHLPP, PLEKHE1, SCOP; PH domain and leucine rich repeat protein phosphatase 1 (EC:3.1.3.16); K16340 PH domain and leucine-rich repeat-containing protein phosphatase [EC:3.1.3.16] 
<http://www.inferico.com/kegg-cmpo.owl#inst36_KEGGMap_hsa04014_Abst_Gene_hsa_4303>&&hsa04014&FOXO4, AFX, AFX1, MLLT7; forkhead box O4; K12358 forkhead box protein O4 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3695>&&&ITGB7; integrin, beta 7; K06590 integrin beta 7 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3562>&R&&IL3, IL-3, MCGF, MULTI-CSF; interleukin 3; K04736 interleukin 3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_25>&CRL&&ABL1, ABL, JTK7, bcr/abl, c-ABL, c-ABL1, p150, v-abl; ABL proto-oncogene 1, non-receptor tyrosine kinase (EC:2.7.10.2); K06619 abelson tyrosine-protein kinase 1 [EC:2.7.10.2] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5523>&&&PPP2R3A, PPP2R3, PR130, PR72; protein phosphatase 2, regulatory subunit B'', alpha (EC:3.1.3.16); K11583 serine/threonine-protein phosphatase 2A regulatory subunit B'' 
<http://www.inferico.com/kegg-cmpo.owl#inst181_KEGGMap_hsa05200_Abst_Gene_hsa_841>&&hsa05200&CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61); K04398 caspase 8 [EC:3.4.22.61] 
<http://www.inferico.com/kegg-cmpo.owl#inst15_KEGGMap_hsa04014_Abst_Gene_hsa_1436family>&&hsa04014&NGFR, CD271, Gp80-LNGFR, TNFRSF16, p75(NTR), p75NTR; nerve growth factor receptor; K02583 nerve growth factor receptor (TNFR superfamily member 16) MET, AUTS9, HGFR, RCCP2, c-Met; MET proto-oncogene, receptor tyrosine kinase (EC:2.7.10.1); K05099 proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1] EGFR, ERBB, ERBB1, HER1, NISBD2, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1] INSR, CD220, HHF5; insulin receptor (EC:2.7.10.1); K04527 insulin receptor [EC:2.7.10.1] IGF1R, CD221, IGFIR, IGFR, JTK13; insulin-like growth factor 1 receptor (EC:2.7.10.1); K05087 insulin-like growth factor 1 receptor [EC:2.7.10.1] KDR, CD309, FLK1, VEGFR, VEGFR2; kinase insert domain receptor (EC:2.7.10.1); K05098 kinase insert domain protein receptor [EC:2.7.10.1] EPHA2, ARCC2, CTPA, CTPP1, CTRCT6, ECK; EPH receptor A2 (EC:2.7.10.1); K05103 Eph receptor A2 [EC:2.7.10.1] FLT1, FLT, FLT-1, VEGFR-1, VEGFR1; fms-related tyrosine kinase 1 (EC:2.7.10.1); K05096 FMS-like tyrosine kinase 1 [EC:2.7.10.1] CSF1R, C-FMS, CD115, CSF-1R, CSFR, FIM2, FMS, HDLS, M-CSF-R; colony stimulating factor 1 receptor (EC:2.7.10.1); K05090 macrophage colony-stimulating factor 1 receptor [EC:2.7.10.1] FLT4, FLT41, LMPH1A, PCL, VEGFR3; fms-related tyrosine kinase 4 (EC:2.7.10.1); K05097 FMS-like tyrosine kinase 4 [EC:2.7.10.1] TEK, CD202B, TIE-2, TIE2, VMCM, VMCM1; TEK tyrosine kinase, endothelial (EC:2.7.10.1); K05121 endothelial-specific receptor tyrosine kinase [EC:2.7.10.1] KIT, C-Kit, CD117, PBT, SCFR; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (EC:2.7.10.1); K05091 proto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1] PDGFRB, CD140B, IBGC4, IMF1, JTK12, PDGFR, PDGFR-1, PDGFR1; platelet-derived growth factor receptor, beta polypeptide (EC:2.7.10.1); K05089 platelet-derived growth factor receptor beta [EC:2.7.10.1] PDGFRA, CD140A, PDGFR-2, PDGFR2, RHEPDGFRA; platelet-derived growth factor receptor, alpha polypeptide (EC:2.7.10.1); K04363 platelet-derived growth factor receptor alpha [EC:2.7.10.1] FGFR2, BBDS, BEK, BFR-1, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25; fibroblast growth factor receptor 2 (EC:2.7.10.1); K05093 fibroblast growth factor receptor 2 [EC:2.7.10.1] FGFR4, CD334, JTK2, TKF; fibroblast growth factor receptor 4 (EC:2.7.10.1); K05095 fibroblast growth factor receptor 4 [EC:2.7.10.1] FGFR3, ACH, CD333, CEK2, HSFGFR3EX, JTK4; fibroblast growth factor receptor 3 (EC:2.7.10.1); K05094 fibroblast growth factor receptor 3 [EC:2.7.10.1] FGFR1, BFGFR, CD331, CEK, FGFBR, FGFR-1, FLG, FLT-2, FLT2, HBGFR, HH2, HRTFDS, KAL2, N-SAM, OGD, bFGF-R-1; fibroblast growth factor receptor 1 (EC:2.7.10.1); K04362 fibroblast growth factor receptor 1 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst38_KEGGMap_hsa05200_Abst_Gene_hsa_5154family>&R&hsa05200&PDGFB, IBGC5, PDGF-2, PDGF2, SIS, SSV, c-sis; platelet-derived growth factor beta polypeptide; K17386 platelet-derived growth factor subunit B PDGFA, PDGF-A, PDGF1; platelet-derived growth factor alpha polypeptide; K04359 platelet-derived growth factor subunit A 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4893>&L&&NRAS, ALPS4, CMNS, N-ras, NCMS, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas 
<http://www.inferico.com/kegg-cmpo.owl#inst47_KEGGMap_hsa04151_Abst_Gene_hsa_117145>&&hsa04151&THEM4, CTMP; thioesterase superfamily member 4 (EC:3.1.2.2); K16339 thioesterase superfamily member 4 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1387>&&&CREBBP, CBP, KAT3A, RSTS; CREB binding protein (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3563>&&&IL3RA, CD123, IL3R, IL3RAY, IL3RX, IL3RY, hIL-3Ra; interleukin 3 receptor, alpha (low affinity); K04737 interleukin 3 receptor alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_51529>&&&ANAPC11, APC11, Apc11p, HSPC214; anaphase promoting complex subunit 11; K03358 anaphase-promoting complex subunit 11 
<http://www.inferico.com/kegg-cmpo.owl#cpd_C00535>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_255189>&&&PLA2G4F, PLA2G4FZ; phospholipase A2, group IVF (EC:3.1.1.4); K16342 cytosolic phospholipase A2 [EC:3.1.1.4] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_317>&&&APAF1, APAF-1, CED4; apoptotic peptidase activating factor 1; K02084 apoptotic protease-activating factor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5522>&&&PPP2R2C, B55-GAMMA, IMYPNO, IMYPNO1, PR52, PR55G; protein phosphatase 2, regulatory subunit B, gamma (EC:3.1.3.16); K04354 serine/threonine-protein phosphatase 2A regulatory subunit B 
<http://www.inferico.com/kegg-cmpo.owl#inst257_KEGGMap_hsa05200_Abst_Gene_Group_Abst_Gene_hsa_3655_Abst_Gene_hsa_3673_Abst_Gene_hsa_3674_Abst_Gene_hsa_3675_Abst_Gene_hsa_3685_Abst_Gene_hsa_3688>&&hsa05200&
<http://www.inferico.com/kegg-cmpo.owl#inst115_KEGGMap_hsa05200_Abst_Gene_hsa_675>&RL&hsa05200&BRCA2, BRCC2, BROVCA2, FACD, FAD, FAD1, FANCD, FANCD1, GLM3, PNCA2, XRCC11; breast cancer 2, early onset; K08775 breast cancer 2 susceptibility protein 
<http://www.inferico.com/kegg-cmpo.owl#inst98_KEGGMap_hsa04151_Abst_Gene_hsa_598>&&hsa04151&BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS; BCL2-like 1; K04570 BCL2-like 1 (apoptosis regulator Bcl-X) 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6502>&&&SKP2, FBL1, FBXL1, FLB1, p45; S-phase kinase-associated protein 2, E3 ubiquitin protein ligase; K03875 F-box and leucine-rich repeat protein 1 (S-phase kinase-associated protein 2) 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1386>&&&ATF2, CRE-BP1, CREB-2, CREB2, HB16, TREB7; activating transcription factor 2 (EC:2.3.1.48); K04450 cyclic AMP-dependent transcription factor ATF-2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3696>&&&ITGB8; integrin, beta 8; K06591 integrin beta 8 
<http://www.inferico.com/kegg-cmpo.owl#inst25_KEGGMap_hsa04012_Abst_Gene_hsa_1027>&L&hsa04012&CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1; cyclin-dependent kinase inhibitor 1B (p27, Kip1); K06624 cyclin-dependent kinase inhibitor 1B 
<http://www.inferico.com/kegg-cmpo.owl#inst29_KEGGMap_hsa04110_Abst_Gene_hsa_9184>&&hsa04110&BUB3, BUB3L, hBUB3; BUB3 mitotic checkpoint protein; K02180 cell cycle arrest protein BUB3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5925>&CL&&RB1, OSRC, PPP1R130, RB, p105-Rb, pRb, pp110; retinoblastoma 1; K06618 retinoblastoma-associated protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_10393_Abst_Gene_hsa_246184_Abst_Gene_hsa_25847_Abst_Gene_hsa_29882_Abst_Gene_hsa_29945_Abst_Gene_hsa_51433_Abst_Gene_hsa_51434_Abst_Gene_hsa_51529_Abst_Gene_hsa_64682_Abst_Gene_hsa_8697_Abst_Gene_hsa_8881_Abst_Gene_hsa_991_Abst_Gene_hsa_996>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst97_KEGGMap_hsa04014_Abst_Gene_hsa_10298family>&&hsa04014&PAK7, PAK5; p21 protein (Cdc42/Rac)-activated kinase 7 (EC:2.7.11.1); K05736 p21-activated kinase 7 [EC:2.7.11.1] PAK6, PAK5; p21 protein (Cdc42/Rac)-activated kinase 6 (EC:2.7.11.1); K05735 p21-activated kinase 6 [EC:2.7.11.1] PAK1, PAKalpha; p21 protein (Cdc42/Rac)-activated kinase 1 (EC:2.7.11.1); K04409 p21-activated kinase 1 [EC:2.7.11.1] PAK4; p21 protein (Cdc42/Rac)-activated kinase 4 (EC:2.7.11.1); K05734 p21-activated kinase 4 [EC:2.7.11.1] PAK3, MRX30, MRX47, OPHN3, PAK-3, PAK3beta, bPAK, beta-PAK; p21 protein (Cdc42/Rac)-activated kinase 3 (EC:2.7.11.1); K05733 p21-activated kinase 3 [EC:2.7.11.1] PAK2, PAK65, PAKgamma; p21 protein (Cdc42/Rac)-activated kinase 2 (EC:2.7.11.1); K04410 p21-activated kinase 2 [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst31_KEGGMap_hsa04110_Abst_Gene_hsa_10971family>&&hsa04110&YWHAB, GW128, HEL-S-1, HS1, KCIP-1, YWHAA; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta; K16197 14-3-3 protein beta/theta/zeta YWHAZ, 14-3-3-zeta, HEL-S-3, HEL4, KCIP-1, YWHAD; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta; K16197 14-3-3 protein beta/theta/zeta YWHAE, 14-3-3E, HEL2, KCIP-1, MDCR, MDS; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon; K06630 14-3-3 protein epsilon YWHAG, 14-3-3GAMMA, PPP1R170; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma; K16198 14-3-3 protein gamma/eta YWHAH, YWHA1; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta; K16198 14-3-3 protein gamma/eta YWHAQ, 14-3-3, 1C5, HS1; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta; K16197 14-3-3 protein beta/theta/zeta 
<http://www.inferico.com/kegg-cmpo.owl#inst48_KEGGMap_hsa04110_Abst_Gene_hsa_5925>&CL&hsa04110&RB1, OSRC, PPP1R130, RB, p105-Rb, pRb, pp110; retinoblastoma 1; K06618 retinoblastoma-associated protein 
<http://www.inferico.com/kegg-cmpo.owl#inst53_KEGGMap_hsa04210_Abst_Gene_hsa_3554family>&&hsa04210&IL1RAP, C3orf13, IL-1RAcP, IL1R3; interleukin 1 receptor accessory protein; K04723 interleukin 1 receptor accessory protein IL1R1, CD121A, D2S1473, IL-1R-alpha, IL1R, IL1RA, P80; interleukin 1 receptor, type I; K04386 interleukin 1 receptor type I 
<http://www.inferico.com/kegg-cmpo.owl#inst16_KEGGMap_hsa04210_Abst_Gene_hsa_100506742>&&hsa04210&CASP12, CASP-12, CASP12P1; caspase 12 (gene/pseudogene); K04741 caspase 12 [EC:3.4.22.-] 
<http://www.inferico.com/kegg-cmpo.owl#inst99_KEGGMap_hsa04110_Abst_Gene_Group_Abst_Gene_hsa_4087_Abst_Gene_hsa_4088_Abst_Gene_hsa_4089>&&hsa04110&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_55970>&&&GNG12; guanine nucleotide binding protein (G protein), gamma 12; K04347 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 
<http://www.inferico.com/kegg-cmpo.owl#cpd_C03917>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_10488>&&&CREB3, LUMAN, LZIP, sLZIP; cAMP responsive element binding protein 3; K09048 cyclic AMP-responsive element-binding protein 3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_7186_Abst_Gene_hsa_8717_Abst_Gene_hsa_8737>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_51176>&&&LEF1, LEF-1, TCF10, TCF1ALPHA, TCF7L3; lymphoid enhancer-binding factor 1; K04492 lymphoid enhancer-binding factor 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_9131>&&&AIFM1, AIF, CMT2D, CMTX4, COWCK, COXPD6, NADMR, NAMSD, PDCD8; apoptosis-inducing factor, mitochondrion-associated, 1; K04727 programmed cell death 8 (apoptosis-inducing factor) [EC:1.-.-.-] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1870>&&&E2F2, E2F-2; E2F transcription factor 2; K09389 transcription factor E2F2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7170>&R&&TPM3, CAPM1, CFTD, HEL-189, HEL-S-82p, NEM1, OK/SW-cl.5, TM-5, TM3, TM30, TM30nm, TM5, TPMsk3, TRK, hscp30; tropomyosin 3; K09290 tropomyosin 3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1301>&&&COL11A1, CO11A1, COLL6, STL2; collagen, type XI, alpha 1; K06236 collagen, type I/II/III/V/XI/XXIV/XXVII, alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_840>&&&CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3; caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60); K04397 caspase 7 [EC:3.4.22.60] 
<http://www.inferico.com/kegg-cmpo.owl#inst105_KEGGMap_hsa04110_Abst_Gene_Group_Abst_Gene_hsa_4171_Abst_Gene_hsa_4172_Abst_Gene_hsa_4173_Abst_Gene_hsa_4174_Abst_Gene_hsa_4175_Abst_Gene_hsa_4176>&&hsa04110&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2549>&&&GAB1; GRB2-associated binding protein 1; K09593 GRB2-associated-binding protein 1 
<http://www.inferico.com/kegg-cmpo.owl#inst95_KEGGMap_hsa05200_Compound_cpd_C01245>&&hsa05200&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5924>&&&RASGRF2, GRF2, RAS-GRF2; Ras protein-specific guanine nucleotide-releasing factor 2; K12326 Ras-specific guanine nucleotide-releasing factor 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_84647>&&&PLA2G12B, FKSG71, GXIIB, GXIIIsPLA2, PLA2G13; phospholipase A2, group XIIB (EC:3.1.1.4); K01047 secretory phospholipase A2 [EC:3.1.1.4] 
<http://www.inferico.com/kegg-cmpo.owl#inst4_KEGGMap_hsa04110_Abst_Gene_hsa_23594family>&&hsa04110&ORC5, ORC5L, ORC5P, ORC5T, PPP1R117; origin recognition complex, subunit 5; K02607 origin recognition complex subunit 5 ORC4, ORC4L, ORC4P; origin recognition complex, subunit 4; K02606 origin recognition complex subunit 4 ORC2, ORC2L; origin recognition complex, subunit 2; K02604 origin recognition complex subunit 2 ORC1, HSORC1, ORC1L, PARC1; origin recognition complex, subunit 1; K02603 origin recognition complex subunit 1 ORC3, LAT, LATHEO, ORC3L; origin recognition complex, subunit 3; K02605 origin recognition complex subunit 3 ORC6, ORC6L; origin recognition complex, subunit 6; K02608 origin recognition complex subunit 6 
<http://www.inferico.com/kegg-cmpo.owl#inst11_KEGGMap_hsa04012_Abst_Gene_hsa_2064>&&hsa04012&ERBB2, CD340, HER-2, HER-2/neu, HER2, MLN_19, NEU, NGL, TKR1; erb-b2 receptor tyrosine kinase 2 (EC:2.7.10.1); K05083 receptor tyrosine-protein kinase erbB-2 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst59_KEGGMap_hsa04012_Abst_Gene_hsa_10000family>&&hsa04012&AKT3, MPPH, MPPH2, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1] AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1] AKT2, HIHGHH, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst37_KEGGMap_hsa05220_Abst_Gene_hsa_4193>&&hsa05220&MDM2, ACTFS, HDMX, hdm2; MDM2 proto-oncogene, E3 ubiquitin protein ligase; K06643 E3 ubiquitin-protein ligase Mdm2 [EC:6.3.2.19] 
<http://www.inferico.com/kegg-cmpo.owl#inst158_KEGGMap_hsa05200_Abst_Gene_hsa_861>&CR&hsa05200&RUNX1, AML1, AML1-EVI-1, AMLCR1, CBFA2, EVI-1, PEBP2aB; runt-related transcription factor 1; K08367 runt-related transcription factor 1 
<http://www.inferico.com/kegg-cmpo.owl#inst51_KEGGMap_hsa04012_Abst_Gene_hsa_3084>&&hsa04012&NRG1, ARIA, GGF, GGF2, HGL, HRG, HRG1, HRGA, MST131, MSTP131, NDF, NRG1-IT2, SMDF; neuregulin 1; K05455 neuregulin 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3084>&&&NRG1, ARIA, GGF, GGF2, HGL, HRG, HRG1, HRGA, MST131, MSTP131, NDF, NRG1-IT2, SMDF; neuregulin 1; K05455 neuregulin 1 
<http://www.inferico.com/kegg-cmpo.owl#inst264_KEGGMap_hsa05200_Abst_Gene_Group_Abst_Gene_hsa_26060_Abst_Gene_hsa_842>&&hsa05200&
<http://www.inferico.com/kegg-cmpo.owl#inst72_KEGGMap_hsa04110_Abst_Gene_hsa_898family>&&hsa04110&CCNE2, CYCE2; cyclin E2; K06626 cyclin E CCNE1, CCNE; cyclin E1; K06626 cyclin E 
<http://www.inferico.com/kegg-cmpo.owl#inst3_KEGGMap_hsa05200_Abst_Gene_hsa_836>&&hsa05200&CASP3, CPP32, CPP32B, SCA-1; caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56); K02187 caspase 3 [EC:3.4.22.56] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_841>&&&CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61); K04398 caspase 8 [EC:3.4.22.61] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_405>&&&ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2; aryl hydrocarbon receptor nuclear translocator; K09097 aryl hydrocarbon receptor nuclear translocator 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5923>&&&RASGRF1, CDC25, CDC25L, GNRP, GRF1, GRF55, H-GRF55, PP13187, ras-GRF1; Ras protein-specific guanine nucleotide-releasing factor 1; K04349 Ras-specific guanine nucleotide-releasing factor 1 
<http://www.inferico.com/kegg-cmpo.owl#inst85_KEGGMap_hsa04014_Abst_Gene_hsa_10681family>&&hsa04014&GNGT1, GNG1; guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1; K04548 guanine nucleotide-binding protein G(T) subunit gamma-T1 GNGT2, G-GAMMA-8, G-GAMMA-C, GNG8, GNG9, GNGT8; guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2; K04549 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 GNG10; guanine nucleotide binding protein (G protein), gamma 10; K04545 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 GNG11, GNGT11; guanine nucleotide binding protein (G protein), gamma 11; K04546 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 GNG12; guanine nucleotide binding protein (G protein), gamma 12; K04347 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 GNG2; guanine nucleotide binding protein (G protein), gamma 2; K07826 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 null GNG13, G(gamma)13, h2-35; guanine nucleotide binding protein (G protein), gamma 13; K04547 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13 GNG8; guanine nucleotide binding protein (G protein), gamma 8; K04544 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8 GNB4, CMTD1F; guanine nucleotide binding protein (G protein), beta polypeptide 4; K04538 guanine nucleotide-binding protein subunit beta-4 GNB1; guanine nucleotide binding protein (G protein), beta polypeptide 1; K04536 guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 GNB2; guanine nucleotide binding protein (G protein), beta polypeptide 2; K04537 guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 GNG7; guanine nucleotide binding protein (G protein), gamma 7; K04543 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 GNG4; guanine nucleotide binding protein (G protein), gamma 4; K04541 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 GNG5; guanine nucleotide binding protein (G protein), gamma 5; K04542 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 GNB3; guanine nucleotide binding protein (G protein), beta polypeptide 3; K07825 guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 GNG3; guanine nucleotide binding protein (G protein), gamma 3; K04540 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3 GNB5, GB5; guanine nucleotide binding protein (G protein), beta 5; K04539 guanine nucleotide-binding protein subunit beta-5 
<http://www.inferico.com/kegg-cmpo.owl#inst167_KEGGMap_hsa05200_Abst_Gene_hsa_1019family>&&hsa05200&CDK6, MCPH12, PLSTIRE; cyclin-dependent kinase 6 (EC:2.7.11.22); K02091 cyclin-dependent kinase 6 [EC:2.7.11.22] CDK4, CMM3, PSK-J3; cyclin-dependent kinase 4 (EC:2.7.11.22); K02089 cyclin-dependent kinase 4 [EC:2.7.11.22] 
<http://www.inferico.com/kegg-cmpo.owl#inst61_KEGGMap_hsa04014_Abst_Gene_hsa_5906family>&L&hsa04014&RAP1B, K-REV, RAL1B; RAP1B, member of RAS oncogene family; K07836 Ras-related protein Rap-1B RAP1A, C21KG, G-22K, KREV-1, KREV1, RAP1, SMGP21; RAP1A, member of RAS oncogene family; K04353 Ras-related protein Rap-1A 
<http://www.inferico.com/kegg-cmpo.owl#inst75_KEGGMap_hsa04012_Abst_Gene_Group_Abst_Gene_hsa_1956_Abst_Gene_hsa_1956>&&hsa04012&
<http://www.inferico.com/kegg-cmpo.owl#inst66_KEGGMap_hsa04014_Abst_Gene_hsa_5894>&L&hsa04014&RAF1, CMD1NN, CRAF, NS5, Raf-1, c-Raf; Raf-1 proto-oncogene, serine/threonine kinase (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst168_KEGGMap_hsa05200_Abst_Gene_hsa_5925>&C&hsa05200&RB1, OSRC, PPP1R130, RB, p105-Rb, pRb, pp110; retinoblastoma 1; K06618 retinoblastoma-associated protein 
<http://www.inferico.com/kegg-cmpo.owl#inst175_KEGGMap_hsa05200_Abst_Gene_hsa_1027>&&hsa05200&CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1; cyclin-dependent kinase inhibitor 1B (p27, Kip1); K06624 cyclin-dependent kinase inhibitor 1B 
<http://www.inferico.com/kegg-cmpo.owl#inst55_KEGGMap_hsa05220_Abst_Gene_Group_Abst_Gene_hsa_1398_Abst_Gene_hsa_1398_Abst_Gene_hsa_1399_Abst_Gene_hsa_1399_Abst_Gene_hsa_23624_Abst_Gene_hsa_867_Abst_Gene_hsa_868>&&hsa05220&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_9133>&&&CCNB2, HsT17299; cyclin B2; K05868 cyclin B 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8900>&&&CCNA1, CT146; cyclin A1; K06627 cyclin A 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1436>&L&&CSF1R, C-FMS, CD115, CSF-1R, CSFR, FIM2, FMS, HDLS, M-CSF-R; colony stimulating factor 1 receptor (EC:2.7.10.1); K05090 macrophage colony-stimulating factor 1 receptor [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst180_KEGGMap_hsa05200_Abst_Gene_hsa_8772>&&hsa05200&FADD, GIG3, MORT1; Fas (TNFRSF6)-associated via death domain; K02373 FAS-associated death domain protein 
<http://www.inferico.com/kegg-cmpo.owl#inst8_KEGGMap_hsa04151_Abst_Gene_hsa_2475>&&hsa04151&MTOR, FRAP, FRAP1, FRAP2, RAFT1, RAPT1; mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1); K07203 FKBP12-rapamycin complex-associated protein 
<http://www.inferico.com/kegg-cmpo.owl#inst90_KEGGMap_hsa04014_Compound_cpd_C01245>&&hsa04014&
<http://www.inferico.com/kegg-cmpo.owl#inst98_KEGGMap_hsa05200_Abst_Gene_hsa_6469>&&hsa05200&SHH, HHG1, HLP3, HPE3, MCOPCB5, SMMCI, TPT, TPTPS; sonic hedgehog; K11988 sonic hedgehog 
<http://www.inferico.com/kegg-cmpo.owl#inst97_KEGGMap_hsa04110_Abst_Gene_hsa_1874family>&&hsa04110&E2F4, E2F-4; E2F transcription factor 4, p107/p130-binding; K04682 transcription factor E2F4/5 E2F5, E2F-5; E2F transcription factor 5, p130-binding; K04682 transcription factor E2F4/5 
<http://www.inferico.com/kegg-cmpo.owl#inst256_KEGGMap_hsa05200_Abst_Gene_Group_Abst_Gene_hsa_367_Abst_Gene_hsa_367>&&hsa05200&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5922>&R&&RASA2, GAP1M; RAS p21 protein activator 2; K08053 Ras GTPase-activating protein 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_54205>&&&CYCS, CYC, HCS, THC4; cytochrome c, somatic; K08738 cytochrome c 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_842>&&&CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3082>&R&&HGF, DFNB39, F-TCF, HGFB, HPTA, SF; hepatocyte growth factor (hepapoietin A; scatter factor); K05460 hepatocyte growth factor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1302>&&&COL11A2, DFNA13, DFNB53, FBCG2, HKE5, PARP, STL3; collagen, type XI, alpha 2; K06236 collagen, type I/II/III/V/XI/XXIV/XXVII, alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1435>&R&&CSF1, CSF-1, MCSF; colony stimulating factor 1 (macrophage) (EC:2.7.10.1); K05453 macrophage colony-stimulating factor 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1871>&&&E2F3, E2F-3; E2F transcription factor 3; K06620 transcription factor E2F3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7040>&&&TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_53358>&&&SHC3, N-Shc, NSHC, RAI, SHCC; SHC (Src homology 2 domain containing) transforming protein 3; K17448 SHC- transforming protein 3 
<http://www.inferico.com/kegg-cmpo.owl#inst51_KEGGMap_hsa05220_Abst_Gene_hsa_5604family>&&hsa05220&MAP2K2, CFC4, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2] MAP2K1, CFC3, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7704>&R&&ZBTB16, PLZF, ZNF145; zinc finger and BTB domain containing 16; K10055 zinc finger and BTB domain-containing protein 16 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5921>&R&&RASA1, CM-AVM, CMAVM, GAP, PKWS, RASA, RASGAP, p120GAP, p120RASGAP; RAS p21 protein activator (GTPase activating protein) 1; K04352 Ras GTPase-activating protein 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_54331>&&&GNG2; guanine nucleotide binding protein (G protein), gamma 2; K07826 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 
<http://www.inferico.com/kegg-cmpo.owl#inst110_KEGGMap_hsa05200_Abst_Gene_hsa_9978>&&hsa05200&RBX1, BA554C12.1, RNF75, ROC1; ring-box 1, E3 ubiquitin protein ligase; K03868 RING-box protein 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3439>&R&&IFNA1, IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@; interferon, alpha 1; K05414 interferon alpha 
<http://www.inferico.com/kegg-cmpo.owl#inst15_KEGGMap_hsa04210_Abst_Gene_hsa_1677>&&hsa04210&DFFB, CAD, CPAN, DFF-40, DFF2, DFF40; DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase); K02311 DNA fragmentation factor, 40 kD, beta subunit [EC:3.-.-.-] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5618>&&&PRLR, HPRL, MFAB, hPRLrI; prolactin receptor; K05081 prolactin receptor 
<http://www.inferico.com/kegg-cmpo.owl#inst32_KEGGMap_hsa04151_Abst_Gene_hsa_598>&&hsa04151&BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS; BCL2-like 1; K04570 BCL2-like 1 (apoptosis regulator Bcl-X) 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_843>&&&CASP10, ALPS2, FLICE2, MCH4; caspase 10, apoptosis-related cysteine peptidase (EC:3.4.22.63); K04400 caspase 10 [EC:3.4.22.63] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_23179>&&&RGL1, RGL; ral guanine nucleotide dissociation stimulator-like 1; K17635 ral guanine nucleotide dissociation stimulator-like 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_10000>&&&AKT3, MPPH, MPPH2, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8817>&R&&FGF18, FGF-18, ZFGF5; fibroblast growth factor 18; K04358 fibroblast growth factor 
<http://www.inferico.com/kegg-cmpo.owl#inst96_KEGGMap_hsa04151_Abst_Gene_hsa_596>&L&hsa04151&BCL2, Bcl-2, PPP1R50; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2 
<http://www.inferico.com/kegg-cmpo.owl#inst40_KEGGMap_hsa05220_Abst_Gene_hsa_5925>&CL&hsa05220&RB1, OSRC, PPP1R130, RB, p105-Rb, pRb, pp110; retinoblastoma 1; K06618 retinoblastoma-associated protein 
<http://www.inferico.com/kegg-cmpo.owl#inst24_KEGGMap_hsa05220_Abst_Gene_hsa_1147family>&&hsa05220&IKBKB, IKK-beta, IKK2, IKKB, IMD15, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10] IKBKG, AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IMD33, IP, IP1, IP2, IPD2, NEMO, ZC2HC9; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; K07210 inhibitor of nuclear factor kappa-B kinase subunit gamma CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4193>&&&MDM2, ACTFS, HDMX, hdm2; MDM2 proto-oncogene, E3 ubiquitin protein ligase; K06643 E3 ubiquitin-protein ligase Mdm2 [EC:6.3.2.19] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5617>&R&&PRL; prolactin; K05439 prolactin 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7175>&R&&TPR; translocated promoter region, nuclear basket protein; K09291 nucleoprotein TPR 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_9134>&RL&&CCNE2, CYCE2; cyclin E2; K06626 cyclin E 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_253314>&&&EIF4E1B; eukaryotic translation initiation factor 4E family member 1B; K03259 translation initiation factor 4E 
<http://www.inferico.com/kegg-cmpo.owl#inst111_KEGGMap_hsa04110_Abst_Gene_Group_Abst_Gene_hsa_10393_Abst_Gene_hsa_246184_Abst_Gene_hsa_25847_Abst_Gene_hsa_29882_Abst_Gene_hsa_29945_Abst_Gene_hsa_51433_Abst_Gene_hsa_51434_Abst_Gene_hsa_51529_Abst_Gene_hsa_64682_Abst_Gene_hsa_8697_Abst_Gene_hsa_8881_Abst_Gene_hsa_991_Abst_Gene_hsa_996>&&hsa04110&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_ko_K06856>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7042>&&&TGFB2, LDS4, TGF-beta2; transforming growth factor, beta 2; K13376 transforming growth factor beta-2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_11200>&&&CHEK2, CDS1, CHK2, HuCds1, LFS2, PP1425, RAD53, hCds1; checkpoint kinase 2 (EC:2.7.11.1); K06641 serine/threonine-protein kinase Chk2 [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst112_KEGGMap_hsa05200_Abst_Gene_hsa_405family>&&hsa05200&ARNT2, WEDAS, bHLHe1; aryl-hydrocarbon receptor nuclear translocator 2; K15589 aryl hydrocarbon receptor nuclear translocator 2 ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2; aryl hydrocarbon receptor nuclear translocator; K09097 aryl hydrocarbon receptor nuclear translocator 
<http://www.inferico.com/kegg-cmpo.owl#inst79_KEGGMap_hsa05200_Abst_Gene_hsa_4609>&&hsa05200&MYC, MRTL, MYCC, bHLHe39, c-Myc; v-myc avian myelocytomatosis viral oncogene homolog; K04377 Myc proto-oncogene protein 
<http://www.inferico.com/kegg-cmpo.owl#inst94_KEGGMap_hsa04014_Abst_Gene_hsa_7535>&&hsa04014&ZAP70, SRK, STCD, STD, TZK, ZAP-70; zeta-chain (TCR) associated protein kinase 70kDa (EC:2.7.10.2); K07360 tyrosine-protein kinase ZAP-70 [EC:2.7.10.2] 
<http://www.inferico.com/kegg-cmpo.owl#inst31_KEGGMap_hsa05220_Abst_Gene_hsa_25759family>&&hsa05220&SHC2, SCK, SHCB, SLI; SHC (Src homology 2 domain containing) transforming protein 2; K17447 SHC- transforming protein 2 SHC1, SHC, SHCA; SHC (Src homology 2 domain containing) transforming protein 1; K06279 SHC- transforming protein 1 SHC4, RaLP, SHCD; SHC (Src homology 2 domain containing) family, member 4; K17449 SHC- transforming protein 4 SHC3, N-Shc, NSHC, RAI, SHCC; SHC (Src homology 2 domain containing) transforming protein 3; K17448 SHC- transforming protein 3 
<http://www.inferico.com/kegg-cmpo.owl#inst61_KEGGMap_hsa04151_Abst_Gene_hsa_1027>&&hsa04151&CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1; cyclin-dependent kinase inhibitor 1B (p27, Kip1); K06624 cyclin-dependent kinase inhibitor 1B 
<http://www.inferico.com/kegg-cmpo.owl#inst1_KEGGMap_hsa04151_Compound_cpd_C05981>&&hsa04151&
<http://www.inferico.com/kegg-cmpo.owl#inst59_KEGGMap_hsa05200_Abst_Gene_hsa_369family>&&hsa05200&RAF1, CMD1NN, CRAF, NS5, Raf-1, c-Raf; Raf-1 proto-oncogene, serine/threonine kinase (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] ARAF, A-RAF, ARAF1, PKS2, RAFA1; A-Raf proto-oncogene, serine/threonine kinase (EC:2.7.11.1); K08845 A-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] BRAF, B-RAF1, BRAF1, NS7, RAFB1; B-Raf proto-oncogene, serine/threonine kinase (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst151_KEGGMap_hsa05200_Abst_Gene_hsa_5914family>&R&hsa05200&RARA, NR1B1, RAR; retinoic acid receptor, alpha; K08527 retinoic acid receptor alpha ZBTB16, PLZF, ZNF145; zinc finger and BTB domain containing 16; K10055 zinc finger and BTB domain-containing protein 16 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6199>&&&RPS6KB2, KLS, P70-beta, P70-beta-1, P70-beta-2, S6K-beta2, S6K2, SRK, STK14B, p70(S6K)-beta, p70S6Kb; ribosomal protein S6 kinase, 70kDa, polypeptide 2 (EC:2.7.11.1); K04688 p70 ribosomal S6 kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2324>&&&FLT4, FLT41, LMPH1A, PCL, VEGFR3; fms-related tyrosine kinase 4 (EC:2.7.10.1); K05097 FMS-like tyrosine kinase 4 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_930>&&&CD19, B4, CVID3; CD19 molecule; K06465 CD19 antigen 
<http://www.inferico.com/kegg-cmpo.owl#inst57_KEGGMap_hsa04014_Abst_Gene_hsa_11186>&&hsa04014&RASSF1, 123F2, NORE2A, RASSF1A, RDA32, REH3P21; Ras association (RalGDS/AF-6) domain family member 1; K09850 Ras association domain-containing protein 1 
<http://www.inferico.com/kegg-cmpo.owl#inst42_KEGGMap_hsa04210_Abst_Gene_hsa_8772>&&hsa04210&FADD, GIG3, MORT1; Fas (TNFRSF6)-associated via death domain; K02373 FAS-associated death domain protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7043>&&&TGFB3, ARVD, ARVD1, RNHF, TGF-beta3; transforming growth factor, beta 3; K13377 transforming growth factor beta-3 
<http://www.inferico.com/kegg-cmpo.owl#inst9_KEGGMap_hsa04014_Abst_Gene_hsa_6654family>&&hsa04014&SOS2; son of sevenless homolog 2 (Drosophila); K03099 son of sevenless SOS1, GF1, GGF1, GINGF, HGF, NS4; son of sevenless homolog 1 (Drosophila); K03099 son of sevenless 
<http://www.inferico.com/kegg-cmpo.owl#inst144_KEGGMap_hsa05200_Abst_Gene_hsa_5468family>&&hsa05200&PAX8; paired box 8; K09293 paired box protein 8 PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma; peroxisome proliferator-activated receptor gamma; K08530 peroxisome proliferator-activated receptor gamma 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1129>&&&CHRM2, HM2; cholinergic receptor, muscarinic 2; K04130 muscarinic acetylcholine receptor M2 
<http://www.inferico.com/kegg-cmpo.owl#inst19_KEGGMap_hsa04014_Abst_Gene_hsa_5879family>&&hsa04014&RAC3; ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3); K07861 Ras-related C3 botulinum toxin substrate 3 RAC2, EN-7, Gx, HSPC022, p21-Rac2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2); K07860 Ras-related C3 botulinum toxin substrate 2 RAC1, MIG5, Rac-1, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_10926_Abst_Gene_hsa_8317>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3655>&&&ITGA6, CD49f, ITGA6B, VLA-6; integrin, alpha 6; K06485 integrin alpha 6 
<http://www.inferico.com/kegg-cmpo.owl#inst17_KEGGMap_hsa05220_Abst_Gene_hsa_7046>&&hsa05220&TGFBR1, AAT5, ACVRLK4, ALK-5, ALK5, ESS1, LDS1, LDS1A, LDS2A, MSSE, SKR4, TGFR-1, tbetaR-I; transforming growth factor, beta receptor 1 (EC:2.7.11.30); K04674 TGF-beta receptor type-1 [EC:2.7.11.30] 
<http://www.inferico.com/kegg-cmpo.owl#inst58_KEGGMap_hsa05220_Abst_Gene_Group_Abst_Gene_hsa_1019_Abst_Gene_hsa_1021_Abst_Gene_hsa_595>&&hsa05220&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5966>&L&&REL, C-Rel; v-rel avian reticuloendotheliosis viral oncogene homolog; K09254 c-Rel proto-oncogene protein 
<http://www.inferico.com/kegg-cmpo.owl#inst13_KEGGMap_hsa04151_Abst_Gene_hsa_10000family>&&hsa04151&AKT3, MPPH, MPPH2, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1] AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1] AKT2, HIHGHH, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_256076>&&&COL6A5, COL29A1, VWA4; collagen, type VI, alpha 5; K06238 collagen, type VI, alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_50509>&&&COL5A3; collagen, type V, alpha 3; K06236 collagen, type I/II/III/V/XI/XXIV/XXVII, alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6198>&&&RPS6KB1, PS6K, S6K, S6K-beta-1, S6K1, STK14A, p70_S6KA, p70(S6K)-alpha, p70-S6K, p70-alpha; ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1); K04688 p70 ribosomal S6 kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst162_KEGGMap_hsa05200_Abst_Gene_hsa_4609>&RL&hsa05200&MYC, MRTL, MYCC, bHLHe39, c-Myc; v-myc avian myelocytomatosis viral oncogene homolog; K04377 Myc proto-oncogene protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5170>&&&PDPK1, PDK1, PDPK2, PDPK2P, PRO0461; 3-phosphoinositide dependent protein kinase 1 (EC:2.7.11.1); K06276 3-phosphoinositide dependent protein kinase-1 [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst58_KEGGMap_hsa04210_Abst_Gene_hsa_4803>&&hsa04210&NGF, Beta-NGF, HSAN5, NGFB; nerve growth factor (beta polypeptide); K02582 nerve growth factor, beta 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7480>&LR&&WNT10B, SHFM6, WNT-12; wingless-type MMTV integration site family, member 10B; K01357 wingless-type MMTV integration site family, member 10 
<http://www.inferico.com/kegg-cmpo.owl#inst142_KEGGMap_hsa05200_Compound_cpd_C16038>&&hsa05200&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1128>&&&CHRM1, HM1, M1, M1R; cholinergic receptor, muscarinic 1; K04129 muscarinic acetylcholine receptor M1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3656>&&&IRAK2, IRAK-2; interleukin-1 receptor-associated kinase 2; K04731 interleukin-1 receptor-associated kinase 2 [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst255_KEGGMap_hsa05200_Abst_Gene_Group_Abst_Gene_hsa_3320_Abst_Gene_hsa_3326_Abst_Gene_hsa_367_Abst_Gene_hsa_7184>&&hsa05200&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2956>&&&MSH6, GTBP, GTMBP, HNPCC5, HSAP, p160; mutS homolog 6; K08737 DNA mismatch repair protein MSH6 
<http://www.inferico.com/kegg-cmpo.owl#inst97_KEGGMap_hsa04151_Abst_Gene_hsa_4170>&&hsa04151&MCL1, BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1, TM, bcl2-L-3, mcl1/EAT; myeloid cell leukemia 1; K02539 myeloid leukemia cell differntiation protein MCL-1 
<http://www.inferico.com/kegg-cmpo.owl#inst35_KEGGMap_hsa04014_Abst_Gene_hsa_4790family>&&hsa04014&RELA, NFKB3, p65; v-rel avian reticuloendotheliosis viral oncogene homolog A; K04735 transcription factor p65 NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor NF-kappa-B p105 subunit 
<http://www.inferico.com/kegg-cmpo.owl#inst60_KEGGMap_hsa04210_Abst_Gene_hsa_7124>&&hsa04210&TNF, DIF, TNF-alpha, TNFA, TNFSF2; tumor necrosis factor; K03156 tumor necrosis factor superfamily, member 2 
<http://www.inferico.com/kegg-cmpo.owl#inst19_KEGGMap_hsa04210_Abst_Gene_hsa_836>&&hsa04210&CASP3, CPP32, CPP32B, SCA-1; caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56); K02187 caspase 3 [EC:3.4.22.56] 
<http://www.inferico.com/kegg-cmpo.owl#inst13_KEGGMap_hsa04012_Abst_Gene_hsa_1956>&&hsa04012&EGFR, ERBB, ERBB1, HER1, NISBD2, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3718>&R&&JAK3, JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK; Janus kinase 3 (EC:2.7.10.2); K11218 Janus kinase 3 [EC:2.7.10.2] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_57818>&&&G6PC2, IGRP; glucose-6-phosphatase, catalytic, 2 (EC:3.1.3.9); K01084 glucose-6-phosphatase [EC:3.1.3.9] 
<http://www.inferico.com/kegg-cmpo.owl#inst4_KEGGMap_hsa04014_Abst_Gene_hsa_5604family>&&hsa04014&MAP2K2, CFC4, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2] MAP2K1, CFC3, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2] 
<http://www.inferico.com/kegg-cmpo.owl#inst193_KEGGMap_hsa05200_Abst_Gene_hsa_5743>&&hsa05200&PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1); K11987 prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst9_KEGGMap_hsa04151_Abst_Gene_hsa_64223>&&hsa04151&MLST8, GBL, GbetaL, LST8, POP3, WAT1; MTOR associated protein, LST8 homolog (S. cerevisiae); K08266 G protein beta subunit-like 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5585>&&&PKN1, DBK, PAK-1, PAK1, PKN, PKN-ALPHA, PRK1, PRKCL1; protein kinase N1 (EC:2.7.11.13); K06071 protein kinase N [EC:2.7.11.13] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_92579>&&&G6PC3, SCN4, UGRP; glucose 6 phosphatase, catalytic, 3 (EC:3.1.3.9); K01084 glucose-6-phosphatase [EC:3.1.3.9] 
<http://www.inferico.com/kegg-cmpo.owl#inst29_KEGGMap_hsa04210_Abst_Gene_hsa_54205>&&hsa04210&CYCS, CYC, HCS, THC4; cytochrome c, somatic; K08738 cytochrome c 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1975>&&&EIF4B, EIF-4B, PRO1843; eukaryotic translation initiation factor 4B; K03258 translation initiation factor 4B 
<http://www.inferico.com/kegg-cmpo.owl#inst105_KEGGMap_hsa05200_Abst_Gene_hsa_112398family>&&hsa05200&EGLN1, C1orf12, ECYT3, HALAH, HIF-PH2, HIFPH2, HPH-2, HPH2, PHD2, SM20, ZMYND6; egl-9 family hypoxia-inducible factor 1 (EC:1.14.11.29); K09592 hypoxia-inducible factor prolyl hydroxylase [EC:1.14.11.29] EGLN3, HIFP4H3, HIFPH3, PHD3; egl-9 family hypoxia-inducible factor 3 (EC:1.14.11.29); K09592 hypoxia-inducible factor prolyl hydroxylase [EC:1.14.11.29] EGLN2, EIT6, HIF-PH1, HIFPH1, HPH-1, HPH-3, PHD1; egl-9 family hypoxia-inducible factor 2 (EC:1.14.11.29); K09592 hypoxia-inducible factor prolyl hydroxylase [EC:1.14.11.29] 
<http://www.inferico.com/kegg-cmpo.owl#inst156_KEGGMap_hsa05200_Abst_Gene_hsa_1050>&&hsa05200&CEBPA, C/EBP-alpha, CEBP; CCAAT/enhancer binding protein (C/EBP), alpha; K09055 CCAAT/enhancer binding protein (C/EBP), alpha 
<http://www.inferico.com/kegg-cmpo.owl#inst51_KEGGMap_hsa04110_Abst_Gene_hsa_1030>&&hsa04110&CDKN2B, CDK4I, INK4B, MTS2, P15, TP15, p15INK4b; cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4); K04685 cyclin-dependent kinase inhibitor 2B 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4690>&&&NCK1, NCK, NCKalpha, nck-1; NCK adaptor protein 1; K07365 NCK adaptor protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4254>&R&&KITLG, FPH2, FPHH, KL-1, Kitl, MGF, SCF, SF, SHEP7; KIT ligand (EC:3.2.1.31); K05461 KIT ligand 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_51365>&&&PLA1A, PS-PLA1, PSPLA1; phospholipase A1 member A (EC:3.1.1.-); K13618 phospholipase A1 member A [EC:3.1.1.-] 
<http://www.inferico.com/kegg-cmpo.owl#cpd_C00020>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst53_KEGGMap_hsa04151_Abst_Gene_hsa_5562family>&&hsa04151&PRKAA2, AMPK, AMPK2, AMPKa2, PRKAA; protein kinase, AMP-activated, alpha 2 catalytic subunit (EC:2.7.11.1 2.7.11.27 2.7.11.31); K07198 5'-AMP-activated protein kinase, catalytic alpha subunit [EC:2.7.11.11] PRKAA1, AMPK, AMPKa1; protein kinase, AMP-activated, alpha 1 catalytic subunit (EC:2.7.11.1 2.7.11.26 2.7.11.27 2.7.11.31); K07198 5'-AMP-activated protein kinase, catalytic alpha subunit [EC:2.7.11.11] 
<http://www.inferico.com/kegg-cmpo.owl#inst67_KEGGMap_hsa04014_Abst_Gene_hsa_9771>&&hsa04014&RAPGEF5, GFR, MR-GEF, REPAC; Rap guanine nucleotide exchange factor (GEF) 5; K08019 Rap guanine nucleotide exchange factor 5 
<http://www.inferico.com/kegg-cmpo.owl#inst7_KEGGMap_hsa04151_Abst_Gene_hsa_57521>&&hsa04151&RPTOR, KOG1, Mip1; regulatory associated protein of MTOR, complex 1; K07204 regulatory associated protein of mTOR 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2736>&&&GLI2, CJS, HPE9, PHS2, THP1, THP2; GLI family zinc finger 2; K16798 zinc finger protein GLI2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_1398_Abst_Gene_hsa_1398_Abst_Gene_hsa_1399_Abst_Gene_hsa_1399_Abst_Gene_hsa_23624_Abst_Gene_hsa_867_Abst_Gene_hsa_868>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst155_KEGGMap_hsa05200_Abst_Gene_hsa_6688>&RL&hsa05200&SPI1, OF, PU.1, SFPI1, SPI-1, SPI-A; Spi-1 proto-oncogene; K09438 transcription factor PU.1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6696>&&&SPP1, BNSP, BSPI, ETA-1, OPN; secreted phosphoprotein 1; K06250 secreted phosphoprotein 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8831>&R&&SYNGAP1, MRD5, RASA1, RASA5, SYNGAP; synaptic Ras GTPase activating protein 1; K17631 Ras/Rap GTPase-activating protein SynGAP 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_26279>&&&PLA2G2D, PLA2IID, SPLASH, sPLA2-IID, sPLA2S; phospholipase A2, group IID (EC:3.1.1.4); K01047 secretory phospholipase A2 [EC:3.1.1.4] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_56924>&&&PAK6, PAK5; p21 protein (Cdc42/Rac)-activated kinase 6 (EC:2.7.11.1); K05735 p21-activated kinase 6 [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst20_KEGGMap_hsa04012_Compound_cpd_C01245>&&hsa04012&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_801>&&&CALM1, CALML2, CAMI, CPVT4, DD132, LQT14, PHKD, caM; calmodulin 1 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_494551>&&&WEE2, WEE1B; WEE1 homolog 2 (S. pombe) (EC:2.7.10.2); K06632 wee1-like protein kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1977>&&&EIF4E, AUTS19, CBP, EIF4E1, EIF4EL1, EIF4F; eukaryotic translation initiation factor 4E; K03259 translation initiation factor 4E 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3716>&R&&JAK1, JAK1A, JAK1B, JTK3; Janus kinase 1 (EC:2.7.10.2); K11217 Janus kinase 1 [EC:2.7.10.2] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_27127>&&&SMC1B, SMC1BETA, SMC1L2; structural maintenance of chromosomes 1B; K06636 structural maintenance of chromosome 1 
<http://www.inferico.com/kegg-cmpo.owl#inst179_KEGGMap_hsa05200_Abst_Gene_hsa_355>&&hsa05200&FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas cell surface death receptor; K04390 tumor necrosis factor receptor superfamily member 6 
<http://www.inferico.com/kegg-cmpo.owl#inst86_KEGGMap_hsa04151_Abst_Gene_hsa_7097family>&&hsa04151&TLR2, CD282, TIL4; toll-like receptor 2; K10159 toll-like receptor 2 TLR4, ARMD10, CD284, TLR-4, TOLL; toll-like receptor 4; K10160 toll-like receptor 4 
<http://www.inferico.com/kegg-cmpo.owl#inst36_KEGGMap_hsa05220_Compound_cpd_C05981>&&hsa05220&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_22801_Abst_Gene_hsa_3655_Abst_Gene_hsa_3672_Abst_Gene_hsa_3673_Abst_Gene_hsa_3674_Abst_Gene_hsa_3675_Abst_Gene_hsa_3676_Abst_Gene_hsa_3678_Abst_Gene_hsa_3679_Abst_Gene_hsa_3680_Abst_Gene_hsa_3685_Abst_Gene_hsa_3688_Abst_Gene_hsa_3690_Abst_Gene_hsa_3691_Abst_Gene_hsa_3693_Abst_Gene_hsa_3694_Abst_Gene_hsa_3695_Abst_Gene_hsa_3696_Abst_Gene_hsa_5747_Abst_Gene_hsa_8515_Abst_Gene_hsa_8516>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2737>&&&GLI3, ACLS, GCPS, GLI3-190, GLI3FL, PAP-A, PAPA, PAPA1, PAPB, PHS, PPDIV; GLI family zinc finger 3; K06230 zinc finger protein GLI3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4914>&R&&NTRK1, MTC, TRK, TRK1, TRKA, Trk-A, p140-TrkA; neurotrophic tyrosine kinase, receptor, type 1 (EC:2.7.10.1); K03176 neurotrophic tyrosine kinase receptor type 1 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3717>&R&&JAK2, JTK10, THCYT3; Janus kinase 2 (EC:2.7.10.2); K04447 Janus kinase 2 [EC:2.7.10.2] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_10156>&R&&RASA4, CAPRI, GAPL; RAS p21 protein activator 4; K17630 Ras GTPase-activating protein 4 
<http://www.inferico.com/kegg-cmpo.owl#inst10_KEGGMap_hsa04151_Abst_Gene_hsa_6009>&&hsa04151&RHEB, RHEB2; Ras homolog enriched in brain; K07208 Ras homolog enriched in brain 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_22798>&&&LAMB4; laminin, beta 4; K06245 laminin, beta 4 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5582>&L&&PRKCG, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13] 
<http://www.inferico.com/kegg-cmpo.owl#inst72_KEGGMap_hsa04151_Abst_Gene_hsa_5604family>&&hsa04151&MAP2K2, CFC4, MAPKK2, MEK2, MKK2, PRKMK2; mitogen-activated protein kinase kinase 2 (EC:2.7.12.2); K04369 mitogen-activated protein kinase kinase 2 [EC:2.7.12.2] MAP2K1, CFC3, MAPKK1, MEK1, MKK1, PRKMK1; mitogen-activated protein kinase kinase 1 (EC:2.7.12.2); K04368 mitogen-activated protein kinase kinase 1 [EC:2.7.12.2] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_9063>&&&PIAS2, ARIP3, DIP, MIZ, MIZ1, PIASX, PIASX-ALPHA, PIASX-BETA, SIZ2, ZMIZ4; protein inhibitor of activated STAT, 2; K16063 E3 SUMO-protein ligase PIAS2 [EC:6.3.2.-] 
<http://www.inferico.com/kegg-cmpo.owl#inst61_KEGGMap_hsa04110_Abst_Gene_hsa_993>&&hsa04110&CDC25A, CDC25A2; cell division cycle 25A (EC:3.1.3.48); K06645 M-phase inducer phosphatase 1 [EC:3.1.3.48] 
<http://www.inferico.com/kegg-cmpo.owl#inst101_KEGGMap_hsa04110_Abst_Gene_Group_Abst_Gene_hsa_1022_Abst_Gene_hsa_902>&&hsa04110&
<http://www.inferico.com/kegg-cmpo.owl#inst130_KEGGMap_hsa05200_Abst_Gene_hsa_1487family>&&hsa05200&CTBP2; C-terminal binding protein 2; K04496 C-terminal binding protein CTBP1, BARS; C-terminal binding protein 1; K04496 C-terminal binding protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6258>&&&RXRG, NR2B3, RXRC; retinoid X receptor, gamma; K08526 retinoid X receptor gamma 
<http://www.inferico.com/kegg-cmpo.owl#inst76_KEGGMap_hsa04012_Abst_Gene_Group_Abst_Gene_hsa_2066_Abst_Gene_hsa_2066>&&hsa04012&
<http://www.inferico.com/kegg-cmpo.owl#inst67_KEGGMap_hsa04210_Abst_Gene_Group_Abst_Gene_hsa_8717_Abst_Gene_hsa_8772>&&hsa04210&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_23604>&R&&DAPK2, DRP-1, DRP1; death-associated protein kinase 2 (EC:2.7.11.1); K08803 death-associated protein kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4609>&LR&&MYC, MRTL, MYCC, bHLHe39, c-Myc; v-myc avian myelocytomatosis viral oncogene homolog; K04377 Myc proto-oncogene protein 
<http://www.inferico.com/kegg-cmpo.owl#inst219_KEGGMap_hsa05200_Abst_Gene_hsa_1441>&&hsa05200&CSF3R, CD114, GCSFR; colony stimulating factor 3 receptor (granulocyte); K05061 granulocyte colony-stimulating factor receptor 
<http://www.inferico.com/kegg-cmpo.owl#inst212_KEGGMap_hsa05200_Abst_Gene_hsa_3576>&&hsa05200&CXCL8, GCP-1, GCP1, IL8, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1; chemokine (C-X-C motif) ligand 8; K10030 interleukin 8 
<http://www.inferico.com/kegg-cmpo.owl#inst88_KEGGMap_hsa04110_Abst_Gene_hsa_4609>&&hsa04110&MYC, MRTL, MYCC, bHLHe39, c-Myc; v-myc avian myelocytomatosis viral oncogene homolog; K04377 Myc proto-oncogene protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6257>&&&RXRB, DAUDI6, H-2RIIBP, NR2B2, RCoR-1; retinoid X receptor, beta; K08525 retinoid X receptor beta 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2735>&L&&GLI1, GLI; GLI family zinc finger 1; K16797 zinc finger protein GLI1 
<http://www.inferico.com/kegg-cmpo.owl#inst218_KEGGMap_hsa05200_Abst_Gene_hsa_1869family>&&hsa05200&E2F1, E2F-1, RBAP1, RBBP3, RBP3; E2F transcription factor 1; K17454 transcription factor E2F1 E2F2, E2F-2; E2F transcription factor 2; K09389 transcription factor E2F2 E2F3, E2F-3; E2F transcription factor 3; K06620 transcription factor E2F3 
<http://www.inferico.com/kegg-cmpo.owl#inst51_KEGGMap_hsa05200_Abst_Gene_hsa_4193>&&hsa05200&MDM2, ACTFS, HDMX, hdm2; MDM2 proto-oncogene, E3 ubiquitin protein ligase; K06643 E3 ubiquitin-protein ligase Mdm2 [EC:6.3.2.19] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_63923>&&&TNN, TN-W; tenascin N; K06252 tenascin 
<http://www.inferico.com/kegg-cmpo.owl#inst191_KEGGMap_hsa05200_Abst_Gene_hsa_4609>&L&hsa05200&MYC, MRTL, MYCC, bHLHe39, c-Myc; v-myc avian myelocytomatosis viral oncogene homolog; K04377 Myc proto-oncogene protein 
<http://www.inferico.com/kegg-cmpo.owl#inst42_KEGGMap_hsa04012_Abst_Gene_hsa_1398family>&&hsa04012&CRKL; v-crk avian sarcoma virus CT10 oncogene homolog-like; K04438 proto-oncogene C-crk CRK, CRKII, p38; v-crk avian sarcoma virus CT10 oncogene homolog; K04438 proto-oncogene C-crk 
<http://www.inferico.com/kegg-cmpo.owl#inst15_KEGGMap_hsa05220_Abst_Gene_hsa_4609>&L&hsa05220&MYC, MRTL, MYCC, bHLHe39, c-Myc; v-myc avian myelocytomatosis viral oncogene homolog; K04377 Myc proto-oncogene protein 
<http://www.inferico.com/kegg-cmpo.owl#inst34_KEGGMap_hsa04014_Abst_Gene_hsa_1147family>&&hsa04014&IKBKB, IKK-beta, IKK2, IKKB, IMD15, NFKBIKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10); K07209 inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10] IKBKG, AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IMD33, IP, IP1, IP2, IPD2, NEMO, ZC2HC9; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; K07210 inhibitor of nuclear factor kappa-B kinase subunit gamma CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7855>&&&FZD5, C2orf31, HFZ5; frizzled class receptor 5; K02375 frizzled 5/8 
<http://www.inferico.com/kegg-cmpo.owl#inst207_KEGGMap_hsa05200_Abst_Gene_hsa_1612family>&R&hsa05200&DAPK1, DAPK; death-associated protein kinase 1 (EC:2.7.11.1); K08803 death-associated protein kinase [EC:2.7.11.1] DAPK3, DLK, ZIP, ZIPK; death-associated protein kinase 3 (EC:2.7.11.1); K08803 death-associated protein kinase [EC:2.7.11.1] DAPK2, DRP-1, DRP1; death-associated protein kinase 2 (EC:2.7.11.1); K08803 death-associated protein kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_805>&&&CALM2, CAMII, LQT15, PHKD, PHKD2, caM; calmodulin 2 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2950>&&&GSTP1, DFN7, FAEES3, GST3, GSTP, HEL-S-22, PI; glutathione S-transferase pi 1 (EC:2.5.1.18); K00799 glutathione S-transferase [EC:2.5.1.18] 
<http://www.inferico.com/kegg-cmpo.owl#inst55_KEGGMap_hsa04012_Compound_cpd_C05981>&&hsa04012&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6256>&&&RXRA, NR2B1; retinoid X receptor, alpha; K08524 retinoid X receptor alpha 
<http://www.inferico.com/kegg-cmpo.owl#inst106_KEGGMap_hsa04151_Compound_cpd_C00020>&&hsa04151&
<http://www.inferico.com/kegg-cmpo.owl#inst41_KEGGMap_hsa04014_Abst_Gene_hsa_5879family>&&hsa04014&RAC3; ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3); K07861 Ras-related C3 botulinum toxin substrate 3 RAC2, EN-7, Gx, HSPC022, p21-Rac2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2); K07860 Ras-related C3 botulinum toxin substrate 2 RAC1, MIG5, Rac-1, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2998>&&&GYS2; glycogen synthase 2 (liver) (EC:2.4.1.11); K00693 glycogen(starch) synthase [EC:2.4.1.11] 
<http://www.inferico.com/kegg-cmpo.owl#inst80_KEGGMap_hsa04110_Abst_Gene_hsa_1031>&&hsa04110&CDKN2C, INK4C, p18, p18-INK4C; cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4); K06622 cyclin-dependent kinase inhibitor 2C 
<http://www.inferico.com/kegg-cmpo.owl#inst18_KEGGMap_hsa04110_Abst_Gene_hsa_4173>&&hsa04110&MCM4, CDC21, CDC54, NKCD, NKGCD, P1-CDC21, hCdc21; minichromosome maintenance complex component 4 (EC:3.6.4.12); K02212 DNA replication licensing factor MCM4 [EC:3.6.4.12] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_9020>&&&MAP3K14, FTDCR1B, HS, HSNIK, NIK; mitogen-activated protein kinase kinase kinase 14 (EC:2.7.11.25); K04466 mitogen-activated protein kinase kinase kinase 14 [EC:2.7.11.25] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3845>&L&&KRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas 
<http://www.inferico.com/kegg-cmpo.owl#inst227_KEGGMap_hsa05200_Abst_Gene_hsa_1026>&&hsa05200&CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1; cyclin-dependent kinase inhibitor 1A (p21, Cip1); K06625 cyclin-dependent kinase inhibitor 1A 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5058>&&&PAK1, PAKalpha; p21 protein (Cdc42/Rac)-activated kinase 1 (EC:2.7.11.1); K04409 p21-activated kinase 1 [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst41_KEGGMap_hsa04012_Abst_Gene_hsa_5599family>&&hsa04012&MAPK10, JNK3, JNK3A, PRKM10, SAPK1b, p493F12, p54bSAPK; mitogen-activated protein kinase 10 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24] MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK; mitogen-activated protein kinase 9 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24] MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c; mitogen-activated protein kinase 8 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24] 
<http://www.inferico.com/kegg-cmpo.owl#inst26_KEGGMap_hsa04110_Abst_Gene_hsa_10926>&&hsa04110&DBF4, ASK, CHIF, DBF4A, ZDBF1; DBF4 zinc finger; K06629 activator of S phase kinase 
<http://www.inferico.com/kegg-cmpo.owl#inst82_KEGGMap_hsa04151_Abst_Gene_hsa_22801family>&&hsa04151&ITGAV, CD51, MSK8, VNRA, VTNR; integrin, alpha V; K06487 integrin alpha V ITGA10, PRO827; integrin, alpha 10; K06586 integrin alpha 10 ITGA8; integrin, alpha 8; K06584 integrin alpha 8 ITGA6, CD49f, ITGA6B, VLA-6; integrin, alpha 6; K06485 integrin alpha 6 ITGA11, HsT18964; integrin, alpha 11; K06587 integrin alpha 11 ITGA9, ALPHA-RLC, ITGA4L, RLC; integrin, alpha 9; K06585 integrin alpha 9 ITGA5, CD49e, FNRA, VLA-5, VLA5A; integrin, alpha 5 (fibronectin receptor, alpha polypeptide); K06484 integrin alpha 5 ITGA3, CD49C, GAP-B3, GAPB3, ILNEB, MSK18, VCA-2, VL3A, VLA3a; integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor); K06482 integrin alpha 3 ITGA4, CD49D, IA4; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor); K06483 integrin alpha 4 ITGA2, BR, CD49B, GPIa, HPA-5, VLA-2, VLAA2; integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor); K06481 integrin alpha 2 ITGA2B, BDPLT16, BDPLT2, CD41, CD41B, GP2B, GPIIb, GT, GTA, HPA3, PPP1R93; integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41); K06476 integrin alpha 2B ITGA1, CD49a, VLA1; integrin, alpha 1; K06480 integrin alpha 1 ITGA7; integrin, alpha 7; K06583 integrin alpha 7 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_85417_Abst_Gene_hsa_891_Abst_Gene_hsa_9133_Abst_Gene_hsa_983>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_112401>&&&BIRC8, ILP-2, ILP2, hILP2; baculoviral IAP repeat containing 8; K16061 baculoviral IAP repeat-containing protein 7/8 
<http://www.inferico.com/kegg-cmpo.owl#inst131_KEGGMap_hsa05200_Abst_Gene_hsa_3065family>&&hsa05200&HDAC1, GON-10, HD1, RPD3, RPD3L1; histone deacetylase 1 (EC:3.5.1.98); K06067 histone deacetylase 1/2 [EC:3.5.1.98] HDAC2, HD2, RPD3, YAF1; histone deacetylase 2 (EC:3.5.1.98); K06067 histone deacetylase 1/2 [EC:3.5.1.98] 
<http://www.inferico.com/kegg-cmpo.owl#inst127_KEGGMap_hsa05200_Abst_Gene_hsa_2956>&&hsa05200&MSH6, GTBP, GTMBP, HNPCC5, HSAP, p160; mutS homolog 6; K08737 DNA mismatch repair protein MSH6 
<http://www.inferico.com/kegg-cmpo.owl#inst69_KEGGMap_hsa04210_Abst_Gene_Group_Abst_Gene_hsa_8717_Abst_Gene_hsa_8772>&&hsa04210&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7060>&&&THBS4, TSP-4, TSP4; thrombospondin 4; K04659 thrombospondin 2/3/4/5 
<http://www.inferico.com/kegg-cmpo.owl#inst12_KEGGMap_hsa04014_Abst_Gene_hsa_23533family>&&hsa04014&PIK3R3, p55, p55-GAMMA, p55PIK; phosphoinositide-3-kinase, regulatory subunit 3 (gamma); K02649 phosphoinositide-3-kinase, regulatory subunit PIK3R5, F730038I15Rik, FOAP-2, P101-PI3K, p101; phosphoinositide-3-kinase, regulatory subunit 5; K02649 phosphoinositide-3-kinase, regulatory subunit PIK3CA, CLOVE, CWS5, MCAP, MCM, MCMTC, PI3K, p110-alpha; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (EC:2.7.11.1 2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] PIK3R2, MPPH, MPPH1, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit PIK3R1, AGM7, GRB1, IMD36, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3, p110gamma, p120-PI3K; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma (EC:2.7.11.1 2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] PIK3CD, APDS, IMD14, P110DELTA, PI3K, p110D; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] PIK3CB, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3451>&R&&IFNA17, IFN-alphaI, IFNA, INFA, LEIF2C1; interferon, alpha 17; K05414 interferon alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_5915_Abst_Gene_hsa_6256_Abst_Gene_hsa_6257_Abst_Gene_hsa_6258>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst12_KEGGMap_hsa04210_Abst_Gene_hsa_836>&&hsa04210&CASP3, CPP32, CPP32B, SCA-1; caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56); K02187 caspase 3 [EC:3.4.22.56] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_163688>&&&CALML6, CAGLP; calmodulin-like 6; K02183 calmodulin 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2253>&R&&FGF8, AIGF, FGF-8, HBGF-8, HH6, KAL6; fibroblast growth factor 8 (androgen-induced); K04358 fibroblast growth factor 
<http://www.inferico.com/kegg-cmpo.owl#inst53_KEGGMap_hsa04110_Abst_Gene_hsa_4089>&&hsa04110&SMAD4, DPC4, JIP, MADH4, MYHRS; SMAD family member 4; K04501 mothers against decapentaplegic homolog 4 
<http://www.inferico.com/kegg-cmpo.owl#inst65_KEGGMap_hsa05200_Abst_Gene_hsa_6789>&&hsa05200&STK4, KRS2, MST1, TIIAC, YSK3; serine/threonine kinase 4 (EC:2.7.11.1); K04411 serine/threonine kinase 4 
<http://www.inferico.com/kegg-cmpo.owl#inst60_KEGGMap_hsa04014_Abst_Gene_hsa_9771>&&hsa04014&RAPGEF5, GFR, MR-GEF, REPAC; Rap guanine nucleotide exchange factor (GEF) 5; K08019 Rap guanine nucleotide exchange factor 5 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3452>&R&&IFNA21, IFN-alphaI, LeIF_F, leIF-F; interferon, alpha 21; K05414 interferon alpha 
<http://www.inferico.com/kegg-cmpo.owl#inst251_KEGGMap_hsa05200_Abst_Gene_hsa_2246family>&R&hsa05200&FGF19; fibroblast growth factor 19; K04358 fibroblast growth factor FGF21; fibroblast growth factor 21; K04358 fibroblast growth factor FGF22; fibroblast growth factor 22; K04358 fibroblast growth factor FGF23, ADHR, FGFN, HPDR2, HYPF, PHPTC; fibroblast growth factor 23; K04358 fibroblast growth factor FGF17, FGF-13, FGF-17, HH20; fibroblast growth factor 17; K04358 fibroblast growth factor FGF16, FGF-16, MF4; fibroblast growth factor 16; K04358 fibroblast growth factor FGF20, FGF-20, RHDA2; fibroblast growth factor 20; K04358 fibroblast growth factor FGF18, FGF-18, ZFGF5; fibroblast growth factor 18; K04358 fibroblast growth factor FGF8, AIGF, FGF-8, HBGF-8, HH6, KAL6; fibroblast growth factor 8 (androgen-induced); K04358 fibroblast growth factor FGF9, FGF-9, GAF, HBFG-9, HBGF-9, SYNS3; fibroblast growth factor 9; K04358 fibroblast growth factor FGF6, HBGF-6, HST2; fibroblast growth factor 6; K04358 fibroblast growth factor FGF7, HBGF-7, KGF; fibroblast growth factor 7; K04358 fibroblast growth factor FGF5, HBGF-5, Smag-82, TCMGLY; fibroblast growth factor 5; K04358 fibroblast growth factor FGF4, HBGF-4, HST, HST-1, HSTF1, K-FGF, KFGF; fibroblast growth factor 4; K04358 fibroblast growth factor FGF2, BFGF, FGF-2, FGFB, HBGF-2; fibroblast growth factor 2 (basic); K18497 fibroblast growth factor 2 FGF3, HBGF-3, INT2; fibroblast growth factor 3; K04358 fibroblast growth factor FGF1, AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-1, FGF-alpha, FGFA, GLIO703, HBGF-1, HBGF1; fibroblast growth factor 1 (acidic); K18496 fibroblast growth factor 1 FGF14, FGF-14, FHF-4, FHF4, SCA27; fibroblast growth factor 14; K04358 fibroblast growth factor FGF12, FGF12B, FHF1; fibroblast growth factor 12; K04358 fibroblast growth factor FGF13, FGF-13, FGF2, FHF-2, FHF2; fibroblast growth factor 13; K04358 fibroblast growth factor FGF10; fibroblast growth factor 10; K04358 fibroblast growth factor FGF11, FGF-11, FHF-3, FHF3; fibroblast growth factor 11; K04358 fibroblast growth factor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_581>&L&&BAX, BCL2L4; BCL2-associated X protein; K02159 apoptosis regulator BAX 
<http://www.inferico.com/kegg-cmpo.owl#inst55_KEGGMap_hsa04210_Abst_Gene_hsa_8793family>&&hsa04210&TNFRSF10A, APO2, CD261, DR4, TRAILR-1, TRAILR1; tumor necrosis factor receptor superfamily, member 10a; K04722 tumor necrosis factor receptor superfamily member 10 TNFRSF10D, CD264, DCR2, TRAIL-R4, TRAILR4, TRUNDD; tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain; K04722 tumor necrosis factor receptor superfamily member 10 TNFRSF10C, CD263, DCR1, DCR1-TNFR, LIT, TRAIL-R3, TRAILR3, TRID; tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain; K04722 tumor necrosis factor receptor superfamily member 10 TNFRSF10B, CD262, DR5, KILLER, KILLER/DR5, TRAIL-R2, TRAILR2, TRICK2, TRICK2A, TRICK2B, TRICKB, ZTNFR9; tumor necrosis factor receptor superfamily, member 10b; K04722 tumor necrosis factor receptor superfamily member 10 
<http://www.inferico.com/kegg-cmpo.owl#inst152_KEGGMap_hsa05200_Abst_Gene_hsa_5371family>&R&hsa05200&RARA, NR1B1, RAR; retinoic acid receptor, alpha; K08527 retinoic acid receptor alpha PML, MYL, PP8675, RNF71, TRIM19; promyelocytic leukemia; K10054 probable transcription factor PML 
<http://www.inferico.com/kegg-cmpo.owl#inst115_KEGGMap_hsa04151_Abst_Gene_Group_Abst_Gene_hsa_1441_Abst_Gene_hsa_2057_Abst_Gene_hsa_2690_Abst_Gene_hsa_3454_Abst_Gene_hsa_3455_Abst_Gene_hsa_3559_Abst_Gene_hsa_3560_Abst_Gene_hsa_3561_Abst_Gene_hsa_3563_Abst_Gene_hsa_3566_Abst_Gene_hsa_3570_Abst_Gene_hsa_3575_Abst_Gene_hsa_3716_Abst_Gene_hsa_3717_Abst_Gene_hsa_3718_Abst_Gene_hsa_5618_Abst_Gene_hsa_9180>&L&hsa04151&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2254>&R&&FGF9, FGF-9, GAF, HBFG-9, HBGF-9, SYNS3; fibroblast growth factor 9; K04358 fibroblast growth factor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_808>&&&CALM3, HEL-S-72, PHKD, PHKD3; calmodulin 3 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2690>&&&GHR, GHBP, GHIP; growth hormone receptor; K05080 growth hormone receptor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_284217>&&&LAMA1, LAMA, PTBHS, S-LAM-alpha; laminin, alpha 1; K05637 laminin, alpha 1/2 
<http://www.inferico.com/kegg-cmpo.owl#inst54_KEGGMap_hsa04151_Abst_Gene_hsa_54541>&&hsa04151&DDIT4, Dig2, REDD-1, REDD1; DNA-damage-inducible transcript 4; K08270 DNA-damage-inducible transcript 4 
<http://www.inferico.com/kegg-cmpo.owl#inst116_KEGGMap_hsa04151_Abst_Gene_Group_Abst_Gene_hsa_22801_Abst_Gene_hsa_3655_Abst_Gene_hsa_3672_Abst_Gene_hsa_3673_Abst_Gene_hsa_3674_Abst_Gene_hsa_3675_Abst_Gene_hsa_3676_Abst_Gene_hsa_3678_Abst_Gene_hsa_3679_Abst_Gene_hsa_3680_Abst_Gene_hsa_3685_Abst_Gene_hsa_3688_Abst_Gene_hsa_3690_Abst_Gene_hsa_3691_Abst_Gene_hsa_3693_Abst_Gene_hsa_3694_Abst_Gene_hsa_3695_Abst_Gene_hsa_3696_Abst_Gene_hsa_5747_Abst_Gene_hsa_8515_Abst_Gene_hsa_8516>&&hsa04151&
<http://www.inferico.com/kegg-cmpo.owl#inst195_KEGGMap_hsa05200_Abst_Gene_hsa_596>&L&hsa05200&BCL2, Bcl-2, PPP1R50; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2 
<http://www.inferico.com/kegg-cmpo.owl#inst267_KEGGMap_hsa05200_Abst_Gene_Group_Abst_Gene_hsa_5915_Abst_Gene_hsa_6256_Abst_Gene_hsa_6257_Abst_Gene_hsa_6258>&L&hsa05200&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_4149_Abst_Gene_hsa_4609>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_10459_Abst_Gene_hsa_4085_Abst_Gene_hsa_701_Abst_Gene_hsa_9184>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst35_KEGGMap_hsa04151_Abst_Gene_hsa_595>&L&hsa04151&CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1 
<http://www.inferico.com/kegg-cmpo.owl#inst3_KEGGMap_hsa05220_Abst_Gene_hsa_598>&&hsa05220&BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS; BCL2-like 1; K04570 BCL2-like 1 (apoptosis regulator Bcl-X) 
<http://www.inferico.com/kegg-cmpo.owl#inst15_KEGGMap_hsa04110_Abst_Gene_hsa_4176>&&hsa04110&MCM7, CDC47, MCM2, P1.1-MCM3, P1CDC47, P85MCM, PNAS146, PPP1R104; minichromosome maintenance complex component 7 (EC:3.6.4.12); K02210 DNA replication licensing factor MCM7 [EC:3.6.4.12] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2033>&&&EP300, KAT3B, RSTS2, p300; E1A binding protein p300 (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2251>&R&&FGF6, HBGF-6, HST2; fibroblast growth factor 6; K04358 fibroblast growth factor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6789>&&&STK4, KRS2, MST1, TIIAC, YSK3; serine/threonine kinase 4 (EC:2.7.11.1); K04411 serine/threonine kinase 4 
<http://www.inferico.com/kegg-cmpo.owl#inst129_KEGGMap_hsa05200_Abst_Gene_hsa_2122family>&R&hsa05200&RUNX1, AML1, AML1-EVI-1, AMLCR1, CBFA2, EVI-1, PEBP2aB; runt-related transcription factor 1; K08367 runt-related transcription factor 1 MECOM, AML1-EVI-1, EVI1, MDS1, MDS1-EVI1, PRDM3; MDS1 and EVI1 complex locus; K04462 ecotropic virus integration site 1 protein 
<http://www.inferico.com/kegg-cmpo.owl#inst51_KEGGMap_hsa04014_Abst_Gene_hsa_5923family>&&hsa04014&RASGRF2, GRF2, RAS-GRF2; Ras protein-specific guanine nucleotide-releasing factor 2; K12326 Ras-specific guanine nucleotide-releasing factor 2 RASGRF1, CDC25, CDC25L, GNRP, GRF1, GRF55, H-GRF55, PP13187, ras-GRF1; Ras protein-specific guanine nucleotide-releasing factor 1; K04349 Ras-specific guanine nucleotide-releasing factor 1 
<http://www.inferico.com/kegg-cmpo.owl#inst199_KEGGMap_hsa05200_Abst_Gene_hsa_598>&&hsa05200&BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS; BCL2-like 1; K04570 BCL2-like 1 (apoptosis regulator Bcl-X) 
<http://www.inferico.com/kegg-cmpo.owl#inst69_KEGGMap_hsa04151_Abst_Gene_hsa_23533family>&RL&hsa04151&PIK3R3, p55, p55-GAMMA, p55PIK; phosphoinositide-3-kinase, regulatory subunit 3 (gamma); K02649 phosphoinositide-3-kinase, regulatory subunit PIK3R5, F730038I15Rik, FOAP-2, P101-PI3K, p101; phosphoinositide-3-kinase, regulatory subunit 5; K02649 phosphoinositide-3-kinase, regulatory subunit PIK3CA, CLOVE, CWS5, MCAP, MCM, MCMTC, PI3K, p110-alpha; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (EC:2.7.11.1 2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] PIK3R2, MPPH, MPPH1, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit PIK3R1, AGM7, GRB1, IMD36, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3, p110gamma, p120-PI3K; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma (EC:2.7.11.1 2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] PIK3CD, APDS, IMD14, P110DELTA, PI3K, p110D; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] PIK3CB, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] 
<http://www.inferico.com/kegg-cmpo.owl#inst31_KEGGMap_hsa04210_Abst_Gene_hsa_637>&&hsa04210&BID, FP497; BH3 interacting domain death agonist; K04726 BH3 interacting domain death agonist 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5894>&L&&RAF1, CMD1NN, CRAF, NS5, Raf-1, c-Raf; Raf-1 proto-oncogene, serine/threonine kinase (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst72_KEGGMap_hsa04012_Abst_Gene_hsa_369family>&&hsa04012&RAF1, CMD1NN, CRAF, NS5, Raf-1, c-Raf; Raf-1 proto-oncogene, serine/threonine kinase (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] ARAF, A-RAF, ARAF1, PKS2, RAFA1; A-Raf proto-oncogene, serine/threonine kinase (EC:2.7.11.1); K08845 A-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] BRAF, B-RAF1, BRAF1, NS7, RAFB1; B-Raf proto-oncogene, serine/threonine kinase (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5106>&&&PCK2, PEPCK, PEPCK-M, PEPCK2; phosphoenolpyruvate carboxykinase 2 (mitochondrial) (EC:4.1.1.32); K01596 phosphoenolpyruvate carboxykinase (GTP) [EC:4.1.1.32] 
<http://www.inferico.com/kegg-cmpo.owl#inst94_KEGGMap_hsa04151_Abst_Gene_hsa_672>&RL&hsa04151&BRCA1, BRCAI, BRCC1, BROVCA1, FANCS, IRIS, PNCA4, PPP1R53, PSCP, RNF53; breast cancer 1, early onset; K10605 breast cancer type 1 susceptibility protein 
<http://www.inferico.com/kegg-cmpo.owl#inst23_KEGGMap_hsa05200_Abst_Gene_hsa_23533family>&&hsa05200&PIK3R3, p55, p55-GAMMA, p55PIK; phosphoinositide-3-kinase, regulatory subunit 3 (gamma); K02649 phosphoinositide-3-kinase, regulatory subunit PIK3R5, F730038I15Rik, FOAP-2, P101-PI3K, p101; phosphoinositide-3-kinase, regulatory subunit 5; K02649 phosphoinositide-3-kinase, regulatory subunit PIK3CA, CLOVE, CWS5, MCAP, MCM, MCMTC, PI3K, p110-alpha; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (EC:2.7.11.1 2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] PIK3R2, MPPH, MPPH1, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit PIK3R1, AGM7, GRB1, IMD36, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3, p110gamma, p120-PI3K; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma (EC:2.7.11.1 2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] PIK3CD, APDS, IMD14, P110DELTA, PI3K, p110D; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] PIK3CB, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2034>&&&EPAS1, ECYT4, HIF2A, HLF, MOP2, PASD2, bHLHe73; endothelial PAS domain protein 1; K09095 hypoxia-inducible factor 2 alpha 
<http://www.inferico.com/kegg-cmpo.owl#inst103_KEGGMap_hsa04014_Abst_Gene_hsa_8844>&&hsa04014&KSR1, KSR, RSU2; kinase suppressor of ras 1; K14958 kinase suppressor of Ras 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2252>&R&&FGF7, HBGF-7, KGF; fibroblast growth factor 7; K04358 fibroblast growth factor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6655>&&&SOS2; son of sevenless homolog 2 (Drosophila); K03099 son of sevenless 
<http://www.inferico.com/kegg-cmpo.owl#inst89_KEGGMap_hsa04014_Compound_cpd_C00165>&&hsa04014&
<http://www.inferico.com/kegg-cmpo.owl#inst174_KEGGMap_hsa05200_Abst_Gene_hsa_8900>&&hsa05200&CCNA1, CT146; cyclin A1; K06627 cyclin A 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_648044>&&&null 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5105>&&&PCK1, PEPCK-C, PEPCK1, PEPCKC; phosphoenolpyruvate carboxykinase 1 (soluble) (EC:4.1.1.32); K01596 phosphoenolpyruvate carboxykinase (GTP) [EC:4.1.1.32] 
<http://www.inferico.com/kegg-cmpo.owl#inst250_KEGGMap_hsa05200_Abst_Gene_hsa_2323>&&hsa05200&FLT3LG, FL, FLT3L; fms-related tyrosine kinase 3 ligand; K05454 fms-related tyrosine kinase 3 ligand 
<http://www.inferico.com/kegg-cmpo.owl#inst63_KEGGMap_hsa05200_Abst_Gene_hsa_4792>&&hsa05200&NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1050>&&&CEBPA, C/EBP-alpha, CEBP; CCAAT/enhancer binding protein (C/EBP), alpha; K09055 CCAAT/enhancer binding protein (C/EBP), alpha 
<http://www.inferico.com/kegg-cmpo.owl#inst34_KEGGMap_hsa05200_Abst_Gene_hsa_10342family>&R&hsa05200&TFG, HMSNP, SPG57, TF6, TRKT3; TRK-fused gene; K09292 protein TFG TPM3, CAPM1, CFTD, HEL-189, HEL-S-82p, NEM1, OK/SW-cl.5, TM-5, TM3, TM30, TM30nm, TM5, TPMsk3, TRK, hscp30; tropomyosin 3; K09290 tropomyosin 3 TPR; translocated promoter region, nuclear basket protein; K09291 nucleoprotein TPR NTRK1, MTC, TRK, TRK1, TRKA, Trk-A, p140-TrkA; neurotrophic tyrosine kinase, receptor, type 1 (EC:2.7.10.1); K03176 neurotrophic tyrosine kinase receptor type 1 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst71_KEGGMap_hsa04014_Abst_Gene_hsa_3265family>&&hsa04014&HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, RASH1, p21ras; Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas NRAS, ALPS4, CMNS, N-ras, NCMS, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas KRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas 
<http://www.inferico.com/kegg-cmpo.owl#inst185_KEGGMap_hsa05200_Abst_Gene_hsa_2735>&L&hsa05200&GLI1, GLI; GLI family zinc finger 1; K16797 zinc finger protein GLI1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6654>&&&SOS1, GF1, GGF1, GINGF, HGF, NS4; son of sevenless homolog 1 (Drosophila); K03099 son of sevenless 
<http://www.inferico.com/kegg-cmpo.owl#inst67_KEGGMap_hsa05200_Abst_Gene_hsa_5979family>&R&hsa05200&CCDC6, D10S170, H4, PTC, TPC, TST1; coiled-coil domain containing 6; K09288 coiled-coil domain-containing protein 6 NCOA4, ARA70, ELE1, PTC3, RFG; nuclear receptor coactivator 4; K09289 nuclear receptor coactivator 4 RET, CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET-ELE1, RET51; ret proto-oncogene (EC:2.7.10.1); K05126 proto-oncogene tyrosine-protein kinase Ret [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8437>&R&&RASAL1, RASAL; RAS protein activator like 1 (GAP1 like); K17632 RAS protein activator-like 1 
<http://www.inferico.com/kegg-cmpo.owl#inst39_KEGGMap_hsa04014_Abst_Gene_hsa_10928>&&hsa04014&RALBP1, RIP1, RLIP1, RLIP76; ralA binding protein 1; K08773 RalA-binding protein 1 
<http://www.inferico.com/kegg-cmpo.owl#inst69_KEGGMap_hsa05200_Abst_Gene_hsa_5335family>&&hsa05200&PLCG2, APLAID, FCAS3, PLC-IV, PLC-gamma-2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phosphatidylinositol phospholipase C, gamma-2 [EC:3.1.4.11] PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K01116 phosphatidylinositol phospholipase C, gamma-1 [EC:3.1.4.11] 
<http://www.inferico.com/kegg-cmpo.owl#inst114_KEGGMap_hsa04151_Abst_Gene_Group_Abst_Gene_hsa_118788_Abst_Gene_hsa_930>&&hsa04151&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_3655_Abst_Gene_hsa_3673_Abst_Gene_hsa_3674_Abst_Gene_hsa_3675_Abst_Gene_hsa_3685_Abst_Gene_hsa_3688>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst57_KEGGMap_hsa05200_Abst_Gene_hsa_6654family>&&hsa05200&SOS2; son of sevenless homolog 2 (Drosophila); K03099 son of sevenless SOS1, GF1, GGF1, GINGF, HGF, NS4; son of sevenless homolog 1 (Drosophila); K03099 son of sevenless 
<http://www.inferico.com/kegg-cmpo.owl#inst45_KEGGMap_hsa04012_Abst_Gene_hsa_2885>&&hsa04012&GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2 
<http://www.inferico.com/kegg-cmpo.owl#inst42_KEGGMap_hsa05200_Abst_Gene_hsa_367>&&hsa05200&AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM; androgen receptor; K08557 androgen receptor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_367>&&&AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM; androgen receptor; K08557 androgen receptor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1978>&&&EIF4EBP1, 4E-BP1, 4EBP1, BP-1, PHAS-I; eukaryotic translation initiation factor 4E binding protein 1; K07205 eukaryotic translation initiation factor 4E binding protein 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_890_Abst_Gene_hsa_8900_Abst_Gene_hsa_983>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2250>&R&&FGF5, HBGF-5, Smag-82, TCMGLY; fibroblast growth factor 5; K04358 fibroblast growth factor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5322>&&&PLA2G5, FRFB, GV-PLA2, PLA2-10, hVPLA(2); phospholipase A2, group V (EC:3.1.1.4); K01047 secretory phospholipase A2 [EC:3.1.1.4] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3363>&&&HTR7, 5-HT7; 5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled; K04163 5-hydroxytryptamine receptor 7 
<http://www.inferico.com/kegg-cmpo.owl#inst30_KEGGMap_hsa04012_Abst_Gene_hsa_2064>&&hsa04012&ERBB2, CD340, HER-2, HER-2/neu, HER2, MLN_19, NEU, NGL, TKR1; erb-b2 receptor tyrosine kinase 2 (EC:2.7.10.1); K05083 receptor tyrosine-protein kinase erbB-2 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst24_KEGGMap_hsa04014_Abst_Gene_hsa_5337family>&&hsa04014&PLD2; phospholipase D2 (EC:3.1.4.4); K01115 phospholipase D1/2 [EC:3.1.4.4] PLD1; phospholipase D1, phosphatidylcholine-specific (EC:3.1.4.4); K01115 phospholipase D1/2 [EC:3.1.4.4] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_51764>&&&GNG13, G(gamma)13, h2-35; guanine nucleotide binding protein (G protein), gamma 13; K04547 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13 
<http://www.inferico.com/kegg-cmpo.owl#inst161_KEGGMap_hsa05200_Abst_Gene_hsa_4286>&&hsa05200&MITF, CMM8, MI, WS2, WS2A, bHLHe32; microphthalmia-associated transcription factor; K09455 microphthalmia-associated transcription factor 
<http://www.inferico.com/kegg-cmpo.owl#inst190_KEGGMap_hsa05200_Abst_Gene_hsa_332>&&hsa05200&BIRC5, API4, EPR-1; baculoviral IAP repeat containing 5; K08731 baculoviral IAP repeat-containing protein 5 
<http://www.inferico.com/kegg-cmpo.owl#inst28_KEGGMap_hsa04012_Abst_Gene_hsa_4690family>&&hsa04012&NCK1, NCK, NCKalpha, nck-1; NCK adaptor protein 1; K07365 NCK adaptor protein NCK2, GRB4, NCKbeta; NCK adaptor protein 2; K07365 NCK adaptor protein 
<http://www.inferico.com/kegg-cmpo.owl#inst91_KEGGMap_hsa04151_Abst_Gene_hsa_1440family>&R&hsa04151&EPO, EP, MVCD2; erythropoietin; K05437 erythropoietin IL2, IL-2, TCGF, lymphokine; interleukin 2; K05429 interleukin 2 IFNA2, IFN-alphaA, IFNA, IFNA2B, INFA2; interferon, alpha 2; K05414 interferon alpha OSM; oncostatin M; K05418 oncostatin M IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6; K05405 interleukin 6 IL4, BCGF-1, BCGF1, BSF-1, BSF1, IL-4; interleukin 4; K05430 interleukin 4 IL3, IL-3, MCGF, MULTI-CSF; interleukin 3; K04736 interleukin 3 IFNA1, IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@; interferon, alpha 1; K05414 interferon alpha PRL; prolactin; K05439 prolactin IFNA17, IFN-alphaI, IFNA, INFA, LEIF2C1; interferon, alpha 17; K05414 interferon alpha IFNA21, IFN-alphaI, LeIF_F, leIF-F; interferon, alpha 21; K05414 interferon alpha IFNA13; interferon, alpha 13; K05414 interferon alpha IFNA14, IFN-alphaH, LEIF2H; interferon, alpha 14; K05414 interferon alpha CSF3, C17orf33, CSF3OS, GCSF, G-CSF; colony stimulating factor 3 (granulocyte); K05423 granulocyte colony-stimulating factor IFNA8, IFN-alphaB; interferon, alpha 8; K05414 interferon alpha IFNA10, IFN-alphaC; interferon, alpha 10; K05414 interferon alpha IFNA6, IFN-alphaK; interferon, alpha 6; K05414 interferon alpha IFNA7, IFN-alphaJ, IFNA-J; interferon, alpha 7; K05414 interferon alpha IL7, IL-7; interleukin 7; K05431 interleukin 7 IFNA4, IFN-alpha4a, INFA4; interferon, alpha 4; K05414 interferon alpha IFNA5, IFN-alpha-5, IFN-alphaG, INA5, INFA5, leIF_G; interferon, alpha 5; K05414 interferon alpha GH2, GH-V, GHL, GHV, hGH-V; growth hormone 2; K05438 growth hormone CSH1, CS-1, CSA, CSMT, PL, hCS-1, hCS-A; chorionic somatomammotropin hormone 1 (placental lactogen); K05438 growth hormone IFNA16, IFN-alphaO; interferon, alpha 16; K05414 interferon alpha GH1, GH, GH-N, GHN, IGHD1B, hGH-N; growth hormone 1; K05438 growth hormone CSH2, CS-2, CSB, PL, hCS-B; chorionic somatomammotropin hormone 2; K05438 growth hormone IFNB1, IFB, IFF, IFNB; interferon, beta 1, fibroblast; K05415 interferon beta 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5321>&&&PLA2G4A, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K16342 cytosolic phospholipase A2 [EC:3.1.1.4] 
<http://www.inferico.com/kegg-cmpo.owl#cpd_C01227>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst36_KEGGMap_hsa04151_Abst_Gene_hsa_5105family>&&hsa04151&PCK2, PEPCK, PEPCK-M, PEPCK2; phosphoenolpyruvate carboxykinase 2 (mitochondrial) (EC:4.1.1.32); K01596 phosphoenolpyruvate carboxykinase (GTP) [EC:4.1.1.32] PCK1, PEPCK-C, PEPCK1, PEPCKC; phosphoenolpyruvate carboxykinase 1 (soluble) (EC:4.1.1.32); K01596 phosphoenolpyruvate carboxykinase (GTP) [EC:4.1.1.32] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_369>&&&ARAF, A-RAF, ARAF1, PKS2, RAFA1; A-Raf proto-oncogene, serine/threonine kinase (EC:2.7.11.1); K08845 A-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst60_KEGGMap_hsa04110_Abst_Gene_hsa_990>&&hsa04110&CDC6, CDC18L, HsCDC18, HsCDC6; cell division cycle 6; K02213 cell division control protein 6 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_672>&RL&&BRCA1, BRCAI, BRCC1, BROVCA1, FANCS, IRIS, PNCA4, PPP1R53, PSCP, RNF53; breast cancer 1, early onset; K10605 breast cancer type 1 susceptibility protein 
<http://www.inferico.com/kegg-cmpo.owl#inst40_KEGGMap_hsa04014_Abst_Gene_hsa_998>&&hsa04014&CDC42, CDC42Hs, G25K; cell division cycle 42; K04393 cell division control protein 42 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8743>&&&TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL; tumor necrosis factor (ligand) superfamily, member 10; K04721 tumor necrosis factor ligand superfamily member 10 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_890>&&&CCNA2, CCN1, CCNA; cyclin A2; K06627 cyclin A 
<http://www.inferico.com/kegg-cmpo.owl#inst197_KEGGMap_hsa05200_Abst_Gene_hsa_7185family>&&hsa05200&TRAF4, CART1, MLN62, RNF83; TNF receptor-associated factor 4; K09848 TNF receptor-associated factor 4 TRAF1, EBI6, MGC:10353; TNF receptor-associated factor 1; K03172 TNF receptor-associated factor 1 TRAF2, MGC:45012, TRAP, TRAP3; TNF receptor-associated factor 2; K03173 TNF receptor-associated factor 2 TRAF3, CAP-1, CAP1, CD40bp, CRAF1, IIAE5, LAP1; TNF receptor-associated factor 3; K03174 TNF receptor-associated factor 3 TRAF5, MGC:39780, RNF84; TNF receptor-associated factor 5; K09849 TNF receptor-associated factor 5 TRAF6, MGC:3310, RNF85; TNF receptor-associated factor 6, E3 ubiquitin protein ligase; K03175 TNF receptor-associated factor 6 
<http://www.inferico.com/kegg-cmpo.owl#inst30_KEGGMap_hsa05200_Abst_Gene_hsa_3815>&&hsa05200&KIT, C-Kit, CD117, PBT, SCFR; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (EC:2.7.10.1); K05091 proto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst21_KEGGMap_hsa04110_Abst_Gene_hsa_983>&&hsa04110&CDK1, CDC2, CDC28A, P34CDC2; cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22); K02087 cyclin-dependent kinase 1 [EC:2.7.11.22 2.7.11.23] 
<http://www.inferico.com/kegg-cmpo.owl#inst44_KEGGMap_hsa05200_Abst_Gene_hsa_2932>&&hsa05200&GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26); K03083 glycogen synthase kinase 3 beta [EC:2.7.11.26] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_64682>&&&ANAPC1, APC1, MCPR, TSG24; anaphase promoting complex subunit 1; K03348 anaphase-promoting complex subunit 1 
<http://www.inferico.com/kegg-cmpo.owl#inst126_KEGGMap_hsa05200_Abst_Gene_hsa_7048>&&hsa05200&TGFBR2, AAT3, FAA3, LDS1B, LDS2, LDS2B, MFS2, RIIC, TAAD2, TGFR-2, TGFbeta-RII; transforming growth factor, beta receptor II (70/80kDa) (EC:2.7.11.30); K04388 TGF-beta receptor type-2 [EC:2.7.11.30] 
<http://www.inferico.com/kegg-cmpo.owl#inst209_KEGGMap_hsa05200_Abst_Gene_hsa_2113>&&hsa05200&ETS1, ETS-1, EWSR2, p54; v-ets avian erythroblastosis virus E26 oncogene homolog 1; K02678 c-ets proto-oncogene protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5320>&&&PLA2G2A, MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2; phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4); K01047 secretory phospholipase A2 [EC:3.1.1.4] 
<http://www.inferico.com/kegg-cmpo.owl#inst55_KEGGMap_hsa04151_Abst_Gene_hsa_6794>&R&hsa04151&STK11, LKB1, PJS, hLKB1; serine/threonine kinase 11 (EC:2.7.11.1); K07298 serine/threonine-protein kinase 11 
<http://www.inferico.com/kegg-cmpo.owl#inst20_KEGGMap_hsa05200_Abst_Gene_hsa_1398family>&RL&hsa05200&CRKL; v-crk avian sarcoma virus CT10 oncogene homolog-like; K04438 proto-oncogene C-crk CRK, CRKII, p38; v-crk avian sarcoma virus CT10 oncogene homolog; K04438 proto-oncogene C-crk 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5586>&&&PKN2, PAK2, PRK2, PRKCL2, PRO2042, Pak-2, STK7; protein kinase N2 (EC:2.7.11.13); K06071 protein kinase N [EC:2.7.11.13] 
<http://www.inferico.com/kegg-cmpo.owl#cpd_C00762>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst4_KEGGMap_hsa04210_Abst_Gene_hsa_581>&L&hsa04210&BAX, BCL2L4; BCL2-associated X protein; K02159 apoptosis regulator BAX 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_673>&&&BRAF, B-RAF1, BRAF1, NS7, RAFB1; B-Raf proto-oncogene, serine/threonine kinase (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_891>&&&CCNB1, CCNB; cyclin B1; K05868 cyclin B 
<http://www.inferico.com/kegg-cmpo.owl#inst41_KEGGMap_hsa05220_Abst_Gene_hsa_4088>&&hsa05220&SMAD3, HSPC193, HsT17436, JV15-2, LDS1C, LDS3, MADH3; SMAD family member 3; K04500 mothers against decapentaplegic homolog 2/3 
<http://www.inferico.com/kegg-cmpo.owl#inst107_KEGGMap_hsa04110_Abst_Gene_Group_Abst_Gene_hsa_85417_Abst_Gene_hsa_891_Abst_Gene_hsa_9133_Abst_Gene_hsa_983>&&hsa04110&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2249>&R&&FGF4, HBGF-4, HST, HST-1, HSTF1, K-FGF, KFGF; fibroblast growth factor 4; K04358 fibroblast growth factor 
<http://www.inferico.com/kegg-cmpo.owl#inst73_KEGGMap_hsa05200_Abst_Gene_hsa_10928>&&hsa05200&RALBP1, RIP1, RLIP1, RLIP76; ralA binding protein 1; K08773 RalA-binding protein 1 
<http://www.inferico.com/kegg-cmpo.owl#inst20_KEGGMap_hsa05220_Abst_Gene_hsa_4790family>&&hsa05220&RELA, NFKB3, p65; v-rel avian reticuloendotheliosis viral oncogene homolog A; K04735 transcription factor p65 NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor NF-kappa-B p105 subunit 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7057>&&&THBS1, THBS, THBS-1, TSP, TSP-1, TSP1; thrombospondin 1; K16857 thrombospondin 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_ko_K06227>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3447>&R&&IFNA13; interferon, alpha 13; K05414 interferon alpha 
<http://www.inferico.com/kegg-cmpo.owl#inst21_KEGGMap_hsa04210_Abst_Gene_hsa_572>&&hsa04210&BAD, BBC2, BCL2L8; BCL2-associated agonist of cell death; K02158 BCL2-antagonist of cell death 
<http://www.inferico.com/kegg-cmpo.owl#inst50_KEGGMap_hsa05220_Abst_Gene_hsa_5594family>&&hsa05220&MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 mitogen-activated protein kinase 1/3 [EC:2.7.11.24] MAPK1, ERK, ERK-2, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk, p42-MAPK; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 mitogen-activated protein kinase 1/3 [EC:2.7.11.24] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2335>&&&FN1, CIG, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF; fibronectin 1; K05717 fibronectin 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_9586>&&&CREB5, CRE-BPA, CREB-5; cAMP responsive element binding protein 5; K09047 cyclic AMP-responsive element-binding protein 5 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7143>&&&TNR, TN-R; tenascin R; K06252 tenascin 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7010>&&&TEK, CD202B, TIE-2, TIE2, VMCM, VMCM1; TEK tyrosine kinase, endothelial (EC:2.7.10.1); K05121 endothelial-specific receptor tyrosine kinase [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7058>&&&THBS2, TSP2; thrombospondin 2; K04659 thrombospondin 2/3/4/5 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3448>&R&&IFNA14, IFN-alphaH, LEIF2H; interferon, alpha 14; K05414 interferon alpha 
<http://www.inferico.com/kegg-cmpo.owl#inst19_KEGGMap_hsa05220_Abst_Gene_hsa_4089>&&hsa05220&SMAD4, DPC4, JIP, MADH4, MYHRS; SMAD family member 4; K04501 mothers against decapentaplegic homolog 4 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_675>&RL&&BRCA2, BRCC2, BROVCA2, FACD, FAD, FAD1, FANCD, FANCD1, GLM3, PNCA2, XRCC11; breast cancer 2, early onset; K08775 breast cancer 2 susceptibility protein 
<http://www.inferico.com/kegg-cmpo.owl#inst2_KEGGMap_hsa04012_Abst_Gene_hsa_2885>&&hsa04012&GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1440>&R&&CSF3, C17orf33, CSF3OS, GCSF, G-CSF; colony stimulating factor 3 (granulocyte); K05423 granulocyte colony-stimulating factor 
<http://www.inferico.com/kegg-cmpo.owl#inst64_KEGGMap_hsa05200_Abst_Gene_hsa_4790family>&&hsa05200&RELA, NFKB3, p65; v-rel avian reticuloendotheliosis viral oncogene homolog A; K04735 transcription factor p65 NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor NF-kappa-B p105 subunit NFKB2, CVID10, H2TF1, LYT-10, LYT10, NF-kB2, p100, p52; nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100); K04469 nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 
<http://www.inferico.com/kegg-cmpo.owl#inst7_KEGGMap_hsa04110_Abst_Gene_hsa_6500family>&&hsa04110&SKP1, EMC19, OCP-II, OCP2, SKP1A, TCEB1L, p19A; S-phase kinase-associated protein 1 (EC:3.1.1.3); K03094 S-phase kinase-associated protein 1 CUL1; cullin 1; K03347 cullin 1 RBX1, BA554C12.1, RNF75, ROC1; ring-box 1, E3 ubiquitin protein ligase; K03868 RING-box protein 1 
<http://www.inferico.com/kegg-cmpo.owl#inst260_KEGGMap_hsa05200_Abst_Gene_Group_Abst_Gene_hsa_4149_Abst_Gene_hsa_4609>&R&hsa05200&
<http://www.inferico.com/kegg-cmpo.owl#inst36_KEGGMap_hsa04110_Abst_Gene_hsa_4193>&&hsa04110&MDM2, ACTFS, HDMX, hdm2; MDM2 proto-oncogene, E3 ubiquitin protein ligase; K06643 E3 ubiquitin-protein ligase Mdm2 [EC:6.3.2.19] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_112399>&&&EGLN3, HIFP4H3, HIFPH3, PHD3; egl-9 family hypoxia-inducible factor 3 (EC:1.14.11.29); K09592 hypoxia-inducible factor prolyl hydroxylase [EC:1.14.11.29] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2247>&R&&FGF2, BFGF, FGF-2, FGFB, HBGF-2; fibroblast growth factor 2 (basic); K18497 fibroblast growth factor 2 
<http://www.inferico.com/kegg-cmpo.owl#inst110_KEGGMap_hsa04151_Abst_Gene_hsa_596>&L&hsa04151&BCL2, Bcl-2, PPP1R50; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2114>&L&&ETS2, ETS2IT1; v-ets avian erythroblastosis virus E26 oncogene homolog 2; K02678 c-ets proto-oncogene protein 
<http://www.inferico.com/kegg-cmpo.owl#inst71_KEGGMap_hsa04151_Abst_Gene_hsa_5894>&&hsa04151&RAF1, CMD1NN, CRAF, NS5, Raf-1, c-Raf; Raf-1 proto-oncogene, serine/threonine kinase (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_324>&RL&&APC, BTPS2, DP2, DP2.5, DP3, GS, PPP1R46; adenomatous polyposis coli; K02085 adenomatosis polyposis coli protein 
<http://www.inferico.com/kegg-cmpo.owl#inst11_KEGGMap_hsa05200_Abst_Gene_hsa_3688>&&hsa05200&ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12); K05719 integrin beta 1 
<http://www.inferico.com/kegg-cmpo.owl#inst48_KEGGMap_hsa04014_Compound_cpd_C00044>&&hsa04014&
<http://www.inferico.com/kegg-cmpo.owl#inst88_KEGGMap_hsa04014_Abst_Gene_hsa_5335family>&&hsa04014&PLCG2, APLAID, FCAS3, PLC-IV, PLC-gamma-2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phosphatidylinositol phospholipase C, gamma-2 [EC:3.1.4.11] PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K01116 phosphatidylinositol phospholipase C, gamma-1 [EC:3.1.4.11] 
<http://www.inferico.com/kegg-cmpo.owl#inst42_KEGGMap_hsa05220_Abst_Gene_hsa_1019family>&&hsa05220&CDK6, MCPH12, PLSTIRE; cyclin-dependent kinase 6 (EC:2.7.11.22); K02091 cyclin-dependent kinase 6 [EC:2.7.11.22] CDK4, CMM3, PSK-J3; cyclin-dependent kinase 4 (EC:2.7.11.22); K02089 cyclin-dependent kinase 4 [EC:2.7.11.22] 
<http://www.inferico.com/kegg-cmpo.owl#inst23_KEGGMap_hsa04210_Abst_Gene_hsa_112401family>&&hsa04210&BIRC7, KIAP, LIVIN, ML-IAP, MLIAP, RNF50; baculoviral IAP repeat containing 7; K16061 baculoviral IAP repeat-containing protein 7/8 BIRC8, ILP-2, ILP2, hILP2; baculoviral IAP repeat containing 8; K16061 baculoviral IAP repeat-containing protein 7/8 BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1; baculoviral IAP repeat containing 2; K16060 baculoviral IAP repeat-containing protein 2/3 BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2; baculoviral IAP repeat containing 3; K16060 baculoviral IAP repeat-containing protein 2/3 XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3; X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase; K04725 E3 ubiquitin-protein ligase XIAP 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7059>&&&THBS3, TSP3; thrombospondin 3; K04659 thrombospondin 2/3/4/5 
<http://www.inferico.com/kegg-cmpo.owl#inst36_KEGGMap_hsa04012_Abst_Gene_hsa_2066>&&hsa04012&ERBB4, ALS19, HER4, p180erbB4; erb-b2 receptor tyrosine kinase 4 (EC:2.7.10.1); K05085 receptor tyrosine-protein kinase erbB-4 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst32_KEGGMap_hsa04110_Abst_Gene_hsa_2810>&&hsa04110&SFN, YWHAS; stratifin; K06644 stratifin 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3445>&R&&IFNA8, IFN-alphaB; interferon, alpha 8; K05414 interferon alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1488>&&&CTBP2; C-terminal binding protein 2; K04496 C-terminal binding protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_894>&RL&&CCND2, KIAK0002, MPPH3; cyclin D2; K10151 cyclin D2 
<http://www.inferico.com/kegg-cmpo.owl#inst210_KEGGMap_hsa05200_Abst_Gene_hsa_2277family>&&hsa05200&FIGF, VEGF-D, VEGFD; c-fos induced growth factor (vascular endothelial growth factor D); K05449 vascular endothelial growth factor C/D PGF, D12S1900, PGFL, PLGF, PlGF-2, SHGC-10760; placental growth factor; K16859 placenta growth factor VEGFA, MVCD1, VEGF, VPF; vascular endothelial growth factor A; K05448 vascular endothelial growth factor A VEGFB, VEGFL, VRF; vascular endothelial growth factor B; K16858 vascular endothelial growth factor B VEGFC, Flt4-L, LMPH1D, VRP; vascular endothelial growth factor C; K05449 vascular endothelial growth factor C/D 
<http://www.inferico.com/kegg-cmpo.owl#inst54_KEGGMap_hsa04210_Abst_Gene_hsa_7132>&&hsa04210&TNFRSF1A, CD120a, FPF, MS5, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR1-d2, TNFR55, TNFR60, p55, p55-R, p60; tumor necrosis factor receptor superfamily, member 1A; K03158 tumor necrosis factor receptor superfamily member 1A 
<http://www.inferico.com/kegg-cmpo.owl#cpd_C00410>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2248>&R&&FGF3, HBGF-3, INT2; fibroblast growth factor 3; K04358 fibroblast growth factor 
<http://www.inferico.com/kegg-cmpo.owl#inst14_KEGGMap_hsa04110_Abst_Gene_hsa_4998>&&hsa04110&ORC1, HSORC1, ORC1L, PARC1; origin recognition complex, subunit 1; K02603 origin recognition complex subunit 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_30814>&&&PLA2G2E, GIIE_sPLA2, sPLA2-IIE; phospholipase A2, group IIE (EC:3.1.1.4); K01047 secretory phospholipase A2 [EC:3.1.1.4] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_23035>&R&&PHLPP2, PHLPPL; PH domain and leucine rich repeat protein phosphatase 2 (EC:3.1.3.16); K16340 PH domain and leucine-rich repeat-containing protein phosphatase [EC:3.1.3.16] 
<http://www.inferico.com/kegg-cmpo.owl#inst45_KEGGMap_hsa04210_Abst_Gene_hsa_8737>&&hsa04210&RIPK1, RIP, RIP1; receptor (TNFRSF)-interacting serine-threonine kinase 1 (EC:2.7.11.1); K02861 receptor-interacting serine/threonine-protein kinase 1 [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst177_KEGGMap_hsa05200_Abst_Gene_hsa_1029>&CR&hsa05200&CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A; K06621 cyclin-dependent kinase inhibitor 2A 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3446>&R&&IFNA10, IFN-alphaC; interferon, alpha 10; K05414 interferon alpha 
<http://www.inferico.com/kegg-cmpo.owl#inst80_KEGGMap_hsa04012_Abst_Gene_Group_Abst_Gene_hsa_2064_Abst_Gene_hsa_2066>&&hsa04012&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1487>&&&CTBP1, BARS; C-terminal binding protein 1; K04496 C-terminal binding protein 
<http://www.inferico.com/kegg-cmpo.owl#inst37_KEGGMap_hsa04012_Abst_Gene_hsa_2065>&&hsa04012&ERBB3, ErbB-3, HER3, LCCS2, MDA-BF-1, c-erbB-3, c-erbB3, erbB3-S, p180-ErbB3, p45-sErbB3, p85-sErbB3; erb-b2 receptor tyrosine kinase 3 (EC:2.7.10.1); K05084 receptor tyrosine-protein kinase erbB-3 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5319>&&&PLA2G1B, PLA2, PLA2A, PPLA2; phospholipase A2, group IB (pancreas) (EC:3.1.1.4); K01047 secretory phospholipase A2 [EC:3.1.1.4] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5888>&&&RAD51, BRCC5, HRAD51, HsRad51, HsT16930, MRMV2, RAD51A, RECA; RAD51 recombinase; K04482 DNA repair protein RAD51 
<http://www.inferico.com/kegg-cmpo.owl#inst108_KEGGMap_hsa04110_Abst_Gene_Group_Abst_Gene_hsa_1019_Abst_Gene_hsa_1021_Abst_Gene_hsa_595_Abst_Gene_hsa_894_Abst_Gene_hsa_896>&&hsa04110&
<http://www.inferico.com/kegg-cmpo.owl#inst82_KEGGMap_hsa04014_Abst_Gene_hsa_10125family>&&hsa04014&RASGRP1, CALDAG-GEFI, CALDAG-GEFII, RASGRP, V, hRasGRP1; RAS guanyl releasing protein 1 (calcium and DAG-regulated); K04350 RAS guanyl-releasing protein 1 RASGRP2, CALDAG-GEFI, CDC25L; RAS guanyl releasing protein 2 (calcium and DAG-regulated); K12361 RAS guanyl-releasing protein 2 RASGRP3, GRP3; RAS guanyl releasing protein 3 (calcium and DAG-regulated); K12362 RAS guanyl-releasing protein 3 RASGRP4; RAS guanyl releasing protein 4; K12363 RAS guanyl-releasing protein 4 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_391013>&&&PLA2G2C; phospholipase A2, group IIC (EC:3.1.1.4); K01047 secretory phospholipase A2 [EC:3.1.1.4] 
<http://www.inferico.com/kegg-cmpo.owl#inst3_KEGGMap_hsa04210_Abst_Gene_hsa_5530family>&&hsa04210&PPP3CC, CALNA3, CNA3, PP2Bgamma; protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16); K04348 serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16] PPP3CB, CALNA2, CALNB, CNA2, PP2Bbeta; protein phosphatase 3, catalytic subunit, beta isozyme (EC:3.1.3.16); K04348 serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16] PPP3CA, CALN, CALNA, CALNA1, CCN1, CNA1, PPP2B; protein phosphatase 3, catalytic subunit, alpha isozyme (EC:3.1.3.16); K04348 serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16] PPP3R2, PPP3RL; protein phosphatase 3, regulatory subunit B, beta (EC:3.1.3.16); K06268 serine/threonine-protein phosphatase 2B regulatory subunit PPP3R1, CALNB1, CNB, CNB1; protein phosphatase 3, regulatory subunit B, alpha (EC:3.1.3.16); K06268 serine/threonine-protein phosphatase 2B regulatory subunit 
<http://www.inferico.com/kegg-cmpo.owl#inst252_KEGGMap_hsa05200_Compound_cpd_C00535>&&hsa05200&
<http://www.inferico.com/kegg-cmpo.owl#inst31_KEGGMap_hsa04012_Abst_Gene_hsa_572>&&hsa04012&BAD, BBC2, BCL2L8; BCL2-associated agonist of cell death; K02158 BCL2-antagonist of cell death 
<http://www.inferico.com/kegg-cmpo.owl#inst43_KEGGMap_hsa05200_Abst_Gene_hsa_367>&&hsa05200&AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM; androgen receptor; K08557 androgen receptor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3576>&&&CXCL8, GCP-1, GCP1, IL8, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1; chemokine (C-X-C motif) ligand 8; K10030 interleukin 8 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3443>&R&&IFNA6, IFN-alphaK; interferon, alpha 6; K05414 interferon alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_896>&RL&&CCND3; cyclin D3; K10152 cyclin D3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_112398>&&&EGLN2, EIT6, HIF-PH1, HIFPH1, HPH-1, HPH-3, PHD1; egl-9 family hypoxia-inducible factor 2 (EC:1.14.11.29); K09592 hypoxia-inducible factor prolyl hydroxylase [EC:1.14.11.29] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2246>&R&&FGF1, AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-1, FGF-alpha, FGFA, GLIO703, HBGF-1, HBGF1; fibroblast growth factor 1 (acidic); K18496 fibroblast growth factor 1 
<http://www.inferico.com/kegg-cmpo.owl#cpd_C00416>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst85_KEGGMap_hsa04151_Abst_Gene_hsa_5747>&&hsa04151&PTK2, FADK, FAK, FAK1, FRNK, PPP1R71, p125FAK, pp125FAK; protein tyrosine kinase 2 (EC:2.7.10.2); K05725 focal adhesion kinase 1 [EC:2.7.10.2] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2113>&L&&ETS1, ETS-1, EWSR2, p54; v-ets avian erythroblastosis virus E26 oncogene homolog 1; K02678 c-ets proto-oncogene protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_545>&R&&ATR, FCTCS, FRP1, MEC1, SCKL, SCKL1; ATR serine/threonine kinase (EC:2.7.11.1); K06640 serine/threonine-protein kinase ATR [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_9542>&&&NRG2, DON1, HRG2, NTAK; neuregulin 2; K05456 neuregulin 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_80326>&LR&&WNT10A, OODD, SSPS, STHAG4; wingless-type MMTV integration site family, member 10A; K01357 wingless-type MMTV integration site family, member 10 
<http://www.inferico.com/kegg-cmpo.owl#inst79_KEGGMap_hsa04012_Abst_Gene_Group_Abst_Gene_hsa_2064_Abst_Gene_hsa_2065>&&hsa04012&
<http://www.inferico.com/kegg-cmpo.owl#inst76_KEGGMap_hsa04014_Abst_Gene_hsa_10928>&&hsa04014&RALBP1, RIP1, RLIP1, RLIP76; ralA binding protein 1; K08773 RalA-binding protein 1 
<http://www.inferico.com/kegg-cmpo.owl#inst11_KEGGMap_hsa04014_Abst_Gene_hsa_10000family>&&hsa04014&AKT3, MPPH, MPPH2, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2; v-akt murine thymoma viral oncogene homolog 3 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1] AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1] AKT2, HIHGHH, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst75_KEGGMap_hsa05200_Abst_Gene_hsa_5599family>&&hsa05200&MAPK10, JNK3, JNK3A, PRKM10, SAPK1b, p493F12, p54bSAPK; mitogen-activated protein kinase 10 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24] MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK; mitogen-activated protein kinase 9 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24] MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c; mitogen-activated protein kinase 8 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_55012>&&&PPP2R3C, C14orf10, G4-1, G5pr; protein phosphatase 2, regulatory subunit B'', gamma; K11583 serine/threonine-protein phosphatase 2A regulatory subunit B'' 
<http://www.inferico.com/kegg-cmpo.owl#inst73_KEGGMap_hsa04012_Abst_Gene_hsa_3265family>&&hsa04012&HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, RASH1, p21ras; Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas NRAS, ALPS4, CMNS, N-ras, NCMS, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas KRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3444>&R&&IFNA7, IFN-alphaJ, IFNA-J; interferon, alpha 7; K05414 interferon alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7450>&&&VWF, F8VWF, VWD; von Willebrand factor; K03900 von Willebrand factor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3574>&R&&IL7, IL-7; interleukin 7; K05431 interleukin 7 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5535>&&&PPP3R2, PPP3RL; protein phosphatase 3, regulatory subunit B, beta (EC:3.1.3.16); K06268 serine/threonine-protein phosphatase 2B regulatory subunit 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3441>&R&&IFNA4, IFN-alpha4a, INFA4; interferon, alpha 4; K05414 interferon alpha 
<http://www.inferico.com/kegg-cmpo.owl#inst55_KEGGMap_hsa05200_Abst_Gene_hsa_6772>&&hsa05200&STAT1, CANDF7, IMD31A, IMD31B, IMD31C, ISGF-3, STAT91; signal transducer and activator of transcription 1, 91kDa; K11220 signal transducer and activator of transcription 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8697>&&&CDC23, ANAPC8, APC8, CUT23; cell division cycle 23; K03355 anaphase-promoting complex subunit 8 
<http://www.inferico.com/kegg-cmpo.owl#inst95_KEGGMap_hsa04014_Abst_Gene_hsa_27040>&&hsa04014&LAT, LAT1, pp36; linker for activation of T cells; K07362 linker for activation of T cells 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_22808>&L&&MRAS, M-RAs, R-RAS3, RRAS3; muscle RAS oncogene homolog; K07831 Ras-related protein M-Ras 
<http://www.inferico.com/kegg-cmpo.owl#inst117_KEGGMap_hsa04151_Abst_Gene_Group_Abst_Gene_hsa_10161_Abst_Gene_hsa_10681_Abst_Gene_hsa_1128_Abst_Gene_hsa_1129_Abst_Gene_hsa_1902_Abst_Gene_hsa_2149_Abst_Gene_hsa_23566_Abst_Gene_hsa_2782_Abst_Gene_hsa_2783_Abst_Gene_hsa_2784_Abst_Gene_hsa_2785_Abst_Gene_hsa_2786_Abst_Gene_hsa_2787_Abst_Gene_hsa_2788_Abst_Gene_hsa_2790_Abst_Gene_hsa_2791_Abst_Gene_hsa_2792_Abst_Gene_hsa_2793_Abst_Gene_hsa_2846_Abst_Gene_hsa_51764_Abst_Gene_hsa_54331_Abst_Gene_hsa_55970_Abst_Gene_hsa_57121_Abst_Gene_hsa_59345_Abst_Gene_hsa_648044_Abst_Gene_hsa_9170_Abst_Gene_hsa_94235>&&hsa04151&
<http://www.inferico.com/kegg-cmpo.owl#inst57_KEGGMap_hsa04012_Abst_Gene_hsa_25family>&L&hsa04012&ABL2, ABLL, ARG; ABL proto-oncogene 2, non-receptor tyrosine kinase (EC:2.7.10.2); K08887 abelson tyrosine-protein kinase 2 [EC:2.7.10.2] ABL1, ABL, JTK7, bcr/abl, c-ABL, c-ABL1, p150, v-abl; ABL proto-oncogene 1, non-receptor tyrosine kinase (EC:2.7.10.2); K06619 abelson tyrosine-protein kinase 1 [EC:2.7.10.2] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7148>&&&TNXB, EDS3, HXBL, TENX, TN-X, TNX, TNXB1, TNXB2, TNXBS, VUR8, XB, XBS; tenascin XB; K06252 tenascin 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_94235>&&&GNG8; guanine nucleotide binding protein (G protein), gamma 8; K04544 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8 
<http://www.inferico.com/kegg-cmpo.owl#inst44_KEGGMap_hsa04014_Abst_Gene_hsa_2113family>&L&hsa04014&ETS2, ETS2IT1; v-ets avian erythroblastosis virus E26 oncogene homolog 2; K02678 c-ets proto-oncogene protein ETS1, ETS-1, EWSR2, p54; v-ets avian erythroblastosis virus E26 oncogene homolog 1; K02678 c-ets proto-oncogene protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1399>&RL&&CRKL; v-crk avian sarcoma virus CT10 oncogene homolog-like; K04438 proto-oncogene C-crk 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3442>&R&&IFNA5, IFN-alpha-5, IFN-alphaG, INA5, INFA5, leIF_G; interferon, alpha 5; K05414 interferon alpha 
<http://www.inferico.com/kegg-cmpo.owl#inst22_KEGGMap_hsa04014_Abst_Gene_hsa_5863>&&hsa04014&RGL2, HKE1.5, KE1.5, RAB2L; ral guanine nucleotide dissociation stimulator-like 2; K17636 ral guanine nucleotide dissociation stimulator-like 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5885>&&&RAD21, CDLS4, HR21, HRAD21, MCD1, NXP1, SCC1, hHR21; RAD21 homolog (S. pombe); K06670 cohesin complex subunit SCC1 
<http://www.inferico.com/kegg-cmpo.owl#inst2_KEGGMap_hsa05220_Abst_Gene_hsa_2122family>&R&hsa05220&RUNX1, AML1, AML1-EVI-1, AMLCR1, CBFA2, EVI-1, PEBP2aB; runt-related transcription factor 1; K08367 runt-related transcription factor 1 MECOM, AML1-EVI-1, EVI1, MDS1, MDS1-EVI1, PRDM3; MDS1 and EVI1 complex locus; K04462 ecotropic virus integration site 1 protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5534>&&&PPP3R1, CALNB1, CNB, CNB1; protein phosphatase 3, regulatory subunit B, alpha (EC:3.1.3.16); K06268 serine/threonine-protein phosphatase 2B regulatory subunit 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_983>&&&CDK1, CDC2, CDC28A, P34CDC2; cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22); K02087 cyclin-dependent kinase 1 [EC:2.7.11.22 2.7.11.23] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_329>&&&BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1; baculoviral IAP repeat containing 2; K16060 baculoviral IAP repeat-containing protein 2/3 
<http://www.inferico.com/kegg-cmpo.owl#inst23_KEGGMap_hsa04014_Abst_Gene_hsa_5898family>&&hsa04014&RALB; v-ral simian leukemia viral oncogene homolog B; K07835 Ras-related protein Ral-B RALA, RAL; v-ral simian leukemia viral oncogene homolog A (ras related); K07834 Ras-related protein Ral-A 
<http://www.inferico.com/kegg-cmpo.owl#inst222_KEGGMap_hsa05200_Abst_Gene_hsa_596>&&hsa05200&BCL2, Bcl-2, PPP1R50; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_898>&RL&&CCNE1, CCNE; cyclin E1; K06626 cyclin E 
<http://www.inferico.com/kegg-cmpo.owl#inst24_KEGGMap_hsa05200_Abst_Gene_hsa_6776family>&&hsa05200&STAT5B, STAT5; signal transducer and activator of transcription 5B; K11224 signal transducer and activator of transcription 5B STAT5A, MGF, STAT5; signal transducer and activator of transcription 5A; K11223 signal transducer and activator of transcription 5A 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_10459>&&&MAD2L2, MAD2B, POLZ2, REV7; MAD2 mitotic arrest deficient-like 2 (yeast); K13728 mitotic spindle assembly checkpoint protein MAD2B 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5970>&&&RELA, NFKB3, p65; v-rel avian reticuloendotheliosis viral oncogene homolog A; K04735 transcription factor p65 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1398>&RL&&CRK, CRKII, p38; v-crk avian sarcoma virus CT10 oncogene homolog; K04438 proto-oncogene C-crk 
<http://www.inferico.com/kegg-cmpo.owl#inst45_KEGGMap_hsa04151_Abst_Gene_hsa_6654family>&&hsa04151&SOS2; son of sevenless homolog 2 (Drosophila); K03099 son of sevenless SOS1, GF1, GGF1, GINGF, HGF, NS4; son of sevenless homolog 1 (Drosophila); K03099 son of sevenless 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3575>&&&IL7R, CD127, CDW127, IL-7R-alpha, IL7RA, ILRA; interleukin 7 receptor; K05072 interleukin 7 receptor 
<http://www.inferico.com/kegg-cmpo.owl#inst13_KEGGMap_hsa04110_Abst_Gene_hsa_4999>&&hsa04110&ORC2, ORC2L; origin recognition complex, subunit 2; K02604 origin recognition complex subunit 2 
<http://www.inferico.com/kegg-cmpo.owl#inst62_KEGGMap_hsa04151_Abst_Gene_hsa_1017family>&&hsa04151&CDK6, MCPH12, PLSTIRE; cyclin-dependent kinase 6 (EC:2.7.11.22); K02091 cyclin-dependent kinase 6 [EC:2.7.11.22] CDK2, CDKN2, p33(CDK2); cyclin-dependent kinase 2 (EC:2.7.11.22); K02206 cyclin-dependent kinase 2 [EC:2.7.11.22] CDK4, CMM3, PSK-J3; cyclin-dependent kinase 4 (EC:2.7.11.22); K02089 cyclin-dependent kinase 4 [EC:2.7.11.22] 
<http://www.inferico.com/kegg-cmpo.owl#inst93_KEGGMap_hsa04110_Abst_Gene_hsa_3065family>&&hsa04110&HDAC1, GON-10, HD1, RPD3, RPD3L1; histone deacetylase 1 (EC:3.5.1.98); K06067 histone deacetylase 1/2 [EC:3.5.1.98] HDAC2, HD2, RPD3, YAF1; histone deacetylase 2 (EC:3.5.1.98); K06067 histone deacetylase 1/2 [EC:3.5.1.98] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7097>&&&TLR2, CD282, TIL4; toll-like receptor 2; K10159 toll-like receptor 2 
<http://www.inferico.com/kegg-cmpo.owl#inst45_KEGGMap_hsa04110_Abst_Gene_hsa_6502>&&hsa04110&SKP2, FBL1, FBXL1, FLB1, p45; S-phase kinase-associated protein 2, E3 ubiquitin protein ligase; K03875 F-box and leucine-rich repeat protein 1 (S-phase kinase-associated protein 2) 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2997>&&&GYS1, GSY, GYS; glycogen synthase 1 (muscle) (EC:2.4.1.11); K00693 glycogen(starch) synthase [EC:2.4.1.11] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8030>&R&&CCDC6, D10S170, H4, PTC, TPC, TST1; coiled-coil domain containing 6; K09288 coiled-coil domain-containing protein 6 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_10235>&&&RASGRP2, CALDAG-GEFI, CDC25L; RAS guanyl releasing protein 2 (calcium and DAG-regulated); K12361 RAS guanyl-releasing protein 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4824>&R&&NKX3-1, BAPX2, NKX3, NKX3.1, NKX3A; NK3 homeobox 1; K09348 homeobox protein Nkx-3.1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_64600>&&&PLA2G2F; phospholipase A2, group IIF (EC:3.1.1.4); K01047 secretory phospholipase A2 [EC:3.1.1.4] 
<http://www.inferico.com/kegg-cmpo.owl#inst112_KEGGMap_hsa04110_Abst_Gene_Group_Abst_Gene_hsa_10393_Abst_Gene_hsa_246184_Abst_Gene_hsa_25847_Abst_Gene_hsa_29882_Abst_Gene_hsa_29945_Abst_Gene_hsa_51343_Abst_Gene_hsa_51433_Abst_Gene_hsa_51434_Abst_Gene_hsa_51529_Abst_Gene_hsa_64682_Abst_Gene_hsa_8697_Abst_Gene_hsa_8881_Abst_Gene_hsa_996>&&hsa04110&
<http://www.inferico.com/kegg-cmpo.owl#inst57_KEGGMap_hsa04210_Abst_Gene_hsa_3562>&&hsa04210&IL3, IL-3, MCGF, MULTI-CSF; interleukin 3; K04736 interleukin 3 
<http://www.inferico.com/kegg-cmpo.owl#inst10_KEGGMap_hsa05200_Abst_Gene_hsa_1499>&&hsa05200&CTNNB1, CTNNB, MRD19, armadillo; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin beta 1 
<http://www.inferico.com/kegg-cmpo.owl#inst29_KEGGMap_hsa05200_Abst_Gene_hsa_3480>&&hsa05200&IGF1R, CD221, IGFIR, IGFR, JTK13; insulin-like growth factor 1 receptor (EC:2.7.10.1); K05087 insulin-like growth factor 1 receptor [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst17_KEGGMap_hsa04014_Abst_Gene_hsa_5781>&&hsa04014&PTPN11, BPTP3, CFC, NS1, PTP-1D, PTP2C, SH-PTP2, SH-PTP3, SHP2; protein tyrosine phosphatase, non-receptor type 11 (EC:3.1.3.48); K07293 tyrosine-protein phosphatase non-receptor type 11 [EC:3.1.3.48] 
<http://www.inferico.com/kegg-cmpo.owl#inst119_KEGGMap_hsa05200_Abst_Gene_hsa_7040family>&&hsa05200&TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1 TGFB2, LDS4, TGF-beta2; transforming growth factor, beta 2; K13376 transforming growth factor beta-2 TGFB3, ARVD, ARVD1, RNHF, TGF-beta3; transforming growth factor, beta 3; K13377 transforming growth factor beta-3 
<http://www.inferico.com/kegg-cmpo.owl#inst68_KEGGMap_hsa04151_Compound_cpd_C05981>&&hsa04151&
<http://www.inferico.com/kegg-cmpo.owl#inst10_KEGGMap_hsa04210_Abst_Gene_hsa_2021>&&hsa04210&ENDOG; endonuclease G; K01173 endonuclease G, mitochondrial 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8031>&R&&NCOA4, ARA70, ELE1, PTC3, RFG; nuclear receptor coactivator 4; K09289 nuclear receptor coactivator 4 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7099>&&&TLR4, ARMD10, CD284, TLR-4, TOLL; toll-like receptor 4; K10160 toll-like receptor 4 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_10018>&&&BCL2L11, BAM, BIM, BOD; BCL2-like 11 (apoptosis facilitator); K16341 Bcl-2-like protein 11 
<http://www.inferico.com/kegg-cmpo.owl#inst39_KEGGMap_hsa04110_Abst_Gene_hsa_9088>&&hsa04110&PKMYT1, MYT1, PPP1R126; protein kinase, membrane associated tyrosine/threonine 1 (EC:2.7.11.1); K06633 membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst153_KEGGMap_hsa05200_Abst_Gene_hsa_861family>&R&hsa05200&RUNX1, AML1, AML1-EVI-1, AMLCR1, CBFA2, EVI-1, PEBP2aB; runt-related transcription factor 1; K08367 runt-related transcription factor 1 RUNX1T1, AML1T1, CBFA2T1, CDR, ETO, MTG8, ZMYND2; runt-related transcription factor 1; translocated to, 1 (cyclin D-related); K10053 runt-related transcription factor 1; translocated to, 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7184>&&&HSP90B1, ECGP, GP96, GRP94, HEL-S-125m, HEL35, TRA1; heat shock protein 90kDa beta (Grp94), member 1; K09487 heat shock protein 90kDa beta 
<http://www.inferico.com/kegg-cmpo.owl#inst18_KEGGMap_hsa04210_Abst_Gene_hsa_840>&&hsa04210&CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3; caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60); K04397 caspase 7 [EC:3.4.22.60] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_83439>&&&TCF7L1, TCF-3, TCF3; transcription factor 7-like 1 (T-cell specific, HMG-box); K04490 transcription factor 7-like 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5934>&L&&RBL2, P130, Rb2; retinoblastoma-like 2; K16332 retinoblastoma-like protein 2 
<http://www.inferico.com/kegg-cmpo.owl#inst56_KEGGMap_hsa04210_Abst_Gene_hsa_355>&&hsa04210&FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas cell surface death receptor; K04390 tumor necrosis factor receptor superfamily member 6 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4292>&R&&MLH1, COCA2, FCC2, HNPCC, HNPCC2, hMLH1; mutL homolog 1; K08734 DNA mismatch repair protein MLH1 
<http://www.inferico.com/kegg-cmpo.owl#inst45_KEGGMap_hsa05200_Abst_Gene_hsa_8312family>&RL&hsa05200&AXIN1, AXIN, PPP1R49; axin 1; K02157 axin 1 AXIN2, AXIL, ODCRCS; axin 2; K04385 axin 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_25780>&&&RASGRP3, GRP3; RAS guanyl releasing protein 3 (calcium and DAG-regulated); K12362 RAS guanyl-releasing protein 3 
<http://www.inferico.com/kegg-cmpo.owl#inst52_KEGGMap_hsa04210_Abst_Gene_hsa_4914>&&hsa04210&NTRK1, MTC, TRK, TRK1, TRKA, Trk-A, p140-TrkA; neurotrophic tyrosine kinase, receptor, type 1 (EC:2.7.10.1); K03176 neurotrophic tyrosine kinase receptor type 1 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst221_KEGGMap_hsa05200_Abst_Gene_hsa_1436>&L&hsa05200&CSF1R, C-FMS, CD115, CSF-1R, CSFR, FIM2, FMS, HDLS, M-CSF-R; colony stimulating factor 1 receptor (EC:2.7.10.1); K05090 macrophage colony-stimulating factor 1 receptor [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst118_KEGGMap_hsa05200_Abst_Gene_hsa_4436>&R&hsa05200&MSH2, COCA1, FCC1, HNPCC, HNPCC1, LCFS2; mutS homolog 2; K08735 DNA mismatch repair protein MSH2 
<http://www.inferico.com/kegg-cmpo.owl#inst21_KEGGMap_hsa04014_Abst_Gene_hsa_23179>&&hsa04014&RGL1, RGL; ral guanine nucleotide dissociation stimulator-like 1; K17635 ral guanine nucleotide dissociation stimulator-like 1 
<http://www.inferico.com/kegg-cmpo.owl#inst90_KEGGMap_hsa04110_Abst_Gene_hsa_25>&CR&hsa04110&ABL1, ABL, JTK7, bcr/abl, c-ABL, c-ABL1, p150, v-abl; ABL proto-oncogene 1, non-receptor tyrosine kinase (EC:2.7.10.2); K06619 abelson tyrosine-protein kinase 1 [EC:2.7.10.2] 
<http://www.inferico.com/kegg-cmpo.owl#inst145_KEGGMap_hsa05200_Abst_Gene_hsa_6256family>&&hsa05200&RXRG, NR2B3, RXRC; retinoid X receptor, gamma; K08526 retinoid X receptor gamma RXRB, DAUDI6, H-2RIIBP, NR2B2, RCoR-1; retinoid X receptor, beta; K08525 retinoid X receptor beta RXRA, NR2B1; retinoid X receptor, alpha; K08524 retinoid X receptor alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7185>&&&TRAF1, EBI6, MGC:10353; TNF receptor-associated factor 1; K03172 TNF receptor-associated factor 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7849>&&&PAX8; paired box 8; K09293 paired box protein 8 
<http://www.inferico.com/kegg-cmpo.owl#inst19_KEGGMap_hsa04012_Compound_cpd_C00165>&&hsa04012&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5933>&RL&&RBL1, CP107, PRB1, p107; retinoblastoma-like 1; K04681 retinoblastoma-like protein 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2689>&R&&GH2, GH-V, GHL, GHV, hGH-V; growth hormone 2; K05438 growth hormone 
<http://www.inferico.com/kegg-cmpo.owl#inst117_KEGGMap_hsa05200_Abst_Gene_hsa_4292>&R&hsa05200&MLH1, COCA2, FCC2, HNPCC, HNPCC2, hMLH1; mutL homolog 1; K08734 DNA mismatch repair protein MLH1 
<http://www.inferico.com/kegg-cmpo.owl#inst93_KEGGMap_hsa05200_Compound_cpd_C05981>&&hsa05200&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_637>&&&BID, FP497; BH3 interacting domain death agonist; K04726 BH3 interacting domain death agonist 
<http://www.inferico.com/kegg-cmpo.owl#inst84_KEGGMap_hsa04110_Abst_Gene_hsa_10274family>&&hsa04110&STAG1, SA1, SCC3A; stromal antigen 1; K06671 cohesin complex subunit SA-1/2 STAG2, SA-2, SA2, SCC3B, bA517O1.1; stromal antigen 2; K06671 cohesin complex subunit SA-1/2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7186>&&&TRAF2, MGC:45012, TRAP, TRAP3; TNF receptor-associated factor 2; K03173 TNF receptor-associated factor 2 
<http://www.inferico.com/kegg-cmpo.owl#inst192_KEGGMap_hsa05200_Abst_Gene_hsa_595>&L&hsa05200&CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1 
<http://www.inferico.com/kegg-cmpo.owl#inst96_KEGGMap_hsa05200_Compound_cpd_C00076>&&hsa05200&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3091>&&&HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78; hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor); K08268 hypoxia-inducible factor 1 alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_9232>&&&PTTG1, EAP1, HPTTG, PTTG, TUTR1; pituitary tumor-transforming 1; K06635 securin 
<http://www.inferico.com/kegg-cmpo.owl#inst94_KEGGMap_hsa05200_Compound_cpd_C00165>&&hsa05200&
<http://www.inferico.com/kegg-cmpo.owl#inst27_KEGGMap_hsa05220_Abst_Gene_hsa_1029>&CR&hsa05220&CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A; K06621 cyclin-dependent kinase inhibitor 2A 
<http://www.inferico.com/kegg-cmpo.owl#inst29_KEGGMap_hsa04151_Abst_Gene_hsa_2309>&&hsa04151&FOXO3, AF6q21, FKHRL1, FKHRL1P2, FOXO2, FOXO3A; forkhead box O3; K09408 forkhead box protein O3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1442>&R&&CSH1, CS-1, CSA, CSMT, PL, hCS-1, hCS-A; chorionic somatomammotropin hormone 1 (placental lactogen); K05438 growth hormone 
<http://www.inferico.com/kegg-cmpo.owl#inst50_KEGGMap_hsa04151_Abst_Gene_hsa_11140>&&hsa04151&CDC37, P50CDC37; cell division cycle 37; K09554 cell division cycle protein 37 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_11211>&&&FZD10, CD350, FZ-10, Fz10, FzE7, hFz10; frizzled class receptor 10; K02842 frizzled 9/10 
<http://www.inferico.com/kegg-cmpo.owl#inst182_KEGGMap_hsa05200_Abst_Gene_hsa_637>&&hsa05200&BID, FP497; BH3 interacting domain death agonist; K04726 BH3 interacting domain death agonist 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7187>&&&TRAF3, CAP-1, CAP1, CD40bp, CRAF1, IIAE5, LAP1; TNF receptor-associated factor 3; K03174 TNF receptor-associated factor 3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_22801>&&&ITGA11, HsT18964; integrin, alpha 11; K06587 integrin alpha 11 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4602>&L&&MYB, Cmyb, c-myb, c-myb_CDS, efg; v-myb avian myeloblastosis viral oncogene homolog; K09420 myb proto-oncogene protein 
<http://www.inferico.com/kegg-cmpo.owl#inst128_KEGGMap_hsa05200_Abst_Gene_hsa_2122>&CR&hsa05200&MECOM, AML1-EVI-1, EVI1, MDS1, MDS1-EVI1, PRDM3; MDS1 and EVI1 complex locus; K04462 ecotropic virus integration site 1 protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_51806>&&&CALML5, CLSP; calmodulin-like 5; K02183 calmodulin 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_10393_Abst_Gene_hsa_246184_Abst_Gene_hsa_25847_Abst_Gene_hsa_29882_Abst_Gene_hsa_29945_Abst_Gene_hsa_51343_Abst_Gene_hsa_51433_Abst_Gene_hsa_51434_Abst_Gene_hsa_51529_Abst_Gene_hsa_64682_Abst_Gene_hsa_8697_Abst_Gene_hsa_8881_Abst_Gene_hsa_996>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1441>&&&CSF3R, CD114, GCSFR; colony stimulating factor 3 receptor (granulocyte); K05061 granulocyte colony-stimulating factor receptor 
<http://www.inferico.com/kegg-cmpo.owl#inst31_KEGGMap_hsa04151_Abst_Gene_hsa_4193>&&hsa04151&MDM2, ACTFS, HDMX, hdm2; MDM2 proto-oncogene, E3 ubiquitin protein ligase; K06643 E3 ubiquitin-protein ligase Mdm2 [EC:6.3.2.19] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7272>&&&TTK, CT96, ESK, MPH1, MPS1, MPS1L1, PYT; TTK protein kinase (EC:2.7.12.1); K08866 serine/threonine-protein kinase TTK/MPS1 [EC:2.7.12.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst226_KEGGMap_hsa05200_Abst_Gene_hsa_5467>&&hsa05200&PPARD, FAAR, NR1C2, NUC1, NUCI, NUCII, PPARB; peroxisome proliferator-activated receptor delta; K04504 peroxisome proliferator-activated receptor delta 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5979>&R&&RET, CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET-ELE1, RET51; ret proto-oncogene (EC:2.7.10.1); K05126 proto-oncogene tyrosine-protein kinase Ret [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst108_KEGGMap_hsa04151_Abst_Gene_hsa_3164>&&hsa04151&NR4A1, GFRP1, HMR, N10, NAK-1, NGFIB, NP10, NUR77, TR3; nuclear receptor subfamily 4, group A, member 1; K04465 nuclear receptor subfamily 4 group A member 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4999>&&&ORC2, ORC2L; origin recognition complex, subunit 2; K02604 origin recognition complex subunit 2 
<http://www.inferico.com/kegg-cmpo.owl#inst99_KEGGMap_hsa04014_Abst_Gene_hsa_29110>&&hsa04014&TBK1, NAK, T2K; TANK-binding kinase 1 (EC:2.7.11.1); K05410 TANK-binding kinase 1 [EC:2.7.11.10] 
<http://www.inferico.com/kegg-cmpo.owl#inst81_KEGGMap_hsa04014_Abst_Gene_hsa_5923>&&hsa04014&RASGRF1, CDC25, CDC25L, GNRP, GRF1, GRF55, H-GRF55, PP13187, ras-GRF1; Ras protein-specific guanine nucleotide-releasing factor 1; K04349 Ras-specific guanine nucleotide-releasing factor 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7188>&&&TRAF5, MGC:39780, RNF84; TNF receptor-associated factor 5; K09849 TNF receptor-associated factor 5 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_22800>&L&&RRAS2, TC21; related RAS viral (r-ras) oncogene homolog 2; K07830 Ras-related protein R-Ras2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3449>&R&&IFNA16, IFN-alphaO; interferon, alpha 16; K05414 interferon alpha 
<http://www.inferico.com/kegg-cmpo.owl#inst205_KEGGMap_hsa05200_Abst_Gene_hsa_7040family>&&hsa05200&TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1 TGFB2, LDS4, TGF-beta2; transforming growth factor, beta 2; K13376 transforming growth factor beta-2 TGFB3, ARVD, ARVD1, RNHF, TGF-beta3; transforming growth factor, beta 3; K13377 transforming growth factor beta-3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3667>&&&IRS1, HIRS-1; insulin receptor substrate 1; K16172 insulin receptor substrate 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6608>&&&SMO, FZD11, Gx, SMOH; smoothened, frizzled class receptor; K06226 smoothened 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1311>&&&COMP, EDM1, EPD1, MED, PSACH, THBS5; cartilage oligomeric matrix protein; K04659 thrombospondin 2/3/4/5 
<http://www.inferico.com/kegg-cmpo.owl#inst5_KEGGMap_hsa04151_Abst_Gene_hsa_1975>&&hsa04151&EIF4B, EIF-4B, PRO1843; eukaryotic translation initiation factor 4B; K03258 translation initiation factor 4B 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_11213>&&&IRAK3, ASRT5, IRAKM; interleukin-1 receptor-associated kinase 3 (EC:2.7.11.1); K04732 interleukin-1 receptor-associated kinase 3 [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst46_KEGGMap_hsa04110_Abst_Gene_hsa_5925>&CL&hsa04110&RB1, OSRC, PPP1R130, RB, p105-Rb, pRb, pp110; retinoblastoma 1; K06618 retinoblastoma-associated protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2688>&R&&GH1, GH, GH-N, GHN, IGHD1B, hGH-N; growth hormone 1; K05438 growth hormone 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4998>&&&ORC1, HSORC1, ORC1L, PARC1; origin recognition complex, subunit 1; K02603 origin recognition complex subunit 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_810>&&&CALML3, CLP; calmodulin-like 3; K02183 calmodulin 
<http://www.inferico.com/kegg-cmpo.owl#inst206_KEGGMap_hsa05200_Abst_Gene_hsa_6513>&&hsa05200&SLC2A1, DYT17, DYT18, DYT9, EIG12, GLUT, GLUT-1, GLUT1, GLUT1DS, HTLVR, PED, CSE; solute carrier family 2 (facilitated glucose transporter), member 1; K07299 MFS transporter, SP family, solute carrier family 2 (facilitated glucose transporter), member 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7189>&&&TRAF6, MGC:3310, RNF85; TNF receptor-associated factor 6, E3 ubiquitin protein ligase; K03175 TNF receptor-associated factor 6 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4515>&R&&MTCP1, P13MTCP1, p8MTCP1; mature T-cell proliferation 1; K16837 mature T-cell proliferation-1 type B1 
<http://www.inferico.com/kegg-cmpo.owl#inst213_KEGGMap_hsa05200_Abst_Gene_hsa_595>&L&hsa05200&CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1 
<http://www.inferico.com/kegg-cmpo.owl#inst1_KEGGMap_hsa04110_Abst_Gene_hsa_1029>&CR&hsa04110&CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A; K06621 cyclin-dependent kinase inhibitor 2A 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1443>&R&&CSH2, CS-2, CSB, PL, hCS-B; chorionic somatomammotropin hormone 2; K05438 growth hormone 
<http://www.inferico.com/kegg-cmpo.owl#cpd_C00280>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_11145>&&&PLA2G16, AdPLA, H-REV107-1, HRASLS3, HREV107, HREV107-1, HREV107-3, HRSL3; phospholipase A2, group XVI (EC:3.1.1.4 3.1.1.32); K16817 HRAS-like suppressor 3 [EC:3.1.1.32 3.1.1.4] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_59345>&&&GNB4, CMTD1F; guanine nucleotide binding protein (G protein), beta polypeptide 4; K04538 guanine nucleotide-binding protein subunit beta-4 
<http://www.inferico.com/kegg-cmpo.owl#inst43_KEGGMap_hsa05220_Abst_Gene_hsa_595>&RL&hsa05220&CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1 
<http://www.inferico.com/kegg-cmpo.owl#inst63_KEGGMap_hsa04110_Abst_Gene_hsa_983>&&hsa04110&CDK1, CDC2, CDC28A, P34CDC2; cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22); K02087 cyclin-dependent kinase 1 [EC:2.7.11.22 2.7.11.23] 
<http://www.inferico.com/kegg-cmpo.owl#inst20_KEGGMap_hsa04110_Abst_Gene_hsa_4171>&&hsa04110&MCM2, BM28, CCNL1, CDCL1, D3S3194, MITOTIN, cdc19; minichromosome maintenance complex component 2 (EC:3.6.4.12); K02540 DNA replication licensing factor MCM2 [EC:3.6.4.12] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_10298>&&&PAK4; p21 protein (Cdc42/Rac)-activated kinase 4 (EC:2.7.11.1); K05734 p21-activated kinase 4 [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3815>&&&KIT, C-Kit, CD117, PBT, SCFR; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (EC:2.7.10.1); K05091 proto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_51378>&R&&ANGPT4, AGP4, ANG-3, ANG4; angiopoietin 4; K05467 angiopoietin 4 
<http://www.inferico.com/kegg-cmpo.owl#inst124_KEGGMap_hsa05200_Abst_Gene_hsa_581>&&hsa05200&BAX, BCL2L4; BCL2-associated X protein; K02159 apoptosis regulator BAX 
<http://www.inferico.com/kegg-cmpo.owl#inst116_KEGGMap_hsa05200_Abst_Gene_hsa_5888>&&hsa05200&RAD51, BRCC5, HRAD51, HsRad51, HsT16930, MRMV2, RAD51A, RECA; RAD51 recombinase; K04482 DNA repair protein RAD51 
<http://www.inferico.com/kegg-cmpo.owl#inst57_KEGGMap_hsa05220_Abst_Gene_Group_Abst_Gene_hsa_1487_Abst_Gene_hsa_1488_Abst_Gene_hsa_3065_Abst_Gene_hsa_3066>&&hsa05220&
<http://www.inferico.com/kegg-cmpo.owl#inst42_KEGGMap_hsa04110_Abst_Gene_hsa_9700>&&hsa04110&ESPL1, ESP1, SEPA; extra spindle pole bodies homolog 1 (S. cerevisiae) (EC:3.4.22.49); K02365 separase [EC:3.4.22.49] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6794>&R&&STK11, LKB1, PJS, hLKB1; serine/threonine kinase 11 (EC:2.7.11.1); K07298 serine/threonine-protein kinase 11 
<http://www.inferico.com/kegg-cmpo.owl#inst78_KEGGMap_hsa04151_Abst_Gene_ko_K06856>&&hsa04151&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5908>&L&&RAP1B, K-REV, RAL1B; RAP1B, member of RAS oncogene family; K07836 Ras-related protein Rap-1B 
<http://www.inferico.com/kegg-cmpo.owl#inst83_KEGGMap_hsa04151_Abst_Gene_hsa_3688family>&&hsa04151&ITGB5; integrin, beta 5; K06588 integrin beta 5 ITGB6, AI1H; integrin, beta 6; K06589 integrin beta 6 ITGB4, CD104; integrin, beta 4; K06525 integrin beta 4 ITGB3, BDPLT16, BDPLT2, CD61, GP3A, GPIIIa, GT; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); K06493 integrin beta 3 ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12); K05719 integrin beta 1 ITGB7; integrin, beta 7; K06590 integrin beta 7 ITGB8; integrin, beta 8; K06591 integrin beta 8 
<http://www.inferico.com/kegg-cmpo.owl#inst85_KEGGMap_hsa04110_Abst_Gene_hsa_5885>&&hsa04110&RAD21, CDLS4, HR21, HRAD21, MCD1, NXP1, SCC1, hHR21; RAD21 homolog (S. pombe); K06670 cohesin complex subunit SCC1 
<http://www.inferico.com/kegg-cmpo.owl#cpd_C00165>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3371>&&&TNC, 150-225, DFNA56, GMEM, GP, HXB, JI, TN, TN-C; tenascin C; K06252 tenascin 
<http://www.inferico.com/kegg-cmpo.owl#inst18_KEGGMap_hsa04012_Compound_cpd_C00076>&&hsa04012&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5159>&&&PDGFRB, CD140B, IBGC4, IMF1, JTK12, PDGFR, PDGFR-1, PDGFR1; platelet-derived growth factor receptor, beta polypeptide (EC:2.7.10.1); K05089 platelet-derived growth factor receptor beta [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst32_KEGGMap_hsa05200_Abst_Gene_hsa_4233>&&hsa05200&MET, AUTS9, HGFR, RCCP2, c-Met; MET proto-oncogene, receptor tyrosine kinase (EC:2.7.10.1); K05099 proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst32_KEGGMap_hsa04014_Abst_Gene_hsa_572>&&hsa04014&BAD, BBC2, BCL2L8; BCL2-associated agonist of cell death; K02158 BCL2-antagonist of cell death 
<http://www.inferico.com/kegg-cmpo.owl#inst159_KEGGMap_hsa05200_Abst_Gene_hsa_7157>&C&hsa05200&TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1856>&&&DVL2; dishevelled segment polarity protein 2; K02353 segment polarity protein dishevelled 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3728>&&&JUP, ARVD12, CTNNG, DP3, DPIII, PDGB, PKGB; junction plakoglobin; K10056 junction plakoglobin 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5111>&&&PCNA, ATLD2; proliferating cell nuclear antigen; K04802 proliferating cell nuclear antigen 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3065>&&&HDAC1, GON-10, HD1, RPD3, RPD3L1; histone deacetylase 1 (EC:3.5.1.98); K06067 histone deacetylase 1/2 [EC:3.5.1.98] 
<http://www.inferico.com/kegg-cmpo.owl#inst25_KEGGMap_hsa04110_Abst_Gene_hsa_472family>&R&hsa04110&ATM, AT1, ATA, ATC, ATD, ATDC, ATE, TEL1, TELO1; ATM serine/threonine kinase (EC:2.7.11.1); K04728 ataxia telangiectasia mutated family protein [EC:2.7.11.1] ATR, FCTCS, FRP1, MEC1, SCKL, SCKL1; ATR serine/threonine kinase (EC:2.7.11.1); K06640 serine/threonine-protein kinase ATR [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5595>&&&MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 mitogen-activated protein kinase 1/3 [EC:2.7.11.24] 
<http://www.inferico.com/kegg-cmpo.owl#inst104_KEGGMap_hsa04014_Abst_Gene_hsa_8315>&&hsa04014&BRAP, BRAP2, IMP, RNF52; BRCA1 associated protein; K10632 BRCA1-associated protein [EC:6.3.2.19] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7428>&RL&&VHL, HRCA1, RCA1, VHL1, pVHL; von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase; K03871 von Hippel-Lindau disease tumor supressor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_284>&R&&ANGPT1, AGP1, AGPT, ANG1; angiopoietin 1; K05465 angiopoietin 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5906>&L&&RAP1A, C21KG, G-22K, KREV-1, KREV1, RAP1, SMGP21; RAP1A, member of RAS oncogene family; K04353 Ras-related protein Rap-1A 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_28227>&&&PPP2R3B, NYREN8, PPP2R3L, PPP2R3LY, PR48; protein phosphatase 2, regulatory subunit B'', beta; K11583 serine/threonine-protein phosphatase 2A regulatory subunit B'' 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8844>&&&KSR1, KSR, RSU2; kinase suppressor of ras 1; K14958 kinase suppressor of Ras 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5594>&&&MAPK1, ERK, ERK-2, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk, p42-MAPK; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 mitogen-activated protein kinase 1/3 [EC:2.7.11.24] 
<http://www.inferico.com/kegg-cmpo.owl#inst13_KEGGMap_hsa05200_Abst_Gene_hsa_10319family>&&hsa05200&LAMB1, CLM, LIS5; laminin, beta 1; K05636 laminin, beta 1 LAMB2, LAMS, NPHS5; laminin, beta 2 (laminin S); K06243 laminin, beta 2 LAMA4, CMD1JJ, LAMA3, LAMA4*-1; laminin, alpha 4; K06241 laminin, alpha 4 LAMA5; laminin, alpha 5; K06240 laminin, alpha 3/5 LAMC2, B2T, BM600, CSF, EBR2, EBR2A, LAMB2T, LAMNB2; laminin, gamma 2; K06246 laminin, gamma 2 LAMB3, AI1A, BM600-125KDA, LAM5, LAMNB1; laminin, beta 3; K06244 laminin, beta 3 LAMC1, LAMB2; laminin, gamma 1 (formerly LAMB2); K05635 laminin, gamma 1 COL4A6, CXDELq22.3, DELXq22.3, DFNX6; collagen, type IV, alpha 6; K06237 collagen, type IV, alpha COL4A5, ASLN, ATS, CA54; collagen, type IV, alpha 5; K06237 collagen, type IV, alpha LAMC3, OCCM; laminin, gamma 3; K06247 laminin, gamma 3 LAMB4; laminin, beta 4; K06245 laminin, beta 4 LAMA1, LAMA, PTBHS, S-LAM-alpha; laminin, alpha 1; K05637 laminin, alpha 1/2 FN1, CIG, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF; fibronectin 1; K05717 fibronectin 1 COL4A2, ICH, POREN2; collagen, type IV, alpha 2; K06237 collagen, type IV, alpha LAMA2, LAMM; laminin, alpha 2; K05637 laminin, alpha 1/2 LAMA3, BM600, E170, LAMNA, LOCS; laminin, alpha 3; K06240 laminin, alpha 3/5 COL4A4, CA44; collagen, type IV, alpha 4; K06237 collagen, type IV, alpha COL4A3; collagen, type IV, alpha 3 (Goodpasture antigen); K06237 collagen, type IV, alpha COL4A1, BSVD, RATOR; collagen, type IV, alpha 1; K06237 collagen, type IV, alpha 
<http://www.inferico.com/kegg-cmpo.owl#inst7_KEGGMap_hsa04012_Abst_Gene_hsa_2065>&&hsa04012&ERBB3, ErbB-3, HER3, LCCS2, MDA-BF-1, c-erbB-3, c-erbB3, erbB3-S, p180-ErbB3, p45-sErbB3, p85-sErbB3; erb-b2 receptor tyrosine kinase 3 (EC:2.7.10.1); K05084 receptor tyrosine-protein kinase erbB-3 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3066>&&&HDAC2, HD2, RPD3, YAF1; histone deacetylase 2 (EC:3.5.1.98); K06067 histone deacetylase 1/2 [EC:3.5.1.98] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1855>&&&DVL1, DRS2, DVL, DVL1L1, DVL1P1; dishevelled segment polarity protein 1; K02353 segment polarity protein dishevelled 
<http://www.inferico.com/kegg-cmpo.owl#inst19_KEGGMap_hsa04110_Abst_Gene_hsa_4172>&&hsa04110&MCM3, HCC5, P1-MCM3, P1.h, RLFB; minichromosome maintenance complex component 3 (EC:3.6.4.12); K02541 DNA replication licensing factor MCM3 [EC:3.6.4.12] 
<http://www.inferico.com/kegg-cmpo.owl#inst67_KEGGMap_hsa04110_Abst_Gene_hsa_1017>&&hsa04110&CDK2, CDKN2, p33(CDK2); cyclin-dependent kinase 2 (EC:2.7.11.22); K02206 cyclin-dependent kinase 2 [EC:2.7.11.22] 
<http://www.inferico.com/kegg-cmpo.owl#cpd_C00035>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_285>&R&&ANGPT2, AGPT2, ANG2; angiopoietin 2; K05466 angiopoietin 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_815>&&&CAMK2A, CAMKA; calcium/calmodulin-dependent protein kinase II alpha (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4176>&&&MCM7, CDC47, MCM2, P1.1-MCM3, P1CDC47, P85MCM, PNAS146, PPP1R104; minichromosome maintenance complex component 7 (EC:3.6.4.12); K02210 DNA replication licensing factor MCM7 [EC:3.6.4.12] 
<http://www.inferico.com/kegg-cmpo.owl#inst29_KEGGMap_hsa04014_Compound_cpd_C00165>&&hsa04014&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_50487>&&&PLA2G3, GIII-SPLA2, SPLA2III, sPLA2-III; phospholipase A2, group III (EC:3.1.1.4); K01047 secretory phospholipase A2 [EC:3.1.1.4] 
<http://www.inferico.com/kegg-cmpo.owl#inst19_KEGGMap_hsa04151_Abst_Gene_hsa_5728>&R&hsa04151&PTEN, 10q23del, BZS, CWS1, DEC, GLM2, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [EC:3.1.3.16 3.1.3.48 3.1.3.67] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_11140>&&&CDC37, P50CDC37; cell division cycle 37; K09554 cell division cycle protein 37 
<http://www.inferico.com/kegg-cmpo.owl#inst17_KEGGMap_hsa05200_Abst_Gene_hsa_11211family>&&hsa05200&FZD7, FzE3; frizzled class receptor 7; K02432 frizzled 1/7 FZD8, FZ-8, hFZ8; frizzled class receptor 8; K02375 frizzled 5/8 FZD9, CD349, FZD3; frizzled class receptor 9; K02842 frizzled 9/10 FZD1; frizzled class receptor 1; K02432 frizzled 1/7 FZD4, CD344, EVR1, FEVR, FZD4S, Fz-4, Fz4, FzE4, GPCR, hFz4; frizzled class receptor 4; K02354 frizzled 4 FZD6, FZ-6, FZ6, HFZ6, NDNC10; frizzled class receptor 6; K02376 frizzled 6 FZD2, Fz2, fz-2, fzE2, hFz2; frizzled class receptor 2; K02235 frizzled 2 FZD3, Fz-3; frizzled class receptor 3; K02329 frizzled 3 FZD5, C2orf31, HFZ5; frizzled class receptor 5; K02375 frizzled 5/8 FZD10, CD350, FZ-10, Fz10, FzE7, hFz10; frizzled class receptor 10; K02842 frizzled 9/10 
<http://www.inferico.com/kegg-cmpo.owl#inst23_KEGGMap_hsa05220_Abst_Gene_hsa_4193>&&hsa05220&MDM2, ACTFS, HDMX, hdm2; MDM2 proto-oncogene, E3 ubiquitin protein ligase; K06643 E3 ubiquitin-protein ligase Mdm2 [EC:6.3.2.19] 
<http://www.inferico.com/kegg-cmpo.owl#inst106_KEGGMap_hsa04014_Abst_Gene_hsa_5566family>&&hsa04014&PRKACG, BDPLT19, KAPG, PKACg; protein kinase, cAMP-dependent, catalytic, gamma (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11] PRKACB, PKA_C-beta, PKACB; protein kinase, cAMP-dependent, catalytic, beta (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11] PRKACA, PKACA, PPNAD4; protein kinase, cAMP-dependent, catalytic, alpha (EC:2.7.11.11); K04345 protein kinase A [EC:2.7.11.11] PRKX, PKX1; protein kinase, X-linked (EC:2.7.11.1); K04345 protein kinase A [EC:2.7.11.11] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_51684>&RL&&SUFU, PRO1280, SUFUH, SUFUXL; suppressor of fused homolog (Drosophila); K06229 suppressor of fused 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_816>&&&CAMK2B, CAM2, CAMK2, CAMKB; calcium/calmodulin-dependent protein kinase II beta (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17] 
<http://www.inferico.com/kegg-cmpo.owl#inst14_KEGGMap_hsa04012_Abst_Gene_hsa_1956>&RL&hsa04012&EGFR, ERBB, ERBB1, HER1, NISBD2, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_10161>&&&LPAR6, ARWH1, HYPT8, LAH3, P2RY5, P2Y5; lysophosphatidic acid receptor 6; K04273 lysophosphatidic acid receptor 6 
<http://www.inferico.com/kegg-cmpo.owl#inst173_KEGGMap_hsa05200_Abst_Gene_hsa_1163family>&&hsa05200&CKS1B, CKS1, PNAS-16, PNAS-18, ckshs1; CDC28 protein kinase regulatory subunit 1B; K02219 cyclin-dependent kinase regulatory subunit CKS1 CKS2, CKSHS2; CDC28 protein kinase regulatory subunit 2; K02219 cyclin-dependent kinase regulatory subunit CKS1 
<http://www.inferico.com/kegg-cmpo.owl#inst81_KEGGMap_hsa04151_Abst_Gene_hsa_10681family>&&hsa04151&GNGT1, GNG1; guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1; K04548 guanine nucleotide-binding protein G(T) subunit gamma-T1 GNGT2, G-GAMMA-8, G-GAMMA-C, GNG8, GNG9, GNGT8; guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2; K04549 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 GNG10; guanine nucleotide binding protein (G protein), gamma 10; K04545 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 GNG11, GNGT11; guanine nucleotide binding protein (G protein), gamma 11; K04546 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 GNG12; guanine nucleotide binding protein (G protein), gamma 12; K04347 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 GNG2; guanine nucleotide binding protein (G protein), gamma 2; K07826 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 null GNG13, G(gamma)13, h2-35; guanine nucleotide binding protein (G protein), gamma 13; K04547 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13 GNG8; guanine nucleotide binding protein (G protein), gamma 8; K04544 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8 GNB4, CMTD1F; guanine nucleotide binding protein (G protein), beta polypeptide 4; K04538 guanine nucleotide-binding protein subunit beta-4 GNB1; guanine nucleotide binding protein (G protein), beta polypeptide 1; K04536 guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 GNB2; guanine nucleotide binding protein (G protein), beta polypeptide 2; K04537 guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 GNG7; guanine nucleotide binding protein (G protein), gamma 7; K04543 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 GNG4; guanine nucleotide binding protein (G protein), gamma 4; K04541 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 GNG5; guanine nucleotide binding protein (G protein), gamma 5; K04542 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 GNB3; guanine nucleotide binding protein (G protein), beta polypeptide 3; K07825 guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 GNG3; guanine nucleotide binding protein (G protein), gamma 3; K04540 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3 GNB5, GB5; guanine nucleotide binding protein (G protein), beta 5; K04539 guanine nucleotide-binding protein subunit beta-5 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5156>&&&PDGFRA, CD140A, PDGFR-2, PDGFR2, RHEPDGFRA; platelet-derived growth factor receptor, alpha polypeptide (EC:2.7.10.1); K04363 platelet-derived growth factor receptor alpha [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst10_KEGGMap_hsa05220_Abst_Gene_hsa_7157>&CRL&hsa05220&TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53 
<http://www.inferico.com/kegg-cmpo.owl#inst86_KEGGMap_hsa04014_Compound_cpd_C00076>&&hsa04014&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_29119>&&&CTNNA3, ARVD13, VR22; catenin (cadherin-associated protein), alpha 3; K05691 catenin alpha 
<http://www.inferico.com/kegg-cmpo.owl#inst12_KEGGMap_hsa05200_Abst_Gene_hsa_1855family>&&hsa05200&DVL2; dishevelled segment polarity protein 2; K02353 segment polarity protein dishevelled DVL1, DRS2, DVL, DVL1L1, DVL1P1; dishevelled segment polarity protein 1; K02353 segment polarity protein dishevelled DVL3; dishevelled segment polarity protein 3; K02353 segment polarity protein dishevelled 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2308>&L&&FOXO1, FKH1, FKHR, FOXO1A; forkhead box O1; K07201 forkhead box protein O1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4174>&&&MCM5, CDC46, P1-CDC46; minichromosome maintenance complex component 5 (EC:3.6.4.12); K02209 DNA replication licensing factor MCM5 [EC:3.6.4.12] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_902>&&&CCNH, CAK, CycH, p34, p37; cyclin H; K06634 cyclin H 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4089>&&&SMAD4, DPC4, JIP, MADH4, MYHRS; SMAD family member 4; K04501 mothers against decapentaplegic homolog 4 
<http://www.inferico.com/kegg-cmpo.owl#inst54_KEGGMap_hsa05200_Abst_Gene_hsa_6774>&&hsa05200&STAT3, ADMIO, APRF, HIES; signal transducer and activator of transcription 3 (acute-phase response factor); K04692 signal transducer and activator of transcription 3 
<http://www.inferico.com/kegg-cmpo.owl#inst39_KEGGMap_hsa05200_Abst_Gene_hsa_3479>&&hsa05200&IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_817>&&&CAMK2D, CAMKD; calcium/calmodulin-dependent protein kinase II delta (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17] 
<http://www.inferico.com/kegg-cmpo.owl#inst2_KEGGMap_hsa04151_Abst_Gene_hsa_1977family>&&hsa04151&EIF4E2, 4E-LP, 4EHP, EIF4EL3, IF4e; eukaryotic translation initiation factor 4E family member 2; K03259 translation initiation factor 4E EIF4E1B; eukaryotic translation initiation factor 4E family member 1B; K03259 translation initiation factor 4E EIF4E, AUTS19, CBP, EIF4E1, EIF4EL1, EIF4F; eukaryotic translation initiation factor 4E; K03259 translation initiation factor 4E 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5155>&RL&&PDGFB, IBGC5, PDGF-2, PDGF2, SIS, SSV, c-sis; platelet-derived growth factor beta polypeptide; K17386 platelet-derived growth factor subunit B 
<http://www.inferico.com/kegg-cmpo.owl#inst230_KEGGMap_hsa05200_Abst_Gene_hsa_5594family>&&hsa05200&MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 mitogen-activated protein kinase 1/3 [EC:2.7.11.24] MAPK1, ERK, ERK-2, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk, p42-MAPK; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 mitogen-activated protein kinase 1/3 [EC:2.7.11.24] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5591>&&&PRKDC, DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, IMD26, XRCC7, p350; protein kinase, DNA-activated, catalytic polypeptide (EC:2.7.11.1); K06642 DNA-dependent protein kinase catalytic subunit [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_10912>&&&GADD45G, CR6, DDIT2, GADD45gamma, GRP17; growth arrest and DNA-damage-inducible, gamma; K04402 growth arrest and DNA-damage-inducible protein 
<http://www.inferico.com/kegg-cmpo.owl#inst143_KEGGMap_hsa05200_Compound_cpd_C00777family>&&hsa05200&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2309>&&&FOXO3, AF6q21, FKHRL1, FKHRL1P2, FOXO2, FOXO3A; forkhead box O3; K09408 forkhead box protein O3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4175>&&&MCM6, MCG40308, Mis5, P105MCM; minichromosome maintenance complex component 6 (EC:3.6.4.12); K02542 DNA replication licensing factor MCM6 [EC:3.6.4.12] 
<http://www.inferico.com/kegg-cmpo.owl#inst30_KEGGMap_hsa05220_Abst_Gene_hsa_2885>&&hsa05220&GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2 
<http://www.inferico.com/kegg-cmpo.owl#inst77_KEGGMap_hsa04014_Abst_Gene_hsa_10928>&&hsa04014&RALBP1, RIP1, RLIP1, RLIP76; ralA binding protein 1; K08773 RalA-binding protein 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_10297>&RL&&APC2, APCL; adenomatosis polyposis coli 2; K02085 adenomatosis polyposis coli protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_85301>&&&COL27A1, STLS; collagen, type XXVII, alpha 1; K06236 collagen, type I/II/III/V/XI/XXIV/XXVII, alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5590>&L&&PRKCZ, PKC-ZETA, PKC2; protein kinase C, zeta (EC:2.7.11.13); K18952 atypical protein kinase C zeta type [EC:2.7.11.13] 
<http://www.inferico.com/kegg-cmpo.owl#inst163_KEGGMap_hsa05200_Abst_Gene_hsa_4149>&&hsa05200&MAX, bHLHd4; MYC associated factor X; K04453 Max protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_818>&&&CAMK2G, CAMK, CAMK-II, CAMKG; calcium/calmodulin-dependent protein kinase II gamma (EC:2.7.11.17); K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3725>&L&&JUN, AP-1, AP1, c-Jun; jun proto-oncogene; K04448 transcription factor AP-1 
<http://www.inferico.com/kegg-cmpo.owl#inst58_KEGGMap_hsa04014_Abst_Gene_hsa_6789>&&hsa04014&STK4, KRS2, MST1, TIIAC, YSK3; serine/threonine kinase 4 (EC:2.7.11.1); K04411 serine/threonine kinase 4 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_1441_Abst_Gene_hsa_2057_Abst_Gene_hsa_2690_Abst_Gene_hsa_3454_Abst_Gene_hsa_3455_Abst_Gene_hsa_3559_Abst_Gene_hsa_3560_Abst_Gene_hsa_3561_Abst_Gene_hsa_3563_Abst_Gene_hsa_3566_Abst_Gene_hsa_3570_Abst_Gene_hsa_3575_Abst_Gene_hsa_3716_Abst_Gene_hsa_3717_Abst_Gene_hsa_3718_Abst_Gene_hsa_5618_Abst_Gene_hsa_9180>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst196_KEGGMap_hsa05200_Abst_Gene_hsa_112401family>&&hsa05200&BIRC7, KIAP, LIVIN, ML-IAP, MLIAP, RNF50; baculoviral IAP repeat containing 7; K16061 baculoviral IAP repeat-containing protein 7/8 BIRC8, ILP-2, ILP2, hILP2; baculoviral IAP repeat containing 8; K16061 baculoviral IAP repeat-containing protein 7/8 BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1; baculoviral IAP repeat containing 2; K16060 baculoviral IAP repeat-containing protein 2/3 BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2; baculoviral IAP repeat containing 3; K16060 baculoviral IAP repeat-containing protein 2/3 XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3; X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase; K04725 E3 ubiquitin-protein ligase XIAP 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_118788_Abst_Gene_hsa_930>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_115727>&&&RASGRP4; RAS guanyl releasing protein 4; K12363 RAS guanyl-releasing protein 4 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5154>&R&&PDGFA, PDGF-A, PDGF1; platelet-derived growth factor alpha polypeptide; K04359 platelet-derived growth factor subunit A 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1284>&&&COL4A2, ICH, POREN2; collagen, type IV, alpha 2; K06237 collagen, type IV, alpha 
<http://www.inferico.com/kegg-cmpo.owl#inst94_KEGGMap_hsa04110_Abst_Gene_hsa_5925>&C&hsa04110&RB1, OSRC, PPP1R130, RB, p105-Rb, pRb, pp110; retinoblastoma 1; K06618 retinoblastoma-associated protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8312>&RL&&AXIN1, AXIN, PPP1R49; axin 1; K02157 axin 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7029>&&&TFDP2, DP2; transcription factor Dp-2 (E2F dimerization partner 2); K09392 transcription factor Dp-2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_374>&&&AREG, AR, AREGB, CRDGF, SDGF; amphiregulin; K09782 amphiregulin 
<http://www.inferico.com/kegg-cmpo.owl#inst3_KEGGMap_hsa04110_Abst_Gene_hsa_4171family>&&hsa04110&MCM7, CDC47, MCM2, P1.1-MCM3, P1CDC47, P85MCM, PNAS146, PPP1R104; minichromosome maintenance complex component 7 (EC:3.6.4.12); K02210 DNA replication licensing factor MCM7 [EC:3.6.4.12] MCM5, CDC46, P1-CDC46; minichromosome maintenance complex component 5 (EC:3.6.4.12); K02209 DNA replication licensing factor MCM5 [EC:3.6.4.12] MCM6, MCG40308, Mis5, P105MCM; minichromosome maintenance complex component 6 (EC:3.6.4.12); K02542 DNA replication licensing factor MCM6 [EC:3.6.4.12] MCM3, HCC5, P1-MCM3, P1.h, RLFB; minichromosome maintenance complex component 3 (EC:3.6.4.12); K02541 DNA replication licensing factor MCM3 [EC:3.6.4.12] MCM4, CDC21, CDC54, NKCD, NKGCD, P1-CDC21, hCdc21; minichromosome maintenance complex component 4 (EC:3.6.4.12); K02212 DNA replication licensing factor MCM4 [EC:3.6.4.12] MCM2, BM28, CCNL1, CDCL1, D3S3194, MITOTIN, cdc19; minichromosome maintenance complex component 2 (EC:3.6.4.12); K02540 DNA replication licensing factor MCM2 [EC:3.6.4.12] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8881>&&&CDC16, ANAPC6, APC6, CUT9; cell division cycle 16; K03353 anaphase-promoting complex subunit 6 
<http://www.inferico.com/kegg-cmpo.owl#inst102_KEGGMap_hsa04014_Abst_Gene_hsa_8315>&&hsa04014&BRAP, BRAP2, IMP, RNF52; BRCA1 associated protein; K10632 BRCA1-associated protein [EC:6.3.2.19] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3908>&&&LAMA2, LAMM; laminin, alpha 2; K05637 laminin, alpha 1/2 
<http://www.inferico.com/kegg-cmpo.owl#inst201_KEGGMap_hsa05200_Abst_Gene_hsa_2277family>&&hsa05200&FIGF, VEGF-D, VEGFD; c-fos induced growth factor (vascular endothelial growth factor D); K05449 vascular endothelial growth factor C/D PGF, D12S1900, PGFL, PLGF, PlGF-2, SHGC-10760; placental growth factor; K16859 placenta growth factor VEGFA, MVCD1, VEGF, VPF; vascular endothelial growth factor A; K05448 vascular endothelial growth factor A VEGFB, VEGFL, VRF; vascular endothelial growth factor B; K16858 vascular endothelial growth factor B VEGFC, Flt4-L, LMPH1D, VRP; vascular endothelial growth factor C; K05449 vascular endothelial growth factor C/D 
<http://www.inferico.com/kegg-cmpo.owl#inst15_KEGGMap_hsa04151_Abst_Gene_hsa_5290family>&&hsa04151&PIK3R3, p55, p55-GAMMA, p55PIK; phosphoinositide-3-kinase, regulatory subunit 3 (gamma); K02649 phosphoinositide-3-kinase, regulatory subunit PIK3CA, CLOVE, CWS5, MCAP, MCM, MCMTC, PI3K, p110-alpha; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (EC:2.7.11.1 2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] PIK3R2, MPPH, MPPH1, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit PIK3R1, AGM7, GRB1, IMD36, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit PIK3CD, APDS, IMD14, P110DELTA, PI3K, p110D; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] PIK3CB, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_6921_Abst_Gene_hsa_6923_Abst_Gene_hsa_7428_Abst_Gene_hsa_8453_Abst_Gene_hsa_9978>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7465>&&&WEE1, WEE1A, WEE1hu; WEE1 G2 checkpoint kinase (EC:2.7.10.2); K06632 wee1-like protein kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_10735>&&&STAG2, SA-2, SA2, SCC3B, bA517O1.1; stromal antigen 2; K06671 cohesin complex subunit SA-1/2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_11186>&R&&RASSF1, 123F2, NORE2A, RASSF1A, RDA32, REH3P21; Ras association (RalGDS/AF-6) domain family member 1; K09850 Ras association domain-containing protein 1 
<http://www.inferico.com/kegg-cmpo.owl#inst17_KEGGMap_hsa04110_Abst_Gene_hsa_4174>&&hsa04110&MCM5, CDC46, P1-CDC46; minichromosome maintenance complex component 5 (EC:3.6.4.12); K02209 DNA replication licensing factor MCM5 [EC:3.6.4.12] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8797>&&&TNFRSF10A, APO2, CD261, DR4, TRAILR-1, TRAILR1; tumor necrosis factor receptor superfamily, member 10a; K04722 tumor necrosis factor receptor superfamily member 10 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5338>&&&PLD2; phospholipase D2 (EC:3.1.4.4); K01115 phospholipase D1/2 [EC:3.1.4.4] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8313>&RL&&AXIN2, AXIL, ODCRCS; axin 2; K04385 axin 2 
<http://www.inferico.com/kegg-cmpo.owl#inst78_KEGGMap_hsa04014_Abst_Gene_hsa_382>&&hsa04014&ARF6; ADP-ribosylation factor 6; K07941 ADP-ribosylation factor 6 
<http://www.inferico.com/kegg-cmpo.owl#inst149_KEGGMap_hsa05200_Abst_Gene_hsa_51176family>&&hsa05200&TCF7, TCF-1; transcription factor 7 (T-cell specific, HMG-box); K02620 transcription factor 7 TCF7L2, TCF-4, TCF4; transcription factor 7-like 2 (T-cell specific, HMG-box); K04491 transcription factor 7-like 2 LEF1, LEF-1, TCF10, TCF1ALPHA, TCF7L3; lymphoid enhancer-binding factor 1; K04492 lymphoid enhancer-binding factor 1 TCF7L1, TCF-3, TCF3; transcription factor 7-like 1 (T-cell specific, HMG-box); K04490 transcription factor 7-like 1 
<http://www.inferico.com/kegg-cmpo.owl#inst249_KEGGMap_hsa05200_Abst_Gene_hsa_4254>&&hsa05200&KITLG, FPH2, FPHH, KL-1, Kitl, MGF, SCF, SF, SHEP7; KIT ligand (EC:3.2.1.31); K05461 KIT ligand 
<http://www.inferico.com/kegg-cmpo.owl#inst44_KEGGMap_hsa04151_Abst_Gene_hsa_2885>&&hsa04151&GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2; growth factor receptor-bound protein 2; K04364 growth factor receptor-binding protein 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3909>&&&LAMA3, BM600, E170, LAMNA, LOCS; laminin, alpha 3; K06240 laminin, alpha 3/5 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1946>&R&&EFNA5, AF1, EFL5, EPLG7, GLC1M, LERK7, RAGS; ephrin-A5; K05462 ephrin-A 
<http://www.inferico.com/kegg-cmpo.owl#inst5_KEGGMap_hsa04110_Abst_Gene_hsa_10393family>&&hsa04110&ANAPC13, APC13, SWM1; anaphase promoting complex subunit 13; K12456 anaphase-promoting complex subunit 13 ANAPC10, APC10, DOC1; anaphase promoting complex subunit 10; K03357 anaphase-promoting complex subunit 10 ANAPC7, APC7; anaphase promoting complex subunit 7; K03354 anaphase-promoting complex subunit 7 ANAPC5, APC5; anaphase promoting complex subunit 5; K03352 anaphase-promoting complex subunit 5 CDC26, ANAPC12, APC12, C9orf17; cell division cycle 26; K03359 anaphase-promoting complex subunit 12 ANAPC4, APC4; anaphase promoting complex subunit 4; K03351 anaphase-promoting complex subunit 4 ANAPC2, APC2; anaphase promoting complex subunit 2; K03349 anaphase-promoting complex subunit 2 ANAPC11, APC11, Apc11p, HSPC214; anaphase promoting complex subunit 11; K03358 anaphase-promoting complex subunit 11 ANAPC1, APC1, MCPR, TSG24; anaphase promoting complex subunit 1; K03348 anaphase-promoting complex subunit 1 CDC23, ANAPC8, APC8, CUT23; cell division cycle 23; K03355 anaphase-promoting complex subunit 8 CDC16, ANAPC6, APC6, CUT9; cell division cycle 16; K03353 anaphase-promoting complex subunit 6 CDC27, ANAPC3, APC3, CDC27Hs, D0S1430E, D17S978E, H-NUC, HNUC, NUC2; cell division cycle 27; K03350 anaphase-promoting complex subunit 3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7248>&RL&&TSC1, LAM, TSC; tuberous sclerosis 1; K07206 tuberous sclerosis 1 
<http://www.inferico.com/kegg-cmpo.owl#inst73_KEGGMap_hsa04110_Abst_Gene_hsa_595family>&L&hsa04110&CCND2, KIAK0002, MPPH3; cyclin D2; K10151 cyclin D2 CCND3; cyclin D3; K10152 cyclin D3 CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_23239>&R&&PHLPP1, PHLPP, PLEKHE1, SCOP; PH domain and leucine rich repeat protein phosphatase 1 (EC:3.1.3.16); K16340 PH domain and leucine-rich repeat-containing protein phosphatase [EC:3.1.3.16] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1286>&&&COL4A4, CA44; collagen, type IV, alpha 4; K06237 collagen, type IV, alpha 
<http://www.inferico.com/kegg-cmpo.owl#inst3_KEGGMap_hsa04014_Abst_Gene_hsa_5594family>&&hsa04014&MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK; mitogen-activated protein kinase 3 (EC:2.7.11.24); K04371 mitogen-activated protein kinase 1/3 [EC:2.7.11.24] MAPK1, ERK, ERK-2, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk, p42-MAPK; mitogen-activated protein kinase 1 (EC:2.7.11.24); K04371 mitogen-activated protein kinase 1/3 [EC:2.7.11.24] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5337>&&&PLD1; phospholipase D1, phosphatidylcholine-specific (EC:3.1.4.4); K01115 phospholipase D1/2 [EC:3.1.4.4] 
<http://www.inferico.com/kegg-cmpo.owl#cpd_C00122>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst33_KEGGMap_hsa04012_Abst_Gene_hsa_7039>&&hsa04012&TGFA, TFGA; transforming growth factor, alpha; K08774 transforming growth factor, alpha 
<http://www.inferico.com/kegg-cmpo.owl#inst109_KEGGMap_hsa04151_Abst_Gene_hsa_6256>&&hsa04151&RXRA, NR2B1; retinoid X receptor, alpha; K08524 retinoid X receptor alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7249>&RL&&TSC2, LAM, PPP1R160, TSC4; tuberous sclerosis 2; K07207 tuberous sclerosis 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4792>&&&NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha 
<http://www.inferico.com/kegg-cmpo.owl#inst62_KEGGMap_hsa05200_Abst_Gene_hsa_11186>&&hsa05200&RASSF1, 123F2, NORE2A, RASSF1A, RDA32, REH3P21; Ras association (RalGDS/AF-6) domain family member 1; K09850 Ras association domain-containing protein 1 
<http://www.inferico.com/kegg-cmpo.owl#inst43_KEGGMap_hsa04110_Abst_Gene_hsa_27127family>&&hsa04110&SMC1A, CDLS2, DXS423E, SB1.8, SMC1, SMC1L1, SMC1alpha, SMCB; structural maintenance of chromosomes 1A; K06636 structural maintenance of chromosome 1 SMC1B, SMC1BETA, SMC1L2; structural maintenance of chromosomes 1B; K06636 structural maintenance of chromosome 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2263>&&&FGFR2, BBDS, BEK, BFR-1, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25; fibroblast growth factor receptor 2 (EC:2.7.10.1); K05093 fibroblast growth factor receptor 2 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst65_KEGGMap_hsa04110_Abst_Gene_hsa_890family>&&hsa04110&CCNA1, CT146; cyclin A1; K06627 cyclin A CCNA2, CCN1, CCNA; cyclin A2; K06627 cyclin A 
<http://www.inferico.com/kegg-cmpo.owl#inst58_KEGGMap_hsa05200_Abst_Gene_hsa_3265family>&&hsa05200&HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, RASH1, p21ras; Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas NRAS, ALPS4, CMNS, N-ras, NCMS, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas KRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1285>&&&COL4A3; collagen, type IV, alpha 3 (Goodpasture antigen); K06237 collagen, type IV, alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_595>&LR&&CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3680>&&&ITGA9, ALPHA-RLC, ITGA4L, RLC; integrin, alpha 9; K06585 integrin alpha 9 
<http://www.inferico.com/kegg-cmpo.owl#inst22_KEGGMap_hsa05200_Abst_Gene_hsa_1398family>&RL&hsa05200&CRKL; v-crk avian sarcoma virus CT10 oncogene homolog-like; K04438 proto-oncogene C-crk CRK, CRKII, p38; v-crk avian sarcoma virus CT10 oncogene homolog; K04438 proto-oncogene C-crk 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5336>&&&PLCG2, APLAID, FCAS3, PLC-IV, PLC-gamma-2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phosphatidylinositol phospholipase C, gamma-2 [EC:3.1.4.11] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8315>&&&BRAP, BRAP2, IMP, RNF52; BRCA1 associated protein; K10632 BRCA1-associated protein [EC:6.3.2.19] 
<http://www.inferico.com/kegg-cmpo.owl#inst71_KEGGMap_hsa05200_Abst_Gene_hsa_5898family>&&hsa05200&RALB; v-ral simian leukemia viral oncogene homolog B; K07835 Ras-related protein Ral-B RALA, RAL; v-ral simian leukemia viral oncogene homolog A (ras related); K07834 Ras-related protein Ral-A 
<http://www.inferico.com/kegg-cmpo.owl#inst47_KEGGMap_hsa04012_Abst_Gene_hsa_5578family>&L&hsa04012&PRKCB, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13] PRKCA, AAG6, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13] PRKCG, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13] 
<http://www.inferico.com/kegg-cmpo.owl#inst43_KEGGMap_hsa04151_Abst_Gene_hsa_1435family>&R&hsa04151&EGF, HOMG4, URG; epidermal growth factor; K04357 epidermal growth factor NGF, Beta-NGF, HSAN5, NGFB; nerve growth factor (beta polypeptide); K02582 nerve growth factor, beta FIGF, VEGF-D, VEGFD; c-fos induced growth factor (vascular endothelial growth factor D); K05449 vascular endothelial growth factor C/D FGF19; fibroblast growth factor 19; K04358 fibroblast growth factor FGF21; fibroblast growth factor 21; K04358 fibroblast growth factor FGF22; fibroblast growth factor 22; K04358 fibroblast growth factor FGF23, ADHR, FGFN, HPDR2, HYPF, PHPTC; fibroblast growth factor 23; K04358 fibroblast growth factor FGF17, FGF-13, FGF-17, HH20; fibroblast growth factor 17; K04358 fibroblast growth factor FGF16, FGF-16, MF4; fibroblast growth factor 16; K04358 fibroblast growth factor FGF20, FGF-20, RHDA2; fibroblast growth factor 20; K04358 fibroblast growth factor PGF, D12S1900, PGFL, PLGF, PlGF-2, SHGC-10760; placental growth factor; K16859 placenta growth factor PDGFC, FALLOTEIN, SCDGF; platelet derived growth factor C; K05450 platelet derived growth factor C/D IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1 HGF, DFNB39, F-TCF, HGFB, HPTA, SF; hepatocyte growth factor (hepapoietin A; scatter factor); K05460 hepatocyte growth factor CSF1, CSF-1, MCSF; colony stimulating factor 1 (macrophage) (EC:2.7.10.1); K05453 macrophage colony-stimulating factor 1 FGF18, FGF-18, ZFGF5; fibroblast growth factor 18; K04358 fibroblast growth factor KITLG, FPH2, FPHH, KL-1, Kitl, MGF, SCF, SF, SHEP7; KIT ligand (EC:3.2.1.31); K05461 KIT ligand FGF8, AIGF, FGF-8, HBGF-8, HH6, KAL6; fibroblast growth factor 8 (androgen-induced); K04358 fibroblast growth factor FGF9, FGF-9, GAF, HBFG-9, HBGF-9, SYNS3; fibroblast growth factor 9; K04358 fibroblast growth factor FGF6, HBGF-6, HST2; fibroblast growth factor 6; K04358 fibroblast growth factor FGF7, HBGF-7, KGF; fibroblast growth factor 7; K04358 fibroblast growth factor FGF5, HBGF-5, Smag-82, TCMGLY; fibroblast growth factor 5; K04358 fibroblast growth factor FGF4, HBGF-4, HST, HST-1, HSTF1, K-FGF, KFGF; fibroblast growth factor 4; K04358 fibroblast growth factor FGF2, BFGF, FGF-2, FGFB, HBGF-2; fibroblast growth factor 2 (basic); K18497 fibroblast growth factor 2 FGF3, HBGF-3, INT2; fibroblast growth factor 3; K04358 fibroblast growth factor FGF1, AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-1, FGF-alpha, FGFA, GLIO703, HBGF-1, HBGF1; fibroblast growth factor 1 (acidic); K18496 fibroblast growth factor 1 ANGPT4, AGP4, ANG-3, ANG4; angiopoietin 4; K05467 angiopoietin 4 ANGPT1, AGP1, AGPT, ANG1; angiopoietin 1; K05465 angiopoietin 1 ANGPT2, AGPT2, ANG2; angiopoietin 2; K05466 angiopoietin 2 PDGFB, IBGC5, PDGF-2, PDGF2, SIS, SSV, c-sis; platelet-derived growth factor beta polypeptide; K17386 platelet-derived growth factor subunit B PDGFA, PDGF-A, PDGF1; platelet-derived growth factor alpha polypeptide; K04359 platelet-derived growth factor subunit A EFNA5, AF1, EFL5, EPLG7, GLC1M, LERK7, RAGS; ephrin-A5; K05462 ephrin-A EFNA2, ELF-1, EPLG6, HEK7-L, LERK-6, LERK6; ephrin-A2; K05462 ephrin-A VEGFA, MVCD1, VEGF, VPF; vascular endothelial growth factor A; K05448 vascular endothelial growth factor A EFNA1, B61, ECKLG, EFL1, EPLG1, LERK-1, LERK1, TNFAIP4; ephrin-A1; K05462 ephrin-A EFNA4, EFL4, EPLG4, LERK4; ephrin-A4; K05462 ephrin-A VEGFB, VEGFL, VRF; vascular endothelial growth factor B; K16858 vascular endothelial growth factor B EFNA3, EFL2, EPLG3, Ehk1-L, LERK3; ephrin-A3; K05462 ephrin-A VEGFC, Flt4-L, LMPH1D, VRP; vascular endothelial growth factor C; K05449 vascular endothelial growth factor C/D PDGFD, IEGF, MSTP036, SCDGF-B, SCDGFB; platelet derived growth factor D; K05450 platelet derived growth factor C/D INS, IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10; insulin; K04526 insulin FGF14, FGF-14, FHF-4, FHF4, SCA27; fibroblast growth factor 14; K04358 fibroblast growth factor FGF12, FGF12B, FHF1; fibroblast growth factor 12; K04358 fibroblast growth factor FGF13, FGF-13, FGF2, FHF-2, FHF2; fibroblast growth factor 13; K04358 fibroblast growth factor FGF10; fibroblast growth factor 10; K04358 fibroblast growth factor FGF11, FGF-11, FHF-3, FHF3; fibroblast growth factor 11; K04358 fibroblast growth factor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2264>&&&FGFR4, CD334, JTK2, TKF; fibroblast growth factor receptor 4 (EC:2.7.10.1); K05095 fibroblast growth factor receptor 4 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst111_KEGGMap_hsa05200_Abst_Gene_hsa_2034family>&&hsa05200&EPAS1, ECYT4, HIF2A, HLF, MOP2, PASD2, bHLHe73; endothelial PAS domain protein 1; K09095 hypoxia-inducible factor 2 alpha HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78; hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor); K08268 hypoxia-inducible factor 1 alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_367_Abst_Gene_hsa_367>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5468>&&&PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma; peroxisome proliferator-activated receptor gamma; K08530 peroxisome proliferator-activated receptor gamma 
<http://www.inferico.com/kegg-cmpo.owl#inst69_KEGGMap_hsa04110_Abst_Gene_hsa_1019family>&&hsa04110&CDK6, MCPH12, PLSTIRE; cyclin-dependent kinase 6 (EC:2.7.11.22); K02091 cyclin-dependent kinase 6 [EC:2.7.11.22] CDK4, CMM3, PSK-J3; cyclin-dependent kinase 4 (EC:2.7.11.22); K02089 cyclin-dependent kinase 4 [EC:2.7.11.22] 
<http://www.inferico.com/kegg-cmpo.owl#inst31_KEGGMap_hsa05200_Abst_Gene_hsa_2322>&&hsa05200&FLT3, CD135, FLK-2, FLK2, STK1; fms-related tyrosine kinase 3 (EC:2.7.10.1); K05092 fms-related tyrosine kinase 3 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_596>&RL&&BCL2, Bcl-2, PPP1R50; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1280>&&&COL2A1, ANFH, AOM, COL11A3, SEDC, STL1; collagen, type II, alpha 1; K06236 collagen, type I/II/III/V/XI/XXIV/XXVII, alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5335>&&&PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K01116 phosphatidylinositol phospholipase C, gamma-1 [EC:3.1.4.11] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_330>&&&BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2; baculoviral IAP repeat containing 3; K16060 baculoviral IAP repeat-containing protein 2/3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4790>&&&NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor NF-kappa-B p105 subunit 
<http://www.inferico.com/kegg-cmpo.owl#inst91_KEGGMap_hsa04110_Abst_Gene_hsa_7027family>&&hsa04110&TFDP2, DP2; transcription factor Dp-2 (E2F dimerization partner 2); K09392 transcription factor Dp-2 TFDP1, DP1, DRTF1, Dp-1; transcription factor Dp-1; K04683 transcription factor Dp-1 
<http://www.inferico.com/kegg-cmpo.owl#inst114_KEGGMap_hsa04110_Abst_Gene_Group_Abst_Gene_hsa_10274_Abst_Gene_hsa_10735_Abst_Gene_hsa_27127_Abst_Gene_hsa_5885_Abst_Gene_hsa_8243_Abst_Gene_hsa_9126>&&hsa04110&
<http://www.inferico.com/kegg-cmpo.owl#inst63_KEGGMap_hsa04012_Abst_Gene_hsa_6714>&&hsa04012&SRC, ASV, SRC1, c-SRC, p60-Src; SRC proto-oncogene, non-receptor tyrosine kinase (EC:2.7.10.2); K05704 tyrosine-protein kinase Src [EC:2.7.10.2] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_8717_Abst_Gene_hsa_8772>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_1874_Abst_Gene_hsa_1875_Abst_Gene_hsa_7027_Abst_Gene_hsa_7029>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_100506742>&&&CASP12, CASP-12, CASP12P1; caspase 12 (gene/pseudogene); K04741 caspase 12 [EC:3.4.22.-] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2261>&&&FGFR3, ACH, CD333, CEK2, HSFGFR3EX, JTK4; fibroblast growth factor receptor 3 (EC:2.7.10.1); K05094 fibroblast growth factor receptor 3 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1943>&R&&EFNA2, ELF-1, EPLG6, HEK7-L, LERK-6, LERK6; ephrin-A2; K05462 ephrin-A 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5467>&&&PPARD, FAAR, NR1C2, NUC1, NUCI, NUCII, PPARB; peroxisome proliferator-activated receptor delta; K04504 peroxisome proliferator-activated receptor delta 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_29110>&&&TBK1, NAK, T2K; TANK-binding kinase 1 (EC:2.7.11.1); K05410 TANK-binding kinase 1 [EC:2.7.11.10] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_331>&&&XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3; X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase; K04725 E3 ubiquitin-protein ligase XIAP 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4791>&&&NFKB2, CVID10, H2TF1, LYT-10, LYT10, NF-kB2, p100, p52; nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100); K04469 nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 
<http://www.inferico.com/kegg-cmpo.owl#inst115_KEGGMap_hsa04110_Abst_Gene_Group_Abst_Gene_hsa_1874_Abst_Gene_hsa_1875_Abst_Gene_hsa_7027_Abst_Gene_hsa_7029>&&hsa04110&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1857>&&&DVL3; dishevelled segment polarity protein 3; K02353 segment polarity protein dishevelled 
<http://www.inferico.com/kegg-cmpo.owl#inst58_KEGGMap_hsa04012_Abst_Gene_hsa_23533family>&&hsa04012&PIK3R3, p55, p55-GAMMA, p55PIK; phosphoinositide-3-kinase, regulatory subunit 3 (gamma); K02649 phosphoinositide-3-kinase, regulatory subunit PIK3R5, F730038I15Rik, FOAP-2, P101-PI3K, p101; phosphoinositide-3-kinase, regulatory subunit 5; K02649 phosphoinositide-3-kinase, regulatory subunit PIK3CA, CLOVE, CWS5, MCAP, MCM, MCMTC, PI3K, p110-alpha; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (EC:2.7.11.1 2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] PIK3R2, MPPH, MPPH1, P85B, p85, p85-BETA; phosphoinositide-3-kinase, regulatory subunit 2 (beta); K02649 phosphoinositide-3-kinase, regulatory subunit PIK3R1, AGM7, GRB1, IMD36, p85, p85-ALPHA; phosphoinositide-3-kinase, regulatory subunit 1 (alpha); K02649 phosphoinositide-3-kinase, regulatory subunit PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3, p110gamma, p120-PI3K; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma (EC:2.7.11.1 2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] PIK3CD, APDS, IMD14, P110DELTA, PI3K, p110D; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] PIK3CB, P110BETA, PI3K, PI3KBETA, PIK3C1; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7422>&R&&VEGFA, MVCD1, VEGF, VPF; vascular endothelial growth factor A; K05448 vascular endothelial growth factor A 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8317>&&&CDC7, CDC7L1, HsCDC7, Hsk1, huCDC7; cell division cycle 7 (EC:2.7.11.1); K02214 cell division control protein 7 [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst57_KEGGMap_hsa04110_Abst_Gene_hsa_991>&&hsa04110&CDC20, CDC20A, bA276H19.3, p55CDC; cell division cycle 20; K03363 cell division cycle 20, cofactor of APC complex 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1942>&R&&EFNA1, B61, ECKLG, EFL1, EPLG1, LERK-1, LERK1, TNFAIP4; ephrin-A1; K05462 ephrin-A 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_598>&R&&BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS; BCL2-like 1; K04570 BCL2-like 1 (apoptosis regulator Bcl-X) 
<http://www.inferico.com/kegg-cmpo.owl#inst63_KEGGMap_hsa04014_Abst_Gene_hsa_7074>&&hsa04014&TIAM1; T-cell lymphoma invasion and metastasis 1; K05731 T-lymphoma invasion and metastasis-inducing protein 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5599>&&&MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c; mitogen-activated protein kinase 8 (EC:2.7.11.24); K04440 c-Jun N-terminal kinase [EC:2.7.11.24] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1282>&&&COL4A1, BSVD, RATOR; collagen, type IV, alpha 1; K06237 collagen, type IV, alpha 
<http://www.inferico.com/kegg-cmpo.owl#inst49_KEGGMap_hsa05200_Abst_Gene_hsa_842>&&hsa05200&CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62); K04399 caspase 9 [EC:3.4.22.62] 
<http://www.inferico.com/kegg-cmpo.owl#inst13_KEGGMap_hsa04210_Abst_Gene_hsa_596>&L&hsa04210&BCL2, Bcl-2, PPP1R50; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_11213_Abst_Gene_hsa_3654_Abst_Gene_hsa_3656_Abst_Gene_hsa_4615_Abst_Gene_hsa_51135>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_332>&&&BIRC5, API4, EPR-1; baculoviral IAP repeat containing 5; K08731 baculoviral IAP repeat-containing protein 5 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1945>&R&&EFNA4, EFL4, EPLG4, LERK4; ephrin-A4; K05462 ephrin-A 
<http://www.inferico.com/kegg-cmpo.owl#inst157_KEGGMap_hsa05200_Abst_Gene_hsa_1050>&&hsa05200&CEBPA, C/EBP-alpha, CEBP; CCAAT/enhancer binding protein (C/EBP), alpha; K09055 CCAAT/enhancer binding protein (C/EBP), alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6446>&&&SGK1, SGK; serum/glucocorticoid regulated kinase 1 (EC:2.7.11.1); K13302 serum/glucocorticoid-regulated kinase 1 [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8318>&&&CDC45, CDC45L, CDC45L2, PORC-PI-1; cell division cycle 45; K06628 cell division control protein 45 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7423>&R&&VEGFB, VEGFL, VRF; vascular endothelial growth factor B; K16858 vascular endothelial growth factor B 
<http://www.inferico.com/kegg-cmpo.owl#inst216_KEGGMap_hsa05200_Abst_Gene_hsa_1436>&L&hsa05200&CSF1R, C-FMS, CD115, CSF-1R, CSFR, FIM2, FMS, HDLS, M-CSF-R; colony stimulating factor 1 receptor (EC:2.7.10.1); K05090 macrophage colony-stimulating factor 1 receptor [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_23678>&&&SGK3, CISK, SGK2, SGKL; serum/glucocorticoid regulated kinase family, member 3 (EC:2.7.11.1); K13304 serum/glucocorticoid-regulated kinase 3 [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst22_KEGGMap_hsa05220_Abst_Gene_hsa_1027>&L&hsa05220&CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1; cyclin-dependent kinase inhibitor 1B (p27, Kip1); K06624 cyclin-dependent kinase inhibitor 1B 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_57121>&&&LPAR5, GPR92, GPR93, KPG_010, LPA5; lysophosphatidic acid receptor 5; K08390 lysophosphatidic acid receptor 5 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_100271927>&R&&RASA4B; RAS p21 protein activator 4B; K17630 Ras GTPase-activating protein 4 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1281>&&&COL3A1, EDS4A; collagen, type III, alpha 1; K06236 collagen, type I/II/III/V/XI/XXIV/XXVII, alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1944>&R&&EFNA3, EFL2, EPLG3, Ehk1-L, LERK3; ephrin-A3; K05462 ephrin-A 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2260>&&&FGFR1, BFGFR, CD331, CEK, FGFBR, FGFR-1, FLG, FLT-2, FLT2, HBGFR, HH2, HRTFDS, KAL2, N-SAM, OGD, bFGF-R-1; fibroblast growth factor receptor 1 (EC:2.7.10.1); K04362 fibroblast growth factor receptor 1 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6009>&&&RHEB, RHEB2; Ras homolog enriched in brain; K07208 Ras homolog enriched in brain 
<http://www.inferico.com/kegg-cmpo.owl#inst204_KEGGMap_hsa05200_Abst_Gene_hsa_7039>&&hsa05200&TGFA, TFGA; transforming growth factor, alpha; K08774 transforming growth factor, alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7424>&R&&VEGFC, Flt4-L, LMPH1D, VRP; vascular endothelial growth factor C; K05449 vascular endothelial growth factor C/D 
<http://www.inferico.com/kegg-cmpo.owl#inst43_KEGGMap_hsa04012_Abst_Gene_hsa_5747>&&hsa04012&PTK2, FADK, FAK, FAK1, FRNK, PPP1R71, p125FAK, pp125FAK; protein tyrosine kinase 2 (EC:2.7.10.2); K05725 focal adhesion kinase 1 [EC:2.7.10.2] 
<http://www.inferico.com/kegg-cmpo.owl#inst2_KEGGMap_hsa04110_Abst_Gene_hsa_51343>&&hsa04110&FZR1, CDC20C, CDH1, FZR, FZR2, HCDH, HCDH1; fizzy/cell division cycle 20 related 1 (Drosophila); K03364 cell division cycle 20-like protein 1, cofactor of APC complex 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_685>&&&BTC; betacellulin; K09783 betacellulin 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3326>&&&HSP90AB1, D6S182, HSP84, HSP90B, HSPC2, HSPCB; heat shock protein 90kDa alpha (cytosolic), class B member 1; K04079 molecular chaperone HtpG 
<http://www.inferico.com/kegg-cmpo.owl#inst20_KEGGMap_hsa04210_Abst_Gene_hsa_572>&&hsa04210&BAD, BBC2, BCL2L8; BCL2-associated agonist of cell death; K02158 BCL2-antagonist of cell death 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_23595>&&&ORC3, LAT, LATHEO, ORC3L; origin recognition complex, subunit 3; K02605 origin recognition complex subunit 3 
<http://www.inferico.com/kegg-cmpo.owl#inst119_KEGGMap_hsa04151_Abst_Gene_Group_Abst_Gene_hsa_1017_Abst_Gene_hsa_1019_Abst_Gene_hsa_1021_Abst_Gene_hsa_595_Abst_Gene_hsa_894_Abst_Gene_hsa_896_Abst_Gene_hsa_898_Abst_Gene_hsa_9134>&L&hsa04151&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6921>&&&TCEB1, SIII, eloC; transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C); K03872 transcription elongation factor B, polypeptide 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2782>&&&GNB1; guanine nucleotide binding protein (G protein), beta polypeptide 1; K04536 guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 
<http://www.inferico.com/kegg-cmpo.owl#inst103_KEGGMap_hsa04151_Abst_Gene_hsa_596>&L&hsa04151&BCL2, Bcl-2, PPP1R50; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1147>&&&CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10); K04467 inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_468>&&&ATF4, CREB-2, CREB2, TAXREB67, TXREB; activating transcription factor 4; K04374 cyclic AMP-dependent transcription factor ATF-4 
<http://www.inferico.com/kegg-cmpo.owl#inst38_KEGGMap_hsa05220_Abst_Gene_hsa_7157>&C&hsa05220&TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_80310>&R&&PDGFD, IEGF, MSTP036, SCDGF-B, SCDGFB; platelet derived growth factor D; K05450 platelet derived growth factor C/D 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2783>&&&GNB2; guanine nucleotide binding protein (G protein), beta polypeptide 2; K04537 guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_23594>&&&ORC6, ORC6L; origin recognition complex, subunit 6; K02608 origin recognition complex subunit 6 
<http://www.inferico.com/kegg-cmpo.owl#inst84_KEGGMap_hsa04014_Abst_Gene_hsa_163688family>&&hsa04014&CALM1, CALML2, CAMI, CPVT4, DD132, LQT14, PHKD, caM; calmodulin 1 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin CALM2, CAMII, LQT15, PHKD, PHKD2, caM; calmodulin 2 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin CALML6, CAGLP; calmodulin-like 6; K02183 calmodulin CALM3, HEL-S-72, PHKD, PHKD3; calmodulin 3 (phosphorylase kinase, delta) (EC:2.7.11.19); K02183 calmodulin CALML5, CLSP; calmodulin-like 5; K02183 calmodulin CALML3, CLP; calmodulin-like 3; K02183 calmodulin 
<http://www.inferico.com/kegg-cmpo.owl#inst14_KEGGMap_hsa05200_Abst_Gene_hsa_3655family>&&hsa05200&ITGAV, CD51, MSK8, VNRA, VTNR; integrin, alpha V; K06487 integrin alpha V ITGA6, CD49f, ITGA6B, VLA-6; integrin, alpha 6; K06485 integrin alpha 6 ITGA3, CD49C, GAP-B3, GAPB3, ILNEB, MSK18, VCA-2, VL3A, VLA3a; integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor); K06482 integrin alpha 3 ITGA2, BR, CD49B, GPIa, HPA-5, VLA-2, VLAA2; integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor); K06481 integrin alpha 2 ITGA2B, BDPLT16, BDPLT2, CD41, CD41B, GP2B, GPIIb, GT, GTA, HPA3, PPP1R93; integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41); K06476 integrin alpha 2B 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3678>&&&ITGA5, CD49e, FNRA, VLA-5, VLA5A; integrin, alpha 5 (fibronectin receptor, alpha polypeptide); K06484 integrin alpha 5 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3630>&R&&INS, IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10; insulin; K04526 insulin 
<http://www.inferico.com/kegg-cmpo.owl#inst97_KEGGMap_hsa05200_Compound_cpd_C00416>&&hsa05200&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_990>&&&CDC6, CDC18L, HsCDC18, HsCDC6; cell division cycle 6; K02213 cell division control protein 6 
<http://www.inferico.com/kegg-cmpo.owl#inst109_KEGGMap_hsa04110_Abst_Gene_Group_Abst_Gene_hsa_6500_Abst_Gene_hsa_6502_Abst_Gene_hsa_8454_Abst_Gene_hsa_9978>&&hsa04110&
<http://www.inferico.com/kegg-cmpo.owl#inst258_KEGGMap_hsa05200_Abst_Gene_Group_Abst_Gene_hsa_1398_Abst_Gene_hsa_1398_Abst_Gene_hsa_1399_Abst_Gene_hsa_1399_Abst_Gene_hsa_23624_Abst_Gene_hsa_867_Abst_Gene_hsa_868>&&hsa05200&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2259>&R&&FGF14, FGF-14, FHF-4, FHF4, SCA27; fibroblast growth factor 14; K04358 fibroblast growth factor 
<http://www.inferico.com/kegg-cmpo.owl#inst81_KEGGMap_hsa05200_Abst_Gene_hsa_51176family>&&hsa05200&TCF7, TCF-1; transcription factor 7 (T-cell specific, HMG-box); K02620 transcription factor 7 TCF7L2, TCF-4, TCF4; transcription factor 7-like 2 (T-cell specific, HMG-box); K04491 transcription factor 7-like 2 LEF1, LEF-1, TCF10, TCF1ALPHA, TCF7L3; lymphoid enhancer-binding factor 1; K04492 lymphoid enhancer-binding factor 1 TCF7L1, TCF-3, TCF3; transcription factor 7-like 1 (T-cell specific, HMG-box); K04490 transcription factor 7-like 1 
<http://www.inferico.com/kegg-cmpo.owl#inst38_KEGGMap_hsa04210_Abst_Gene_hsa_8837>&&hsa04210&CFLAR, CASH, CASP8AP1, CLARP, Casper, FLAME, FLAME-1, FLAME1, FLIP, I-FLICE, MRIT, c-FLIP, c-FLIPL, c-FLIPR, c-FLIPS; CASP8 and FADD-like apoptosis regulator; K04724 CASP8 and FADD-like apoptosis regulator 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_9771>&&&RAPGEF5, GFR, MR-GEF, REPAC; Rap guanine nucleotide exchange factor (GEF) 5; K08019 Rap guanine nucleotide exchange factor 5 
<http://www.inferico.com/kegg-cmpo.owl#inst83_KEGGMap_hsa04014_Abst_Gene_hsa_2902family>&&hsa04014&GRIN2B, EIEE27, GluN2B, MRD6, NMDAR2B, NR2B, hNR3; glutamate receptor, ionotropic, N-methyl D-aspartate 2B; K05210 glutamate receptor ionotropic, NMDA 2B GRIN1, GluN1, MRD8, NMD-R1, NMDA1, NMDAR1, NR1; glutamate receptor, ionotropic, N-methyl D-aspartate 1; K05208 glutamate receptor ionotropic, NMDA 1 GRIN2A, EPND, FESD, GluN2A, LKS, NMDAR2A, NR2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A; K05209 glutamate receptor ionotropic, NMDA 2A 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_55770>&&&EXOC2, SEC5, SEC5L1, Sec5p; exocyst complex component 2; K17637 exocyst complex component 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4437>&&&MSH3, DUP, MRP1; mutS homolog 3; K08736 DNA mismatch repair protein MSH3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1101>&&&CHAD, SLRR4A; chondroadherin; K06248 chondroadherin 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3675>&&&ITGA3, CD49C, GAP-B3, GAPB3, ILNEB, MSK18, VCA-2, VL3A, VLA3a; integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor); K06482 integrin alpha 3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8440>&&&NCK2, GRB4, NCKbeta; NCK adaptor protein 2; K07365 NCK adaptor protein 
<http://www.inferico.com/kegg-cmpo.owl#inst3_KEGGMap_hsa04151_Abst_Gene_hsa_1978>&&hsa04151&EIF4EBP1, 4E-BP1, 4EBP1, BP-1, PHAS-I; eukaryotic translation initiation factor 4E binding protein 1; K07205 eukaryotic translation initiation factor 4E binding protein 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_991>&&&CDC20, CDC20A, bA276H19.3, p55CDC; cell division cycle 20; K03363 cell division cycle 20, cofactor of APC complex 
<http://www.inferico.com/kegg-cmpo.owl#inst47_KEGGMap_hsa04014_Abst_Gene_hsa_22800family>&L&hsa04014&RRAS; related RAS viral (r-ras) oncogene homolog; K07829 Ras-related protein R-Ras HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, RASH1, p21ras; Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas NRAS, ALPS4, CMNS, N-ras, NCMS, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas KRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas MRAS, M-RAs, R-RAS3, RRAS3; muscle RAS oncogene homolog; K07831 Ras-related protein M-Ras RRAS2, TC21; related RAS viral (r-ras) oncogene homolog 2; K07830 Ras-related protein R-Ras2 
<http://www.inferico.com/kegg-cmpo.owl#inst6_KEGGMap_hsa04014_Abst_Gene_hsa_22800family>&&hsa04014&RRAS; related RAS viral (r-ras) oncogene homolog; K07829 Ras-related protein R-Ras HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, RASH1, p21ras; Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas NRAS, ALPS4, CMNS, N-ras, NCMS, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas KRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas MRAS, M-RAs, R-RAS3, RRAS3; muscle RAS oncogene homolog; K07831 Ras-related protein M-Ras RRAS2, TC21; related RAS viral (r-ras) oncogene homolog 2; K07830 Ras-related protein R-Ras2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7157>&CLR&&TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53 
<http://www.inferico.com/kegg-cmpo.owl#inst34_KEGGMap_hsa04151_Abst_Gene_hsa_2997family>&&hsa04151&GYS2; glycogen synthase 2 (liver) (EC:2.4.1.11); K00693 glycogen(starch) synthase [EC:2.4.1.11] GYS1, GSY, GYS; glycogen synthase 1 (muscle) (EC:2.4.1.11); K00693 glycogen(starch) synthase [EC:2.4.1.11] 
<http://www.inferico.com/kegg-cmpo.owl#inst232_KEGGMap_hsa05200_Abst_Gene_hsa_1499>&&hsa05200&CTNNB1, CTNNB, MRD19, armadillo; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin beta 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3676>&&&ITGA4, CD49D, IA4; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor); K06483 integrin alpha 4 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1499>&&&CTNNB1, CTNNB, MRD19, armadillo; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin beta 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3673>&&&ITGA2, BR, CD49B, GPIa, HPA-5, VLA-2, VLAA2; integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor); K06481 integrin alpha 2 
<http://www.inferico.com/kegg-cmpo.owl#inst43_KEGGMap_hsa04014_Abst_Gene_hsa_2002>&&hsa04014&ELK1; ELK1, member of ETS oncogene family; K04375 ETS domain-containing protein Elk-1 
<http://www.inferico.com/kegg-cmpo.owl#inst38_KEGGMap_hsa04012_Abst_Gene_hsa_10718>&&hsa04012&NRG3, HRG3, pro-NRG3; neuregulin 3; K05457 neuregulin 3 
<http://www.inferico.com/kegg-cmpo.owl#inst217_KEGGMap_hsa05200_Abst_Gene_hsa_3569>&&hsa05200&IL6, BSF2, HGF, HSF, IFNB2, IL-6; interleukin 6; K05405 interleukin 6 
<http://www.inferico.com/kegg-cmpo.owl#inst13_KEGGMap_hsa04014_Abst_Gene_hsa_25759family>&&hsa04014&SHC2, SCK, SHCB, SLI; SHC (Src homology 2 domain containing) transforming protein 2; K17447 SHC- transforming protein 2 SHC1, SHC, SHCA; SHC (Src homology 2 domain containing) transforming protein 1; K06279 SHC- transforming protein 1 SHC4, RaLP, SHCD; SHC (Src homology 2 domain containing) family, member 4; K17449 SHC- transforming protein 4 SHC3, N-Shc, NSHC, RAI, SHCC; SHC (Src homology 2 domain containing) transforming protein 3; K17448 SHC- transforming protein 3 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2257>&R&&FGF12, FGF12B, FHF1; fibroblast growth factor 12; K04358 fibroblast growth factor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_200186>&&&CRTC2, TORC-2, TORC2; CREB regulated transcription coactivator 2; K16333 CREB-regulated transcription coactivator 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2475>&&&MTOR, FRAP, FRAP1, FRAP2, RAFT1, RAPT1; mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1); K07203 FKBP12-rapamycin complex-associated protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_1487_Abst_Gene_hsa_1488_Abst_Gene_hsa_3065_Abst_Gene_hsa_3066>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst170_KEGGMap_hsa05200_Abst_Gene_hsa_1017>&&hsa05200&CDK2, CDKN2, p33(CDK2); cyclin-dependent kinase 2 (EC:2.7.11.22); K02206 cyclin-dependent kinase 2 [EC:2.7.11.22] 
<http://www.inferico.com/kegg-cmpo.owl#inst103_KEGGMap_hsa05200_Abst_Gene_hsa_51684>&RL&hsa05200&SUFU, PRO1280, SUFUH, SUFUXL; suppressor of fused homolog (Drosophila); K06229 suppressor of fused 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_51196>&&&PLCE1, NPHS3, PLCE, PPLC; phospholipase C, epsilon 1 (EC:3.1.4.11); K05860 phosphatidylinositol phospholipase C, epsilon [EC:3.1.4.11] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_64764>&&&CREB3L2, BBF2H7; cAMP responsive element binding protein 3-like 2; K09048 cyclic AMP-responsive element-binding protein 3 
<http://www.inferico.com/kegg-cmpo.owl#inst41_KEGGMap_hsa04151_Abst_Gene_hsa_10971family>&&hsa04151&YWHAB, GW128, HEL-S-1, HS1, KCIP-1, YWHAA; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta; K16197 14-3-3 protein beta/theta/zeta YWHAZ, 14-3-3-zeta, HEL-S-3, HEL4, KCIP-1, YWHAD; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta; K16197 14-3-3 protein beta/theta/zeta YWHAE, 14-3-3E, HEL2, KCIP-1, MDCR, MDS; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon; K06630 14-3-3 protein epsilon YWHAG, 14-3-3GAMMA, PPP1R170; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma; K16198 14-3-3 protein gamma/eta YWHAH, YWHA1; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta; K16198 14-3-3 protein gamma/eta YWHAQ, 14-3-3, 1C5, HS1; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta; K16197 14-3-3 protein beta/theta/zeta 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_10274_Abst_Gene_hsa_10735_Abst_Gene_hsa_27127_Abst_Gene_hsa_5885_Abst_Gene_hsa_8243_Abst_Gene_hsa_9126>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst224_KEGGMap_hsa05200_Abst_Gene_hsa_595>&L&hsa05200&CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3455>&&&IFNAR2, IFN-R, IFN-alpha-REC, IFNABR, IFNARB; interferon (alpha, beta and omega) receptor 2; K05131 interferon receptor 2 
<http://www.inferico.com/kegg-cmpo.owl#inst83_KEGGMap_hsa04110_Abst_Gene_hsa_9126>&&hsa04110&SMC3, BAM, BMH, CDLS3, CSPG6, HCAP, SMC3L1; structural maintenance of chromosomes 3; K06669 structural maintenance of chromosome 3 (chondroitin sulfate proteoglycan 6) 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_993>&&&CDC25A, CDC25A2; cell division cycle 25A (EC:3.1.3.48); K06645 M-phase inducer phosphatase 1 [EC:3.1.3.48] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8793>&&&TNFRSF10D, CD264, DCR2, TRAIL-R4, TRAILR4, TRUNDD; tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain; K04722 tumor necrosis factor receptor superfamily member 10 
<http://www.inferico.com/kegg-cmpo.owl#inst99_KEGGMap_hsa04151_Abst_Gene_hsa_4602>&L&hsa04151&MYB, Cmyb, c-myb, c-myb_CDS, efg; v-myb avian myeloblastosis viral oncogene homolog; K09420 myb proto-oncogene protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5899>&&&RALB; v-ral simian leukemia viral oncogene homolog B; K07835 Ras-related protein Ral-B 
<http://www.inferico.com/kegg-cmpo.owl#inst41_KEGGMap_hsa04210_Abst_Gene_hsa_4615>&&hsa04210&MYD88, MYD88D; myeloid differentiation primary response 88; K04729 myeloid differentiation primary response protein MyD88 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2258>&R&&FGF13, FGF-13, FGF2, FHF-2, FHF2; fibroblast growth factor 13; K04358 fibroblast growth factor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4303>&&&FOXO4, AFX, AFX1, MLLT7; forkhead box O4; K12358 forkhead box protein O4 
<http://www.inferico.com/kegg-cmpo.owl#inst106_KEGGMap_hsa05200_Abst_Gene_hsa_6923>&&hsa05200&TCEB2, ELOB, SIII; transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B); K03873 transcription elongation factor B, polypeptide 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4436>&R&&MSH2, COCA1, FCC1, HNPCC, HNPCC1, LCFS2; mutS homolog 2; K08735 DNA mismatch repair protein MSH2 
<http://www.inferico.com/kegg-cmpo.owl#inst71_KEGGMap_hsa04110_Abst_Gene_hsa_890family>&&hsa04110&CCNA1, CT146; cyclin A1; K06627 cyclin A CCNA2, CCN1, CCNA; cyclin A2; K06627 cyclin A 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_6500_Abst_Gene_hsa_6502_Abst_Gene_hsa_8454_Abst_Gene_hsa_9978>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst37_KEGGMap_hsa04110_Abst_Gene_hsa_1387family>&&hsa04110&CREBBP, CBP, KAT3A, RSTS; CREB binding protein (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48] EP300, KAT3B, RSTS2, p300; E1A binding protein p300 (EC:2.3.1.48); K04498 E1A/CREB-binding protein [EC:2.3.1.48] 
<http://www.inferico.com/kegg-cmpo.owl#inst101_KEGGMap_hsa05200_Abst_Gene_ko_K06227>&&hsa05200&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3456>&R&&IFNB1, IFB, IFF, IFNB; interferon, beta 1, fibroblast; K05415 interferon beta 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3674>&&&ITGA2B, BDPLT16, BDPLT2, CD41, CD41B, GP2B, GPIIb, GT, GTA, HPA3, PPP1R93; integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41); K06476 integrin alpha 2B 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_207>&&&AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA; v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8794>&&&TNFRSF10C, CD263, DCR1, DCR1-TNFR, LIT, TRAIL-R3, TRAILR3, TRID; tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain; K04722 tumor necrosis factor receptor superfamily member 10 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_861>&RC&&RUNX1, AML1, AML1-EVI-1, AMLCR1, CBFA2, EVI-1, PEBP2aB; runt-related transcription factor 1; K08367 runt-related transcription factor 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5898>&&&RALA, RAL; v-ral simian leukemia viral oncogene homolog A (ras related); K07834 Ras-related protein Ral-A 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_994>&&&CDC25B; cell division cycle 25B (EC:3.1.3.48); K05866 M-phase inducer phosphatase 2 [EC:3.1.3.48] 
<http://www.inferico.com/kegg-cmpo.owl#inst75_KEGGMap_hsa04014_Abst_Gene_hsa_6237>&&hsa04014&RRAS; related RAS viral (r-ras) oncogene homolog; K07829 Ras-related protein R-Ras 
<http://www.inferico.com/kegg-cmpo.owl#inst59_KEGGMap_hsa04014_Abst_Gene_hsa_6789>&&hsa04014&STK4, KRS2, MST1, TIIAC, YSK3; serine/threonine kinase 4 (EC:2.7.11.1); K04411 serine/threonine kinase 4 
<http://www.inferico.com/kegg-cmpo.owl#inst59_KEGGMap_hsa04110_Abst_Gene_hsa_8318>&&hsa04110&CDC45, CDC45L, CDC45L2, PORC-PI-1; cell division cycle 45; K06628 cell division control protein 45 
<http://www.inferico.com/kegg-cmpo.owl#inst41_KEGGMap_hsa05200_Abst_Gene_hsa_3320family>&&hsa05200&HSP90B1, ECGP, GP96, GRP94, HEL-S-125m, HEL35, TRA1; heat shock protein 90kDa beta (Grp94), member 1; K09487 heat shock protein 90kDa beta HSP90AB1, D6S182, HSP84, HSP90B, HSPC2, HSPCB; heat shock protein 90kDa alpha (cytosolic), class B member 1; K04079 molecular chaperone HtpG HSP90AA1, EL52, HSP86, HSP89A, HSP90A, HSP90N, HSPC1, HSPCA, HSPCAL1, HSPCAL4, HSPN, Hsp89, Hsp90, LAP-2, LAP2; heat shock protein 90kDa alpha (cytosolic), class A member 1; K04079 molecular chaperone HtpG 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2255>&R&&FGF10; fibroblast growth factor 10; K04358 fibroblast growth factor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2122>&RC&&MECOM, AML1-EVI-1, EVI1, MDS1, MDS1-EVI1, PRDM3; MDS1 and EVI1 complex locus; K04462 ecotropic virus integration site 1 protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_7027>&&&TFDP1, DP1, DRTF1, Dp-1; transcription factor Dp-1; K04683 transcription factor Dp-1 
<http://www.inferico.com/kegg-cmpo.owl#inst198_KEGGMap_hsa05200_Abst_Gene_hsa_595>&L&hsa05200&CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1 
<http://www.inferico.com/kegg-cmpo.owl#inst68_KEGGMap_hsa05200_Abst_Gene_hsa_11186>&R&hsa05200&RASSF1, 123F2, NORE2A, RASSF1A, RDA32, REH3P21; Ras association (RalGDS/AF-6) domain family member 1; K09850 Ras association domain-containing protein 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1496>&&&CTNNA2, CAP-R, CAPR, CT114, CTNR; catenin (cadherin-associated protein), alpha 2; K05691 catenin alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3320>&&&HSP90AA1, EL52, HSP86, HSP89A, HSP90A, HSP90N, HSPC1, HSPCA, HSPCAL1, HSPCAL4, HSPN, Hsp89, Hsp90, LAP-2, LAP2; heat shock protein 90kDa alpha (cytosolic), class A member 1; K04079 molecular chaperone HtpG 
<http://www.inferico.com/kegg-cmpo.owl#inst95_KEGGMap_hsa04110_Abst_Gene_hsa_5933family>&&hsa04110&RBL2, P130, Rb2; retinoblastoma-like 2; K16332 retinoblastoma-like protein 2 RBL1, CP107, PRB1, p107; retinoblastoma-like 1; K04681 retinoblastoma-like protein 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1278>&&&COL1A2, OI4; collagen, type I, alpha 2; K06236 collagen, type I/II/III/V/XI/XXIV/XXVII, alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_862>&R&&RUNX1T1, AML1T1, CBFA2T1, CDR, ETO, MTG8, ZMYND2; runt-related transcription factor 1; translocated to, 1 (cyclin D-related); K10053 runt-related transcription factor 1; translocated to, 1 
<http://www.inferico.com/kegg-cmpo.owl#inst171_KEGGMap_hsa05200_Abst_Gene_hsa_898family>&&hsa05200&CCNE2, CYCE2; cyclin E2; K06626 cyclin E CCNE1, CCNE; cyclin E1; K06626 cyclin E 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3672>&&&ITGA1, CD49a, VLA1; integrin, alpha 1; K06480 integrin alpha 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_995>&&&CDC25C, CDC25, PPP1R60; cell division cycle 25C (EC:3.1.3.48); K05867 M-phase inducer phosphatase 3 [EC:3.1.3.48] 
<http://www.inferico.com/kegg-cmpo.owl#inst107_KEGGMap_hsa05200_Abst_Gene_hsa_6921>&&hsa05200&TCEB1, SIII, eloC; transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C); K03872 transcription elongation factor B, polypeptide 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1495>&&&CTNNA1, CAP102; catenin (cadherin-associated protein), alpha 1, 102kDa; K05691 catenin alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8795>&&&TNFRSF10B, CD262, DR5, KILLER, KILLER/DR5, TRAIL-R2, TRAILR2, TRICK2, TRICK2A, TRICK2B, TRICKB, ZTNFR9; tumor necrosis factor receptor superfamily, member 10b; K04722 tumor necrosis factor receptor superfamily member 10 
<http://www.inferico.com/kegg-cmpo.owl#cpd_C00777>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_208>&&&AKT2, HIHGHH, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst78_KEGGMap_hsa04012_Abst_Gene_Group_Abst_Gene_hsa_2064_Abst_Gene_hsa_2064>&&hsa04012&
<http://www.inferico.com/kegg-cmpo.owl#inst37_KEGGMap_hsa04151_Abst_Gene_hsa_2538family>&&hsa04151&G6PC, G6PC1, G6PT, GSD1, GSD1a; glucose-6-phosphatase, catalytic subunit (EC:3.1.3.9); K01084 glucose-6-phosphatase [EC:3.1.3.9] G6PC2, IGRP; glucose-6-phosphatase, catalytic, 2 (EC:3.1.3.9); K01084 glucose-6-phosphatase [EC:3.1.3.9] G6PC3, SCN4, UGRP; glucose 6 phosphatase, catalytic, 3 (EC:3.1.3.9); K01084 glucose-6-phosphatase [EC:3.1.3.9] 
<http://www.inferico.com/kegg-cmpo.owl#inst26_KEGGMap_hsa05220_Abst_Gene_hsa_572>&&hsa05220&BAD, BBC2, BCL2L8; BCL2-associated agonist of cell death; K02158 BCL2-antagonist of cell death 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2256>&R&&FGF11, FGF-11, FHF-3, FHF3; fibroblast growth factor 11; K04358 fibroblast growth factor 
<http://www.inferico.com/kegg-cmpo.owl#inst14_KEGGMap_hsa04210_Abst_Gene_hsa_112401family>&&hsa04210&BIRC7, KIAP, LIVIN, ML-IAP, MLIAP, RNF50; baculoviral IAP repeat containing 7; K16061 baculoviral IAP repeat-containing protein 7/8 BIRC8, ILP-2, ILP2, hILP2; baculoviral IAP repeat containing 8; K16061 baculoviral IAP repeat-containing protein 7/8 BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1; baculoviral IAP repeat containing 2; K16060 baculoviral IAP repeat-containing protein 2/3 BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2; baculoviral IAP repeat containing 3; K16060 baculoviral IAP repeat-containing protein 2/3 XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3; X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase; K04725 E3 ubiquitin-protein ligase XIAP 
<http://www.inferico.com/kegg-cmpo.owl#inst35_KEGGMap_hsa05220_Abst_Gene_hsa_1398family>&RL&hsa05220&CRKL; v-crk avian sarcoma virus CT10 oncogene homolog-like; K04438 proto-oncogene C-crk CRK, CRKII, p38; v-crk avian sarcoma virus CT10 oncogene homolog; K04438 proto-oncogene C-crk 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4301>&L&&MLLT4, AF6; myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4; K05702 afadin 
<http://www.inferico.com/kegg-cmpo.owl#inst22_KEGGMap_hsa04210_Abst_Gene_hsa_4790family>&&hsa04210&RELA, NFKB3, p65; v-rel avian reticuloendotheliosis viral oncogene homolog A; K04735 transcription factor p65 NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; K02580 nuclear factor NF-kappa-B p105 subunit 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1277>&&&COL1A1, EDSC, OI1, OI2, OI3, OI4; collagen, type I, alpha 1; K06236 collagen, type I/II/III/V/XI/XXIV/XXVII, alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3454>&&&IFNAR1, AVP, IFN-alpha-REC, IFNAR, IFNBR, IFRC; interferon (alpha, beta and omega) receptor 1; K05130 interferon receptor 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_81029>&LR&&WNT5B; wingless-type MMTV integration site family, member 5B; K00444 wingless-type MMTV integration site family, member 5 
<http://www.inferico.com/kegg-cmpo.owl#inst6_KEGGMap_hsa04012_Abst_Gene_hsa_2065>&&hsa04012&ERBB3, ErbB-3, HER3, LCCS2, MDA-BF-1, c-erbB-3, c-erbB3, erbB3-S, p180-ErbB3, p45-sErbB3, p85-sErbB3; erb-b2 receptor tyrosine kinase 3 (EC:2.7.10.1); K05084 receptor tyrosine-protein kinase erbB-3 [EC:2.7.10.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst154_KEGGMap_hsa05200_Abst_Gene_hsa_6688>&&hsa05200&SPI1, OF, PU.1, SFPI1, SPI-1, SPI-A; Spi-1 proto-oncogene; K09438 transcription factor PU.1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4087>&&&SMAD2, JV18, JV18-1, MADH2, MADR2, hMAD-2, hSMAD2; SMAD family member 2; K04500 mothers against decapentaplegic homolog 2/3 
<http://www.inferico.com/kegg-cmpo.owl#inst47_KEGGMap_hsa04110_Abst_Gene_hsa_10912family>&&hsa04110&GADD45A, DDIT1, GADD45; growth arrest and DNA-damage-inducible, alpha; K04402 growth arrest and DNA-damage-inducible protein GADD45G, CR6, DDIT2, GADD45gamma, GRP17; growth arrest and DNA-damage-inducible, gamma; K04402 growth arrest and DNA-damage-inducible protein GADD45B, GADD45BETA, MYD118; growth arrest and DNA-damage-inducible, beta; K04402 growth arrest and DNA-damage-inducible protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4172>&&&MCM3, HCC5, P1-MCM3, P1.h, RLFB; minichromosome maintenance complex component 3 (EC:3.6.4.12); K02541 DNA replication licensing factor MCM3 [EC:3.6.4.12] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_996>&&&CDC27, ANAPC3, APC3, CDC27Hs, D0S1430E, D17S978E, H-NUC, HNUC, NUC2; cell division cycle 27; K03350 anaphase-promoting complex subunit 3 
<http://www.inferico.com/kegg-cmpo.owl#inst6_KEGGMap_hsa04110_Abst_Gene_hsa_10393family>&&hsa04110&ANAPC13, APC13, SWM1; anaphase promoting complex subunit 13; K12456 anaphase-promoting complex subunit 13 ANAPC10, APC10, DOC1; anaphase promoting complex subunit 10; K03357 anaphase-promoting complex subunit 10 ANAPC7, APC7; anaphase promoting complex subunit 7; K03354 anaphase-promoting complex subunit 7 ANAPC5, APC5; anaphase promoting complex subunit 5; K03352 anaphase-promoting complex subunit 5 CDC26, ANAPC12, APC12, C9orf17; cell division cycle 26; K03359 anaphase-promoting complex subunit 12 ANAPC4, APC4; anaphase promoting complex subunit 4; K03351 anaphase-promoting complex subunit 4 ANAPC2, APC2; anaphase promoting complex subunit 2; K03349 anaphase-promoting complex subunit 2 ANAPC11, APC11, Apc11p, HSPC214; anaphase promoting complex subunit 11; K03358 anaphase-promoting complex subunit 11 ANAPC1, APC1, MCPR, TSG24; anaphase promoting complex subunit 1; K03348 anaphase-promoting complex subunit 1 CDC23, ANAPC8, APC8, CUT23; cell division cycle 23; K03355 anaphase-promoting complex subunit 8 CDC16, ANAPC6, APC6, CUT9; cell division cycle 16; K03353 anaphase-promoting complex subunit 6 CDC27, ANAPC3, APC3, CDC27Hs, D0S1430E, D17S978E, H-NUC, HNUC, NUC2; cell division cycle 27; K03350 anaphase-promoting complex subunit 3 
<http://www.inferico.com/kegg-cmpo.owl#inst16_KEGGMap_hsa05200_Abst_Gene_hsa_5728>&R&hsa05200&PTEN, 10q23del, BZS, CWS1, DEC, GLM2, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [EC:3.1.3.16 3.1.3.48 3.1.3.67] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8837>&&&CFLAR, CASH, CASP8AP1, CLARP, Casper, FLAME, FLAME-1, FLAME1, FLIP, I-FLICE, MRIT, c-FLIP, c-FLIPL, c-FLIPR, c-FLIPS; CASP8 and FADD-like apoptosis regulator; K04724 CASP8 and FADD-like apoptosis regulator 
<http://www.inferico.com/kegg-cmpo.owl#inst40_KEGGMap_hsa05200_Abst_Gene_hsa_367>&&hsa05200&AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM; androgen receptor; K08557 androgen receptor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_117145>&&&THEM4, CTMP; thioesterase superfamily member 4 (EC:3.1.2.2); K16339 thioesterase superfamily member 4 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5371>&R&&PML, MYL, PP8675, RNF71, TRIM19; promyelocytic leukemia; K10054 probable transcription factor PML 
<http://www.inferico.com/kegg-cmpo.owl#inst108_KEGGMap_hsa05200_Abst_Gene_hsa_7428>&RL&hsa05200&VHL, HRCA1, RCA1, VHL1, pVHL; von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase; K03871 von Hippel-Lindau disease tumor supressor 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1676>&&&DFFA, DFF-45, DFF1, ICAD; DNA fragmentation factor, 45kDa, alpha polypeptide; K02310 DNA fragmentation factor, 45 kD, alpha subunit 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5900>&&&RALGDS, RGDS, RGF, RalGEF; ral guanine nucleotide dissociation stimulator; K08732 ral guanine nucleotide dissociation stimulator 
<http://www.inferico.com/kegg-cmpo.owl#inst33_KEGGMap_hsa04110_Abst_Gene_hsa_1111family>&&hsa04110&CHEK1, CHK1; checkpoint kinase 1 (EC:2.7.11.1); K02216 serine/threonine-protein kinase Chk1 [EC:2.7.11.1] CHEK2, CDS1, CHK2, HuCds1, LFS2, PP1425, RAD53, hCds1; checkpoint kinase 2 (EC:2.7.11.1); K06641 serine/threonine-protein kinase Chk2 [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst25_KEGGMap_hsa05200_Abst_Gene_hsa_3716>&&hsa05200&JAK1, JAK1A, JAK1B, JTK3; Janus kinase 1 (EC:2.7.10.2); K11217 Janus kinase 1 [EC:2.7.10.2] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4173>&&&MCM4, CDC21, CDC54, NKCD, NKGCD, P1-CDC21, hCdc21; minichromosome maintenance complex component 4 (EC:3.6.4.12); K02212 DNA replication licensing factor MCM4 [EC:3.6.4.12] 
<http://www.inferico.com/kegg-cmpo.owl#cpd_C00735>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4088>&&&SMAD3, HSPC193, HsT17436, JV15-2, LDS1C, LDS3, MADH3; SMAD family member 3; K04500 mothers against decapentaplegic homolog 2/3 
<http://www.inferico.com/kegg-cmpo.owl#inst33_KEGGMap_hsa04151_Abst_Gene_hsa_7157>&CL&hsa04151&TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4170>&&&MCL1, BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1, TM, bcl2-L-3, mcl1/EAT; myeloid cell leukemia 1; K02539 myeloid leukemia cell differntiation protein MCL-1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2788>&&&GNG7; guanine nucleotide binding protein (G protein), gamma 7; K04543 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4085>&&&MAD2L1, HSMAD2, MAD2; MAD2 mitotic arrest deficient-like 1 (yeast); K02537 mitotic spindle assembly checkpoint protein MAD2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_998>&&&CDC42, CDC42Hs, G25K; cell division cycle 42; K04393 cell division control protein 42 
<http://www.inferico.com/kegg-cmpo.owl#inst68_KEGGMap_hsa04110_Abst_Gene_hsa_1017>&&hsa04110&CDK2, CDKN2, p33(CDK2); cyclin-dependent kinase 2 (EC:2.7.11.22); K02206 cyclin-dependent kinase 2 [EC:2.7.11.22] 
<http://www.inferico.com/kegg-cmpo.owl#inst87_KEGGMap_hsa04151_Abst_Gene_hsa_5879>&&hsa04151&RAC1, MIG5, Rac-1, TC-25, p21-Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); K04392 Ras-related C3 botulinum toxin substrate 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4615>&&&MYD88, MYD88D; myeloid differentiation primary response 88; K04729 myeloid differentiation primary response protein MyD88 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1630>&&&DCC, CRC18, CRCR1, IGDCC1, MRMV1, NTN1R1; DCC netrin 1 receptor; K06765 deleted in colorectal carcinoma 
<http://www.inferico.com/kegg-cmpo.owl#inst7_KEGGMap_hsa05200_Abst_Gene_hsa_1499>&&hsa05200&CTNNB1, CTNNB, MRD19, armadillo; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin beta 1 
<http://www.inferico.com/kegg-cmpo.owl#inst101_KEGGMap_hsa04151_Abst_Gene_hsa_29941family>&&hsa04151&PKN3, UTDP4-1; protein kinase N3 (EC:2.7.11.13); K06071 protein kinase N [EC:2.7.11.13] PKN1, DBK, PAK-1, PAK1, PKN, PKN-ALPHA, PRK1, PRKCL1; protein kinase N1 (EC:2.7.11.13); K06071 protein kinase N [EC:2.7.11.13] PKN2, PAK2, PRK2, PRKCL2, PRO2042, Pak-2, STK7; protein kinase N2 (EC:2.7.11.13); K06071 protein kinase N [EC:2.7.11.13] 
<http://www.inferico.com/kegg-cmpo.owl#inst107_KEGGMap_hsa04151_Abst_Gene_hsa_4515family>&R&hsa04151&TCL1B, SYN-1, TML1; T-cell leukemia/lymphoma 1B; K16836 T-cell leukemia/lymphoma 1B TCL1A, TCL1; T-cell leukemia/lymphoma 1A; K10167 T-cell leukemia/lymphoma 1A MTCP1, P13MTCP1, p8MTCP1; mature T-cell proliferation 1; K16837 mature T-cell proliferation-1 type B1 
<http://www.inferico.com/kegg-cmpo.owl#cpd_C05981>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst50_KEGGMap_hsa04110_Abst_Gene_hsa_1027family>&&hsa04110&CDKN1C, BWCR, BWS, KIP2, WBS, p57, p57Kip2; cyclin-dependent kinase inhibitor 1C (p57, Kip2); K09993 cyclin-dependent kinase inhibitor 1C CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1; cyclin-dependent kinase inhibitor 1B (p27, Kip1); K06624 cyclin-dependent kinase inhibitor 1B 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4171>&&&MCM2, BM28, CCNL1, CDCL1, D3S3194, MITOTIN, cdc19; minichromosome maintenance complex component 2 (EC:3.6.4.12); K02540 DNA replication licensing factor MCM2 [EC:3.6.4.12] 
<http://www.inferico.com/kegg-cmpo.owl#inst86_KEGGMap_hsa04110_Abst_Gene_hsa_5933>&RL&hsa04110&RBL1, CP107, PRB1, p107; retinoblastoma-like 1; K04681 retinoblastoma-like protein 1 
<http://www.inferico.com/kegg-cmpo.owl#cpd_C00951>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5728>&RL&&PTEN, 10q23del, BZS, CWS1, DEC, GLM2, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [EC:3.1.3.16 3.1.3.48 3.1.3.67] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_999>&&&CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO; cadherin 1, type 1, E-cadherin (epithelial); K05689 cadherin 1, type 1, E-cadherin 
<http://www.inferico.com/kegg-cmpo.owl#inst189_KEGGMap_hsa05200_Abst_Gene_hsa_354>&&hsa05200&KLK3, APS, KLK2A1, PSA, hK3; kallikrein-related peptidase 3 (EC:3.4.21.77); K01351 semenogelase [EC:3.4.21.77] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_4616>&&&GADD45B, GADD45BETA, MYD118; growth arrest and DNA-damage-inducible, beta; K04402 growth arrest and DNA-damage-inducible protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1677>&&&DFFB, CAD, CPAN, DFF-40, DFF2, DFF40; DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase); K02311 DNA fragmentation factor, 40 kD, beta subunit [EC:3.-.-.-] 
<http://www.inferico.com/kegg-cmpo.owl#inst28_KEGGMap_hsa04151_Abst_Gene_hsa_10018>&&hsa04151&BCL2L11, BAM, BIM, BOD; BCL2-like 11 (apoptosis facilitator); K16341 Bcl-2-like protein 11 
<http://www.inferico.com/kegg-cmpo.owl#inst25_KEGGMap_hsa05220_Abst_Gene_hsa_598>&&hsa05220&BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS; BCL2-like 1; K04570 BCL2-like 1 (apoptosis regulator Bcl-X) 
<http://www.inferico.com/kegg-cmpo.owl#inst109_KEGGMap_hsa05200_Abst_Gene_hsa_8453>&&hsa05200&CUL2; cullin 2; K03870 cullin 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5727>&L&&PTCH1, BCNS, HPE7, NBCCS, PTC, PTC1, PTCH, PTCH11; patched 1; K06225 patched 1 
<http://www.inferico.com/kegg-cmpo.owl#inst82_KEGGMap_hsa04110_Abst_Gene_hsa_1029>&CR&hsa04110&CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A; K06621 cyclin-dependent kinase inhibitor 2A 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_867>&LR&&CBL, C-CBL, CBL2, FRA11B, NSLL, RNF55; Cbl proto-oncogene, E3 ubiquitin protein ligase; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19] 
<http://www.inferico.com/kegg-cmpo.owl#inst114_KEGGMap_hsa05200_Abst_Gene_hsa_54205>&&hsa05200&CYCS, CYC, HCS, THC4; cytochrome c, somatic; K08738 cytochrome c 
<http://www.inferico.com/kegg-cmpo.owl#inst259_KEGGMap_hsa05200_Abst_Gene_Group_Abst_Gene_hsa_7046_Abst_Gene_hsa_7048>&&hsa05200&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2786>&&&GNG4; guanine nucleotide binding protein (G protein), gamma 4; K04541 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 
<http://www.inferico.com/kegg-cmpo.owl#inst77_KEGGMap_hsa05200_Abst_Gene_hsa_3725>&&hsa05200&JUN, AP-1, AP1, c-Jun; jun proto-oncogene; K04448 transcription factor AP-1 
<http://www.inferico.com/kegg-cmpo.owl#inst89_KEGGMap_hsa04151_Abst_Gene_hsa_1441family>&&hsa04151&IL2RB, CD122, IL15RB, P70-75; interleukin 2 receptor, beta; K05069 interleukin 2 receptor beta IL2RG, CD132, CIDX, IL-2RG, IMD4, P64, SCIDX, SCIDX1; interleukin 2 receptor, gamma; K05070 interleukin 2 receptor gamma EPOR, EPO-R; erythropoietin receptor; K05079 erythropoietin receptor IL2RA, CD25, IDDM10, IL2R, TCGFR, p55; interleukin 2 receptor, alpha; K05068 interleukin 2 receptor alpha IL6R, CD126, IL-6R-1, IL-6RA, IL6Q, IL6RA, IL6RQ, gp80; interleukin 6 receptor; K05055 interleukin 6 receptor OSMR, OSMRB, PLCA1; oncostatin M receptor; K05057 oncostatin M receptor IL4R, CD124, IL-4RA, IL4RA; interleukin 4 receptor; K05071 interleukin 4 receptor IL3RA, CD123, IL3R, IL3RAY, IL3RX, IL3RY, hIL-3Ra; interleukin 3 receptor, alpha (low affinity); K04737 interleukin 3 receptor alpha PRLR, HPRL, MFAB, hPRLrI; prolactin receptor; K05081 prolactin receptor GHR, GHBP, GHIP; growth hormone receptor; K05080 growth hormone receptor IL7R, CD127, CDW127, IL-7R-alpha, IL7RA, ILRA; interleukin 7 receptor; K05072 interleukin 7 receptor CSF3R, CD114, GCSFR; colony stimulating factor 3 receptor (granulocyte); K05061 granulocyte colony-stimulating factor receptor IFNAR2, IFN-R, IFN-alpha-REC, IFNABR, IFNARB; interferon (alpha, beta and omega) receptor 2; K05131 interferon receptor 2 IFNAR1, AVP, IFN-alpha-REC, IFNAR, IFNBR, IFRC; interferon (alpha, beta and omega) receptor 1; K05130 interferon receptor 1 
<http://www.inferico.com/kegg-cmpo.owl#inst103_KEGGMap_hsa04110_Abst_Gene_Group_Abst_Gene_hsa_890_Abst_Gene_hsa_8900_Abst_Gene_hsa_983>&&hsa04110&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_9462>&R&&RASAL2, NGAP; RAS protein activator like 2; K17633 RAS protein activator-like 2 
<http://www.inferico.com/kegg-cmpo.owl#inst22_KEGGMap_hsa04151_Abst_Gene_hsa_10161family>&&hsa04151&LPAR2, EDG-4, EDG4, LPA-2, LPA2; lysophosphatidic acid receptor 2; K04291 lysophosphatidic acid receptor 2 LPAR4, GPR23, LPA4, P2RY9, P2Y5-LIKE, P2Y9; lysophosphatidic acid receptor 4; K04275 lysophosphatidic acid receptor 4 LPAR1, EDG2, GPR26, Gpcr26, LPA1, Mrec1.3, VZG1, edg-2, rec.1.3, vzg-1; lysophosphatidic acid receptor 1; K04289 lysophosphatidic acid receptor 1 LPAR3, EDG7, Edg-7, GPCR, HOFNH30, LP-A3, LPA3, RP4-678I3; lysophosphatidic acid receptor 3; K04294 lysophosphatidic acid receptor 3 F2R, CF2R, HTR, PAR-1, PAR1, TR; coagulation factor II (thrombin) receptor; K03914 coagulation factor II (thrombin) receptor CHRM2, HM2; cholinergic receptor, muscarinic 2; K04130 muscarinic acetylcholine receptor M2 CHRM1, HM1, M1, M1R; cholinergic receptor, muscarinic 1; K04129 muscarinic acetylcholine receptor M1 LPAR6, ARWH1, HYPT8, LAH3, P2RY5, P2Y5; lysophosphatidic acid receptor 6; K04273 lysophosphatidic acid receptor 6 LPAR5, GPR92, GPR93, KPG_010, LPA5; lysophosphatidic acid receptor 5; K08390 lysophosphatidic acid receptor 5 
<http://www.inferico.com/kegg-cmpo.owl#inst266_KEGGMap_hsa05200_Abst_Gene_Group_Abst_Gene_hsa_1487_Abst_Gene_hsa_1488_Abst_Gene_hsa_3065_Abst_Gene_hsa_3066>&&hsa05200&
<http://www.inferico.com/kegg-cmpo.owl#inst112_KEGGMap_hsa04151_Abst_Gene_Group_Abst_Gene_hsa_7248_Abst_Gene_hsa_7249>&&hsa04151&
<http://www.inferico.com/kegg-cmpo.owl#inst4_KEGGMap_hsa05220_Abst_Gene_hsa_5781>&&hsa05220&PTPN11, BPTP3, CFC, NS1, PTP-1D, PTP2C, SH-PTP2, SH-PTP3, SHP2; protein tyrosine phosphatase, non-receptor type 11 (EC:3.1.3.48); K07293 tyrosine-protein phosphatase non-receptor type 11 [EC:3.1.3.48] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2787>&&&GNG5; guanine nucleotide binding protein (G protein), gamma 5; K04542 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_868>&LR&&CBLB, Cbl-b, Nbla00127, RNF56; Cbl proto-oncogene B, E3 ubiquitin protein ligase; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19] 
<http://www.inferico.com/kegg-cmpo.owl#inst9_KEGGMap_hsa05200_Abst_Gene_hsa_1495family>&&hsa05200&CTNNA3, ARVD13, VR22; catenin (cadherin-associated protein), alpha 3; K05691 catenin alpha CTNNA2, CAP-R, CAPR, CT114, CTNR; catenin (cadherin-associated protein), alpha 2; K05691 catenin alpha CTNNA1, CAP102; catenin (cadherin-associated protein), alpha 1, 102kDa; K05691 catenin alpha 
<http://www.inferico.com/kegg-cmpo.owl#inst50_KEGGMap_hsa04210_Abst_Gene_hsa_1439family>&&hsa04210&CSF2RB, CD131, CDw131, IL3RB, IL5RB, SMDP5; colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage); K04738 cytokine receptor common subunit beta IL3RA, CD123, IL3R, IL3RAY, IL3RX, IL3RY, hIL-3Ra; interleukin 3 receptor, alpha (low affinity); K04737 interleukin 3 receptor alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_10110>&&&SGK2, H-SGK2, dJ138B7.2; serum/glucocorticoid regulated kinase 2 (EC:2.7.11.1); K13303 serum/glucocorticoid-regulated kinase 2 [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#cpd_C00076>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1017>&&&CDK2, CDKN2, p33(CDK2); cyclin-dependent kinase 2 (EC:2.7.11.22); K02206 cyclin-dependent kinase 2 [EC:2.7.11.22] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_1022_Abst_Gene_hsa_902>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5063>&&&PAK3, MRX30, MRX47, OPHN3, PAK-3, PAK3beta, bPAK, beta-PAK; p21 protein (Cdc42/Rac)-activated kinase 3 (EC:2.7.11.1); K05733 p21-activated kinase 3 [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst53_KEGGMap_hsa04012_Abst_Gene_hsa_685>&&hsa04012&BTC; betacellulin; K09783 betacellulin 
<http://www.inferico.com/kegg-cmpo.owl#inst82_KEGGMap_hsa05200_Abst_Gene_hsa_5578family>&&hsa05200&PRKCB, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13] PRKCA, AAG6, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13] PRKCG, PKC-gamma, PKCC, PKCG, SCA14; protein kinase C, gamma (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8398>&&&PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2, iPLA2beta; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K16343 calcium-independent phospholipase A2 [EC:3.1.1.4] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_2475_Abst_Gene_hsa_57521_Abst_Gene_hsa_64223>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst165_KEGGMap_hsa05200_Abst_Gene_hsa_595>&RL&hsa05200&CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_131873>&&&COL6A6; collagen, type VI, alpha 6; K06238 collagen, type VI, alpha 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2784>&&&GNB3; guanine nucleotide binding protein (G protein), beta polypeptide 3; K07825 guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 
<http://www.inferico.com/kegg-cmpo.owl#inst229_KEGGMap_hsa05200_Abst_Gene_hsa_4824>&R&hsa05200&NKX3-1, BAPX2, NKX3, NKX3.1, NKX3A; NK3 homeobox 1; K09348 homeobox protein Nkx-3.1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_5062>&&&PAK2, PAK65, PAKgamma; p21 protein (Cdc42/Rac)-activated kinase 2 (EC:2.7.11.1); K04410 p21-activated kinase 2 [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_6923>&&&TCEB2, ELOB, SIII; transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B); K03873 transcription elongation factor B, polypeptide 2 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_3679>&&&ITGA7; integrin, alpha 7; K06583 integrin alpha 7 
<http://www.inferico.com/kegg-cmpo.owl#inst3_KEGGMap_hsa04012_Abst_Gene_hsa_2002>&&hsa04012&ELK1; ELK1, member of ETS oncogene family; K04375 ETS domain-containing protein Elk-1 
<http://www.inferico.com/kegg-cmpo.owl#inst52_KEGGMap_hsa05220_Abst_Gene_hsa_369family>&&hsa05220&RAF1, CMD1NN, CRAF, NS5, Raf-1, c-Raf; Raf-1 proto-oncogene, serine/threonine kinase (EC:2.7.11.1); K04366 RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] ARAF, A-RAF, ARAF1, PKS2, RAFA1; A-Raf proto-oncogene, serine/threonine kinase (EC:2.7.11.1); K08845 A-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] BRAF, B-RAF1, BRAF1, NS7, RAFB1; B-Raf proto-oncogene, serine/threonine kinase (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] 
<http://www.inferico.com/kegg-cmpo.owl#inst33_KEGGMap_hsa04014_Abst_Gene_hsa_598>&&hsa04014&BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS; BCL2-like 1; K04570 BCL2-like 1 (apoptosis regulator Bcl-X) 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_8399>&&&PLA2G10, GXPLA2, GXSPLA2, SPLA2; phospholipase A2, group X (EC:3.1.1.4); K01047 secretory phospholipase A2 [EC:3.1.1.4] 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_1019_Abst_Gene_hsa_1021_Abst_Gene_hsa_595>&&&
<http://www.inferico.com/kegg-cmpo.owl#inst49_KEGGMap_hsa04012_Abst_Gene_hsa_5335family>&&hsa04012&PLCG2, APLAID, FCAS3, PLC-IV, PLC-gamma-2; phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11); K05859 phosphatidylinositol phospholipase C, gamma-2 [EC:3.1.4.11] PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1; phospholipase C, gamma 1 (EC:3.1.4.11); K01116 phosphatidylinositol phospholipase C, gamma-1 [EC:3.1.4.11] 
<http://www.inferico.com/kegg-cmpo.owl#inst43_KEGGMap_hsa04210_Abst_Gene_hsa_8717>&&hsa04210&TRADD, Hs.89862; TNFRSF1A-associated via death domain; K03171 tumor necrosis factor receptor type 1-associated DEATH domain protein 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_Group_Abst_Gene_hsa_7248_Abst_Gene_hsa_7249>&&&
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_2785>&&&GNG3; guanine nucleotide binding protein (G protein), gamma 3; K04540 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3 
<http://www.inferico.com/kegg-cmpo.owl#inst187_KEGGMap_hsa05200_Abst_Gene_hsa_5727family>&L&hsa05200&PTCH2, PTC2; patched 2; K11101 patched 2 PTCH1, BCNS, HPE7, NBCCS, PTC, PTC1, PTCH, PTCH11; patched 1; K06225 patched 1 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_10681>&&&GNB5, GB5; guanine nucleotide binding protein (G protein), beta 5; K04539 guanine nucleotide-binding protein subunit beta-5 
<http://www.inferico.com/kegg-cmpo.owl#Abst_Gene_hsa_1019>&&&CDK4, CMM3, PSK-J3; cyclin-dependent kinase 4 (EC:2.7.11.22); K02089 cyclin-dependent kinase 4 [EC:2.7.11.22] 
<http://www.inferico.com/kegg-cmpo.owl#inst52_KEGGMap_hsa04151_Compound_cpd_C00533>&&hsa04151&
<http://www.inferico.com/kegg-cmpo.owl#inst150_KEGGMap_hsa05200_Abst_Gene_hsa_3728>&&hsa05200&JUP, ARVD12, CTNNG, DP3, DPIII, PDGB, PKGB; junction plakoglobin; K10056 junction plakoglobin 
<http://www.inferico.com/kegg-cmpo.owl#inst78_KEGGMap_hsa05200_Abst_Gene_hsa_2353>&&hsa05200&FOS, AP-1, C-FOS, p55; FBJ murine osteosarcoma viral oncogene homolog; K04379 proto-oncogene protein c-fos 
